Research classified by Journal of Economic Literature (JEL) codes

---

Top JEL
/ L: Industrial Organization
/ / L6: Industry Studies: Manufacturing
/ / / L65: Chemicals; Rubber; Drugs; Biotechnology; Plastics

---

This topic is covered by the following reading lists:

1. Industrial Sociology (FCT-UNL)

2024

• Juan Pablo Atal & José Ignacio Cuesta & Felipe González & Cristóbal Otero, 2024. "The Economics of the Public Option: Evidence from Local Pharmaceutical Markets," American Economic Review, American Economic Association, vol. 114(3), pages 615-644, March.
  • Juan Pablo Atala & José Ignacio Cuesta & Felipe González & Cristóbal Otero, 2021. "The Economics of the Public Option: Evidence from Local Pharmaceutical Markets," Documentos de Trabajo 561, Instituto de Economia. Pontificia Universidad Católica de Chile..
  • Juan Pablo Atal & Jose Ignacio Cuesta & Felipe Gonzalez & Cristobal Otero, 2023. "The Economics of the Public Option: Evidence from Local Pharmaceutical Markets," Working Papers 951, Queen Mary University of London, School of Economics and Finance.
  • Juan Pablo Atal & José Ignacio Cuesta & Felipe González & Cristóbal Otero, 2022. "The Economics of the Public Option: Evidence from Local Pharmaceutical Markets," NBER Working Papers 30779, National Bureau of Economic Research, Inc.
  • Juan Pablo Atal & Jose Ignacio Cuesta & Felipe Gonzalez & Cristobal Otero, 2021. "The Economics of the Public Option:Evidence from Local Pharmaceutical Markets," PIER Working Paper Archive 21-012, Penn Institute for Economic Research, Department of Economics, University of Pennsylvania.
• Abby Alpert & Sarah Dykstra & Mireille Jacobson, 2024. "Hassle Costs versus Information: How Do Prescription Drug Monitoring Programs Reduce Opioid Prescribing?," American Economic Journal: Economic Policy, American Economic Association, vol. 16(1), pages 87-123, February.
• Leemore Dafny & Kate Ho & Edward Kong, 2024. "How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?," American Economic Journal: Economic Policy, American Economic Association, vol. 16(3), pages 314-346, August.
• Shengmao Cao & Lisa Xuejie Yi & Chuan Yu, 2024. "Competitive Bidding in Drug Procurement: Evidence from China," American Economic Journal: Economic Policy, American Economic Association, vol. 16(3), pages 481-513, August.
• Mireille Jacobson & David Powell, 2024. "Price Sensitivity and Information Barriers to the Take-up of Naloxone," American Economic Journal: Economic Policy, American Economic Association, vol. 16(4), pages 463-490, November.
  • Mireille Jacobson & David Powell, 2024. "Price Sensitivity and Information Barriers to the Take-up of Naloxone," NBER Working Papers 32029, National Bureau of Economic Research, Inc.
• Alexander B. Gusev & Maksim A. Yurevich, 2024. "Economies of Scale in The Russian Pharmaceutical Industry: Empirical Assessments," Journal of Applied Economic Research, Graduate School of Economics and Management, Ural Federal University, vol. 23(4), pages 1055-1076.
• Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024. "Pioneering a new classification: a comprehensive study of healthcare products in global trade," Working Papers 2024-02, CEPII research center.
  • Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulmac & Deniz Ünal, 2024. "Pioneering a New Classification: a Comprehensive Study of Healthcare Products in Global Trade," Working papers 963, Banque de France.
  • Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024. "Pioneering a new classification: a comprehensive study of healthcare products in global trade," Working Papers DT/2024/01, DIAL (Développement, Institutions et Mondialisation).
• Claudio Deiana & Ludovica Giua & Roberto Nisticò, 2024. "Opium Price Shocks and Prescription Opioids in the USA," Oxford Bulletin of Economics and Statistics, Department of Economics, University of Oxford, vol. 86(3), pages 449-484, June.
  • Deiana, C. & Giua, L. & Nisticò, R., 2020. "Opium Price Shocks and Prescription Opioids in the US," Health, Econometrics and Data Group (HEDG) Working Papers 20/23, HEDG, c/o Department of Economics, University of York.
• Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2024. "Competing with precision: incentives for developing predictive biomarker tests," Scandinavian Journal of Economics, Wiley Blackwell, vol. 126(1), pages 60-97, January.
  • Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022. "Competing with precision: incentives for developing predictive biomarker tests," NIPE Working Papers 3/2022, NIPE - Universidade do Minho.
  • Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Competing with precision: incentives for developing predictive biomarker tests," Discussion Paper Series in Economics 6/2022, Norwegian School of Economics, Department of Economics.
• Weder, Rolf & Bentele, Riccardo, 2024. "On the Importance of Swiss Patient Data for Pharmaceutical R&D in Switzerland," Working papers 2024/02, Faculty of Business and Economics - University of Basel.
• Congressional Budget Office, 2024. "Alternative Approaches to Reducing Prescription Drug Prices," Reports 58793, Congressional Budget Office.
• Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulmac & Deniz Ünal, 2024. "Pioneering a New Classification: a Comprehensive Study of Healthcare Products in Global Trade," Working papers 963, Banque de France.
  • Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024. "Pioneering a new classification: a comprehensive study of healthcare products in global trade," Working Papers 2024-02, CEPII research center.
  • Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024. "Pioneering a new classification: a comprehensive study of healthcare products in global trade," Working Papers DT/2024/01, DIAL (Développement, Institutions et Mondialisation).
• Sztulwark, Sebastián & Locher, Valentina & Wahren, Pablo & Girard, Melisa, 2024. "Transición paradigmática en la industriaagro-biotecnológica mundial," Ensayos de Economía 21230, Universidad Nacional de Colombia Sede Medellín.
• Jan Malek & Melissa Newham & Jo Seldeslachts & Reinhilde Veugelers, 2024. "Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development," Working Papers of Department of Management, Strategy and Innovation, Leuven 735739, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Malek, Jan & Newham, Melissa & Seldeslachts, Jo & Veugelers, Reinhilde, 2024. "Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development," CEPR Discussion Papers 18816, C.E.P.R. Discussion Papers.
  • Jan Malek & Melissa Newham & Jo Seldeslachts & Reinhilde Veugelers, 2024. "Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development," Discussion Papers of DIW Berlin 2073, DIW Berlin, German Institute for Economic Research.
• Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024. "Pioneering a new classification: a comprehensive study of healthcare products in global trade," Working Papers 2024-02, CEPII research center.
  • Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2024. "Pioneering a new classification: a comprehensive study of healthcare products in global trade," Working Papers DT/2024/01, DIAL (Développement, Institutions et Mondialisation).
  • Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulmac & Deniz Ünal, 2024. "Pioneering a New Classification: a Comprehensive Study of Healthcare Products in Global Trade," Working papers 963, Banque de France.
• Jo Seldeslachts & Jan Malek & Melissa Newham & Reinhilde Veugelers, 2024. "Übernahmen in der Pharmaindustrie: Fokus mehr auf Innovationsmärkte als auf Marktverdrängung richten," DIW Wochenbericht, DIW Berlin, German Institute for Economic Research, vol. 91(37), pages 579-585.
• Jan Malek & Melissa Newham & Jo Seldeslachts & Reinhilde Veugelers, 2024. "Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development," Working Papers of Department of Management, Strategy and Innovation, Leuven 735739, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Jan Malek & Melissa Newham & Jo Seldeslachts & Reinhilde Veugelers, 2024. "Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development," Discussion Papers of DIW Berlin 2073, DIW Berlin, German Institute for Economic Research.
  • Malek, Jan & Newham, Melissa & Seldeslachts, Jo & Veugelers, Reinhilde, 2024. "Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development," CEPR Discussion Papers 18816, C.E.P.R. Discussion Papers.
• Xi Sun & Sophie M. Behr & Merve Kücük, 2024. "Enabling Circular Economy Dynamics in the Plastics and Steel Industries: Perspectives from Multiple Stakeholders," Discussion Papers of DIW Berlin 2093, DIW Berlin, German Institute for Economic Research.
• Wan, Paijie & He, Feng & Zhang, Hongjie, 2024. "Can the separation of marketing authorization from manufacturing authorization stimulate pharmaceutical innovation? Evidence from China's pharmaceutical industry reform," Economic Analysis and Policy, Elsevier, vol. 83(C), pages 734-748.
• Cheng, Haotian & Ng'ombe, John N. & Lambert, Dayton M., 2024. "A Bayesian generalized rank ordered logit model," Journal of choice modelling, Elsevier, vol. 50(C).
• Bokhari, Farasat A.S. & Mariuzzo, Franco & Yan, Weijie, 2024. "Antibacterial resistance and the cost of affecting demand: The case of UK antibiotics," International Journal of Industrial Organization, Elsevier, vol. 95(C).
• Cotterlaz, Pierre & Gaulier, Guillaume & Sztulman, Aude & Ünal, Deniz, 2024. "Broadening the definition of healthcare products in global trade: Insights from a new classification," International Economics, Elsevier, vol. 180(C).
• Sarig, Oren, 2024. "Pharmaceutical demand response to utilization management," Journal of Health Economics, Elsevier, vol. 93(C).
• Hermosilla, Manuel, 2024. "Regulating ethical experimentation: Impacts of the breakthrough therapy designation on drug R&D," Journal of Health Economics, Elsevier, vol. 94(C).
• Scheibe, Andrew & Shelly, Shaun & Stowe, M. J., 2024. "Insights into the value of the market for cocaine, heroin and methamphetamine in South Africa," LSE Research Online Documents on Economics 122162, London School of Economics and Political Science, LSE Library.
• Fujii-Gambero, Gerardo & Morales-López, Rodrigo, 2024. "Calidad de las exportaciones manufactureras de México en el contexto de fragmentación internacional de la producción," El Trimestre Económico, Fondo de Cultura Económica, vol. 91(361), pages 7-46, enero-mar.
• Sucharita Bhattacharyya & Bibek Ray Chaudhuri & Susmita Chatterjee & Debashis Chakraborty, 2024. "Pharmaceutical exports and patents in India – a systems approach," Indian Growth and Development Review, Emerald Group Publishing Limited, vol. 17(3), pages 341-360, May.
• Malek, Jan & Newham, Melissa & Seldeslachts, Jo & Veugelers, Reinhilde, 2024. "Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development," CEPR Discussion Papers 18816, C.E.P.R. Discussion Papers.
  • Jan Malek & Melissa Newham & Jo Seldeslachts & Reinhilde Veugelers, 2024. "Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development," Working Papers of Department of Management, Strategy and Innovation, Leuven 735739, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Jan Malek & Melissa Newham & Jo Seldeslachts & Reinhilde Veugelers, 2024. "Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development," Discussion Papers of DIW Berlin 2073, DIW Berlin, German Institute for Economic Research.
• Konstantinos N. Baltas & Robert Mann & Nicholaos C. Baltas, 2024. "The COVID-19 Pandemic and Unsustainable PPE Materials: A Correlation and Causality Analysis," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 87(6), pages 1651-1671, June.
• Marisol Carvajal-Camperos & Paloma Almodóvar & Ignacio Danvila-del-Valle, 2024. "Examining the conditions for signing a strategic alliance contract: a configurational approach to the biotechnology sector," The Journal of Technology Transfer, Springer, vol. 49(1), pages 44-68, February.
• Haruo Kakehi & Ryo Nakajima, 2024. "Role of Pharmacists in Generic Pharmaceutical Adoption," Keio-IES Discussion Paper Series 2024-015, Institute for Economics Studies, Keio University.
• Arielle D'Souza & Kendall Hoyt & Christopher M. Snyder & Alec Stapp, 2024. "Can Operation Warp Speed Serve as a Model for Accelerating Innovations Beyond COVID Vaccines?," NBER Chapters, in: Entrepreneurship and Innovation Policy and the Economy, volume 4, National Bureau of Economic Research, Inc.
  • Arielle D'Souza & Kendall Hoyt & Christopher M. Snyder & Alec Stapp, 2024. "Can Operation Warp Speed Serve as a Model for Accelerating Innovations Beyond COVID Vaccines?," NBER Working Papers 32831, National Bureau of Economic Research, Inc.
• Rachel Glennerster & Thomas Kelly & Claire T. McMahon & Christopher M. Snyder, 2024. "Quantifying the Social Value of a Universal COVID-19 Vaccine and Incentivizing Its Development," NBER Working Papers 32059, National Bureau of Economic Research, Inc.
• Phares Akari & Chirantan Chatterjee & Matthew J. Higgins, 2024. "Don’t Throw the Baby Out With the Bathwater: Firm Response to Downstream Product Shocks," NBER Working Papers 32703, National Bureau of Economic Research, Inc.
• Arielle D'Souza & Kendall Hoyt & Christopher M. Snyder & Alec Stapp, 2024. "Can Operation Warp Speed Serve as a Model for Accelerating Innovations Beyond COVID Vaccines?," NBER Chapters, in: Entrepreneurship and Innovation Policy and the Economy, volume 4, National Bureau of Economic Research, Inc.
  • Arielle D'Souza & Kendall Hoyt & Christopher M. Snyder & Alec Stapp, 2024. "Can Operation Warp Speed Serve as a Model for Accelerating Innovations Beyond COVID Vaccines?," NBER Working Papers 32831, National Bureau of Economic Research, Inc.
• Rachel Glennerster & Catherine Che & Sarrin M. Chethik & Claire T. McMahon & Christopher M. Snyder, 2024. "Investing in Vaccines to Mitigate Harm from COVID-19 and Future Pandemics," NBER Working Papers 32984, National Bureau of Economic Research, Inc.
• Marjolijn Moens & Eliana Barrenho & Valérie Paris, 2024. "Exploring the feasibility of sharing information on medicine prices across countries," OECD Health Working Papers 171, OECD Publishing.
• Bum Cheul Park & Andrew Brown & Frithjof Laubinger & Peter Börkey, 2024. "Monitoring trade in plastic waste and scrap," OECD Environment Working Papers 233, OECD Publishing.
• Cho, Eun Kyo, 2024. "Changes and Implications of China’s High-tech Industry Development Policy after the US-China Conflict," Industrial Economic Review 24-2, Korea Institute for Industrial Economics and Trade.
• Kim, Dongsoo, 2024. "From Dependence to Partnership: Korea's Quest for Supply Chain Stability in Critical Mineral Resources," Research Papers 24/1, Korea Institute for Industrial Economics and Trade.
• Kim, Kye Hwan & Yang, Jooyoung & Cho, Eun Kyo, 2024. "Korea in the Tech Crossfire: Strategic Responses to the US-China Decoupling in Batteries and Semiconductors," Research Papers 24/2, Korea Institute for Industrial Economics and Trade.
• Svetlana G. Cheglakova (Чеглакова, Светлана) & Oksana G. Koryabina (Корябина, Оксана), 2024. "Threats to Economic Security in the Activities of the Enterprises Producing Plastic Products in the Ryazan Region [Угрозы Экономической Безопасности В Деятельности Предприятий Производства Пластмас," Economic environment, Russian Presidential Academy of National Economy and Public Administration, vol. 13(1), pages 94-102.
• Rachel Glennerster & Thomas Kelly & Claire T. McMahon & Christopher M. Snyder, 2024. "Quantifying the social value of a universal COVID-19 vaccine and incentivizing its development," Review of Economic Design, Springer;Society for Economic Design, vol. 28(4), pages 723-761, December.
• Bronwyn H. Hall, 2024. "Patents, innovation, and development," International Review of Applied Economics, Taylor & Francis Journals, vol. 38(1-2), pages 17-42, March.
  • Bronwyn H. Hall, 2020. "Patents, Innovation, and Development," NBER Working Papers 27203, National Bureau of Economic Research, Inc.
• Oner Tulum & William Lazonick, 2024. "Setting Pharmaceutical Drug Prices: What the Medicare Negotiators Need to Know About Innovation and Financialization," Working Papers Series inetwp226, Institute for New Economic Thinking.
• Beck Hanno & Prinz Aloys, 2024. "Die Legalisierung von Cannabis in Deutschland," Wirtschaftsdienst, Sciendo, vol. 104(2), pages 128-135, February.
• Malin, Lydia & Schumacher, Simon, 2024. "Pharmaindustrie: Steigender Druck auf dem Arbeitsmarkt. Fachkräftesituation entlang der pharmazeutischen Wertschöpfungskette," IW-Reports 2/2024, Institut der deutschen Wirtschaft (IW) / German Economic Institute.

2023

• Zarek Brot-Goldberg & Timothy Layton & Boris Vabson & Adelina Yanyue Wang, 2023. "The Behavioral Foundations of Default Effects: Theory and Evidence from Medicare Part D," American Economic Review, American Economic Association, vol. 113(10), pages 2718-2758, October.
  • Zarek C. Brot-Goldberg & Timothy Layton & Boris Vabson & Adelina Yanyue Wang, 2021. "The Behavioral Foundations of Default Effects: Theory and Evidence from Medicare Part D," NBER Working Papers 28331, National Bureau of Economic Research, Inc.
  • Zarek Brot-Goldberg & Timothy J. Layton & Boris Vabson & Adelina Yanyue Wang, 2021. "The Behavioral Foundations of Default Effects: Theory and Evidence from Medicare Part D," Working Papers 2021-03, Becker Friedman Institute for Research In Economics.
• Mariana Carrera & Sofia Villas-Boas, 2023. "Generic Aversion and Observational Learning in the Over-the-Counter Drug Market," American Economic Journal: Applied Economics, American Economic Association, vol. 15(3), pages 380-410, July.
  • Villas-Boas, Sofia B & Carrera, Mariana, 2016. "Generic aversion and observational learning in the over-the-counter drug market," Department of Agricultural & Resource Economics, UC Berkeley, Working Paper Series qt0q03b5f2, Department of Agricultural & Resource Economics, UC Berkeley.
  • Carrera, Mariana & Villas-Boas, Sofia B, 2020. "Generic Aversion and Observational Learning in the Over-the-Counter Drug Market," Department of Agricultural & Resource Economics, UC Berkeley, Working Paper Series qt7ks7s9jf, Department of Agricultural & Resource Economics, UC Berkeley.
• Luca Maini & Fabio Pammolli, 2023. "Reference Pricing as a Deterrent to Entry: Evidence from the European Pharmaceutical Market," American Economic Journal: Microeconomics, American Economic Association, vol. 15(2), pages 345-383, May.
• Murali Agastya & Oleksii Birulin, 2023. "Optimal Task Scheduling under Adverse Selection and Hidden Actions," American Economic Journal: Microeconomics, American Economic Association, vol. 15(2), pages 660-698, May.
• Josh Feng & Thomas Hwang & Luca Maini, 2023. "Profiting from Most-Favored-Customer Procurement Rules: Evidence from Medicaid," American Economic Journal: Economic Policy, American Economic Association, vol. 15(2), pages 166-197, May.
• Michael D. Frakes & Melissa F. Wasserman, 2023. "Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination," American Economic Journal: Economic Policy, American Economic Association, vol. 15(3), pages 151-183, August.
• Amitabh Chandra & Courtney Coile & Corina Mommaerts, 2023. "What Can Economics Say about Alzheimer's Disease?," Journal of Economic Literature, American Economic Association, vol. 61(2), pages 428-470, June.
  • Amitabh Chandra & Courtney Coile & Corina Mommaerts, 2020. "What Can Economics Say About Alzheimer's Disease?," NBER Working Papers 27760, National Bureau of Economic Research, Inc.
• Agnes Horvath & Adrienn Takacsne Papp & L szl Molnar & Katalin Liptak & Zoltan Musinszki & Klara Szucsne Markovics, 2023. "Climate and Energy Issues of Energy-Intensive Sectors," The AMFITEATRU ECONOMIC journal, Academy of Economic Studies - Bucharest, Romania, vol. 25(64), pages 813-813, August.
• Reinhard Ellwanger & Hinnerk Gnutzmann & Piotr Śpiewanowski, 2023. "Cost Pass-Through with Capacity Constraints and International Linkages," Staff Working Papers 23-16, Bank of Canada.
• Kortelainen, Mika & Markkanen, Jaakko & Siikanen, Markku & Toivanen, Otto, 2023. "The Effects of Price Regulation on Pharmaceutical Expenditure and Availability," Working Papers 157, VATT Institute for Economic Research.
  • Kortelainen, Mika & Markkanen, Jaakko & Toivanen, Otto & Siikanen, Markku, 2023. "The Effects of Price Regulation on Pharmaceutical Expenditure and Availability," CEPR Discussion Papers 18497, C.E.P.R. Discussion Papers.
• Jo Seldeslachts & Albert Banal-Estañol & Nuria Boot, 2023. "Mehr gemeinsame Anteilseigner, mehr US-Investoren: Eigentümerstrukturen deutscher Firmen haben sich verändert," DIW Wochenbericht, DIW Berlin, German Institute for Economic Research, vol. 90(32), pages 429-436.
• Yin, Nina, 2023. "Pharmaceuticals, incremental innovation and market exclusivity," International Journal of Industrial Organization, Elsevier, vol. 87(C).
• Dosi, Giovanni & Palagi, Elisa & Roventini, Andrea & Russo, Emanuele, 2023. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Journal of Economic Behavior & Organization, Elsevier, vol. 212(C), pages 564-589.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," LEM Papers Series 2021/37, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," SciencePo Working papers Main hal-04114900, HAL.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Working Papers hal-04114900, HAL.
• Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 90(C).
• Snyder, Christopher M. & Hoyt, Kendall & Gouglas, Dimitrios, 2023. "An optimal mechanism to fund the development of vaccines against emerging epidemics," Journal of Health Economics, Elsevier, vol. 91(C).
  • Christopher M. Snyder & Kendall Hoyt & Dimitrios Gouglas, 2022. "An Optimal Mechanism to Fund the Development of Vaccines Against Emerging Epidemics," NBER Working Papers 30619, National Bureau of Economic Research, Inc.
• Liebman, Eli & Lawler, Emily C. & Dunn, Abe & Ridley, David B., 2023. "Consequences of a shortage and rationing: Evidence from a pediatric vaccine," Journal of Health Economics, Elsevier, vol. 92(C).
  • Eli B. Liebman & Emily C. Lawler & Abe Dunn & David B. Ridley, 2023. "Consequences of a Shortage and Rationing: Evidence from a Pediatric Vaccine," NBER Working Papers 31479, National Bureau of Economic Research, Inc.
• Hu, Mei-Ying & Lu, You-Xun & Lai, Ching-chong, 2023. "Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis," Journal of Macroeconomics, Elsevier, vol. 76(C).
  • Hu, Mei-Ying & Lu, You-Xun & Lai, Ching-Chong, 2022. "Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis," MPRA Paper 113923, University Library of Munich, Germany.
• Aggarwal, Mayank & Chakrabarti, Anindya S. & Chatterjee, Chirantan & Higgins, Matthew J., 2023. "Research and market structure: Evidence from an antibiotic-resistant pathogenic outbreak," Research Policy, Elsevier, vol. 52(1).
  • Mayank Aggarwal & Anindya Chakrabarti & Chirantan Chatterjee & Matthew J. Higgins, 2021. "Research and Market Structure: Evidence from an Antibiotic-Resistant Pathogenic Outbreak," NBER Working Papers 28840, National Bureau of Economic Research, Inc.
• Yousaf, Imran & Pham, Linh & Goodell, John W., 2023. "Interconnectedness between healthcare tokens and healthcare stocks: Evidence from a quantile VAR approach," International Review of Economics & Finance, Elsevier, vol. 86(C), pages 271-283.
• Dosi, Giovanni & Marengo, Luigi & Staccioli, Jacopo & Virgillito, Maria Enrica, 2023. "Big Pharma and monopoly capitalism: A long-term view," Structural Change and Economic Dynamics, Elsevier, vol. 65(C), pages 15-35.
  • Giovanni Dosi & Luigi Marengo & Jacopo Staccioli & Maria Enrica Virgillito, 2021. "Big pharma and monopoly capitalism: A long-term view," LEM Papers Series 2021/26, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
• Boutillier, Sophie & Laperche, Blandine & Lebert, Didier & Elouaer-Mrizak, Sana, 2023. "A systemic analysis of the technological trajectory at company level based on patent data: The case of Sanofi's vaccine technology," Technovation, Elsevier, vol. 124(C).
• Vipin Valiyattoor & Anup Kumar Bhandari, 2023. "Towards a better measure of productivity in India: a case of chemical and chemical products industry," Indian Growth and Development Review, Emerald Group Publishing Limited, vol. 16(2), pages 105-122, March.
• Kortelainen, Mika & Markkanen, Jaakko & Toivanen, Otto & Siikanen, Markku, 2023. "The Effects of Price Regulation on Pharmaceutical Expenditure and Availability," CEPR Discussion Papers 18497, C.E.P.R. Discussion Papers.
  • Kortelainen, Mika & Markkanen, Jaakko & Siikanen, Markku & Toivanen, Otto, 2023. "The Effects of Price Regulation on Pharmaceutical Expenditure and Availability," Working Papers 157, VATT Institute for Economic Research.
• Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022. "The price of cost-effectiveness thresholds," NIPE Working Papers 5/2022, NIPE - Universidade do Minho.
  • Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "The price of cost-effectiveness thresholds," Discussion Paper Series in Economics 4/2023, Norwegian School of Economics, Department of Economics.
• Kurt R. Brekke & Odd Rune Straume & Dag Morten Dalen, 2023. "Taking the competitor´s pill: when combination therapies enter pharmaceutical markets," NIPE Working Papers 12/2023, NIPE - Universidade do Minho.
  • Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "Taking the competitor’s pill: when combination therapies enter pharmaceutical markets," Discussion Paper Series in Economics 19/2023, Norwegian School of Economics, Department of Economics.
• Moges Tufa & Mans Söderbom & Zerayehu Sime, 2023. "The Impact of Sector-Specific Industrial Policy on Manufacturing Firm Performance: Quasi-experimental Evidence from Ethiopian Chemical Industries," Journal of Industry, Competition and Trade, Springer, vol. 23(3), pages 363-397, December.
• Sang-Min Park & Nicholas S. Vonortas, 2023. "Translational research: from basic research to regional biomedical entrepreneurship," Small Business Economics, Springer, vol. 60(4), pages 1761-1783, April.
• Benjamin Jones & Josh Lerner, 2023. "Entrepreneurship and Innovation Policy and the Economy, volume 2," NBER Books, National Bureau of Economic Research, Inc, number lern-15.
• Daron Acemoglu, 2023. "Distorted Innovation: Does the Market Get the Direction of Technology Right?," AEA Papers and Proceedings, American Economic Association, vol. 113, pages 1-28, May.
  • Daron Acemoglu, 2023. "Distorted Innovation: Does the Market Get the Direction of Technology Right?," NBER Working Papers 30922, National Bureau of Economic Research, Inc.
• Josh Feng & Matthew J. Higgins & Elena Patel, 2023. "Pediatric Drug Adherence and Parental Attention: Evidence from Comprehensive Claims Data," NBER Working Papers 30968, National Bureau of Economic Research, Inc.
• Alexander P. Frankel & Joshua L. Krieger & Danielle Li & Dimitris Papanikolaou, 2023. "Evaluation and Learning in R&D Investment," NBER Working Papers 31290, National Bureau of Economic Research, Inc.
• Liebman, Eli & Lawler, Emily C. & Dunn, Abe & Ridley, David B., 2023. "Consequences of a shortage and rationing: Evidence from a pediatric vaccine," Journal of Health Economics, Elsevier, vol. 92(C).
  • Eli B. Liebman & Emily C. Lawler & Abe Dunn & David B. Ridley, 2023. "Consequences of a Shortage and Rationing: Evidence from a Pediatric Vaccine," NBER Working Papers 31479, National Bureau of Economic Research, Inc.
• Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "Taking the competitor’s pill: when combination therapies enter pharmaceutical markets," Discussion Paper Series in Economics 19/2023, Norwegian School of Economics, Department of Economics.
  • Kurt R. Brekke & Odd Rune Straume & Dag Morten Dalen, 2023. "Taking the competitor´s pill: when combination therapies enter pharmaceutical markets," NIPE Working Papers 12/2023, NIPE - Universidade do Minho.
• Andrew Brown & Frithjof Laubinger & Peter Börkey, 2023. "Monitoring trade in plastic waste and scrap," OECD Environment Working Papers 210, OECD Publishing.
• Andrew Brown & Frithjof Laubinger & Peter Börkey, 2023. "New Aspects of EPR: Extending producer responsibility to additional product groups and challenges throughout the product lifecycle," OECD Environment Working Papers 225, OECD Publishing.
• Yves-Marie Rault-Chodankar & Dinar Kale, 2023. "‘Manufacturers without factories’ and economic development in the Global South: India’s pharmaceutical firms," Journal of Economic Geography, Oxford University Press, vol. 23(2), pages 319-341.
• Rachel Glennerster & Christopher M. Snyder & Brandon Joel Tan, 2023. "Calculating the Costs and Benefits of Advance Preparations for Future Pandemics," IMF Economic Review, Palgrave Macmillan;International Monetary Fund, vol. 71(3), pages 611-648, September.
  • Rachel Glennerster & Christopher M. Snyder & Brandon Joel Tan, 2022. "Calculating the Costs and Benefits of Advance Preparations for Future Pandemics," NBER Working Papers 30565, National Bureau of Economic Research, Inc.
• Cho, Yongwon, 2023. "Impact on the Plant Industry in Korea Caused by Oil Companies’ Entry into the Petrochemical Market," Industrial Economic Review 19-13, Korea Institute for Industrial Economics and Trade.
• Cho, Eun Kyo & Shim, Woojung, 2023. "The Battle Over Batteries: Chinese Ascendancy and Challenges for Korea," Research Papers 23/1, Korea Institute for Industrial Economics and Trade.
• Gazi Salah Uddin & Muhammad Yahya & Stelios Bekiros & Raanadeva Jayasekera & Gerhard Kling, 2023. "Systematic risk in the biopharmaceutical sector: a multiscale approach," Annals of Operations Research, Springer, vol. 330(1), pages 243-266, November.
• Subhrabaran Das & Ariful Hoque, 2023. "Firm-level productivity and its determinants in the Indian pharmaceutical industry," DECISION: Official Journal of the Indian Institute of Management Calcutta, Springer;Indian Institute of Management Calcutta, vol. 50(4), pages 439-459, December.
• Ali Faridzad & Mahta Ghafarian Ghadim, 2023. "CO2 intensity decomposition analysis in the Netherlands' manufacturing industry: an application of monetary and physical indicators," Environment, Development and Sustainability: A Multidisciplinary Approach to the Theory and Practice of Sustainable Development, Springer, vol. 25(8), pages 8799-8817, August.
• Tobias Basse & Christoph Schwarzbach & J.-Matthias Schulenburg, 2023. "Dividend policy issues in the European pharmaceutical industry: new empirical evidence," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(5), pages 803-816, July.
• YongChan Kim & Erdal Atukeren & Yeon W. Lee, 2023. "Digital Double Diamond (DiDD) Model Analysis of National Competitiveness Under Digital Transformation: An Application to Healthcare and Pharmaceutical Industries in South Korea and Switzerland," International Journal of Global Business and Competitiveness, Springer, vol. 18(1), pages 1-18, December.
• Aruna Pain & Indrani Chakraborty, 2023. "What Factors are Driving R&D in the Pharmaceutical Industry in India? A Study of the Post-Liberalization Period," Journal of Quantitative Economics, Springer;The Indian Econometric Society (TIES), vol. 21(3), pages 617-640, September.
• Sharat Ganapati & Rebecca McKibbin, 2023. "Markups and Fixed Costs in Generic and Off-Patent Pharmaceutical Markets," The Review of Economics and Statistics, MIT Press, vol. 105(6), pages 1606-1614, November.
  • Sharat Ganapati & Rebecca McKibbin, 2021. "Markups and Fixed Costs in Generic and Off-Patent Pharmaceutical Markets," NBER Working Papers 29206, National Bureau of Economic Research, Inc.
• Dubois, Pierre & Majewska, Gosia & Reig, Valentina, 2023. "Drug Shortages: Empirical Evidence from France," TSE Working Papers 23-1417, Toulouse School of Economics (TSE).
• Gugler, Klaus & Szücs, Florian, 2023. "Market Power and Regulation in Pharmaceutical Markets," Department of Economics Working Paper Series 343, WU Vienna University of Economics and Business.
  • Klaus Gugler & Florian Szücs, 2023. "Market Power and Regulation in Pharmaceutical Markets," Department of Economics Working Papers wuwp343, Vienna University of Economics and Business, Department of Economics.
• Klaus Gugler & Florian Szücs, 2023. "Market Power and Regulation in Pharmaceutical Markets," Department of Economics Working Papers wuwp343, Vienna University of Economics and Business, Department of Economics.
  • Gugler, Klaus & Szücs, Florian, 2023. "Market Power and Regulation in Pharmaceutical Markets," Department of Economics Working Paper Series 343, WU Vienna University of Economics and Business.
• Dubois, P.; & Majewska, G.; & Reig, V.;, 2023. "Drug Shortages: Empirical Evidence from France," Health, Econometrics and Data Group (HEDG) Working Papers 23/07, HEDG, c/o Department of Economics, University of York.
• Mayimele, Nsovo & Demana, Patrick & Keele, Mothobi, 2023. "An assessment of positions, perceptions and valued leadership competencies of pharmacists that work in manufacturing pharmaceutical companies (MPCs) in South Africa," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 7(4), pages 66-79.
• Nyeleti Mayimele, Nsovo & Hulisani Demana, Patrick & Godfrey Keele, Mothobi, 2023. "Pharmacists as Strategic Leaders of Manufacturing Pharmaceutical Companies with Operations in South Africa," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 7(4), pages 200-209.
• Haag, Maike & Kohlisch, Enno & Koppel, Oliver, 2023. "China auf dem Weg zur führenden Technologienation: Analyse der Patentaktivität Chinas sowie ausgewählter Schlüsseltechnologien und -branchen des 14. Fünfjahresplans," IW-Reports 53/2023, Institut der deutschen Wirtschaft (IW) / German Economic Institute.
• Kirchhoff, Jasmina & Schumacher, Simon, 2023. "Ökonomische Folgen der Energiepreiskrise am Beispiel der pharmazeutischen Industrie in Deutschland [The economic consequences of the energy price crisis as exemplified by the pharmaceutical industr," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, vol. 50(2), pages 97-114.

2022

• Bradley T. Shapiro, 2022. "Promoting Wellness or Waste? Evidence from Antidepressant Advertising," American Economic Journal: Microeconomics, American Economic Association, vol. 14(2), pages 439-477, May.
• Leila Agha & Dan Zeltzer, 2022. "Drug Diffusion through Peer Networks: The Influence of Industry Payments," American Economic Journal: Economic Policy, American Economic Association, vol. 14(2), pages 1-33, May.
  • Leila Agha & Dan Zeltzer, 2019. "Drug Diffusion Through Peer Networks: The Influence of Industry Payments," NBER Working Papers 26338, National Bureau of Economic Research, Inc.
• Alberto Galasso & Hong Luo, 2022. "When Does Product Liability Risk Chill Innovation? Evidence from Medical Implants," American Economic Journal: Economic Policy, American Economic Association, vol. 14(2), pages 366-401, May.
• Mary F. Evans & Matthew C. Harris & Lawrence M. Kessler, 2022. "The Hazards of Unwinding the Prescription Opioid Epidemic: Implications for Child Maltreatment," American Economic Journal: Economic Policy, American Economic Association, vol. 14(4), pages 192-231, November.
• Tal Gross & Timothy J. Layton & Daniel Prinz, 2022. "The Liquidity Sensitivity of Healthcare Consumption: Evidence from Social Security Payments," American Economic Review: Insights, American Economic Association, vol. 4(2), pages 175-190, June.
  • Tal Gross & Timothy Layton & Daniel Prinz, 2020. "The Liquidity Sensitivity of Healthcare Consumption: Evidence from Social Security Payments," NBER Working Papers 27977, National Bureau of Economic Research, Inc.
• Leila Agha & Soomi Kim & Danielle Li, 2022. "Insurance Design and Pharmaceutical Innovation," American Economic Review: Insights, American Economic Association, vol. 4(2), pages 191-208, June.
• Andrew W. Lo & Richard T. Thakor, 2022. "Financing Biomedical Innovation," Annual Review of Financial Economics, Annual Reviews, vol. 14(1), pages 231-270, November.
• Congressional Budget Office, 2022. "Prescription Drugs: Spending, Use, and Prices," Reports 57050, Congressional Budget Office.
• Brekke, Kurt R. & Canta, Chiara & Straume, Odd Rune, 2015. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," Discussion Paper Series in Economics 11/2015, Norwegian School of Economics, Department of Economics.
  • Kurt R. Brekke & Chiara Canta & Odd Rune Straume, 2022. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," CESifo Working Paper Series 9853, CESifo.
  • Kurt R. Brekke & Chiara Canta & Odd Rune StraumeAuthor-Email: o.r.straume@eeg.uminho.p, 2015. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," NIPE Working Papers 6/2015, NIPE - Universidade do Minho.
• Pierre Cotterlaz & Guillaume Gaulier & Aude Sztulman & Deniz Ünal, 2022. "Industrie pharmaceutique européenne : quand rentabilité rime avec vulnérabilité," La Lettre du CEPII, CEPII research center, issue 423.
• Yang, Ann Shawing & Yulianto, Fritz Andryan, 2022. "Cost of equity and corporate social responsibility for environmental sensitive industries: Evidence from international pharmaceutical and chemical firms," Finance Research Letters, Elsevier, vol. 47(PA).
• Dewatripont, Mathias, 2022. "Which policies for vaccine innovation and delivery in Europe?," International Journal of Industrial Organization, Elsevier, vol. 84(C).
• Clark, Robert & Fabiilli, Christopher & Lasio, Laura, 2022. "Collusion in the US generic drug industry," International Journal of Industrial Organization, Elsevier, vol. 85(C).
  • Robert Clark & Christopher Anthony Fabiilli & Laura Lasio, 2021. "Collusion in the US Generic Drug Industry," Working Paper 1474, Economics Department, Queen's University.
• Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," Journal of Health Economics, Elsevier, vol. 83(C).
  • Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2021. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," NIPE Working Papers 01/2021, NIPE - Universidade do Minho.
• Nishimura, Junichi & Nagaoka, Sadao & Yoneyama-Hirozane, Mariko, 2022. "The impact of science-intensive drugs on longevity and cure rate: Evidence from new prescription drugs launched in Japan," Journal of the Japanese and International Economies, Elsevier, vol. 64(C).
• Khalifa, Mariem & Trabelsi, Samir & Matoussi, Hamadi, 2022. "Leverage, R&D expenditures, and accounting conservatism: Evidence from technology firms," The Quarterly Review of Economics and Finance, Elsevier, vol. 84(C), pages 285-304.
• Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022. "Generic competition and the incentives for early-stage pharmaceutical innovation," Research Policy, Elsevier, vol. 51(10).
  • Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
• Md. Musfiqur Rahman & Md. Shuvo Howlader, 2022. "The impact of research and development expenditure on firm performance and firm value: evidence from a South Asian emerging economy," Journal of Applied Accounting Research, Emerald Group Publishing Limited, vol. 23(4), pages 825-845, May.
• Billette de Villemeur, Etienne & Scannell, Jack & Versaevel, Bruno, 2021. "Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?," MPRA Paper 108233, University Library of Munich, Germany.
  • Jack Scannell & Bruno Versaevel & Etienne Billette de Villemeur, 2022. "Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?," Post-Print hal-03967759, HAL.
• Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2024. "Competing with precision: incentives for developing predictive biomarker tests," Scandinavian Journal of Economics, Wiley Blackwell, vol. 126(1), pages 60-97, January.
  • Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022. "Competing with precision: incentives for developing predictive biomarker tests," NIPE Working Papers 3/2022, NIPE - Universidade do Minho.
  • Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Competing with precision: incentives for developing predictive biomarker tests," Discussion Paper Series in Economics 6/2022, Norwegian School of Economics, Department of Economics.
• Samira Guennif, 2022. "Capture and passive predation in times of COVID-19 pandemic," Public Choice, Springer, vol. 193(3), pages 163-186, December.
• David Granlund, 2022. "The Price Effects of Competition from Parallel Imports and Therapeutic Alternatives: Using Dynamic Models to Estimate the Causal Effect on the Extensive and Intensive Margins," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 60(1), pages 63-92, February.
• Amanda Starc & Thomas G. Wollmann, 2022. "Does Entry Remedy Collusion? Evidence from the Generic Prescription Drug Cartel," NBER Working Papers 29886, National Bureau of Economic Research, Inc.
• Blankart, Katharina & Lichtenberg, Frank R., 2022. "The effects of off-label drug use on disability and medical expenditure," Ruhr Economic Papers 969, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
  • Katharina E. Blankart & Frank R. Lichtenberg, 2022. "The Effects of Off-label Drug Use on Disability and Medical Expenditure," NBER Working Papers 30440, National Bureau of Economic Research, Inc.
• Richard G. Frank & Andrew L. Hicks & Ernst R. Berndt, 2022. "Auditing the Prescription Drug Consumer Price Index in a Changing Marketplace," NBER Working Papers 30448, National Bureau of Economic Research, Inc.
• Rachel Glennerster & Christopher M. Snyder & Brandon Joel Tan, 2023. "Calculating the Costs and Benefits of Advance Preparations for Future Pandemics," IMF Economic Review, Palgrave Macmillan;International Monetary Fund, vol. 71(3), pages 611-648, September.
  • Rachel Glennerster & Christopher M. Snyder & Brandon Joel Tan, 2022. "Calculating the Costs and Benefits of Advance Preparations for Future Pandemics," NBER Working Papers 30565, National Bureau of Economic Research, Inc.
• Andrew W. Lo & Richard T. Thakor, 2022. "Financial Intermediation and the Funding of Biomedical Innovation: A Review," NBER Working Papers 30594, National Bureau of Economic Research, Inc.
• Snyder, Christopher M. & Hoyt, Kendall & Gouglas, Dimitrios, 2023. "An optimal mechanism to fund the development of vaccines against emerging epidemics," Journal of Health Economics, Elsevier, vol. 91(C).
  • Christopher M. Snyder & Kendall Hoyt & Dimitrios Gouglas, 2022. "An Optimal Mechanism to Fund the Development of Vaccines Against Emerging Epidemics," NBER Working Papers 30619, National Bureau of Economic Research, Inc.
• Ivanova, N. & Mamedyarov, Z., 2022. "Pharmaceutical industry in Russia: Key trends and developments," Journal of the New Economic Association, New Economic Association, vol. 53(1), pages 248-255.
• Milena Filipova & Yulia Nedelcheva, 2022. "Value-Added Chain Of A New Pharmaceutical Product," Economics and Management, Faculty of Economics, SOUTH-WEST UNIVERSITY "NEOFIT RILSKI", BLAGOEVGRAD, vol. 19(1), pages 65-78.
• Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2024. "Competing with precision: incentives for developing predictive biomarker tests," Scandinavian Journal of Economics, Wiley Blackwell, vol. 126(1), pages 60-97, January.
  • Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Competing with precision: incentives for developing predictive biomarker tests," Discussion Paper Series in Economics 6/2022, Norwegian School of Economics, Department of Economics.
  • Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022. "Competing with precision: incentives for developing predictive biomarker tests," NIPE Working Papers 3/2022, NIPE - Universidade do Minho.
• Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022. "The price of cost-effectiveness thresholds," NIPE Working Papers 5/2022, NIPE - Universidade do Minho.
  • Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "The price of cost-effectiveness thresholds," Discussion Paper Series in Economics 4/2023, Norwegian School of Economics, Department of Economics.
• Ana-Cristina Balgar, 2022. "The Strategic Role of Sino-U.S. Bilateral Investments in China’s Advance in the Field of Biotechnologies," Global Economic Observer, "Nicolae Titulescu" University of Bucharest, Faculty of Economic Sciences;Institute for World Economy of the Romanian Academy, vol. 10(1), pages 49-62, June.
• Andrew Brown & Frithjof Laubinger & Peter Börkey, 2022. "Monitoring trade in plastic waste and scrap," OECD Environment Working Papers 194, OECD Publishing.
• Guillermo Hernández & Miguel Amaral, 2022. "Case studies on agile regulatory governance to harness innovation: Civilian drones and bio-solutions," OECD Regulatory Policy Working Papers 18, OECD Publishing.
• Adam Jørring & Andrew W Lo & Tomas J Philipson & Manita Singh & Richard T Thakor, 2022. "Sharing R&D Risk in Healthcare via FDA Hedges [Bank lines of credit as contingent liquidity: Covenant violations and their implications]," The Review of Corporate Finance Studies, Society for Financial Studies, vol. 11(4), pages 880-922.
  • Adam Jørring & Andrew W. Lo & Tomas J. Philipson & Manita Singh & Richard T. Thakor, 2017. "Sharing R&D Risk in Healthcare via FDA Hedges," NBER Working Papers 23344, National Bureau of Economic Research, Inc.
• Alberto Cavaliere & Ashin Moayedizadeh, 2022. "Competition between Generic and Brand Name Drugs: New Evidence from the U.S. Pharmaceutical Market," DEM Working Papers Series 209, University of Pavia, Department of Economics and Management.
• Hu, Mei-Ying & Lu, You-Xun & Lai, Ching-chong, 2023. "Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis," Journal of Macroeconomics, Elsevier, vol. 76(C).
  • Hu, Mei-Ying & Lu, You-Xun & Lai, Ching-Chong, 2022. "Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis," MPRA Paper 113923, University Library of Munich, Germany.
• Park, Yumi, 2022. "Policies and Corporate Responses to the Plastic Pollution Crisis," Industrial Economic Review 22-10, Korea Institute for Industrial Economics and Trade.
• Frank R. Lichtenberg, 2022. "The effects of dynamic and static competition on prescription drug prices in Denmark, 1997–2017," Journal of Evolutionary Economics, Springer, vol. 32(4), pages 1155-1173, September.
• Justus Haucap & Leon Knoke, 2022. "Warum und wie die Liberalisierung des Cannabismarktes in Deutschland erfolgen sollte [Why and How the Liberalisation of the Cannabis Market in Germany Should Occur]," Wirtschaftsdienst, Springer;ZBW - Leibniz Information Centre for Economics, vol. 102(1), pages 32-39, January.
• Fabian Gaessler & Stefan Wagner, 2022. "Patents, Data Exclusivity, and the Development of New Drugs," The Review of Economics and Statistics, MIT Press, vol. 104(3), pages 571-586, May.
  • Gaessler, Fabian & Wagner, Stefan, 2019. "Patents, Data Exclusivity, and the Development of New Drugs," Rationality and Competition Discussion Paper Series 176, CRC TRR 190 Rationality and Competition.
• Bortnowska Hanna & Seiler Bartosz, 2022. "CSR in mission statements of Polish chemical industry companies (content analysis results)," Management, Sciendo, vol. 26(2), pages 1-23, December.
• Adatto, Laurent & Aouinaït, Camille & Le, Son Thi Kim & Mongo, Michelle, 2022. "Industrial and Organizational Mutations in the Medical and Pharmaceutical Sectors impulsed by Open Innovation during the Pandemic," Proceedings of the ENTRENOVA - ENTerprise REsearch InNOVAtion Conference (2022), Hybrid Conference, Opatija, Croatia, in: Proceedings of the ENTRENOVA - ENTerprise REsearch InNOVAtion Conference, Hybrid Conference, Opatija, Croatia, 17-18 June 2022, pages 421-434, IRENET - Society for Advancing Innovation and Research in Economy, Zagreb.
• Kirchhoff, Jasmina, 2022. "Arzneimittelversorgung und -produktion gefährdet: AMNOG-Reform auf dem Prüfstand," IW policy papers 8/2022, Institut der deutschen Wirtschaft (IW) / German Economic Institute.
• Kirchhoff, Jasmina, 2022. "Vorleistungsverflechtungen der deutschen Pharmaindustrie im internationalen Vergleich," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, vol. 49(1), pages 3-19.
• Grömling, Michael, 2022. "Produktivitätseffekte der Kapitalbildung in Deutschland," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, vol. 49(2), pages 3-25.
• Kirchhoff, Jasmina & Malin, Lydia & Schumacher, Simon, 2022. "Pharmaindustrie im Wandel: Fachkräftebedarfe in Zeiten transformatorischer Herausforderungen [Pharmaceuticals in transition: The need for skilled labour in an era of digital transformation]," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, vol. 49(2), pages 97-116.

2021

• Florian Heiss & Daniel McFadden & Joachim Winter & Amelie Wuppermann & Bo Zhou, 2021. "Inattention and Switching Costs as Sources of Inertia in Medicare Part D," American Economic Review, American Economic Association, vol. 111(9), pages 2737-2781, September.
• David Dranove & Christopher Ody & Amanda Starc, 2021. "A Dose of Managed Care: Controlling Drug Spending in Medicaid," American Economic Journal: Applied Economics, American Economic Association, vol. 13(1), pages 170-197, January.
  • David Dranove & Christopher Ody & Amanda Starc, 2017. "A Dose of Managed Care: Controlling Drug Spending in Medicaid," NBER Working Papers 23956, National Bureau of Economic Research, Inc.
• Wallace P. Mullin & Christopher M. Snyder, 2021. "A Simple Method for Bounding the Elasticity of Growing Demand with Applications to the Analysis of Historic Antitrust Cases," American Economic Journal: Microeconomics, American Economic Association, vol. 13(4), pages 172-217, November.
• Amanda Starc & Ashley Swanson, 2021. "Preferred Pharmacy Networks and Drug Costs," American Economic Journal: Economic Policy, American Economic Association, vol. 13(3), pages 406-446, August.
• Lauren Cohen & Umit G. Gurun & Danielle Li, 2021. "Internal Deadlines, Drug Approvals, and Safety Problems," American Economic Review: Insights, American Economic Association, vol. 3(1), pages 67-82, March.
• Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Lee & Canice Prendergast & Christopher M. Snyder & Ale, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," AEA Papers and Proceedings, American Economic Association, vol. 111, pages 331-335, May.
  • Ahuja, Amrita & Athey, Susan & Baker, Arthur & Budish, Eric & Camilo Castillo, Juan & Glennerster, Rachel & Kominers, Scott Duke & Kremer, Michael & Lee, Jean & Prendergast, Canice & Snyder, Christoph, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," Research Papers 3966, Stanford University, Graduate School of Business.
  • Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Nahrae Lee & Canice Prendergast & Christopher M. Snyde, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," NBER Working Papers 28492, National Bureau of Economic Research, Inc.
  • Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Lee & Candice Prendergast & Christopher M. Snyder & Al, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," Working Papers 2021-08, Becker Friedman Institute for Research In Economics.
• Efraim Benmelech & Janice Eberly & Dimitris Papanikolaou & Joshua Krieger, 2021. "Private and Social Returns to R&D: Drug Development and Demographics," AEA Papers and Proceedings, American Economic Association, vol. 111, pages 336-340, May.
  • Efraim Benmelech & Janice C. Eberly & Joshua L. Krieger & Dimitris Papanikolaou, 2021. "Private and Social Returns to R&D: Drug Development and Demographics," NBER Working Papers 28355, National Bureau of Economic Research, Inc.
• Maya Durvasula & Lisa Larrimore Ouellette & Heidi Williams, 2021. "Private and Public Investments in Biomedical Research," AEA Papers and Proceedings, American Economic Association, vol. 111, pages 341-345, May.
  • Maya M. Durvasula & Lisa Larrimore Ouellette & Heidi L. Williams, 2021. "Private and Public Investments in Biomedical Research," NBER Working Papers 28349, National Bureau of Economic Research, Inc.
• David M. Cutler & Edward L. Glaeser, 2021. "When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic," Journal of Economic Perspectives, American Economic Association, vol. 35(4), pages 171-196, Fall.
• Mariia Shkolnykova, 2021. "On the way from invention to innovation: the role of applicant and inventor team characteristics," Bremen Papers on Economics & Innovation 2110, University of Bremen, Faculty of Business Studies and Economics.
• Alla Dunska & Kateryna Boiarynova & Maryna Kravchenko, 2021. "Scientific Approach To Determining The Vectors Of Innovative Development Of Industrial Enterprises," Baltic Journal of Economic Studies, Publishing house "Baltija Publishing", vol. 7(4).
• Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Lee & Canice Prendergast & Christopher M. Snyder & Ale, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," AEA Papers and Proceedings, American Economic Association, vol. 111, pages 331-335, May.
  • Ahuja, Amrita & Athey, Susan & Baker, Arthur & Budish, Eric & Camilo Castillo, Juan & Glennerster, Rachel & Kominers, Scott Duke & Kremer, Michael & Lee, Jean & Prendergast, Canice & Snyder, Christoph, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," Research Papers 3966, Stanford University, Graduate School of Business.
  • Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Lee & Candice Prendergast & Christopher M. Snyder & Al, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," Working Papers 2021-08, Becker Friedman Institute for Research In Economics.
  • Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Nahrae Lee & Canice Prendergast & Christopher M. Snyde, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," NBER Working Papers 28492, National Bureau of Economic Research, Inc.
• Gérard de Pouvourville, 2021. "Logique médicale, économique, industrielle et politique dans la définition du « prix » du médicament," Revue d'économie financière, Association d'économie financière, vol. 0(3), pages 213-229.
• Congressional Budget Office, 2021. "Research and Development in the Pharmaceutical Industry," Reports 57025, Congressional Budget Office.
• Katrin Demmelhuber, 2021. "Branchen im Fokus: Einzelhandel – Apotheken," ifo Schnelldienst, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 74(03), pages 63-69, March.
• de Roux, Nicolás & Eslava, Marcela & Franco, Santiago & Verhoogen, Eric, 2020. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," IZA Discussion Papers 14006, Institute of Labor Economics (IZA).
  • Nicolás de Roux & Marcela Eslava & Santiago Franco & Eric Verhoogen, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," Documentos CEDE 18705, Universidad de los Andes, Facultad de Economía, CEDE.
  • Verhoogen, Eric & de Roux, Nicolás & Eslava, Marcela & Franco, Santiago, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," CEPR Discussion Papers 15626, C.E.P.R. Discussion Papers.
  • Nicolás de Roux & Marcela Eslava & Santiago Franco & Eric Verhoogen, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," NBER Working Papers 28323, National Bureau of Economic Research, Inc.
• Filiberto Enrique Valdés Medina & María Luisa Saavedra García & Antonio Alejandro Gutiérrez Navarro, 2021. "Análisis del impacto de la pandemia COVID-19 en las cotizaciones de las empresas farmacéuticas listadas en el índice NYSE," Revista Cuadernos de Economia, Universidad Nacional de Colombia, FCE, CID, vol. 40(85), pages 1033-1053, December.
• de Roux, Nicolás & Eslava, Marcela & Franco, Santiago & Verhoogen, Eric, 2020. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," IZA Discussion Papers 14006, Institute of Labor Economics (IZA).
  • Verhoogen, Eric & de Roux, Nicolás & Eslava, Marcela & Franco, Santiago, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," CEPR Discussion Papers 15626, C.E.P.R. Discussion Papers.
  • Nicolás de Roux & Marcela Eslava & Santiago Franco & Eric Verhoogen, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," NBER Working Papers 28323, National Bureau of Economic Research, Inc.
  • Nicolás de Roux & Marcela Eslava & Santiago Franco & Eric Verhoogen, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," Documentos CEDE 18705, Universidad de los Andes, Facultad de Economía, CEDE.
• Anderson, Simon & Renault, Régis, 2021. "Search Direction: Position Externalities and Position Auction Bias," CEPR Discussion Papers 16724, C.E.P.R. Discussion Papers.
• Xi Sun & Frederik Lettow & Karsten Neuhoff, 2021. "Climate Neutrality Requires Coordinated Measures for High Quality Recycling," DIW Weekly Report, DIW Berlin, German Institute for Economic Research, vol. 11(26), pages 187-195.
• Xi Sun & Frederik Lettow & Karsten Neuhoff, 2021. "Klimaneutralität braucht koordinierte Maßnahmen zur Stärkung von hochwertigem Recycling," DIW Wochenbericht, DIW Berlin, German Institute for Economic Research, vol. 88(26), pages 443-452.
• Conti, Annamaria & Ortega, Leonardo & Sung, Elie, 2021. "Sharpen your Sword for Litigation: Incumbent Strategic Reaction to the Threat of Entry," HEC Research Papers Series 1448, HEC Paris.
• Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Lee & Canice Prendergast & Christopher M. Snyder & Ale, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," AEA Papers and Proceedings, American Economic Association, vol. 111, pages 331-335, May.
  • Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Lee & Candice Prendergast & Christopher M. Snyder & Al, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," Working Papers 2021-08, Becker Friedman Institute for Research In Economics.
  • Ahuja, Amrita & Athey, Susan & Baker, Arthur & Budish, Eric & Camilo Castillo, Juan & Glennerster, Rachel & Kominers, Scott Duke & Kremer, Michael & Lee, Jean & Prendergast, Canice & Snyder, Christoph, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," Research Papers 3966, Stanford University, Graduate School of Business.
  • Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Nahrae Lee & Canice Prendergast & Christopher M. Snyde, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," NBER Working Papers 28492, National Bureau of Economic Research, Inc.
• Komang Adi Kurniawan Saputra & Daniel T. H. Manurung & Lia Rachmawati & Eka Siskawati & Franklin Kharisma Genta, 2021. "Combining the Concept of Green Accounting with the Regulation of Prohibition of Disposable Plastic Use," International Journal of Energy Economics and Policy, Econjournals, vol. 11(4), pages 84-90.
• Zhang, Xuan & Nie, Huihua, 2021. "Public health insurance and pharmaceutical innovation: Evidence from China," Journal of Development Economics, Elsevier, vol. 148(C).
• Befort, N., 2021. "The promises of drop-in vs. functional innovations: The case of bioplastics," Ecological Economics, Elsevier, vol. 181(C).
• Higgins, Matthew J. & Yan, Xin & Chatterjee, Chirantan, 2021. "Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling," Research Policy, Elsevier, vol. 50(1).
  • Matthew J. Higgins & Xin Yan & Chirantan Chatterjee, 2018. "Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling," NBER Working Papers 24957, National Bureau of Economic Research, Inc.
• Kristie Briggs, 2021. "Prescribing originality: investigating the impact of original knowledge on patent quality in the pharmaceutical sector," Journal of Entrepreneurship and Public Policy, Emerald Group Publishing Limited, vol. 10(1), pages 78-97, February.
• Kristie Briggs, 2021. "Prescribing originality: investigating the impact of original knowledge on patent quality in the pharmaceutical sector," Journal of Entrepreneurship and Public Policy, Emerald Group Publishing Limited, vol. 10(1), pages 78-97, February.
• Urszula Mikiewicz & Miroslaw Moroz, 2021. "Trade-Offs Occurring in the Process of Commercialization of SARS-CoV-2 Test in a Narrow Window of Opportunity," European Research Studies Journal, European Research Studies Journal, vol. 0(2), pages 294-313.
• Dosi, Giovanni & Palagi, Elisa & Roventini, Andrea & Russo, Emanuele, 2023. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Journal of Economic Behavior & Organization, Elsevier, vol. 212(C), pages 564-589.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," LEM Papers Series 2021/37, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," SciencePo Working papers Main hal-04114900, HAL.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Working Papers hal-04114900, HAL.
• Dosi, Giovanni & Palagi, Elisa & Roventini, Andrea & Russo, Emanuele, 2023. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Journal of Economic Behavior & Organization, Elsevier, vol. 212(C), pages 564-589.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," LEM Papers Series 2021/37, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Working Papers hal-04114900, HAL.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," SciencePo Working papers Main hal-04114900, HAL.
• Gérard Mondello, 2020. "Building Belief Systems and Medical Ethics: The Covid-19 Controversies," GREDEG Working Papers 2020-35, Groupe de REcherche en Droit, Economie, Gestion (GREDEG CNRS), Université Côte d'Azur, France.
  • Gérard Mondello, 2021. "Building Belief Systems And Medical Ethics: The Covid-19 Controversies," Working Papers halshs-03502609, HAL.
• Gérard Mondello, 2020. "Construction de systèmes de croyances et éthique médicale: les controverses autour du Covid-19," GREDEG Working Papers 2020-19, Groupe de REcherche en Droit, Economie, Gestion (GREDEG CNRS), Université Côte d'Azur, France, revised Feb 2022.
  • Gérard Mondello, 2021. "Construction De Systèmes De Croyances Et Éthique Médicale: Les Controverses Autour Du Covid-19," Working Papers halshs-03502610, HAL.
• Ana-Cristina Bâlgăr, 2021. "Sino-Us Bilateral Investment: Active Tools For China'S Advance In Biotechnology," Revista de Economie Mondiala / The Journal of Global Economics, Institute for World Economy, Romanian Academy, vol. 13(2), pages 48-65.
• Farasat A. S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2021. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Small Business Economics, Springer, vol. 57(1), pages 603-634, June.
  • Farasat A.S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2019. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2016-01v3, Centre for Competition Policy, University of East Anglia, Norwich, UK..
• Ruoya Wang & Yaodong Zhou, 2021. "Can R&D Input Influence Market Power? Facts about China's Pharmaceutical Manufacturing Industry," Journal of Institutional and Theoretical Economics (JITE), Mohr Siebeck, Tübingen, vol. 177(4), pages 428-448.
• Emanuela Sirtori & Alessandra Caputo & Domenico Scalera, 2021. "Patterns of development in the European biopharmaceutical industry. A network analysis of cross-sectoral linkages (2000-2016)," Working Papers 202101, CSIL Centre for Industrial Studies.
• de Roux, Nicolás & Eslava, Marcela & Franco, Santiago & Verhoogen, Eric, 2020. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," IZA Discussion Papers 14006, Institute of Labor Economics (IZA).
  • Nicolás de Roux & Marcela Eslava & Santiago Franco & Eric Verhoogen, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," NBER Working Papers 28323, National Bureau of Economic Research, Inc.
  • Nicolás de Roux & Marcela Eslava & Santiago Franco & Eric Verhoogen, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," Documentos CEDE 18705, Universidad de los Andes, Facultad de Economía, CEDE.
  • Verhoogen, Eric & de Roux, Nicolás & Eslava, Marcela & Franco, Santiago, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," CEPR Discussion Papers 15626, C.E.P.R. Discussion Papers.
• Efraim Benmelech & Janice Eberly & Dimitris Papanikolaou & Joshua Krieger, 2021. "Private and Social Returns to R&D: Drug Development and Demographics," AEA Papers and Proceedings, American Economic Association, vol. 111, pages 336-340, May.
  • Efraim Benmelech & Janice C. Eberly & Joshua L. Krieger & Dimitris Papanikolaou, 2021. "Private and Social Returns to R&D: Drug Development and Demographics," NBER Working Papers 28355, National Bureau of Economic Research, Inc.
• Thomas Jungbauer & Sean Nicholson & June Pan & Michael Waldman, 2021. "The Organization of Innovation: Property Rights and the Outsourcing Decision," NBER Working Papers 28379, National Bureau of Economic Research, Inc.
• Aggarwal, Mayank & Chakrabarti, Anindya S. & Chatterjee, Chirantan & Higgins, Matthew J., 2023. "Research and market structure: Evidence from an antibiotic-resistant pathogenic outbreak," Research Policy, Elsevier, vol. 52(1).
  • Mayank Aggarwal & Anindya Chakrabarti & Chirantan Chatterjee & Matthew J. Higgins, 2021. "Research and Market Structure: Evidence from an Antibiotic-Resistant Pathogenic Outbreak," NBER Working Papers 28840, National Bureau of Economic Research, Inc.
• Dennis Byrski & Fabian Gaessler & Matthew J. Higgins, 2021. "Market Size and Research: Evidence from the Pharmaceutical Industry," NBER Working Papers 28858, National Bureau of Economic Research, Inc.
• Xuelin Li & Andrew W. Lo & Richard T. Thakor, 2021. "Paying off the Competition: Contracting, Market Power, and Innovation Incentives," NBER Working Papers 28964, National Bureau of Economic Research, Inc.
• Sharat Ganapati & Rebecca McKibbin, 2023. "Markups and Fixed Costs in Generic and Off-Patent Pharmaceutical Markets," The Review of Economics and Statistics, MIT Press, vol. 105(6), pages 1606-1614, November.
  • Sharat Ganapati & Rebecca McKibbin, 2021. "Markups and Fixed Costs in Generic and Off-Patent Pharmaceutical Markets," NBER Working Papers 29206, National Bureau of Economic Research, Inc.
• Casey B. Mulligan, 2021. "Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation," NBER Working Papers 29574, National Bureau of Economic Research, Inc.
• Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," Journal of Health Economics, Elsevier, vol. 83(C).
  • Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2021. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," NIPE Working Papers 01/2021, NIPE - Universidade do Minho.
• Doina Margaritti & Cristina Tase & Sirma Tomos, 2021. "Management of the Pharmaceutical Entity's Resources in the Conditions of the Sanitary Crisis of COVID-19," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, vol. 0(2), pages 816-822, December.
• Billette de Villemeur, Etienne & Scannell, Jack & Versaevel, Bruno, 2021. "Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?," MPRA Paper 108233, University Library of Munich, Germany.
  • Jack Scannell & Bruno Versaevel & Etienne Billette de Villemeur, 2022. "Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?," Post-Print hal-03967759, HAL.
• Clark, Robert & Fabiilli, Christopher & Lasio, Laura, 2022. "Collusion in the US generic drug industry," International Journal of Industrial Organization, Elsevier, vol. 85(C).
  • Robert Clark & Christopher Anthony Fabiilli & Laura Lasio, 2021. "Collusion in the US Generic Drug Industry," Working Paper 1474, Economics Department, Queen's University.
• Han, Jung Min, 2021. "The Recent Upturn in Korea’s Exports: Background and Implications," i-KIET Issues and Analysis 21/12, Korea Institute for Industrial Economics and Trade.
• Shim, Woojung & Kyung, Heekwon, 2021. "Analysis of the 3D Printing Industry's Competitiveness across the Value Chain and Policy Implications," Research Papers 21/5, Korea Institute for Industrial Economics and Trade.
• Marie Coris & Alain Piveteau & Philippe Gorry & Matthieu Montalban, 2021. "Sécurité sanitaire sous dépendance. Une construction politique à repenser [Beyond health security dependencies. Rethinking public health and industrial policies construction]," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 29.
• Tristan Becker & Bastian Bruns & Stefan Lier & Brigitte Werners, 2021. "Decentralized modular production to increase supply chain efficiency in chemical markets," Journal of Business Economics, Springer, vol. 91(6), pages 867-895, August.
• Ute Laermann-Nguyen & Martin Backfisch, 2021. "Innovation crisis in the pharmaceutical industry? A survey," SN Business & Economics, Springer, vol. 1(12), pages 1-37, December.
• Dosi, Giovanni & Marengo, Luigi & Staccioli, Jacopo & Virgillito, Maria Enrica, 2023. "Big Pharma and monopoly capitalism: A long-term view," Structural Change and Economic Dynamics, Elsevier, vol. 65(C), pages 15-35.
  • Giovanni Dosi & Luigi Marengo & Jacopo Staccioli & Maria Enrica Virgillito, 2021. "Big pharma and monopoly capitalism: A long-term view," LEM Papers Series 2021/26, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
• Dosi, Giovanni & Palagi, Elisa & Roventini, Andrea & Russo, Emanuele, 2023. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Journal of Economic Behavior & Organization, Elsevier, vol. 212(C), pages 564-589.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Working Papers hal-04114900, HAL.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," LEM Papers Series 2021/37, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  • Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," SciencePo Working papers Main hal-04114900, HAL.
• Chiappinelli, Olga & Gerres, Timo & Neuhoff, Karsten & Lettow, Frederik & de Coninck, Heleen & Felsmann, Balázs & Joltreau, Eugénie & Khandekar, Gauri & Linares, Pedro & Richstein, Jörn & Śniegocki, A, 2021. "A green COVID-19 recovery of the EU basic materials sector: identifying potentials, barriers and policy solutions," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 21(10), pages 1328-1346.
  • Olga Chiappinelli & Timo Gerres & Karsten Neuhoff & Frederik Lettow & Heleen de Coninck & Balázs Felsmann & Eugénie Joltreau & Gauri Khandekar & Pedro Linares & Jörn Richstein & Aleksander Śniegocki &, 2021. "A green COVID-19 recovery of the EU basic materials sector: identifying potentials, barriers and policy solutions," Climate Policy, Taylor & Francis Journals, vol. 21(10), pages 1328-1346, November.
  • Olga Chiappinelli & Timo Gerres & Karsten Neuhoff & Frederik Lettow & Heleen de Coninck & Balázs Felsmann & Eugénie Joltreau & Gauri Khandekar & Pedro Linares & Jörn Richstein & Aleksander Śniegocki &, 2020. "A Green COVID-19 Recovery of the EU Basic Materials Sector: Identifying Potentials, Barriers and Policy Solutions," Discussion Papers of DIW Berlin 1921, DIW Berlin, German Institute for Economic Research.
• Mariya V. Podshivalova & Sattar K.Kh. Almrshed, 2021. "Managing the innovation potential of small high-tech enterprises," Upravlenets, Ural State University of Economics, vol. 12(4), pages 16-27, September.
• Olga Chiappinelli & Timo Gerres & Karsten Neuhoff & Frederik Lettow & Heleen de Coninck & Balázs Felsmann & Eugénie Joltreau & Gauri Khandekar & Pedro Linares & Jörn Richstein & Aleksander Śniegocki &, 2021. "A green COVID-19 recovery of the EU basic materials sector: identifying potentials, barriers and policy solutions," Climate Policy, Taylor & Francis Journals, vol. 21(10), pages 1328-1346, November.
  • Chiappinelli, Olga & Gerres, Timo & Neuhoff, Karsten & Lettow, Frederik & de Coninck, Heleen & Felsmann, Balázs & Joltreau, Eugénie & Khandekar, Gauri & Linares, Pedro & Richstein, Jörn & Śniegocki, A, 2021. "A green COVID-19 recovery of the EU basic materials sector: identifying potentials, barriers and policy solutions," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 21(10), pages 1328-1346.
  • Olga Chiappinelli & Timo Gerres & Karsten Neuhoff & Frederik Lettow & Heleen de Coninck & Balázs Felsmann & Eugénie Joltreau & Gauri Khandekar & Pedro Linares & Jörn Richstein & Aleksander Śniegocki &, 2020. "A Green COVID-19 Recovery of the EU Basic Materials Sector: Identifying Potentials, Barriers and Policy Solutions," Discussion Papers of DIW Berlin 1921, DIW Berlin, German Institute for Economic Research.
• Banal-Estañol, Albert & Newham, Melissa & Seldeslachts, Jo, 2021. "Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 66(1), pages 68-99.
  • Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020. "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Discussion Papers of DIW Berlin 1918, DIW Berlin, German Institute for Economic Research.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2020. "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Working Papers 1216, Barcelona School of Economics.
  • Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020. "Common ownership in the US pharmaceutical industry: A network analysis," Working Papers of Department of Management, Strategy and Innovation, Leuven 663270, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2020. "Common ownership in the US pharmaceutical industry: A network analysis," Economics Working Papers 1752, Department of Economics and Business, Universitat Pompeu Fabra.
• Kirchhoff, Jasmina, 2021. "Mehr Arzneimittel 'made in Germany' über internationale Vernetzung: Industriepolitische Handlungsempfehlungen für eine zukunftsfähige Pharmaindustrie," IW policy papers 22/2021, Institut der deutschen Wirtschaft (IW) / German Economic Institute.
• Kirchhoff, Jasmina, 2021. "Die Rolle des Staates in der Impfstoffproduktion: Technologische Restriktionen und ökonomische Ableitungen," IW policy papers 3/2021, Institut der deutschen Wirtschaft (IW) / German Economic Institute.
• Kirchhoff, Jasmina & Schumacher, Simon, 2021. "Pharmaindustrie unter Pandemie-Bedingungen stabil: Konjunkturelle Entwicklung der pharmazeutischen Industrie im Jahr 2020," IW-Reports 3/2021, Institut der deutschen Wirtschaft (IW) / German Economic Institute.

2020

• Kenneth J. Arrow & L. Kamran Bilir & Alan Sorensen, 2020. "The Impact of Information Technology on the Diffusion of New Pharmaceuticals," American Economic Journal: Applied Economics, American Economic Association, vol. 12(3), pages 1-39, July.
  • Kenneth J. Arrow & Kamran Bilir & Alan T. Sorensen, 2017. "The Impact of Information Technology on the Diffusion of New Pharmaceuticals," NBER Working Papers 23257, National Bureau of Economic Research, Inc.
• Jérôme Adda, 2020. "Preventing the Spread of Antibiotic Resistance," AEA Papers and Proceedings, American Economic Association, vol. 110, pages 255-259, May.
• Jin Xie & Joseph Gerakos, 2020. "The Anticompetitive Effects of Common Ownership: The Case of Paragraph IV Generic Entry," AEA Papers and Proceedings, American Economic Association, vol. 110, pages 569-572, May.
• Andrés López & Jeremías Lachman & Sebastián Gómez Roca, 2020. "Convirtiendo mercados negros en mercados legales: el largo y sinuoso camino del cannabis," Asociación Argentina de Economía Política: Working Papers 4370, Asociación Argentina de Economía Política.
• Muhamed Kudic & Mariia Shkolnykova, 2020. "From biotech to bioeconomy: New empirical evidence on the technological transition to plant-based bioeconomy based on patent data," Bremen Papers on Economics & Innovation 2002, University of Bremen, Faculty of Business Studies and Economics.
• Iryna Budnikevych & Vadym Honchar, 2020. "Regulatory Mechanisms Of Ukrainian Pharmaceutical Market Competitiveness In The Context Of European Integration," Three Seas Economic Journal, Publishing house "Baltija Publishing", vol. 1(3).
• Matthew Goodkin-Gold & Michael Kremer & Christopher M. Snyder & Heidi L. Williams, 2020. "Optimal Vaccine Subsidies for Endemic and Epidemic Diseases," NBER Working Papers 28085, National Bureau of Economic Research, Inc.
  • Matthew Goodkin-Gold & Michael Kremer & Christopher M. Snyder & Heidi L. Williams, 2020. "Optimal Vaccine Subsidies for Endemic and Epidemic Diseases," Working Papers 2020-162, Becker Friedman Institute for Research In Economics.
• Banal-Estañol, Albert & Newham, Melissa & Seldeslachts, Jo, 2021. "Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 66(1), pages 68-99.
  • Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020. "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Discussion Papers of DIW Berlin 1918, DIW Berlin, German Institute for Economic Research.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2020. "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Working Papers 1216, Barcelona School of Economics.
  • Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020. "Common ownership in the US pharmaceutical industry: A network analysis," Working Papers of Department of Management, Strategy and Innovation, Leuven 663270, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2020. "Common ownership in the US pharmaceutical industry: A network analysis," Economics Working Papers 1752, Department of Economics and Business, Universitat Pompeu Fabra.
• Mariana Carrera & Sofia Villas-Boas, 2023. "Generic Aversion and Observational Learning in the Over-the-Counter Drug Market," American Economic Journal: Applied Economics, American Economic Association, vol. 15(3), pages 380-410, July.
  • Villas-Boas, Sofia B & Carrera, Mariana, 2016. "Generic aversion and observational learning in the over-the-counter drug market," Department of Agricultural & Resource Economics, UC Berkeley, Working Paper Series qt0q03b5f2, Department of Agricultural & Resource Economics, UC Berkeley.
  • Carrera, Mariana & Villas-Boas, Sofia B, 2020. "Generic Aversion and Observational Learning in the Over-the-Counter Drug Market," Department of Agricultural & Resource Economics, UC Berkeley, Working Paper Series qt7ks7s9jf, Department of Agricultural & Resource Economics, UC Berkeley.
• Zhili Tian & Ralph Siebert, 2020. "Dynamic Effects of Licensing and Knowledge Transfer across Research Stages: Evidence from the Pharmaceutical Industry," CESifo Working Paper Series 8311, CESifo.
• Songane, Mario & Grossmann, Volker, 2019. "The patent buyout price for Human Papilloma Virus (HPV) vaccine and the ratio of R&D costs to the patent value," FSES Working Papers 510, Faculty of Economics and Social Sciences, University of Freiburg/Fribourg Switzerland.
  • Mario Songane & Volker Grossmann, 2020. "The Patent Buyout Price for Human Papilloma Virus (HPV) Vaccine and the Ratio of R&D Costs to the Patent Value," CESifo Working Paper Series 8488, CESifo.
• Katrin Demmelhuber & Klaus Wohlrabe, 2020. "Branchen im Fokus: Chemische Industrie," ifo Schnelldienst, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 73(02), pages 62-64, February.
• Sabine Rumscheidt, 2020. "Branchen im Fokus: Großhandel mit chemischen Erzeugnissen," ifo Schnelldienst, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 73(03), pages 64-67, March.
• Martin Braml & Feodora Teti & Rahel Aichele, 2020. "Apotheke der Welt oder am Tropf der Weltwirtschaft? Deutschlands Außenhandel auf dem Markt für Arzneien und medizinische Ausrüstungen," ifo Schnelldienst, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 73(05), pages 35-42, May.
• Gersbach, Hans & Böttcher, Lucas, 2020. "A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development," CEPR Discussion Papers 15512, C.E.P.R. Discussion Papers.
• Borislav Boyanov, 2020. "European Chemical Industry – Current State and Challenges," Economic Archive, D. A. Tsenov Academy of Economics, Svishtov, Bulgaria, issue 1 Year 20, pages 57-72.
• Борислав Боянов, 2020. "Европейската Химическа Промишленост – Актуално Състояние И Предизвикателства," Economic Archive, D. A. Tsenov Academy of Economics, Svishtov, Bulgaria, issue 1 Year 20, pages 65-82.
• Jörn C. Richstein & Seyed Saeed Hosseinioun, 2020. "Industrial Demand Response: How Network Tariffs and Regulation Do (Not) Impact Flexibility Provision in Electricity Markets and Reserves," Discussion Papers of DIW Berlin 1853, DIW Berlin, German Institute for Economic Research.
• Banal-Estañol, Albert & Newham, Melissa & Seldeslachts, Jo, 2021. "Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 66(1), pages 68-99.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2020. "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Working Papers 1216, Barcelona School of Economics.
  • Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020. "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Discussion Papers of DIW Berlin 1918, DIW Berlin, German Institute for Economic Research.
  • Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020. "Common ownership in the US pharmaceutical industry: A network analysis," Working Papers of Department of Management, Strategy and Innovation, Leuven 663270, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2020. "Common ownership in the US pharmaceutical industry: A network analysis," Economics Working Papers 1752, Department of Economics and Business, Universitat Pompeu Fabra.
• Olga Chiappinelli & Timo Gerres & Karsten Neuhoff & Frederik Lettow & Heleen de Coninck & Balázs Felsmann & Eugénie Joltreau & Gauri Khandekar & Pedro Linares & Jörn Richstein & Aleksander Śniegocki &, 2021. "A green COVID-19 recovery of the EU basic materials sector: identifying potentials, barriers and policy solutions," Climate Policy, Taylor & Francis Journals, vol. 21(10), pages 1328-1346, November.
  • Chiappinelli, Olga & Gerres, Timo & Neuhoff, Karsten & Lettow, Frederik & de Coninck, Heleen & Felsmann, Balázs & Joltreau, Eugénie & Khandekar, Gauri & Linares, Pedro & Richstein, Jörn & Śniegocki, A, 2021. "A green COVID-19 recovery of the EU basic materials sector: identifying potentials, barriers and policy solutions," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 21(10), pages 1328-1346.
  • Olga Chiappinelli & Timo Gerres & Karsten Neuhoff & Frederik Lettow & Heleen de Coninck & Balázs Felsmann & Eugénie Joltreau & Gauri Khandekar & Pedro Linares & Jörn Richstein & Aleksander Śniegocki &, 2020. "A Green COVID-19 Recovery of the EU Basic Materials Sector: Identifying Potentials, Barriers and Policy Solutions," Discussion Papers of DIW Berlin 1921, DIW Berlin, German Institute for Economic Research.
• Alvarez E., Roberto & González, Aldo, 2020. "Análisis comparativo de los precios de los medicamentos en América Latina," Revista CEPAL, Naciones Unidas Comisión Económica para América Latina y el Caribe (CEPAL), April.
• Alvarez E., Roberto & González, Aldo, 2020. "A comparative analysis of medicine prices in Latin America," Revista CEPAL, Naciones Unidas Comisión Económica para América Latina y el Caribe (CEPAL), April.
• Richstein, Jörn C. & Hosseinioun, Seyed Saeed, 2020. "Industrial demand response: How network tariffs and regulation (do not) impact flexibility provision in electricity markets and reserves," Applied Energy, Elsevier, vol. 278(C).
• Lee, Chung-Ying, 2020. "Pricing strategy and moral hazard: Copay coupons in pharmaceuticals," International Journal of Industrial Organization, Elsevier, vol. 70(C).
• Nasirov, Shukhrat, 2020. "Trademark value indicators: Evidence from the trademark protection lifecycle in the U.S. pharmaceutical industry," Research Policy, Elsevier, vol. 49(4).
• Bartley J. Madden, 2020. "Science on FDA Liberalization: A Response to the Status Quo Process for Medical Treatments," Econ Journal Watch, Econ Journal Watch, vol. 17(1), pages 1-90–97, March.
• Varun Mahajan, 2020. "Is productivity of Indian pharmaceutical industry affected with the introduction of product patent act?," Indian Growth and Development Review, Emerald Group Publishing Limited, vol. 13(1), pages 227-258, February.
• Varun Mahajan, 2020. "Is productivity of Indian pharmaceutical industry affected with the introduction of product patent act?," Indian Growth and Development Review, Emerald Group Publishing Limited, vol. 13(1), pages 227-258, February.
• Joanna Dyczkowska & Tomasz Dyczkowski, 2020. "Building Stakeholder Relations through Ongoing Engagement and Constructive Dialogue: Lessons from Large Biopharmaceutical Companies," European Research Studies Journal, European Research Studies Journal, vol. 0(Special 2), pages 733-746.
• Banal-Estañol, Albert & Newham, Melissa & Seldeslachts, Jo, 2021. "Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 66(1), pages 68-99.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2020. "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Working Papers 1216, Barcelona School of Economics.
  • Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020. "Common ownership in the US pharmaceutical industry: A network analysis," Working Papers of Department of Management, Strategy and Innovation, Leuven 663270, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2020. "Common ownership in the US pharmaceutical industry: A network analysis," Economics Working Papers 1752, Department of Economics and Business, Universitat Pompeu Fabra.
  • Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020. "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Discussion Papers of DIW Berlin 1918, DIW Berlin, German Institute for Economic Research.
• Alenka Guzmán & Marco Antonio Pérez, 2020. "Extensión de la pandemia Covid-19 frente al acceso a la vacuna y las capacidades tecnológicas y de innovación del sector biofarmacéutico de México," Economía: teoría y práctica, Universidad Autónoma Metropolitana, México, vol. 0(2), pages 69-98, Diciembre.
• Gérard Mondello, 2020. "Construction de systèmes de croyances et éthique médicale: les controverses autour du Covid-19," GREDEG Working Papers 2020-19, Groupe de REcherche en Droit, Economie, Gestion (GREDEG CNRS), Université Côte d'Azur, France, revised Feb 2022.
  • Gérard Mondello, 2021. "Construction De Systèmes De Croyances Et Éthique Médicale: Les Controverses Autour Du Covid-19," Working Papers halshs-03502610, HAL.
• Gérard Mondello, 2020. "Building Belief Systems and Medical Ethics: The Covid-19 Controversies," GREDEG Working Papers 2020-35, Groupe de REcherche en Droit, Economie, Gestion (GREDEG CNRS), Université Côte d'Azur, France.
  • Gérard Mondello, 2021. "Building Belief Systems And Medical Ethics: The Covid-19 Controversies," Working Papers halshs-03502609, HAL.
• de Roux, Nicolás & Eslava, Marcela & Franco, Santiago & Verhoogen, Eric, 2020. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," IZA Discussion Papers 14006, Institute of Labor Economics (IZA).
  • Nicolás de Roux & Marcela Eslava & Santiago Franco & Eric Verhoogen, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," NBER Working Papers 28323, National Bureau of Economic Research, Inc.
  • Nicolás de Roux & Marcela Eslava & Santiago Franco & Eric Verhoogen, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," Documentos CEDE 18705, Universidad de los Andes, Facultad de Economía, CEDE.
  • Verhoogen, Eric & de Roux, Nicolás & Eslava, Marcela & Franco, Santiago, 2021. "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," CEPR Discussion Papers 15626, C.E.P.R. Discussion Papers.
• Katharina E. Blankart & Frank R. Lichtenberg, 2020. "Are patients more adherent to newer drugs?," Health Care Management Science, Springer, vol. 23(4), pages 605-618, December.
• Laura Borge & Stefanie Bröring, 2020. "What affects technology transfer in emerging knowledge areas? A multi-stakeholder concept mapping study in the bioeconomy," The Journal of Technology Transfer, Springer, vol. 45(2), pages 430-460, April.
• Hugo Ernesto Martínez Ardila & Julián Eduardo Mora Moreno & Jaime Alberto Camacho Pico, 2020. "Networks of collaborative alliances: the second order interfirm technological distance and innovation performance," The Journal of Technology Transfer, Springer, vol. 45(4), pages 1255-1282, August.
• Stefan Houweling & Sven Wolff, 2020. "The influence of scientific prestige and peer effects on the intention to create university spin-offs," The Journal of Technology Transfer, Springer, vol. 45(5), pages 1432-1450, October.
• Jean-Paul Chavas & Guanming Shi & Kyle Stiegert, 2020. "Pricing and Industry Structure when Demand Elasticity Changes," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 57(4), pages 891-907, December.
• Maé Geymond, 2020. "The influence of local institutional and historical frameworks on a globalized industry: The case of the pharmaceutical industry in France and Quebec," Documents de travail du Centre d'Economie de la Sorbonne 20011, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne.
• Michael Kremer & Jonathan Levin & Christopher M. Snyder, 2020. "Advance Market Commitments: Insights from Theory and Experience," AEA Papers and Proceedings, American Economic Association, vol. 110, pages 269-273, May.
  • Michael Kremer & Jonathan D. Levin & Christopher M. Snyder, 2020. "Advance Market Commitments: Insights from Theory and Experience," NBER Working Papers 26775, National Bureau of Economic Research, Inc.
• Andrew W. Lo & Kien Wei Siah & Chi Heem Wong, 2020. "Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs," NBER Working Papers 27176, National Bureau of Economic Research, Inc.
• Bronwyn H. Hall, 2024. "Patents, innovation, and development," International Review of Applied Economics, Taylor & Francis Journals, vol. 38(1-2), pages 17-42, March.
  • Bronwyn H. Hall, 2020. "Patents, Innovation, and Development," NBER Working Papers 27203, National Bureau of Economic Research, Inc.
• Matthew J. Higgins & Mathias J. Kronlund & Ji Min Park & Joshua Pollet, 2020. "The Role of Assets In Place: Loss of Market Exclusivity and Investment," NBER Working Papers 27588, National Bureau of Economic Research, Inc.
• Matthew Goodkin-Gold & Michael Kremer & Christopher M. Snyder & Heidi L. Williams, 2020. "Optimal Vaccine Subsidies for Endemic and Epidemic Diseases," Working Papers 2020-162, Becker Friedman Institute for Research In Economics.
  • Matthew Goodkin-Gold & Michael Kremer & Christopher M. Snyder & Heidi L. Williams, 2020. "Optimal Vaccine Subsidies for Endemic and Epidemic Diseases," NBER Working Papers 28085, National Bureau of Economic Research, Inc.
• BĂRNUŢ Cătălin-Florin, 2020. "Stock Market Performance Analysis Of Pharmaceutical, It And Automotive Companies From Poland," Annals of Faculty of Economics, University of Oradea, Faculty of Economics, vol. 1(1), pages 177-188, July.
• Gabriela-Iuliana Paraschiv (Ganea) & Elena Condrea & Valentina Olteanu, 2020. "Biodegradable and Compostable Products – Essential Components for the Development of a Sustainable Bioeconomy," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, vol. 0(1), pages 211-218, August.
• Doina Margaritti & Cristina Tase, 2020. "Demand on the Pharmaceutical Market in the Conditions of the COVID-19 Health Crisis," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, vol. 0(2), pages 396-400, December.
• Raghbendra Jha & Ashok Sharma, 2020. "India's pharmaceutical industry: Global supply chain and governance in the post-COVID-19 world," ASARC Working Papers 2020-01, The Australian National University, Australia South Asia Research Centre.
• Jakub Growiec & Fabio Pammolli & Massimo Riccaboni, 2020. "Innovation and Corporate Dynamics: A Theoretical Framework," Central European Journal of Economic Modelling and Econometrics, Central European Journal of Economic Modelling and Econometrics, vol. 12(1), pages 1-45, March.
  • Jakub Growiec & Fabio Pammolli & Massimo Riccaboni, 2011. "Innovation and Corporate Dynamics: A Theoretical Framework," DISA Working Papers 2011/08, Department of Computer and Management Sciences, University of Trento, Italy, revised 29 Jul 2011.
  • Massimo, Riccaboni & Jakub, Growiec & Fabio, Pammolli, 2011. "Innovation and Corporate Dynamics: A Theoretical Framework," MPRA Paper 30046, University Library of Munich, Germany.
• Lichtenberg, Frank, 2020. "The Health Impact of, and access to, New Drugs in Korea," East Asian Economic Review, Korea Institute for International Economic Policy, vol. 24(2), pages 127-164, June.
• Atsuko Kamiike, 2020. "The TRIPS Agreement and the Pharmaceutical Industry in India," Journal of Interdisciplinary Economics, , vol. 32(1), pages 95-113, January.
• Meng-Chi Tang & Yi-Nong Wu, 2020. "Medical providers as double agents in a universal health care system: evidence from generic pharmaceutical adoption in Taiwan," Empirical Economics, Springer, vol. 59(1), pages 169-203, July.
• Felicity Lamrock & Laura McCullagh & Lesley Tilson & Michael Barry, 2020. "A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(6), pages 895-901, August.
• Varun Mahajan & D. K. Nauriyal & S. P. Singh, 2020. "Domestic market competitiveness of Indian drug and pharmaceutical industry," Review of Managerial Science, Springer, vol. 14(3), pages 519-559, June.
• F. Di Iorio & M. Letizia Giorgetti, 2020. "Launch of a product and patents: evidence from the US cardiovascular pharmaceutical sector," Industry and Innovation, Taylor & Francis Journals, vol. 27(7), pages 789-803, August.
  • Francesca Di Iorio & Maria Letizia Giorgietti, 2019. "Launch of a product and patents: evidence from the US cardiovascular pharmaceutical sector," DEM Working Papers Series 169, University of Pavia, Department of Economics and Management.
• Banal-Estañol, Albert & Newham, Melissa & Seldeslachts, Jo, 2021. "Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 66(1), pages 68-99.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2020. "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Working Papers 1216, Barcelona School of Economics.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2020. "Common ownership in the US pharmaceutical industry: A network analysis," Economics Working Papers 1752, Department of Economics and Business, Universitat Pompeu Fabra.
  • Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020. "Common ownership in the US pharmaceutical industry: A network analysis," Working Papers of Department of Management, Strategy and Innovation, Leuven 663270, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020. "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Discussion Papers of DIW Berlin 1918, DIW Berlin, German Institute for Economic Research.
• Ralina Dobrinova Mircheva, 2020. "A Crisis Within the Crisis: The Impact of Covid-19 and Brexit On Supply Chains in the Pharmaceutical Industry," Business & Management Compass, University of Economics Varna, issue 3, pages 352-368.
• Claudio Deiana & Ludovica Giua & Roberto Nisticò, 2024. "Opium Price Shocks and Prescription Opioids in the USA," Oxford Bulletin of Economics and Statistics, Department of Economics, University of Oxford, vol. 86(3), pages 449-484, June.
  • Deiana, C. & Giua, L. & Nisticò, R., 2020. "Opium Price Shocks and Prescription Opioids in the US," Health, Econometrics and Data Group (HEDG) Working Papers 20/23, HEDG, c/o Department of Economics, University of York.
• Richstein, Jörn C. & Hosseinioun, Seyed Saeed, 2020. "Industrial demand response: How network tariffs and regulation (do not) impact flexibility provision in electricity markets and reserves," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 278.
• Döhler, Niklas & Wellenreuther, Claudia & Wolf, André, 2020. "Market dynamics of biodegradable bio-based plastics: Projections and linkages to European policies," HWWI Research Papers 193, Hamburg Institute of International Economics (HWWI).
• Wellenreuther, Claudia & Wolf, André, 2020. "Innovative feedstocks in biodegradable bio-based plastics: A literature review," HWWI Research Papers 194, Hamburg Institute of International Economics (HWWI).
• Diel, Anastasia & Kirchhoff, Jasmina, 2020. "Beschäftigungsstruktur der europäischen Pharmaindustrie: Ein Indikator für die Attraktivität eines Standorts?," IW-Reports 2/2020, Institut der deutschen Wirtschaft (IW) / German Economic Institute.
• Grömling, Michael & Kirchhof, Jasmina, 2020. "Produktions- und Zulieferstrukturen der deutschen Pharmaindustrie: Wie abhängig ist die Branche vom Ausland? [Production structures and supply chains in the German pharmaceutical sector: How depend," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, vol. 47(4), pages 23-44.

2019

• Emeric Henry & Marco Ottaviani, 2019. "Research and the Approval Process: The Organization of Persuasion," American Economic Review, American Economic Association, vol. 109(3), pages 911-955, March.
  • Ottaviani, Marco, 2017. "Research and the Approval Process: The Organization of Persuasion," CEPR Discussion Papers 11939, C.E.P.R. Discussion Papers.
  • Emeric Henry & Marco Ottaviani, 2019. "Research and the Approval Process: the Organization of Persuasion," SciencePo Working papers Main hal-03391894, HAL.
  • Emeric Henry & Marco Ottaviani, 2019. "Research and the Approval Process: the Organization of Persuasion," Post-Print hal-03391894, HAL.
• Katalin Antalóczy & Tamás Gáspár & Magdolna Sass, 2019. "The Specialties of the Pharmaceutical Value Chains in Hungary," Acta Oeconomica, Akadémiai Kiadó, Hungary, vol. 69(supplemen), pages 41-72, December.
• Lichtenberg Frank R., 2018. "The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis," Forum for Health Economics & Policy, De Gruyter, vol. 21(2), pages 1-20, December.
  • Frank R. Lichtenberg, 2019. "The impact of new drug launches on hospitalization in 2015 for 67 medical conditions in 15 OECD countries: a two-way fixed-effects analysis," CESifo Working Paper Series 7559, CESifo.
• Aleksina, Anna & Akulenka, Stanislau & Lublóy, Ágnes, 2019. "Success Factors of Crowdfunding Campaigns in Medical Research: Perceptions and Reality," Corvinus Economics Working Papers (CEWP) 2019/07, Corvinus University of Budapest.
• Карина Саркисян-Дикова & Борислав Боянов, 2019. "Въздействие На Европейските Екологични Регулации Върху Международната Конкурентоспособност На Предприятията От Химическата Промишленост В България," Scientific Research Almanac, D. A. Tsenov Academy of Economics, Svishtov, Bulgaria, vol. 27(1 Year 20), pages 253-278.
• Haucap, Justus & Rasch, Alexander & Stiebale, Joel, 2019. "How mergers affect innovation: Theory and evidence," International Journal of Industrial Organization, Elsevier, vol. 63(C), pages 283-325.
  • Stiebale, Joel & Haucap, Justus, 2013. "How Mergers A ffect Innovation: Theory and Evidence," VfS Annual Conference 2013 (Duesseldorf): Competition Policy and Regulation in a Global Economic Order 79831, Verein für Socialpolitik / German Economic Association.
• Billette de Villemeur, Etienne & Versaevel, Bruno, 2019. "One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry," Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
  • Billette de Villemeur, Etienne & Versaevel, Bruno, 2017. "One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry," MPRA Paper 76903, University Library of Munich, Germany.
  • Etienne Billette de Villemeur & Bruno Versaevel, 2019. "One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry," Post-Print hal-02107357, HAL.
  • Bruno Versaevel, 2018. "One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry," Post-Print halshs-01960435, HAL.
  • Bruno Versaevel, 2018. "One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry," Post-Print halshs-01960426, HAL.
• Tylecote, Andrew, 2019. "Biotechnology as a new techno-economic paradigm that will help drive the world economy and mitigate climate change," Research Policy, Elsevier, vol. 48(4), pages 858-868.
• Mitze, Timo & Strotebeck, Falk, 2019. "Determining factors of interregional research collaboration in Germany's biotech network: Capacity, proximity, policy?," Technovation, Elsevier, vol. 80, pages 40-53.
• Philippe Gorry & Diego Useche, 2018. "Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 305-334, National Bureau of Economic Research, Inc.
  • Diego Useche & Philippe Gorry, 2015. "Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies," Post-Print hal-02195963, HAL.
  • Philippe Gorry & Diego Useche, 2019. "Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies," Post-Print hal-02152424, HAL.
  • Diego Useche & Philippe Gorry, 2016. "Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies," Post-Print hal-02195744, HAL.
  • Philippe Gorry & Diego Useche, 2017. "Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies," NBER Working Papers 24021, National Bureau of Economic Research, Inc.
• Emeric Henry & Marco Ottaviani, 2019. "Research and the Approval Process: The Organization of Persuasion," American Economic Review, American Economic Association, vol. 109(3), pages 911-955, March.
  • Ottaviani, Marco, 2017. "Research and the Approval Process: The Organization of Persuasion," CEPR Discussion Papers 11939, C.E.P.R. Discussion Papers.
  • Emeric Henry & Marco Ottaviani, 2019. "Research and the Approval Process: the Organization of Persuasion," SciencePo Working papers Main hal-03391894, HAL.
  • Emeric Henry & Marco Ottaviani, 2019. "Research and the Approval Process: the Organization of Persuasion," Post-Print hal-03391894, HAL.
• Granlund, David, 2019. "A new approach to estimating state dependence in consumers’ brand choices applied to 762 pharmaceutical markets," Umeå Economic Studies 960, Umeå University, Department of Economics.
• Bibek Ray Chaudhuri & Sucharita Bhattacharyya & Susmita Chatterjee, 2019. "Pharmaceutical Exports and Patents in India – An Empirical Investigation," Working Papers 1939, Indian Institute of Foreign Trade.
• Toonika Rinken & Kairi Kivirand (ed.), 2019. "Biosensors for Environmental Monitoring," Books, IntechOpen, number 5929, January-J.
• Xudong Zhang & William Wang & Sunghoon Jang, 2019. "The Modeling, Design, Fabrication, and Application of Biosensor Based on Electric Cell-Substrate Impedance Sensing (ECIS) Technique in Environmental Monitoring," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Fabiano Luiz Naves, 2019. "Normal Boundary Intersection Applied to Controllers in Environmental Controls," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Amra Odobasic & Indira Sestan & Sabina Begic, 2019. "Biosensors for Determination of Heavy Metals in Waters," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Patricia S. Peixoto & Ana Machado & Helder P. Oliveira & Adriano A. Bordalo & Marcela A. Segundo, 2019. "Paper-Based Biosensors for Analysis of Water," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Kairi Kivirand & Mart Min & Toonika Rinken, 2019. "Challenges and Applications of Impedance-Based Biosensors in Water Analysis," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Flavio Colmati & Livia Florio Sgobbi & Guilhermina Ferreira Teixeira & Ramon Silva Vilela & Tatiana Martins & Giovanna Oliveira Figueiredo, 2019. "Electrochemical Biosensors Containing Pure Enzymes or Crude Extracts as Enzyme Sources for Pesticides and Phenolic Compounds with Pharmacological Property Detection and Quantification," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Eliana Mosse Alhadeff & Alfredo Jackson Telles Bosco & Caio Fragale Pastusiak & Thais Anjos Correia & Ninoska Isabel Bojorge Ramirez, 2019. "Development of an Ethanol Biosensor Based on Silver Nanoparticles/Polyaniline/Graphite/Epoxy Composite for Friendly Analytical Application," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Patricia Mussali-Galante & Efrain Tovar-Sanchez & Ramon Suarez-Rodriguez & Augusto Ramirez-Trujillo & Leticia Valencia-Cuevas & Isela Hernandez-Plata, 2019. "The Use of Biosensors for Biomonitoring Environmental Metal Pollution," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Geovany Albino De Souza & Tatiana Martins & Flavio Colmati, 2019. "Dynamic Luminescent Biosensors Based on Peptides for Oxygen Determination," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Umer Farooq & Qiaoli Yang & Muhammad Wajid Ullah & Shenqi Wang, 2019. "Principle and Development of Phage-Based Biosensors," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Toonika Rinken & Kairi Kivirand, 2019. "Introductory Chapter: The Prospective of Biosensing in Environmental Monitoring," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Shenqi Wang & Umer Farooq & Muhammad Wajid Ullah & Qiaoli Yang, 2019. "Applications of Phage-Based Biosensors in the Diagnosis of Infectious Diseases, Food Safety, and Environmental Monitoring," Chapters, in: Toonika Rinken & Kairi Kivirand (ed.), Biosensors for Environmental Monitoring, IntechOpen.
• Claudio Deiana & Ludovica Giua & Roberto Nisticò, 2019. "The Economics Behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US," CSEF Working Papers 525, Centre for Studies in Economics and Finance (CSEF), University of Naples, Italy, revised 13 May 2019.
  • Deiana, Claudio & Giua, Ludovica & Nistico, Roberto, 2019. "The Economics behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US," IZA Discussion Papers 12872, Institute of Labor Economics (IZA).
• Annika Lorenz & Michael Raven & Knut Blind, 2019. "The role of standardization at the interface of product and process development in biotechnology," The Journal of Technology Transfer, Springer, vol. 44(4), pages 1097-1133, August.
• Supriya Munshaw & Soo-Hoon Lee & Phillip H. Phan & Kieren A. Marr, 2019. "The influence of human capital and perceived university support on patent applications of biomedical investigators," The Journal of Technology Transfer, Springer, vol. 44(4), pages 1216-1235, August.
• Richard G. Frank & Andrew Hicks & Ernst R. Berndt, 2019. "The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines," NBER Working Papers 26120, National Bureau of Economic Research, Inc.
• Rena M. Conti & Ernst R. Berndt, 2019. "Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets," NBER Working Papers 26194, National Bureau of Economic Research, Inc.
• Neriman Beste Kaygisiz & Yashna Shivdasani & Rena M. Conti & Ernst R. Berndt, 2019. "The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications," NBER Working Papers 26524, National Bureau of Economic Research, Inc.
• Yulia Nedelcheva, 2019. "Competitiveness In The Pharmaceutical Industry: A Historical Overview," Entrepreneurship, Faculty of Economics, SOUTH-WEST UNIVERSITY "NEOFIT RILSKI", BLAGOEVGRAD, vol. 7(1), pages 36-47.
• Malyshev Victor & Kushchevska Nina & Korotieieva Antonina & Bruskova Diana-Maria & Lukashenko Tetiana & Zalubovskiy Mark, 2019. "Investigation of state, trends and structure of the world market of nanopowders," Technology audit and production reserves, 2(46) 2019, Socionet;Technology audit and production reserves, vol. 2(4(46)), pages 34-42.
• Shevtsova Hanna & Maslosh Olha, 2019. "Chemical production modernization in the formative phase of Industry 4.0: study of trends and problems of investment support," Technology audit and production reserves, 1(45) 2019, Socionet;Technology audit and production reserves, vol. 1(4(45)), pages 30-37.
• Malyshev Victor & Kushchevska Nina & Korotieieva Antonina & Bruskova Diana-Maria & Zalubovskiy Mark & Lukashenko Tetiana, 2019. "Analysis and systematization of marketing studies data of the Ukrainian nanopowder market and formation of the program for its development," Technology audit and production reserves, 3(47) 2019, Socionet;Technology audit and production reserves, vol. 3(4(47)), pages 28-34.
• Ekaterina Bogomilova, 2019. "Analysis of Threats to the Physical Protection of Nuclear Facilities and Sites," Godishnik na UNSS, University of National and World Economy, Sofia, Bulgaria, issue 1, pages 253-264, December.
• Solon Moreira & Goretti Cabaleiro & Toke Reichstein, 2019. "Licensing decision: a rent dissipation lens applied to product market competition, openness to external knowledge and exogenous sunk costs," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 28(4), pages 773-792.
• Mary Donegan & Allison Forbes & Paige Clayton & Alyse Polly & Maryann Feldman & Nichola Lowe, 2019. "The tortoise, the hare, and the hybrid: effects of prior employment on the development of an entrepreneurial ecosystem," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 28(4), pages 899-920.
• Eduardo Morales & Gloria Sheu & Andrés Zahler, 2019. "Extended Gravity," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 86(6), pages 2668-2712.
  • Gloria Sheu & Andres Zahler & Eduardo Morales, 2016. "Extended Gravity," 2016 Meeting Papers 1565, Society for Economic Dynamics.
• F. Di Iorio & M. Letizia Giorgetti, 2020. "Launch of a product and patents: evidence from the US cardiovascular pharmaceutical sector," Industry and Innovation, Taylor & Francis Journals, vol. 27(7), pages 789-803, August.
  • Francesca Di Iorio & Maria Letizia Giorgietti, 2019. "Launch of a product and patents: evidence from the US cardiovascular pharmaceutical sector," DEM Working Papers Series 169, University of Pavia, Department of Economics and Management.
• Fujii, Hidemichi & Managi, Shunsuke & Kawahara, Hiromitsu, 2019. "The Pollution Release and Transfer Register System in the U.S. and Japan: An Analysis of Productivity," MPRA Paper 92235, University Library of Munich, Germany.
• Fabian Gaessler & Stefan Wagner, 2022. "Patents, Data Exclusivity, and the Development of New Drugs," The Review of Economics and Statistics, MIT Press, vol. 104(3), pages 571-586, May.
  • Gaessler, Fabian & Wagner, Stefan, 2019. "Patents, Data Exclusivity, and the Development of New Drugs," Rationality and Competition Discussion Paper Series 176, CRC TRR 190 Rationality and Competition.
• Junghee Lee, 2019. "Study on the improvement of the enumeration of Legionella in environmental water samples using real-time PCR," Proceedings of International Academic Conferences 9711393, International Institute of Social and Economic Sciences.
• Pablo Montoro Leal & Juan Carlos García Mesa & María Mar López Guerrero & Elisa Isabel Vereda Alonso, 2019. "Synthesis and characterization of a new magnetic material join to graphene oxide as sorbent," Proceedings of International Academic Conferences 9811007, International Institute of Social and Economic Sciences.
• Emeric Henry & Gianmarco Ottaviano, 2019. "Research and the Approval Process: the Organization of Persuasion," Sciences Po publications info:hdl:2441/1gr6n3t28b9, Sciences Po.
• Farasat A. S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2021. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Small Business Economics, Springer, vol. 57(1), pages 603-634, June.
  • Farasat A.S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2019. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2016-01v3, Centre for Competition Policy, University of East Anglia, Norwich, UK..
• John Ashton & Tim Burnett & Ivan Diaz Rainey & Peter L. Ormosi, 2018. "Has the financial regulatory environment improved in the UK? Capture-Recapture approach to estimate detection and deterrence," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2018-03, Centre for Competition Policy, University of East Anglia, Norwich, UK..
• Farasat A.S. Bokhari & Franco Mariuzzo & Weijie Yan, 2019. "Antibacterial resistance and the cost of affecting demand: the case of UK antibiotics," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2019-03, Centre for Competition Policy, University of East Anglia, Norwich, UK..
• Izhak, Olena, 2019. "Extra costs of integrity: Pharmacy markups and generic substitution in Finland," DICE Discussion Papers 307, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
• Kirchhoff, Jasmina, 2019. "Auswirkungen des Brexits auf die deutsche Pharmaindustrie: Relevanz des Vereinigten Königreichs für pharmazeutische Unternehmen in Deutschland," IW-Reports 36/2019, Institut der deutschen Wirtschaft (IW) / German Economic Institute.

2018

• Pierre Dubois & Laura Lasio, 2018. "Identifying Industry Margins with Price Constraints: Structural Estimation on Pharmaceuticals," American Economic Review, American Economic Association, vol. 108(12), pages 3685-3724, December.
• Mariana Carrera & Dana P. Goldman & Geoffrey Joyce & Neeraj Sood, 2018. "Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients?," American Economic Journal: Economic Policy, American Economic Association, vol. 10(1), pages 113-152, February.
• Liran Einav & Amy Finkelstein & Maria Polyakova, 2018. "Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D," American Economic Journal: Economic Policy, American Economic Association, vol. 10(3), pages 122-153, August.
  • Liran Einav & Amy Finkelstein & Maria Polyakova, 2016. "Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D," NBER Working Papers 22277, National Bureau of Economic Research, Inc.
• Kurt Lavetti & Kosali Simon, 2018. "Strategic Formulary Design in Medicare Part D Plans," American Economic Journal: Economic Policy, American Economic Association, vol. 10(3), pages 154-192, August.
  • Kurt Lavetti & Kosali Simon, 2016. "Strategic Formulary Design in Medicare Part D Plans," NBER Working Papers 22338, National Bureau of Economic Research, Inc.
• Darius N. Lakdawalla, 2018. "Economics of the Pharmaceutical Industry," Journal of Economic Literature, American Economic Association, vol. 56(2), pages 397-449, June.
• Maria-Silvia Sandulescu & Drago? Andrei Stoica & Catalin-Nicolae Albu & Nadia Albu, 2018. "Types of Intellectual Capital Employed in Bioeconomic Projects – A Longitudinal Case Study," The AMFITEATRU ECONOMIC journal, Academy of Economic Studies - Bucharest, Romania, vol. 20(49), pages 667-667, August.
• Kseniya Yurtayeva & Yevhenia Hladkova & Alona Shcherbakova, 2018. "Role Of Mass Media In Combating Drug-Related Crime," Baltic Journal of Economic Studies, Publishing house "Baltija Publishing", vol. 4(3).
• Plamena Nedyalkova, 2018. "Features, Characteristics and Methodology of Internal Control over Nanotech Manufacturing and Nano-Production in Food Industry," Economic Studies journal, Bulgarian Academy of Sciences - Economic Research Institute, issue 3, pages 157-189.
• Newham, M. & Seldeslachts, J. & Banal-Estanol, A., 2018. "Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry," Working Papers 18/03, Department of Economics, City University London.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2018. "Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry," Working Papers 1042, Barcelona School of Economics.
  • Melissa Newham & Jo Seldeslachts & Albert Banal-Estanol, 2018. "Common ownership and market entry: Evidence from the pharmaceutical industry," Working Papers of Department of Management, Strategy and Innovation, Leuven 623896, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Melisa Newham & Jo Seldeslachts & Albert Banal-Estañol, 2018. "Common ownership and market entry: Evidence from the pharmaceutical industry," Economics Working Papers 1612, Department of Economics and Business, Universitat Pompeu Fabra.
  • Melissa Newham & Jo Seldeslachts & Albert Banal-Estanol, 2018. "Common Ownership and Market Entry: Evidence from Pharmaceutical Industry," Discussion Papers of DIW Berlin 1738, DIW Berlin, German Institute for Economic Research.
• Marco Ceccagnoli & Matthew J. Higgins & Hyunsung D. Kang, 2018. "Corporate venture capital as a real option in the markets for technology," Strategic Management Journal, Wiley Blackwell, vol. 39(13), pages 3355-3381, December.
  • Marco Ceccagnoli & Matthew J. Higgins & Hyunsung D. Kang, 2015. "Corporate Venture Capital as a Real Option in the Markets for Technology," NBER Working Papers 21424, National Bureau of Economic Research, Inc.
• Kang Hyunsung D, 2018. "A Start-Up’s R&D Stages and the Evolution of Financing Sources: Evidence from the Biotechnology Industry," Entrepreneurship Research Journal, De Gruyter, vol. 8(3), pages 1-19, July.
• Lichtenberg Frank R., 2018. "The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis," Forum for Health Economics & Policy, De Gruyter, vol. 21(2), pages 1-20, December.
  • Frank R. Lichtenberg, 2019. "The impact of new drug launches on hospitalization in 2015 for 67 medical conditions in 15 OECD countries: a two-way fixed-effects analysis," CESifo Working Paper Series 7559, CESifo.
• Víctor Manuel NIETO & Santiago Alberto PEREA, 2018. "Cadena Productiva de Pinturas, Masillas, Pigmentos, Tintas y Removedores Estructura, Comercio Internacional y Protección," Archivos de Economía 16498, Departamento Nacional de Planeación.
• Carmen Padilla-Lozano & Danny Arévalo-Avecillas & Nancy Wong-Laborde, 2018. "Influencia de la responsabilidad social en el desempeno financiero del sector químico-farmacéutico," Revista Equidad y Desarrollo, Universidad de la Salle, issue 32, pages 121-141, July.
• Kremer, Michael & Snyder, Christopher, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global D," CEPR Discussion Papers 12751, C.E.P.R. Discussion Papers.
• Lichtenberg, Frank R., 2018. "The Impact Of New Drug Launches On Life-Years Lost In 2015 From 19 Types Of Cancer In 36 Countries," Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
  • Frank R. LICHTENBERG, 2018. "The Impact of New Drug Launch on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," JODE - Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
  • Frank R. Lichtenberg, 2018. "The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," Working Papers id:12757, eSocialSciences.
  • Frank R. Lichtenberg, 2018. "The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," NBER Working Papers 24536, National Bureau of Economic Research, Inc.
• Melissa Newham & Jo Seldeslachts & Albert Banal-Estanol, 2018. "Common Ownership and Market Entry: Evidence from Pharmaceutical Industry," Discussion Papers of DIW Berlin 1738, DIW Berlin, German Institute for Economic Research.
  • Newham, M. & Seldeslachts, J. & Banal-Estanol, A., 2018. "Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry," Working Papers 18/03, Department of Economics, City University London.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2018. "Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry," Working Papers 1042, Barcelona School of Economics.
  • Melissa Newham & Jo Seldeslachts & Albert Banal-Estanol, 2018. "Common ownership and market entry: Evidence from the pharmaceutical industry," Working Papers of Department of Management, Strategy and Innovation, Leuven 623896, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Melisa Newham & Jo Seldeslachts & Albert Banal-Estañol, 2018. "Common ownership and market entry: Evidence from the pharmaceutical industry," Economics Working Papers 1612, Department of Economics and Business, Universitat Pompeu Fabra.
• Frank R. LICHTENBERG, 2018. "The Impact of New Drug Launch on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," JODE - Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
  • Lichtenberg, Frank R., 2018. "The Impact Of New Drug Launches On Life-Years Lost In 2015 From 19 Types Of Cancer In 36 Countries," Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
  • Frank R. Lichtenberg, 2018. "The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," Working Papers id:12757, eSocialSciences.
  • Frank R. Lichtenberg, 2018. "The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," NBER Working Papers 24536, National Bureau of Economic Research, Inc.
• Atal, Juan Pablo & Cuesta, José Ignacio & Sæthre, Morten, 2018. "Quality Regulation and Competition: Evidence from Pharmaceutical Markets," Discussion Paper Series in Economics 20/2018, Norwegian School of Economics, Department of Economics.
  • Juan Pablo Atal & José Ignacio Cuesta & Morten Sæthre, 2022. "Quality Regulation and Competition: Evidence from Pharmaceutical Markets," NBER Working Papers 30325, National Bureau of Economic Research, Inc.
  • Jesus Juan Pablo Atal & Jose´ Ignacio Cuesta & Morten Sæthre, 2019. "Quality Regulation and Competition: Evidence from Pharmaceutical Markets," PIER Working Paper Archive 19-017, Penn Institute for Economic Research, Department of Economics, University of Pennsylvania.
  • Atal, Juan Pablo & Cuesta, Jose Ignacio & Sæthre, Morten, 2018. "Quality Regulation and Competition: Evidence from Pharmaceutical Markets," Research Department working papers 1211, CAF Development Bank Of Latinamerica.
• Melissa Newham & Jo Seldeslachts & Albert Banal-Estanol, 2018. "Common ownership and market entry: Evidence from the pharmaceutical industry," Working Papers of Department of Management, Strategy and Innovation, Leuven 623896, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Melissa Newham & Jo Seldeslachts & Albert Banal-Estanol, 2018. "Common Ownership and Market Entry: Evidence from Pharmaceutical Industry," Discussion Papers of DIW Berlin 1738, DIW Berlin, German Institute for Economic Research.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2018. "Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry," Working Papers 1042, Barcelona School of Economics.
  • Melisa Newham & Jo Seldeslachts & Albert Banal-Estañol, 2018. "Common ownership and market entry: Evidence from the pharmaceutical industry," Economics Working Papers 1612, Department of Economics and Business, Universitat Pompeu Fabra.
  • Newham, M. & Seldeslachts, J. & Banal-Estanol, A., 2018. "Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry," Working Papers 18/03, Department of Economics, City University London.
• Granlund, David & Bergman, Mats A., 2018. "Price competition in pharmaceuticals – Evidence from 1303 Swedish markets," Journal of Health Economics, Elsevier, vol. 61(C), pages 1-12.
• Honjo, Yuji & Nagaoka, Sadao, 2018. "Initial public offering and financing of biotechnology start-ups: Evidence from Japan," Research Policy, Elsevier, vol. 47(1), pages 180-193.
  • HONJO, Yuji & 本庄, 裕司 & NAGAOKA, Sadao & 長岡, 貞男, 2015. "Initial Public Offering and Financing of Biotechnology Start-ups: Evidence from Japan," IIR Working Paper 15-20, Institute of Innovation Research, Hitotsubashi University.
• Lawrence Kryzanowski & Trang Phuong Tran, 2018. "Informed trading around biotech M&As," Studies in Economics and Finance, Emerald Group Publishing Limited, vol. 35(1), pages 44-64, March.
• Frank R. LICHTENBERG, 2018. "The Impact of New Drug Launch on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," JODE - Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
  • Lichtenberg, Frank R., 2018. "The Impact Of New Drug Launches On Life-Years Lost In 2015 From 19 Types Of Cancer In 36 Countries," Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
  • Frank R. Lichtenberg, 2018. "The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," NBER Working Papers 24536, National Bureau of Economic Research, Inc.
  • Frank R. Lichtenberg, 2018. "The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," Working Papers id:12757, eSocialSciences.
• Newham, M. & Seldeslachts, J. & Banal-Estanol, A., 2018. "Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry," Working Papers 18/03, Department of Economics, City University London.
  • Melissa Newham & Jo Seldeslachts & Albert Banal-Estanol, 2018. "Common ownership and market entry: Evidence from the pharmaceutical industry," Working Papers of Department of Management, Strategy and Innovation, Leuven 623896, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2018. "Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry," Working Papers 1042, Barcelona School of Economics.
  • Melisa Newham & Jo Seldeslachts & Albert Banal-Estañol, 2018. "Common ownership and market entry: Evidence from the pharmaceutical industry," Economics Working Papers 1612, Department of Economics and Business, Universitat Pompeu Fabra.
  • Melissa Newham & Jo Seldeslachts & Albert Banal-Estanol, 2018. "Common Ownership and Market Entry: Evidence from Pharmaceutical Industry," Discussion Papers of DIW Berlin 1738, DIW Berlin, German Institute for Economic Research.
• Atal, Juan Pablo & Cuesta, Jose Ignacio & Sæthre, Morten, 2018. "Quality Regulation and Competition: Evidence from Pharmaceutical Markets," Research Department working papers 1211, CAF Development Bank Of Latinamerica.
  • Atal, Juan Pablo & Cuesta, José Ignacio & Sæthre, Morten, 2018. "Quality Regulation and Competition: Evidence from Pharmaceutical Markets," Discussion Paper Series in Economics 20/2018, Norwegian School of Economics, Department of Economics.
  • Juan Pablo Atal & José Ignacio Cuesta & Morten Sæthre, 2022. "Quality Regulation and Competition: Evidence from Pharmaceutical Markets," NBER Working Papers 30325, National Bureau of Economic Research, Inc.
  • Jesus Juan Pablo Atal & Jose´ Ignacio Cuesta & Morten Sæthre, 2019. "Quality Regulation and Competition: Evidence from Pharmaceutical Markets," PIER Working Paper Archive 19-017, Penn Institute for Economic Research, Department of Economics, University of Pennsylvania.
• Granlund, David & Rudholm, Niklas, 2018. "Risker och kostnader för prissamordningar på den svenska generikamarknaden," Umeå Economic Studies 958, Umeå University, Department of Economics.
• Luca Verginer & Massimo Riccaboni, 2018. "Brain-Circulation Network: The Global Mobility of the Life Scientists," Working Papers 10/2018, IMT School for Advanced Studies Lucca, revised Oct 2018.
• Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 235-273, August.
  • Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," NBER Working Papers 24206, National Bureau of Economic Research, Inc.
• Christopher M. Snyder & Victor J. Tremblay, 2018. "Introduction to the Special Issue on “The Intersection Between Industrial Organization and Healthcare Economics”," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 1-6, August.
• John Hagedoorn & Boris Lokshin & Stéphane Malo, 2018. "Alliances and the innovation performance of corporate and public research spin-off firms," Small Business Economics, Springer, vol. 50(4), pages 763-781, April.
  • Hagedoorn, John & Lokshin, Boris & Malo, Stéphane, 2016. "Alliances and the innovation performance of corporate and public research spin-off firms," Research Memorandum 041, Maastricht University, Graduate School of Business and Economics (GSBE).
• Martin Backfisch, 2018. "The Development of Firm Size and Innovativeness in the Pharmaceutical industry between 1989 and 2010," MAGKS Papers on Economics 201813, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
• Ana Aizcorbe & Colin Baker & Ernst R. Berndt & David M. Cutler, 2018. "Measuring and Modeling Health Care Costs," NBER Books, National Bureau of Economic Research, Inc, number aizc13-1.
• Ernst R. Berndt & Mark R. Trusheim, 2018. "The Information Pharms Race and Competitive Dynamics of Precision Medicine: Insights from Game Theory," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 87-114, National Bureau of Economic Research, Inc.
• Manuel Hermosilla & Jorge Lemus, 2018. "Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 21-52, National Bureau of Economic Research, Inc.
  • Manuel I. Hermosilla & Jorge A. Lemus, 2017. "Therapeutic Translation of Genomic Science: Opportunities and limitations of GWAS," NBER Working Papers 23989, National Bureau of Economic Research, Inc.
• Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 235-273, August.
  • Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," NBER Working Papers 24206, National Bureau of Economic Research, Inc.
• Barry Bosworth & John Bieler & Michael Kleinrock & Eric Koepcke & Ernst R. Berndt, 2018. "An Evaluation of the CPI Indexes for Prescription Drugs," NBER Working Papers 24210, National Bureau of Economic Research, Inc.
• Frank R. LICHTENBERG, 2018. "The Impact of New Drug Launch on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," JODE - Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
  • Lichtenberg, Frank R., 2018. "The Impact Of New Drug Launches On Life-Years Lost In 2015 From 19 Types Of Cancer In 36 Countries," Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
  • Frank R. Lichtenberg, 2018. "The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," Working Papers id:12757, eSocialSciences.
  • Frank R. Lichtenberg, 2018. "The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," NBER Working Papers 24536, National Bureau of Economic Research, Inc.
• Wallace P. Mullin & Christopher M. Snyder, 2018. "Revealed Growth: A Method for Bounding the Elasticity of Demand with an Application to Assessing the Antitrust Remedy in the Du Pont Decision," NBER Working Papers 24786, National Bureau of Economic Research, Inc.
• Higgins, Matthew J. & Yan, Xin & Chatterjee, Chirantan, 2021. "Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling," Research Policy, Elsevier, vol. 50(1).
  • Matthew J. Higgins & Xin Yan & Chirantan Chatterjee, 2018. "Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling," NBER Working Papers 24957, National Bureau of Economic Research, Inc.
• Yujin Kim & Chirantan Chatterjee & Matthew J. Higgins, 2018. "Moving Beyond the Valley of Death: Regulation and Venture Capital Investments in Early-Stage Biopharmaceutical Firms," NBER Working Papers 25202, National Bureau of Economic Research, Inc.
• April Bhattacharjee & Mihir Dash, 2018. "Determinants of Capital Structure in the Indian Pharma Sector," Journal of Applied Management and Investments, Department of Business Administration and Corporate Security, International Humanitarian University, vol. 7(3), pages 125-131, September.
• Christos Kolympiris & Sebastian Hoenen & Nicholas Kalaitzandonakes, 2018. "Geographic distance between venture capitalists and target firms and the value of quality signals," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 27(1), pages 189-220.
• Eric Brouillat & Maïder Saint Jean & Nabila Arfaoui, 2018. "“Reach for the sky”: modeling the impact of policy stringency on industrial dynamics in the case of the REACH regulation," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 27(2), pages 289-320.
  • Maider Saint Jean & Nabila Arfaoui & Eric Brouillat, 2015. "“Reach for the sky”: modelling the impact of policy stringency on industrial dynamics in the case of the REACH regulation”," Post-Print hal-03152236, HAL.
  • Eric Brouillat & Maïder Saint Jean & Nabila Arfaoui, 2017. "“Reach for the sky”: modeling the impact of policy stringency on industrial dynamics in the case of the REACH regulation," Post-Print hal-02502669, HAL.
  • Maider Saint Jean & Nabila Arfaoui & Eric Brouillat, 2015. "“Reach for the sky”: modelling the impact of policy stringency on industrial dynamics in the case of the REACH regulation”," Post-Print hal-03148867, HAL.
• Osamu Suzuki, 2018. "Enabling or constraining? Unraveling the influence of organizational slack on innovation," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 27(3), pages 555-575.
• Francesca Di Iorio & Maria Letizia Giorgetti, 2018. "The impact of submarket concentration in the US pharmaceutical industry in 1987-1998," DEM Working Papers Series 163, University of Pavia, Department of Economics and Management.
• Fan, Peilei, 2018. "Catching Up in Economic Transition: Innovation in the People’s Republic of China and India," ADBI Working Papers 809, Asian Development Bank Institute.
• Gwak, Daejong, 2018. "The Post-2020 Climate Regime and the Korean Cement Industry: Greenhouse Gases, Energy Efficiency and Policy Implications," Industrial Economic Review 18-6, Korea Institute for Industrial Economics and Trade.
• Béfort, Nicolas, 2018. "Régulation, verrous technologiques et transition écologique : le cas des formaldéhydes," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 22.
• Varun Mahajan & D. K. Nauriyal & S. P. Singh, 2018. "Efficiency and Its Determinants: Panel Data Evidence from the Indian Pharmaceutical Industry," Margin: The Journal of Applied Economic Research, National Council of Applied Economic Research, vol. 12(1), pages 19-40, February.
• Deiana, Claudio & Giua, Ludovica & Nistico, Roberto, 2019. "The Economics behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US," IZA Discussion Papers 12872, Institute of Labor Economics (IZA).
  • Claudio Deiana & Ludovica Giua & Roberto Nisticò, 2019. "The Economics Behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US," CSEF Working Papers 525, Centre for Studies in Economics and Finance (CSEF), University of Naples, Italy, revised 13 May 2019.
• Bonwook Koo & Jiyoon Do & Jeasung Park & ByungJo Yu & In Park, 2018. "Derivatization of Commercial Vitamin A to Develop the Bio-based Anti-aging cosmetic materials," Proceedings of International Academic Conferences 7709559, International Institute of Social and Economic Sciences.
• Tien Lo & Ha Soo Hwang & In Park, 2018. "Fluoroalkyl-Modified Polysilazanes for Omniphobic Coatings," Proceedings of International Academic Conferences 7709584, International Institute of Social and Economic Sciences.
• Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2018. "Generalized spatial autocorrelation in a panel-probit model with an application to exporting in China," Empirical Economics, Springer, vol. 55(1), pages 193-211, August.
• Melissa Newham & Jo Seldeslachts & Albert Banal-Estanol, 2018. "Common ownership and market entry: Evidence from the pharmaceutical industry," Working Papers of Department of Management, Strategy and Innovation, Leuven 623896, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
  • Melisa Newham & Jo Seldeslachts & Albert Banal-Estañol, 2018. "Common ownership and market entry: Evidence from the pharmaceutical industry," Economics Working Papers 1612, Department of Economics and Business, Universitat Pompeu Fabra.
  • Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2018. "Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry," Working Papers 1042, Barcelona School of Economics.
  • Melissa Newham & Jo Seldeslachts & Albert Banal-Estanol, 2018. "Common Ownership and Market Entry: Evidence from Pharmaceutical Industry," Discussion Papers of DIW Berlin 1738, DIW Berlin, German Institute for Economic Research.
  • Newham, M. & Seldeslachts, J. & Banal-Estanol, A., 2018. "Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry," Working Papers 18/03, Department of Economics, City University London.
• Witkowska Janina, 2018. "Corporate Social Responsibility (CSR) of Innovative Pharmaceutical Corporations. The Case of BIOGEN," Comparative Economic Research, Sciendo, vol. 21(3), pages 45-62, September.
• ten Brink, Patrick & Schweitzer, Jean-Pierre & Watkins, Emma & Janssens, Charlotte & De Smet, Michiel & Leslie, Heather & Galgani, François, 2018. "Circular economy measures to keep plastics and their value in the economy, avoid waste and reduce marine litter," Economics Discussion Papers 2018-3, Kiel Institute for the World Economy (IfW Kiel).
• Kirchhoff, Jasmina, 2018. "Turbulentes Jahr 2017, gedämpfte Aussichten für 2018: Deutschlands Pharmaindustrie 2017/2018," IW-Reports 42/2018, Institut der deutschen Wirtschaft (IW) / German Economic Institute.
• Diel, Anastasia & Kirchhoff, Jasmina, 2018. "Gibt es einen Fachkräfteengpass in der deutschen Pharmaindustrie? [Is there a shortage of skilled workers in the german pharmaceutical industry?]," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, vol. 45(3), pages 79-95.

2017

• Banu Yeşim Buyukakinci & Nihal Sokmen, 2017. "Investigation Of Indigo Dyeing Using Sodium Borohydride As Reducing Agent," CBU International Conference Proceedings, ISE Research Institute, vol. 5(0), pages 1061-1063, September.
• Manolis Galenianos & Alessandro Gavazza, 2017. "A Structural Model of the Retail Market for Illicit Drugs," American Economic Review, American Economic Association, vol. 107(3), pages 858-896, March.
  • Gavazza, Alessandro & Galenianos, Manolis, 2015. "A Structural Model of the Retail Market for Illicit Drugs," CEPR Discussion Papers 10363, C.E.P.R. Discussion Papers.
  • Galenianos, Manolis & Gavazza, Alessandro, 2017. "A structural model of the retail market for illicit drugs," LSE Research Online Documents on Economics 80287, London School of Economics and Political Science, LSE Library.
• Anne Fitzpatrick, 2017. "Shopping While Female: Who Pays Higher Prices and Why?," American Economic Review, American Economic Association, vol. 107(5), pages 146-149, May.
• Adam Sacarny & David Yokum & Shantanu Agrawal, 2017. "Government-Academic Partnerships in Randomized Evaluations: The Case of Inappropriate Prescribing," American Economic Review, American Economic Association, vol. 107(5), pages 466-470, May.
• Margaret Kyle & Heidi Williams, 2017. "Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs," American Economic Review, American Economic Association, vol. 107(5), pages 486-490, May.
  • Margaret Kyle & Heidi Williams, 2016. "Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs," Post-Print hal-01448505, HAL.
  • Margaret Kyle & Heidi L. Williams, 2017. "Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs," NBER Working Papers 23068, National Bureau of Economic Research, Inc.
  • Margaret Kyle & Heidi Williams, 2017. "Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs," Post-Print hal-01952720, HAL.
• Eric W. Bond & Kamal Saggi, 2023. "Bargaining over Entry with a Compulsory License Deadline: Price Spillovers and Surplus Expansion," World Scientific Book Chapters, in: Kamal Saggi (ed.), Technology Transfer, Foreign Direct Investment, and the Protection of Intellectual Property in the Global Economy, chapter 20, pages 449-480, World Scientific Publishing Co. Pte. Ltd..
  • Eric W. Bond & Kamal Saggi, 2017. "Bargaining over Entry with a Compulsory License Deadline: Price Spillovers and Surplus Expansion," American Economic Journal: Microeconomics, American Economic Association, vol. 9(1), pages 31-62, February.
  • Eric W Bond & Kamal Saggi, 2016. "Bargaining over entry with a compulsory license deadline: Price spillovers and surplus expansion," Vanderbilt University Department of Economics Working Papers 16-00009, Vanderbilt University Department of Economics.
• Oleg Baranov & Christina Aperjis & Lawrence M. Ausubel & Thayer Morrill, 2017. "Efficient Procurement Auctions with Increasing Returns," American Economic Journal: Microeconomics, American Economic Association, vol. 9(3), pages 1-27, August.
• Colleen Carey, 2017. "Technological Change and Risk Adjustment: Benefit Design Incentives in Medicare Part D," American Economic Journal: Economic Policy, American Economic Association, vol. 9(1), pages 38-73, February.
• Ali Yurukoglu & Eli Liebman & David B. Ridley, 2017. "The Role of Government Reimbursement in Drug Shortages," American Economic Journal: Economic Policy, American Economic Association, vol. 9(2), pages 348-382, May.
  • Ali Yurukoglu & Eli Liebman & David B. Ridley, 2012. "The Role of Government Reimbursement in Drug Shortages," NBER Working Papers 17987, National Bureau of Economic Research, Inc.
• Leemore Dafny & Christopher Ody & Matt Schmitt, 2017. "When Discounts Raise Costs: The Effect of Copay Coupons on Generic Utilization," American Economic Journal: Economic Policy, American Economic Association, vol. 9(2), pages 91-123, May.
  • Leemore Dafny & Christopher Ody & Matthew Schmitt, 2016. "When Discounts Raise Costs: The Effect of Copay Coupons on Generic Utilization," NBER Working Papers 22745, National Bureau of Economic Research, Inc.
• Cezar, R., 2017. "La situation des entreprises en France en 2015," Bulletin de la Banque de France, Banque de France, issue 209, pages 57-69.
• Cezar, R., 2017. "L’industrie pharmaceutique française dans les chaînes de valeur mondiales," Bulletin de la Banque de France, Banque de France, issue 209, pages 57-69.
• Víctor Manuel NIETO & Gina Marcela CALDERÓN, 2017. "Cadena de Productos Lácteos Estructura, Comercio Internacional y Protección," Archivos de Economía 15502, Departamento Nacional de Planeación.
• José Morelos Gómez & Miguel Ángel Nu?nez Bottini, 2017. "Productividad de las empresas de la zona extractiva minera-energética y su incidencia en el desempeno financiero en Colombia," Estudios Gerenciales, Universidad Icesi, vol. 33(145), pages 330-340, November.
• Jo Seldeslachts & Melissa Newham & Albert Banal-Estanol, 2017. "Changes in Common Ownership of German Companies," DIW Economic Bulletin, DIW Berlin, German Institute for Economic Research, vol. 7(30), pages 303-311.
• Jo Seldeslachts & Melissa Newham & Albert Banal-Estanol, 2017. "Veränderungen bei gemeinsamen Eigentümerstrukturen deutscher Unternehmen," DIW Wochenbericht, DIW Berlin, German Institute for Economic Research, vol. 84(30), pages 611-621.
• Baltagi, Badi H. & Egger, Peter H. & Kesina, Michaela, 2017. "Determinants of firm-level domestic sales and exports with spillovers: Evidence from China," Journal of Econometrics, Elsevier, vol. 199(2), pages 184-201.
  • Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2017. "Determinants of Firm-Level Domestic Sales and Exports with Spillovers: Evidence from China," Center for Policy Research Working Papers 209, Center for Policy Research, Maxwell School, Syracuse University.
• Banerjee, Tannista & Siebert, Ralph, 2017. "Dynamic impact of uncertainty on R&D cooperation formation and research performance: Evidence from the bio-pharmaceutical industry," Research Policy, Elsevier, vol. 46(7), pages 1255-1271.
• Manolis Galenianos & Alessandro Gavazza, 2017. "A Structural Model of the Retail Market for Illicit Drugs," American Economic Review, American Economic Association, vol. 107(3), pages 858-896, March.
  • Galenianos, Manolis & Gavazza, Alessandro, 2017. "A structural model of the retail market for illicit drugs," LSE Research Online Documents on Economics 80287, London School of Economics and Political Science, LSE Library.
  • Galenianos, Manolis & Gavazza, Alessandro, 2017. "Structural model of the retail market for illicit drugs," LSE Research Online Documents on Economics 67817, London School of Economics and Political Science, LSE Library.
• Eric Brouillat & Maïder Saint Jean & Nabila Arfaoui, 2018. "“Reach for the sky”: modeling the impact of policy stringency on industrial dynamics in the case of the REACH regulation," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 27(2), pages 289-320.
  • Maider Saint Jean & Nabila Arfaoui & Eric Brouillat, 2015. "“Reach for the sky”: modelling the impact of policy stringency on industrial dynamics in the case of the REACH regulation”," Post-Print hal-03152236, HAL.
  • Eric Brouillat & Maïder Saint Jean & Nabila Arfaoui, 2017. "“Reach for the sky”: modeling the impact of policy stringency on industrial dynamics in the case of the REACH regulation," Post-Print hal-02502669, HAL.
  • Maider Saint Jean & Nabila Arfaoui & Eric Brouillat, 2015. "“Reach for the sky”: modelling the impact of policy stringency on industrial dynamics in the case of the REACH regulation”," Post-Print hal-03148867, HAL.
• Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers halshs-01072741, HAL.
  • Izabela Jelovac & Nicolas Houy, 2017. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01657274, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178631, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers 1425, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178636, HAL.
  • Izabela Jelovac & Nicolas Houy, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01261578, HAL.
  • Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01138229, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178630, HAL.
• Granlund, David & Bergman, Mats A., 2017. "Price competition in pharmaceuticals – evidence from 1303 Swedish markets," Umeå Economic Studies 952, Umeå University, Department of Economics.
• Natalia Shmatko & Alina Lavrynenko & Dirk Meissner, 2017. "Communicating Company Innovation Culture: Assessment Through Job Advertisements Analysis," HSE Working papers WP BRP 74/STI/2017, National Research University Higher School of Economics.
• John Romley & Tiffany Shih, 2017. "Product safety spillovers and market viability for biologic drugs," International Journal of Health Economics and Management, Springer, vol. 17(2), pages 135-158, June.
• Philip E. Auerswald & Lokesh Dani, 2017. "The adaptive life cycle of entrepreneurial ecosystems: the biotechnology cluster," Small Business Economics, Springer, vol. 49(1), pages 97-117, June.
• Chia-Lin Chang & Renu Sukharomana, 2017. "Demand for Narcotics in Thailand, with Policy Implications," Journal of Reviews on Global Economics, Lifescience Global, vol. 6, pages 279-284.
  • Sukharomana, Renu & Chang, Chia-Lin, 2017. "Demand for Narcotics in Thailand, with Policy Implications," MPRA Paper 79081, University Library of Munich, Germany.
• Martin Backfisch, 2017. "Have Pharmaceutical R&D Project Success Rates Decreased? A Critical Review and New Empirical Results," MAGKS Papers on Economics 201746, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
• Baltagi, Badi H. & Egger, Peter H. & Kesina, Michaela, 2017. "Determinants of firm-level domestic sales and exports with spillovers: Evidence from China," Journal of Econometrics, Elsevier, vol. 199(2), pages 184-201.
  • Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2017. "Determinants of Firm-Level Domestic Sales and Exports with Spillovers: Evidence from China," Center for Policy Research Working Papers 209, Center for Policy Research, Maxwell School, Syracuse University.
• Francesca DI IORIO & Maria Letizia GIORGETTI, 2017. "A Deeper Analysis on Pharmaceutical Submarket Concentration: the US market in 1987-1998," Departmental Working Papers 2017-02, Department of Economics, Management and Quantitative Methods at Università degli Studi di Milano.
• Francesca DI IORIO & Maria Letizia GIORGETTI, 2017. "Entry and Patents: Evidence from the US Cardiovascular Pharmaceutical Sector," Departmental Working Papers 2017-07, Department of Economics, Management and Quantitative Methods at Università degli Studi di Milano.
• Ezio Ritrovato, 2017. "Energy Self-Sufficiency and the State Oil Industry. The Birth of ANIC," Rivista di storia economica, Società editrice il Mulino, issue 3, pages 351-387.
• Philippe Gorry & Diego Useche, 2018. "Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 305-334, National Bureau of Economic Research, Inc.
  • Diego Useche & Philippe Gorry, 2015. "Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies," Post-Print hal-02195963, HAL.
  • Diego Useche & Philippe Gorry, 2016. "Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies," Post-Print hal-02195744, HAL.
  • Philippe Gorry & Diego Useche, 2017. "Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies," NBER Working Papers 24021, National Bureau of Economic Research, Inc.
• Adam Jørring & Andrew W Lo & Tomas J Philipson & Manita Singh & Richard T Thakor, 2022. "Sharing R&D Risk in Healthcare via FDA Hedges [Bank lines of credit as contingent liquidity: Covenant violations and their implications]," The Review of Corporate Finance Studies, Society for Financial Studies, vol. 11(4), pages 880-922.
  • Adam Jørring & Andrew W. Lo & Tomas J. Philipson & Manita Singh & Richard T. Thakor, 2017. "Sharing R&D Risk in Healthcare via FDA Hedges," NBER Working Papers 23344, National Bureau of Economic Research, Inc.
• Manuel Hermosilla & Jorge Lemus, 2018. "Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 21-52, National Bureau of Economic Research, Inc.
  • Manuel I. Hermosilla & Jorge A. Lemus, 2017. "Therapeutic Translation of Genomic Science: Opportunities and limitations of GWAS," NBER Working Papers 23989, National Bureau of Economic Research, Inc.
• Ernst R. Berndt & Mark R. Trusheim, 2017. "The Information Pharms Race and Competitive Dynamics of Precision Medicine: Insights from Game Theory," NBER Working Papers 24020, National Bureau of Economic Research, Inc.
• Philippe Gorry & Diego Useche, 2018. "Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 305-334, National Bureau of Economic Research, Inc.
  • Diego Useche & Philippe Gorry, 2015. "Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies," Post-Print hal-02195963, HAL.
  • Philippe Gorry & Diego Useche, 2017. "Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies," NBER Working Papers 24021, National Bureau of Economic Research, Inc.
  • Diego Useche & Philippe Gorry, 2016. "Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies," Post-Print hal-02195744, HAL.
• Yulia Nedelcheva, 2017. "External Factors For Outsourcing In Pharmaceutical Sector: Evidence From Bulgaria," Entrepreneurship, Faculty of Economics, SOUTH-WEST UNIVERSITY "NEOFIT RILSKI", BLAGOEVGRAD, vol. 5(2), pages 106-123.
• Carolin Haeussler & Bastian Rake, 2017. "The changing geography of clinical research: a critical analysis of its drivers," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 26(2), pages 285-310.
• Karen Ruckman & Ian McCarthy, 2017. "Why do some patents get licensed while others do not?," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 26(4), pages 667-688.
• Hakan Ener, 2017. "The unfulfilled promise of biotechnology firms: a top management team-based explanation," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 26(5), pages 887-906.
• Chia-Lin Chang & Renu Sukharomana, 2017. "Demand for Narcotics in Thailand, with Policy Implications," Journal of Reviews on Global Economics, Lifescience Global, vol. 6, pages 279-284.
  • Sukharomana, Renu & Chang, Chia-Lin, 2017. "Demand for Narcotics in Thailand, with Policy Implications," MPRA Paper 79081, University Library of Munich, Germany.
• Mitze, Timo & Strotebeck, Falk, 2017. "Modeling interregional research collaborations in German biotechnology using industry directory data: A quantitative social network analysis," MPRA Paper 83392, University Library of Munich, Germany.
• Hajibabaei, Ehsan & Ghasmi, Alireza & Hosseini, Seyed Abbas, 2017. "Numerical Investigation of Head Frontal Velocity of nonconservative Dense Flows in Small Inclined Beds," MPRA Paper 88383, University Library of Munich, Germany, revised Jan 2017.
• Morales, Rosa & Radoniqi, Fatos, 2017. "Intangibles and the Market Value of Biopharmaceutical Startups," MPRA Paper 88580, University Library of Munich, Germany.
• Marlon Rojas & Leslie Arcila & Antonieta Rios & Abdu Orduña & Valentin Lopez & Orlando Zaca & Gerardo Muñoz, 2017. "Gold nanoparticles on the development of fluorescent biosensors for the detection of pathogenic bacteria in water and foods," Proceedings of International Academic Conferences 5907865, International Institute of Social and Economic Sciences.
• Fernando Gascón & Jesús Lozano & Borja Ponte & David Fuente, 2017. "Measuring the efficiency of large pharmaceutical companies: an industry analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(5), pages 587-608, June.
• Bastian Rake, 2017. "Determinants of pharmaceutical innovation: the role of technological opportunities revisited," Journal of Evolutionary Economics, Springer, vol. 27(4), pages 691-727, September.
  • Bastian Rake, 2012. "Determinants of Pharmaceutical Innovation: The Role of Technological Opportunities Revisited," Jena Economics Research Papers 2012-018, Friedrich-Schiller-University Jena.
  • Bastian Rake, 2013. "Determinants of Pharmaceutical Innovation: The Role of Technological Opportunities Revisited," DRUID Working Papers 13-03, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
• Frank R. Lichtenberg, 2017. "The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013," Latin American Economic Review, Springer;Centro de Investigaciòn y Docencia Económica (CIDE), vol. 26(1), pages 1-22, December.
• Jannatul Ferdaous & Mohammad Mizanur Rahman, 2017. "The Effects of Research and Development Expenditure on Firm Performance: an Examination of Pharmaceuticals Industry in Bangladesh," Business & Entrepreneurship Journal, SCIENPRESS Ltd, vol. 6(2), pages 1-1.
• William Lazonick & Matt Hopkins & Ken Jacobson & Mustafa Erdem Sakinc & Oner Tulum, 2017. "US Pharma`s Financialized Business Model," Working Papers Series 60, Institute for New Economic Thinking.
• Henry Grabowski & Carlos Brain & Anna Taub & Rahul Guha, 2017. "Pharmaceutical Patent Challenges: Company Strategies and Litigation Outcomes," American Journal of Health Economics, MIT Press, vol. 3(1), pages 33-59, Winter.
• Henry Grabowski & Carlos Brain & Anna Taub & Rahul Guha, 2017. "Pharmaceutical Patent Challenges: Company Strategies and Litigation Outcomes," American Journal of Health Economics, University of Chicago Press, vol. 3(1), pages 33-59, Winter.
• J.S Keshminder & VGR Chandran, 2017. "Eco-Innovation in the Chemical Manufacturing Firms: Insights for Policy Response," Institutions and Economies (formerly known as International Journal of Institutions and Economies), Faculty of Economics and Administration, University of Malaya, vol. 9(1), pages 21-42, January.
• Tsanko Valentinov Ivanov, 2017. "Methodological Framework for Analysis and Evaluation of Security Threats Within Industrial Enterprises," Business & Management Compass, University of Economics Varna, issue 3, pages 303-320.
• Diel, Anastasia & Kirchhoff, Jasmina, 2017. "Geringe Dynamik im Inlandsgeschäft: Deutschlands Pharmaindustrie 2016/2017," IW-Reports 36/2017, Institut der deutschen Wirtschaft (IW) / German Economic Institute.
• Kirchhoff, Jasmina, 2017. "Exportschlager Gesundheit: Wachstumstreiber Schwellenländer?," IW-Reports 6/2017, Institut der deutschen Wirtschaft (IW) / German Economic Institute.

2016

• Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016. "Patents and the Global Diffusion of New Drugs," American Economic Review, American Economic Association, vol. 106(1), pages 136-164, January.
  • Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," NBER Working Papers 20492, National Bureau of Economic Research, Inc.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2016. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 65415, London School of Economics and Political Science, LSE Library.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2014. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 60450, London School of Economics and Political Science, LSE Library.
  • Iain Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," CEP Discussion Papers dp1298, Centre for Economic Performance, LSE.
  • Schankerman, Mark & Cockburn, Iain M & Lanjouw, Jean, 2014. "Patents and the Global Diffusion of New Drugs," CEPR Discussion Papers 10149, C.E.P.R. Discussion Papers.
• Mark Duggan & Craig Garthwaite & Aparajita Goyal, 2016. "The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India," American Economic Review, American Economic Association, vol. 106(1), pages 99-135, January.
  • Mark Duggan & Craig Garthwaite & Aparajita Goyal, 2014. "The Market Impacts Of Pharmaceutical Product Patents In Developing Countries: Evidence From India," Discussion Papers 14-005, Stanford Institute for Economic Policy Research.
  • Mark Duggan & Craig Garthwaite & Aparajita Goyal, 2014. "The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India," NBER Working Papers 20548, National Bureau of Economic Research, Inc.
• Jonas Björnerstedt & Frank Verboven, 2016. "Does Merger Simulation Work? Evidence from the Swedish Analgesics Market," American Economic Journal: Applied Economics, American Economic Association, vol. 8(3), pages 125-164, July.
• Duncan S. Gilchrist, 2016. "Patents as a Spur to Subsequent Innovation? Evidence from Pharmaceuticals," American Economic Journal: Applied Economics, American Economic Association, vol. 8(4), pages 189-221, October.
• Rousselière, Samira & Rousselière, Damien & Ramani, Shyama, 2016. "Innovation Led Alliances: Theory and application to the GM Plant Industry," 149th Seminar, October 27-28, 2016, Rennes, France 244949, European Association of Agricultural Economists.
  • Rousselière, Samira & Rousselière, Damien & Ramani, Shyama, 2016. "Innovation Led Alliances: Theory and application to the GM Plant Industry," 2016 Annual Meeting, July 31-August 2, Boston, Massachusetts 235711, Agricultural and Applied Economics Association.
• Rousselière, Samira & Rousselière, Damien & Ramani, Shyama, 2016. "Innovation Led Alliances: Theory and application to the GM Plant Industry," 2016 Annual Meeting, July 31-August 2, Boston, Massachusetts 235711, Agricultural and Applied Economics Association.
  • Rousselière, Samira & Rousselière, Damien & Ramani, Shyama, 2016. "Innovation Led Alliances: Theory and application to the GM Plant Industry," 149th Seminar, October 27-28, 2016, Rennes, France 244949, European Association of Agricultural Economists.
• Richard A. Jensen, 2016. "University–Industry Linkages in the Support of Biotechnology Discoveries," Annual Review of Resource Economics, Annual Reviews, vol. 8(1), pages 377-396, October.
• Bojan Moric Milovanovic & Karla Kunst & Stjepan Srhoj, 2016. "Diagnosing Entrepreneurial Climate – Case Study In Pharmaceutical Industry," Economic Thought and Practice, Department of Economics and Business, University of Dubrovnik, vol. 25(1), pages 73-104, june.
• R. Cezar, 2016. "France’s pharmaceutical industry in global value chains," Quarterly selection of articles - Bulletin de la Banque de France, Banque de France, issue 44, pages 52-63, Winter.
• Simon P. Anderson & Federico Ciliberto & Jura Liaukonyte & Régis Renault, 2016. "Push-me pull-you: comparative advertising in the OTC analgesics industry," RAND Journal of Economics, RAND Corporation, vol. 47(4), pages 1029-1056, November.
  • Anderson, Simon & Renault, Régis & Ciliberto, Federico & Liaukonyte, Jura, 2012. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," CEPR Discussion Papers 8988, C.E.P.R. Discussion Papers.
  • Simon P. Anderson & Federico Ciliberto & Jura Liaukonyte & Régis Renault, 2015. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," CESifo Working Paper Series 5418, CESifo.
  • Anderson, Simon & Ciliberto, Federico & Liaukonyte, Jura & Renault, Regis, 2012. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," MPRA Paper 38626, University Library of Munich, Germany.
• Granlund David & Köksal-Ayhan Miyase Yesim, 2016. "EU Enlargement, Parallel Trade and Price Competition in Pharmaceuticals: Has the Price Competition increased?," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 16(2), pages 1069-1092, April.
• Jens K. Perret, 2016. "Strukturwandel in der Europäischen Union am Beispiel ausgewählter Leitmärkte mit besonderem Bezug auf die Innovationstätigkeit der Mitgliedsländer," EIIW Discussion paper disbei223, Universitätsbibliothek Wuppertal, University Library.
• Mariana Carrera & Sofia Villas-Boas, 2023. "Generic Aversion and Observational Learning in the Over-the-Counter Drug Market," American Economic Journal: Applied Economics, American Economic Association, vol. 15(3), pages 380-410, July.
  • Villas-Boas, Sofia B & Carrera, Mariana, 2016. "Generic aversion and observational learning in the over-the-counter drug market," Department of Agricultural & Resource Economics, UC Berkeley, Working Paper Series qt0q03b5f2, Department of Agricultural & Resource Economics, UC Berkeley.
  • Carrera, Mariana & Villas-Boas, Sofia B, 2020. "Generic Aversion and Observational Learning in the Over-the-Counter Drug Market," Department of Agricultural & Resource Economics, UC Berkeley, Working Paper Series qt7ks7s9jf, Department of Agricultural & Resource Economics, UC Berkeley.
• José Morelos Gómez, 2016. "Análisis de la variación de la eficiencia en la producción de biocombustibles en América Latina," Estudios Gerenciales, Universidad Icesi, vol. 32(139), pages 120-126, June.
• Sylwester Bejger, 2016. "The specifics of supply chain of medical kits product group in the context of using Enterprise Resource Planning class systems," Ekonomia i Prawo, Uniwersytet Mikolaja Kopernika, vol. 15(4), pages 419-438, December.
• Andreas Panagopoulos & Christos Pitelis & Panos Desyllas, 2016. "Cross-Border Co-opetition through Market Co-creation," Working Papers 1612, University of Crete, Department of Economics.
• LOPES, Joao Carlos & SANTOS, Ana, 2016. "Vertical Specialization, Global Value Chains And International Trade: The Rubber And Plastics Industry In Portugal And Comparison With Northern And Southern Eu Countries," Regional and Sectoral Economic Studies, Euro-American Association of Economic Development, vol. 16(2), pages 15-28.
• DiMasi, Joseph A. & Grabowski, Henry G. & Hansen, Ronald W., 2016. "Innovation in the pharmaceutical industry: New estimates of R&D costs," Journal of Health Economics, Elsevier, vol. 47(C), pages 20-33.
• Krammer, Sorin M.S., 2016. "The role of diversification profiles and dyadic characteristics in the formation of technological alliances: Differences between exploitation and exploration in a low-tech industry," Research Policy, Elsevier, vol. 45(2), pages 517-532.
  • Krammer, Sorin M.S., 2015. "The role of diversification profiles and dyadic characteristics in the formation of technological alliances: Differences between exploitation and exploration in a low-tech industry," MPRA Paper 64843, University Library of Munich, Germany.
• Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016. "Patents and the Global Diffusion of New Drugs," American Economic Review, American Economic Association, vol. 106(1), pages 136-164, January.
  • Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," NBER Working Papers 20492, National Bureau of Economic Research, Inc.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2016. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 65415, London School of Economics and Political Science, LSE Library.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2014. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 60450, London School of Economics and Political Science, LSE Library.
  • Iain Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," CEP Discussion Papers dp1298, Centre for Economic Performance, LSE.
  • Schankerman, Mark & Cockburn, Iain M & Lanjouw, Jean, 2014. "Patents and the Global Diffusion of New Drugs," CEPR Discussion Papers 10149, C.E.P.R. Discussion Papers.
• Durgaprasad Navulla, 2016. "The Analysis of Industrial Sickness with Reference to the FCIL," GATR Journals jfbr115, Global Academy of Training and Research (GATR) Enterprise.
• Philippe Gorry & Diego Useche, 2018. "Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 305-334, National Bureau of Economic Research, Inc.
  • Diego Useche & Philippe Gorry, 2015. "Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies," Post-Print hal-02195963, HAL.
  • Diego Useche & Philippe Gorry, 2016. "Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies," Post-Print hal-02195744, HAL.
  • Philippe Gorry & Diego Useche, 2017. "Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies," NBER Working Papers 24021, National Bureau of Economic Research, Inc.
• Luiz Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 45-60, January.
  • Luiz Flavio Andrade, 2011. "Entry time effects and follow on drug competition," Post-Print halshs-00658247, HAL.
  • Luiz Flavio Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," Post-Print halshs-01156509, HAL.
  • Luiz Flavio Andrade, 2012. "Entry Time Effects and Follow-on Drugs Competition," Working Papers DT49, IRDES institut for research and information in health economics, revised Jun 2012.
• Bergman, Mats & Granlund, David & Rudholm, Niklas, 2016. "Squeezing the last drop out of your suppliers: an empirical study of market-based purchasing policies for generic pharmaceuticals," HUI Working Papers 116, HUI Research.
• Bergman , Mats A. & Granlund, David & Rudholm, Niklas, 2016. "Squeezing the last drop out of your suppliers: an empirical study of market-based purchasing policies for generic pharmaceuticals," Umeå Economic Studies 921, Umeå University, Department of Economics.
• Fabio Pammolli & Armando Rungi, 2016. "Access to Medicines and European Market Integration," Working Papers 01/2016, IMT School for Advanced Studies Lucca, revised Jan 2016.
• Sergio Castro Aranda & Virginia Guadalupe Lopez Torres & Graciela Guerra Rivas, 2016. "Proposal Of Base Business Model For Biotechnology Companies In Mexico, Propuesta De Modelo De Negocio Base Para Las Empresas De Biotecnologia En Mexico," Revista Global de Negocios, The Institute for Business and Finance Research, vol. 4(4), pages 29-51.
• Quintana García, Cristina, 2016. "Impacto De La Mujer Directiva En La Salida A Bolsa De Empresas De Alta Tecnología: El Efecto Mediador De Las Patentes Y El Desarrollo De Productos / Impact Of Female Managers On High-Technology Firms ," European Research on Management and Business Economics (ERMBE), Academia Europea de Dirección y Economía de la Empresa (AEDEM), vol. 22(2), pages 63-69.
• Florela Stoian, 2016. "The Growth Prospects for the World Tire Market in the Short and Medium-Term," Revista de Economie Mondiala / The Journal of Global Economics, Institute for World Economy, Romanian Academy, vol. 8(2).
• Andrew T. Ching & Robert Clark & Ignatius Horstmann & Hyunwoo Lim, 2016. "The Effects of Publicity on Demand: The Case of Anti-Cholesterol Drugs," Marketing Science, INFORMS, vol. 35(1), pages 158-181, January.
  • Andrew Ching & Robert Clark & Ignatius Horstmann & Hyunwoo Lim, 2015. "The Effects of Publicity on Demand: The Case of Anti-cholesterol Drugs," Working Papers 150007, Canadian Centre for Health Economics.
• Sylvain Béal & Marc Deschamps, 2016. "On compensation schemes for data sharing within the European REACH legislation," European Journal of Law and Economics, Springer, vol. 41(1), pages 157-181, February.
  • Sylvain Béal & Marc Deschamps, 2016. "On compensation schemes for data sharing within the European REACH legislation," European Journal of Law and Economics, Springer, vol. 41(1), pages 157-181, February.
  • Sylvain Béal & Marc Deschamps, 2014. "On compensation schemes for data sharing within the european REACH legislation," Working Papers 2014-01, CRESE.
  • Sylvain Béal & Marc Deschamps, 2014. "On compensation schemes for data sharing within the european REACH legislation," Working Papers hal-01377925, HAL.
  • Sylvain Béal & Marc Deschamps, 2014. "On Compensation Schemes for Data Sharing within the European REACH Legislation," Post-Print halshs-01083135, HAL.
  • Sylvain Béal & Marc Deschamps, 2016. "On compensation schemes for data sharing within the European REACH legislation," Post-Print halshs-01111885, HAL.
• Sylvain Béal & Marc Deschamps, 2016. "On compensation schemes for data sharing within the European REACH legislation," European Journal of Law and Economics, Springer, vol. 41(1), pages 157-181, February.
  • Sylvain Béal & Marc Deschamps, 2014. "On compensation schemes for data sharing within the european REACH legislation," Working Papers 2014-01, CRESE.
  • Sylvain Béal & Marc Deschamps, 2016. "On compensation schemes for data sharing within the European REACH legislation," Post-Print halshs-01111885, HAL.
• Mats A. Bergman & David Granlund & Niklas Rudholm, 2016. "Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily dose," International Journal of Health Economics and Management, Springer, vol. 16(3), pages 201-214, September.
• Dietrich Earnhart & Dylan G. Rassier, 2016. "“Effective regulatory stringency” and firms’ profitability: the effects of effluent limits and government monitoring," Journal of Regulatory Economics, Springer, vol. 50(2), pages 111-145, October.
• Maria Letizia GIORGETTI & Maria Luisa MANCUSI, 2016. "Entry and Patenting in the Pharmaceutical Industry," Departmental Working Papers 2016-02, Department of Economics, Management and Quantitative Methods at Università degli Studi di Milano.
• Rena M. Conti & Ernst R. Berndt, 2016. "Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001–2007," NBER Chapters, in: Measuring and Modeling Health Care Costs, pages 273-321, National Bureau of Economic Research, Inc.
• Mark Pauly & Kyle Myers, 2016. "A Ricardian-Demand Explanation for Changing Pharmaceutical R&D Productivity," NBER Working Papers 22720, National Bureau of Economic Research, Inc.
• Leemore Dafny & Christopher Ody & Matt Schmitt, 2017. "When Discounts Raise Costs: The Effect of Copay Coupons on Generic Utilization," American Economic Journal: Economic Policy, American Economic Association, vol. 9(2), pages 91-123, May.
  • Leemore Dafny & Christopher Ody & Matthew Schmitt, 2016. "When Discounts Raise Costs: The Effect of Copay Coupons on Generic Utilization," NBER Working Papers 22745, National Bureau of Economic Research, Inc.
• Ternus Lamb, Israel & Pacheco Lacerda, Daniel & Dresch, Aline, 2016. "A tecnologia empresarial Odebrecht como filosofia de projeto organizacional – um estudo de caso na Braskem S.A [Odebrecht entrepreneurial technology as organisational project philosophy – a case st," MPRA Paper 82482, University Library of Munich, Germany, revised 20 May 2016.
• Doerhoefer, Steffen & Funder, Maria, 2016. "'You’ll (n)ever walk alone'. Innovative Wissensarbeit zwischen individualistischem Leistungsregime und kommunitaerer Teamkultur ('You’ll (n)ever walk alone'. Innovative knowledge work: Individual perf," Industrielle Beziehungen - Zeitschrift fuer Arbeit, Organisation und Management - The German Journal of Industrial Relations, Rainer Hampp Verlag, vol. 23(4), pages 458-476.
• Eduardo Morales & Gloria Sheu & Andrés Zahler, 2019. "Extended Gravity," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 86(6), pages 2668-2712.
  • Gloria Sheu & Andres Zahler & Eduardo Morales, 2016. "Extended Gravity," 2016 Meeting Papers 1565, Society for Economic Dynamics.
• Aas Mohammad & Bandi Kamaiah, 2016. "Efficiency Analysis of Indian Pharmaceutical Companies in the Post-TRIPS and Post Product Patent Regime using Stochastic Frontier Approach," Romanian Economic Journal, Department of International Business and Economics from the Academy of Economic Studies Bucharest, vol. 19(62), pages 5-24, December.
• Yasin Ç?LHOROZ & Cuma SON?UR & Mehmet GÖZLÜ & Murat KONCA, 2016. "Mergers And Acquisit?ons In Pharmaceutical Industry As A Growth Strategy: An Investigation Upon Practice," Proceedings of International Academic Conferences 4006562, International Institute of Social and Economic Sciences.
• Yasin Ç?LHOROZ & Cuma SON?UR & Mehmet GÖZLÜ & Murat KONCA, 2016. "Mergers And Acquisit?ons In Pharmaceutical Industry As A Growth Strategy: An Investigation Upon Practice," International Journal of Business and Management, International Institute of Social and Economic Sciences, vol. 4(3), pages 1-12, August.
• Luiz Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 45-60, January.
  • Luiz Flavio Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 45-60, January.
  • Luiz Flavio Andrade, 2011. "Entry time effects and follow on drug competition," Post-Print halshs-00658247, HAL.
  • Luiz Flavio Andrade, 2012. "Entry Time Effects and Follow-on Drugs Competition," Working Papers DT49, IRDES institut for research and information in health economics, revised Jun 2012.
  • Luiz Flavio Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," Post-Print halshs-01156509, HAL.
• Luiz Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 45-60, January.
  • Luiz Flavio Andrade, 2011. "Entry time effects and follow on drug competition," Post-Print halshs-00658247, HAL.
  • Luiz Flavio Andrade, 2012. "Entry Time Effects and Follow-on Drugs Competition," Working Papers DT49, IRDES institut for research and information in health economics, revised Jun 2012.
  • Luiz Flavio Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," Post-Print halshs-01156509, HAL.
• Ying Yao & Makoto Tanaka, 2016. "Price offers of pharmaceutical procurement in China: evidence from Guangdong province," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(5), pages 563-575, June.
• Frank R. Lichtenberg, 2016. "The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(7), pages 833-854, September.
• Thomas Brenner & Johann Peter Murmann, 2016. "Using simulation experiments to test historical explanations: the development of the German dye industry 1857-1913," Journal of Evolutionary Economics, Springer, vol. 26(4), pages 907-932, October.
• Mindaugas Kiškis & Tadas Limba & Gintarė Gulevičiūtė, 2016. "Business value of Intellectual Property in Biotech SMEs: case studies of Lithuanian and Arizona’s (US) firms," Entrepreneurship and Sustainability Issues, VsI Entrepreneurship and Sustainability Center, vol. 4(2), pages 221-234, December.
• Dominik Heinisch & Önder Nomaler & Guido Buenstorf & Koen Frenken & Harry Lintsen, 2016. "Same place, same knowledge -- same people? The geography of non-patent citations in Dutch polymer patents," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 25(6), pages 553-572, September.
  • Dominik Heinisch & Önder Nomaler & Guido Buenstorf & Koen Frenken & Harry Lintsen, 2015. "Same Place, Same Knowledge – Same People? The Geography of Non-Patent Citations in Dutch Polymer Patents," MAGKS Papers on Economics 201527, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
  • Dominik Heinisch & Önder Nomaler & Guido Buenstorf & Koen Frenken & Harry Lintsen, 2015. "Same Place, Same Knowledge – Same People? The Geography of Non-Patent Citations in Dutch Polymer Patents," Papers in Evolutionary Economic Geography (PEEG) 1526, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Aug 2015.
• Tamires Ster de Paula Beltrão & Paulo Roberto Scalco, 2016. "O uso da inovação como estratégia competitiva no mercado de defensivos agrícolas no Brasil," REOESTE - Revista de Economia do Centro-Oeste, Nepec - Curso de Ciencias Economicas da Universidade Federal de Goias - FACE, vol. 2(1), pages 2-25.
• John Hagedoorn & Boris Lokshin & Stéphane Malo, 2018. "Alliances and the innovation performance of corporate and public research spin-off firms," Small Business Economics, Springer, vol. 50(4), pages 763-781, April.
  • Hagedoorn, John & Lokshin, Boris & Malo, Stéphane, 2016. "Alliances and the innovation performance of corporate and public research spin-off firms," Research Memorandum 041, Maastricht University, Graduate School of Business and Economics (GSBE).
• TUNSOIU, Nicolae & CITU, Daniela, 2016. "Logistic Flow Design For Sme`S," Journal of Financial and Monetary Economics, Centre of Financial and Monetary Research "Victor Slavescu", vol. 3(1), pages 165-171, October.
• Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2016. "Firm‐Level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman‐Taylor Approach," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 31(1), pages 214-248, January.
  • Badi H. Baltagi & Peter Egger & Michaela Kesina, 2014. "Firm-level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," CESifo Working Paper Series 5114, CESifo.
  • Badi H. Baltagi & Peter H. Egger, 2014. "Firm-Level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," Center for Policy Research Working Papers 173, Center for Policy Research, Maxwell School, Syracuse University.
  • Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2014. "Firm-level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," Center for Policy Research Working Papers 175, Center for Policy Research, Maxwell School, Syracuse University.

2015

• Eric Budish & Benjamin N. Roin & Heidi Williams, 2015. "Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials," American Economic Review, American Economic Association, vol. 105(7), pages 2044-2085, July.
  • Eric Budish & Benjamin N. Roin & Heidi Williams, 2013. "Do firms underinvest in long-term research? Evidence from cancer clinical trials," NBER Working Papers 19430, National Bureau of Economic Research, Inc.
• David H. Howard & Peter B. Bach & Ernst R. Berndt & Rena M. Conti, 2015. "Pricing in the Market for Anticancer Drugs," Journal of Economic Perspectives, American Economic Association, vol. 29(1), pages 139-162, Winter.
• Tosun, Jale & Schaub, Simon, 2015. "To mobilize or not: political attention and the regulation of GMOs," GMCC-15: Seventh GMCC, November 17-20, 2015, Amsterdam, the Netherlands 211493, International Conference on Coexistence between Genetically Modified (GM) and non-GM based Agricultural Supply Chains (GMCC).
• Vives-Vallés, J.A. & La Paz, J.L. & Corujo, M. & Martínez-Cañellas, A. & Galmés, J., 2015. "Field cross-fertilization between GM and non-GM maize in Mallorca: a Mediterranean insular approach," GMCC-15: Seventh GMCC, November 17-20, 2015, Amsterdam, the Netherlands 211640, International Conference on Coexistence between Genetically Modified (GM) and non-GM based Agricultural Supply Chains (GMCC).
• Dmytro Gladkykh, 2015. "European Chemical Industry Competitiveness: Historical Trends And Development Prospects," Baltic Journal of Economic Studies, Publishing house "Baltija Publishing", vol. 1(1).
• Pierre Dubois & Olivier de Mouzon & Fiona Scott-Morton & Paul Seabright, 2015. "Market size and pharmaceutical innovation," RAND Journal of Economics, RAND Corporation, vol. 46(4), pages 844-871, October.
  • Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," IDEI Working Papers 670, Institut d'Économie Industrielle (IDEI), Toulouse, revised Mar 2014.
  • Seabright, Paul & Scott Morton, Fiona & Dubois, Pierre & de Mouzon, Olivier, 2011. "Market Size and Pharmaceutical Innovation," CEPR Discussion Papers 8367, C.E.P.R. Discussion Papers.
  • Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," TSE Working Papers 11-232, Toulouse School of Economics (TSE), revised Mar 2014.
• Granlund David, 2015. "The Effect of Pharmacies’ Right to Negotiate Discounts on the Market Share of Parallel Imported Pharmaceuticals," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 15(3), pages 1197-1235, July.
• Andrew T. Ching & Robert Clark & Ignatius Horstmann & Hyunwoo Lim, 2016. "The Effects of Publicity on Demand: The Case of Anti-Cholesterol Drugs," Marketing Science, INFORMS, vol. 35(1), pages 158-181, January.
  • Andrew Ching & Robert Clark & Ignatius Horstmann & Hyunwoo Lim, 2015. "The Effects of Publicity on Demand: The Case of Anti-cholesterol Drugs," Working Papers 150007, Canadian Centre for Health Economics.
• María José Abud & Bronwyn Hall & Christian Helmers, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," PLOS ONE, Public Library of Science, vol. 10(4), pages 1-17, April.
  • María José Abud Sittler & Bronwyn Hall & Christian Helmers, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," NBER Working Papers 20995, National Bureau of Economic Research, Inc.
  • Abud, María José & Hall, Bronwyn & Helmers, Christian, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," Department of Economics, Working Paper Series qt9tv8s2rw, Department of Economics, Institute for Business and Economic Research, UC Berkeley.
• Frank R. Lichtenberg, 2015. "Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 277-299, July.
  • Frank Lichtenberg, 2015. "Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010," CESifo Working Paper Series 5166, CESifo.
• Simon P. Anderson & Federico Ciliberto & Jura Liaukonyte & Régis Renault, 2016. "Push-me pull-you: comparative advertising in the OTC analgesics industry," RAND Journal of Economics, RAND Corporation, vol. 47(4), pages 1029-1056, November.
  • Anderson, Simon & Renault, Régis & Ciliberto, Federico & Liaukonyte, Jura, 2012. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," CEPR Discussion Papers 8988, C.E.P.R. Discussion Papers.
  • Simon P. Anderson & Federico Ciliberto & Jura Liaukonyte & Régis Renault, 2015. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," CESifo Working Paper Series 5418, CESifo.
  • Anderson, Simon & Ciliberto, Federico & Liaukonyte, Jura & Renault, Regis, 2012. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," MPRA Paper 38626, University Library of Munich, Germany.
• Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune, 2015. "Price regulation and parallel imports of pharmaceuticals," Journal of Public Economics, Elsevier, vol. 129(C), pages 92-105.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2014. "Price Regulation and Parallel Imports of Pharmaceuticals," NIPE Working Papers 01/2014, NIPE - Universidade do Minho.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2015. "Price Regulation and Parallel Imports of Pharmaceuticals," CESifo Working Paper Series 5469, CESifo.
  • Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune, 2014. "Price Regulation and Parallel Imports of Pharmaceuticals," Discussion Paper Series in Economics 1/2014, Norwegian School of Economics, Department of Economics.
• Oscar Fabián García Aponte & Bibiana Margarita Vallejo Díaz & Claudia Elizabeth Mora Huertas, 2015. "La calidad desde el diseno: principios y oportunidades para la industria farmacéutica," Estudios Gerenciales, Universidad Icesi, January.
• Manolis Galenianos & Alessandro Gavazza, 2017. "A Structural Model of the Retail Market for Illicit Drugs," American Economic Review, American Economic Association, vol. 107(3), pages 858-896, March.
  • Gavazza, Alessandro & Galenianos, Manolis, 2015. "A Structural Model of the Retail Market for Illicit Drugs," CEPR Discussion Papers 10363, C.E.P.R. Discussion Papers.
  • Galenianos, Manolis & Gavazza, Alessandro, 2017. "A structural model of the retail market for illicit drugs," LSE Research Online Documents on Economics 80287, London School of Economics and Political Science, LSE Library.
• Felipa de Mello-Sampayo & Sofia de Sousa-Vale & Francisco Camoes, 2015. "Substitutability Between Drugs, Innovation, and Fiscal Policy in the Pharmaceutical Industry," Annals of Economics and Finance, Society for AEF, vol. 16(2), pages 273-289, November.
• Sven Wydra & Timo Leimbach, 2015. "Integration von Industrie- und Innovationspolitik: Beispiele aus den USA und Israel und Ansätze der neuen EU-Industriepolitik," Vierteljahrshefte zur Wirtschaftsforschung / Quarterly Journal of Economic Research, DIW Berlin, German Institute for Economic Research, vol. 84(1), pages 121-134.
• Jiang, Jingze & Marsh, Thomas L. & Tozer, Peter R., 2015. "Policy induced price volatility transmission: Linking the U.S. crude oil, corn and plastics markets," Energy Economics, Elsevier, vol. 52(PA), pages 217-227.
• Kolympiris, Christos & Kalaitzandonakes, Nicholas & Miller, Douglas, 2015. "Location choice of academic entrepreneurs: Evidence from the US biotechnology industry," Journal of Business Venturing, Elsevier, vol. 30(2), pages 227-254.
• Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune, 2015. "Price regulation and parallel imports of pharmaceuticals," Journal of Public Economics, Elsevier, vol. 129(C), pages 92-105.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2014. "Price Regulation and Parallel Imports of Pharmaceuticals," NIPE Working Papers 01/2014, NIPE - Universidade do Minho.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2015. "Price Regulation and Parallel Imports of Pharmaceuticals," CESifo Working Paper Series 5469, CESifo.
  • Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune, 2014. "Price Regulation and Parallel Imports of Pharmaceuticals," Discussion Paper Series in Economics 1/2014, Norwegian School of Economics, Department of Economics.
• Hostenkamp, Gisela & Lichtenberg, Frank R., 2015. "The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence," Social Science & Medicine, Elsevier, vol. 130(C), pages 162-171.
  • Frank Lichtenberg & Gisela Hostenkamp, 2013. "The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence," CESifo Working Paper Series 4516, CESifo.
• Skipper, Niels & Vejlin, Rune, 2015. "Determinants of generic vs. brand drug choice: Evidence from population-wide Danish data," Social Science & Medicine, Elsevier, vol. 130(C), pages 204-215.
  • Niels Skipper & Rune Vejlin, 2013. "Determinants of Generic vs. Brand Drug Choice: Evidence from Population-wide Danish Data," Economics Working Papers 2013-05, Department of Economics and Business Economics, Aarhus University.
• Dominik Heinisch & Önder Nomaler & Guido Buenstorf & Koen Frenken & Harry Lintsen, 2016. "Same place, same knowledge -- same people? The geography of non-patent citations in Dutch polymer patents," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 25(6), pages 553-572, September.
  • Dominik Heinisch & Önder Nomaler & Guido Buenstorf & Koen Frenken & Harry Lintsen, 2015. "Same Place, Same Knowledge – Same People? The Geography of Non-Patent Citations in Dutch Polymer Patents," MAGKS Papers on Economics 201527, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
  • Dominik Heinisch & Önder Nomaler & Guido Buenstorf & Koen Frenken & Harry Lintsen, 2015. "Same Place, Same Knowledge – Same People? The Geography of Non-Patent Citations in Dutch Polymer Patents," Papers in Evolutionary Economic Geography (PEEG) 1526, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Aug 2015.
• Dragutinovic, Stefan & Zubovic, Jovan & Reljic, Marija, 2014. "Pharmaceutical Sector in Serbia in the Period 1990-2013," Ekonomika, Journal for Economic Theory and Practice and Social Issues, Society of Economists Ekonomika, Nis, Serbia, vol. 60(4), December.
  • Stefan Dragutinovic, Jovan Zubovic, Marija Reljic, 2015. "Pharmaceutical Sector In Serbia In The Period 1990-2013," Ekonomika, Journal for Economic Theory and Practice and Social Issues 2014-04, „Ekonomika“ Society of Economists, Niš (Serbia).
• Jaime de Melo, 2015. "Developing Countries in the World Economy," World Scientific Books, World Scientific Publishing Co. Pte. Ltd., number 8790, August.
  • Jaime DE MELO, 2015. "Developing Countries in the World Economy," Working Papers P128, FERDI.
  • Jaime DE MELO, 2015. "Developing Countries in the World Economy," Working Papers P128, FERDI.
• Jaime de Melo, 2015. "Developing Countries in the World Economy," World Scientific Books, World Scientific Publishing Co. Pte. Ltd., number 8790, August.
  • Jaime DE MELO, 2015. "Developing Countries in the World Economy," Working Papers P128, FERDI.
  • Jaime DE MELO, 2015. "Developing Countries in the World Economy," Working Papers P128, FERDI.
• Luciana Lazzeretti & Francesco Capone, 2015. "Resilience, creativity and innovation. The case of Chemical innovations after the 1966 Flood in Florence," Working Papers - Business wp2015_01.rdf, Universita' degli Studi di Firenze, Dipartimento di Scienze per l'Economia e l'Impresa.
• Christian Dianoux & Jean-Luc Herrmann & Ridha Chakroun & Sandrine Heitz-Spahn, 2015. "Comparative versus Noncomparative Sales Pitches: Impact on New Product Buying Behaviors and Moderating Role of Buyer-Seller Relationship," Post-Print hal-01370234, HAL.
• Cédric Brun & Steeves Demazeux & Pierangelo Di Vittorio & François Gonon & Philippe Gorry & Jan Peter Konsman & Fanny Lung & Yannick Lung & Michel Minard & Matthieu Montalban & Nicole Rumeau & Andy Sm, 2015. "Construction of mental health categories [La construction des catégories diagnostiques de maladie mentale]," Post-Print hal-02195583, HAL.
• Philippe Gorry & Diego Useche, 2018. "Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 305-334, National Bureau of Economic Research, Inc.
  • Diego Useche & Philippe Gorry, 2015. "Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies," Post-Print hal-02195963, HAL.
  • Diego Useche & Philippe Gorry, 2016. "Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies," Post-Print hal-02195744, HAL.
  • Philippe Gorry & Diego Useche, 2017. "Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies," NBER Working Papers 24021, National Bureau of Economic Research, Inc.
• Brun, Cédric & Demazeux, Steeves & Vittorio, Pierangelo Di & Gonon, François & Gorry, Philippe & Konsman, Jan Peter & Lung, Fanny & Lung, Yannick & Minard, Michel & Montalban, Matthieu & Rumeau, Nicol, 2015. "La construction des catégories diagnostiques de maladie mentale," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.
  • C Brun & S Demazeu & P Di Vittorio & F Gonon & Philippe Gorry & Jp Konsman & F. Lung & Yannick Lung & M. Minard & Matthieu Montalban & M. Rumeau & S. Smith, 2015. "La construction des catégories diagnostiques de maladie mentale?," Post-Print hal-02195583, HAL.
  • C. Brun & S. Demazeux & P. Di Vittorio & F. Gonon & Ph. Gorry & J-P. Konsmann & F. Lung & Y. Lung & M. Minard & M. Montalban & N. Rumeau & A. Smith, 2015. "La construction des catégories diagnostiques de maladie mentale," Post-Print hal-02269934, HAL.
• Eric Brouillat & Maïder Saint Jean & Nabila Arfaoui, 2018. "“Reach for the sky”: modeling the impact of policy stringency on industrial dynamics in the case of the REACH regulation," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 27(2), pages 289-320.
  • Maider Saint Jean & Nabila Arfaoui & Eric Brouillat, 2015. "“Reach for the sky”: modelling the impact of policy stringency on industrial dynamics in the case of the REACH regulation”," Post-Print hal-03152236, HAL.
  • Eric Brouillat & Maïder Saint Jean & Nabila Arfaoui, 2017. "“Reach for the sky”: modeling the impact of policy stringency on industrial dynamics in the case of the REACH regulation," Post-Print hal-02502669, HAL.
  • Maider Saint Jean & Nabila Arfaoui & Eric Brouillat, 2015. "“Reach for the sky”: modelling the impact of policy stringency on industrial dynamics in the case of the REACH regulation”," Post-Print hal-03148867, HAL.
• Eric Brouillat & Maïder Saint Jean & Nabila Arfaoui, 2018. "“Reach for the sky”: modeling the impact of policy stringency on industrial dynamics in the case of the REACH regulation," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 27(2), pages 289-320.
  • Maider Saint Jean & Nabila Arfaoui & Eric Brouillat, 2015. "“Reach for the sky”: modelling the impact of policy stringency on industrial dynamics in the case of the REACH regulation”," Post-Print hal-03148867, HAL.
  • Eric Brouillat & Maïder Saint Jean & Nabila Arfaoui, 2017. "“Reach for the sky”: modeling the impact of policy stringency on industrial dynamics in the case of the REACH regulation," Post-Print hal-02502669, HAL.
  • Maider Saint Jean & Nabila Arfaoui & Eric Brouillat, 2015. "“Reach for the sky”: modelling the impact of policy stringency on industrial dynamics in the case of the REACH regulation”," Post-Print hal-03152236, HAL.
• Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers halshs-01072741, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178630, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178631, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers 1425, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178636, HAL.
  • Izabela Jelovac & Nicolas Houy, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01261578, HAL.
  • Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01138229, HAL.
  • Izabela Jelovac & Nicolas Houy, 2017. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01657274, HAL.
• Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers halshs-01072741, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178631, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers 1425, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178636, HAL.
  • Izabela Jelovac & Nicolas Houy, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01261578, HAL.
  • Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01138229, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178630, HAL.
  • Izabela Jelovac & Nicolas Houy, 2017. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01657274, HAL.
• Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers halshs-01072741, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178636, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178631, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers 1425, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Izabela Jelovac & Nicolas Houy, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01261578, HAL.
  • Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01138229, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178630, HAL.
  • Izabela Jelovac & Nicolas Houy, 2017. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01657274, HAL.
• Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers halshs-01072741, HAL.
  • Izabela Jelovac & Nicolas Houy, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01261578, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178631, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers 1425, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178636, HAL.
  • Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01138229, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178630, HAL.
  • Izabela Jelovac & Nicolas Houy, 2017. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01657274, HAL.
• Kurt R. Brekke & Chiara Canta & Odd Rune StraumeAuthor-Email: o.r.straume@eeg.uminho.p, 2015. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," NIPE Working Papers 6/2015, NIPE - Universidade do Minho.
  • Kurt R. Brekke & Chiara Canta & Odd Rune Straume, 2022. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," CESifo Working Paper Series 9853, CESifo.
  • Brekke, Kurt R. & Canta, Chiara & Straume, Odd Rune, 2015. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," Discussion Paper Series in Economics 11/2015, Norwegian School of Economics, Department of Economics.
• Honjo, Yuji & Nagaoka, Sadao, 2018. "Initial public offering and financing of biotechnology start-ups: Evidence from Japan," Research Policy, Elsevier, vol. 47(1), pages 180-193.
  • HONJO, Yuji & 本庄, 裕司 & NAGAOKA, Sadao & 長岡, 貞男, 2015. "Initial Public Offering and Financing of Biotechnology Start-ups: Evidence from Japan," IIR Working Paper 15-20, Institute of Innovation Research, Hitotsubashi University.
• Agud Eliza Maria, 2015. "In vitro alteration of some taxoni in danger of extinction from protected areas from Bihor country (drosera rotundifolia huds.)," Impact of Socio-economic and Technological Transformations at National, European and International Level (ISETT), Institute for World Economy, Romanian Academy, vol. 2.
• João Lopes & Ana Santos, 2015. "Vertical Specialization, Global Value Chains and the changing Geography of Trade: the Portuguese Rubber and Plastics Industry Case," Proceedings of Business and Management Conferences 3105028, International Institute of Social and Economic Sciences.
  • João Carlos Lopes & Ana Santos, 2015. "Vertical Specialization, Global Value Chains and the changing Geography of Trade: the Portuguese Rubber and Plastics Industry Case," Working Papers Department of Economics 2015/12, ISEG - Lisbon School of Economics and Management, Department of Economics, Universidade de Lisboa.
• Chen-Ming Chen & Tzu-Chun Sheng & Yung-Lieh Yang, 2015. "Market Structure, Government Shareholding and Cost Efficiency in Taiwan's Biotech Industry," Journal of Economics and Management, College of Business, Feng Chia University, Taiwan, vol. 11(1), pages 69-100, January.
• Marilena Locatelli & Steinar Strøm, 2015. "Longitudinal Analysis of Generic Substitution," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 43(3), pages 363-374, September.
  • Dalen Dag Morten & Strom Steinar & Locatelli Marilena, 2010. "Longitudinal analysis of generic substitution," Department of Economics and Statistics Cognetti de Martiis. Working Papers 201013, University of Turin.
  • Dag Morten Dalen & Marilena Locatelli & Steinar Strøm, 2010. "Longitudinal Analysis of Generic Substitution," CESifo Working Paper Series 3176, CESifo.
• Tannista Banerjee & Arnab Nayak, 2015. "Comparing Domestic and Cross-Border Mergers and Acquisitions in the Pharmaceutical Industry," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 43(4), pages 489-499, December.
• Frank Lichtenberg, 2015. "The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011," International Journal of Health Economics and Management, Springer, vol. 15(3), pages 339-359, September.
  • Frank R. Lichtenberg, 2015. "The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011," NBER Working Papers 21239, National Bureau of Economic Research, Inc.
• Badi Baltagi & Peter Egger & Michaela Kesina, 2015. "Sources of productivity spillovers: panel data evidence from China," Journal of Productivity Analysis, Springer, vol. 43(3), pages 389-402, June.
  • Badi H. Baltagi & Peter Egger & Michaela Kesina, 2014. "Sources of Productivity Spillovers: Panel Data Evidence from China," CESifo Working Paper Series 4812, CESifo.
• Antonio Malva & Stijn Kelchtermans & Bart Leten & Reinhilde Veugelers, 2015. "Basic science as a prescription for breakthrough inventions in the pharmaceutical industry," The Journal of Technology Transfer, Springer, vol. 40(4), pages 670-695, August.
• Santosh K. Sahu & Nitika Agarwal, 2015. "Mergers and Acquisitions in the Indian Pharmaceutical Sector," Working Papers 2015-122, Madras School of Economics,Chennai,India.
• Dominik Heinisch & Önder Nomaler & Guido Buenstorf & Koen Frenken & Harry Lintsen, 2016. "Same place, same knowledge -- same people? The geography of non-patent citations in Dutch polymer patents," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 25(6), pages 553-572, September.
  • Dominik Heinisch & Önder Nomaler & Guido Buenstorf & Koen Frenken & Harry Lintsen, 2015. "Same Place, Same Knowledge – Same People? The Geography of Non-Patent Citations in Dutch Polymer Patents," Papers in Evolutionary Economic Geography (PEEG) 1526, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Aug 2015.
  • Dominik Heinisch & Önder Nomaler & Guido Buenstorf & Koen Frenken & Harry Lintsen, 2015. "Same Place, Same Knowledge – Same People? The Geography of Non-Patent Citations in Dutch Polymer Patents," MAGKS Papers on Economics 201527, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
• Richard T. Thakor & Andrew W. Lo, 2015. "Competition and R&D Financing Decisions: Theory and Evidence from the Biopharmaceutical Industry," NBER Working Papers 20903, National Bureau of Economic Research, Inc.
• María José Abud & Bronwyn Hall & Christian Helmers, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," PLOS ONE, Public Library of Science, vol. 10(4), pages 1-17, April.
  • Abud, María José & Hall, Bronwyn & Helmers, Christian, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," Department of Economics, Working Paper Series qt9tv8s2rw, Department of Economics, Institute for Business and Economic Research, UC Berkeley.
  • María José Abud Sittler & Bronwyn Hall & Christian Helmers, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," NBER Working Papers 20995, National Bureau of Economic Research, Inc.
• Vincenzo Palermo & Matthew J. Higgins & Marco Ceccagnoli, 2015. "Assets with "Warts": How Reliable is the Market for Technology?," NBER Working Papers 21103, National Bureau of Economic Research, Inc.
• Mark R. Trusheim & Ernst R. Berndt, 2015. "An Overview of the Stratified Economics of Stratified Medicine," NBER Working Papers 21233, National Bureau of Economic Research, Inc.
• Frank Lichtenberg, 2015. "The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011," International Journal of Health Economics and Management, Springer, vol. 15(3), pages 339-359, September.
  • Frank R. Lichtenberg, 2015. "The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011," NBER Working Papers 21239, National Bureau of Economic Research, Inc.
• Marco Ceccagnoli & Matthew J. Higgins & Hyunsung D. Kang, 2018. "Corporate venture capital as a real option in the markets for technology," Strategic Management Journal, Wiley Blackwell, vol. 39(13), pages 3355-3381, December.
  • Marco Ceccagnoli & Matthew J. Higgins & Hyunsung D. Kang, 2015. "Corporate Venture Capital as a Real Option in the Markets for Technology," NBER Working Papers 21424, National Bureau of Economic Research, Inc.
• Brekke, Kurt R. & Canta, Chiara & Straume, Odd Rune, 2015. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," Discussion Paper Series in Economics 11/2015, Norwegian School of Economics, Department of Economics.
  • Kurt R. Brekke & Chiara Canta & Odd Rune Straume, 2022. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," CESifo Working Paper Series 9853, CESifo.
  • Kurt R. Brekke & Chiara Canta & Odd Rune StraumeAuthor-Email: o.r.straume@eeg.uminho.p, 2015. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," NIPE Working Papers 6/2015, NIPE - Universidade do Minho.
• Haakonsson, Stine Jessen & Ujjual, Vandana, 2015. "Internationalisation of R&D: New insights into multinational enterprises’ R&D strategies in emerging markets," management revue - Socio-Economic Studies, Nomos Verlagsgesellschaft mbH & Co. KG, vol. 26(2), pages 101-122.
• Suzuki, Osamu, 2015. "Unpacking performance benefits of innovation ambidexterity: Evidence from the pharmaceutical industry," management revue - Socio-Economic Studies, Nomos Verlagsgesellschaft mbH & Co. KG, vol. 26(4), pages 328-348.
• Pierre-Alexandre Balland & David Rigby & Ron Boschma, 2015. "The technological resilience of US cities," Cambridge Journal of Regions, Economy and Society, Cambridge Political Economy Society, vol. 8(2), pages 167-184.
  • Pierre-Alexandre Balland & David Rigby & Ron Boschma, 2014. "The Technological Resilience of U.S. Cities," Papers in Evolutionary Economic Geography (PEEG) 1419, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Oct 2014.
  • Balland, Pierre-Alexandre & Rigby, David & Boschma, Ron, 2014. "The Technological Resilience of U.S. Cities," Papers in Innovation Studies 2014/32, Lund University, CIRCLE - Centre for Innovation Research.
• Ron Boschma & Pierre-Alexandre Balland & Dieter Franz Kogler, 2015. "Relatedness and technological change in cities: the rise and fall of technological knowledge in US metropolitan areas from 1981 to 2010," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 24(1), pages 223-250.
  • Ron Boschma & Pierre-Alexandre Balland & Dieter Franz Kogler, 2013. "Relatedness and Technological Change in Cities: The rise and fall of technological knowledge in U.S. metropolitan areas from 1981 to 2010," Papers in Evolutionary Economic Geography (PEEG) 1316, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Sep 2013.
• Margaritti Doina & Tomos Sirma, 2015. "How the Distribution System and the Granting of Drug Discounts, is an Influencing Factor for a Pharmaceutical Units’ Financial Performance," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, vol. 0(1), pages 803-808, May.
• Amin Babaei Falah & Morteza Sardari, 2015. "A novel application of grey principal component analysis to determine stockholder’s approach towards financial ratios," Business and Economic Horizons (BEH), Prague Development Center, vol. 11(1), pages 41-50, April.
• María José Abud & Bronwyn Hall & Christian Helmers, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," PLOS ONE, Public Library of Science, vol. 10(4), pages 1-17, April.
  • María José Abud Sittler & Bronwyn Hall & Christian Helmers, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," NBER Working Papers 20995, National Bureau of Economic Research, Inc.
  • Abud, María José & Hall, Bronwyn & Helmers, Christian, 2015. "An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile," Department of Economics, Working Paper Series qt9tv8s2rw, Department of Economics, Institute for Business and Economic Research, UC Berkeley.
• Krammer, Sorin M.S., 2016. "The role of diversification profiles and dyadic characteristics in the formation of technological alliances: Differences between exploitation and exploration in a low-tech industry," Research Policy, Elsevier, vol. 45(2), pages 517-532.
  • Krammer, Sorin M.S., 2015. "The role of diversification profiles and dyadic characteristics in the formation of technological alliances: Differences between exploitation and exploration in a low-tech industry," MPRA Paper 64843, University Library of Munich, Germany.
• Haakonsson, Stine Jessen & Ujjual, Vandana, 2015. "Internationalisation of R&D: New insights into multinational enterprises’ R&D strategies in emerging markets," management revue. Socio-economic Studies, Rainer Hampp Verlag, vol. 26(2), pages 101-122.
• Suzuki, Osamu, 2015. "Unpacking performance benefits of innovation ambidexterity: Evidence from the pharmaceutical industry," management revue. Socio-economic Studies, Rainer Hampp Verlag, vol. 26(4), pages 328-348.
• Manon JUBIEN, 2015. "Les innovations de produits dans la chimie du végétal comme substituts aux plastiques [Products innovation in bio-based chemistry as a subtitute to plastics]," Working Papers 293, Laboratoire de Recherche sur l'Industrie et l'Innovation. ULCO / Research Unit on Industry and Innovation.
• Ipatova, Irina, 2015. "The dynamics of total factor productivity and its components: Russian plastic production," Applied Econometrics, Russian Presidential Academy of National Economy and Public Administration (RANEPA), vol. 38(2), pages 21-40.
• Brun, Cédric & Demazeux, Steeves & Vittorio, Pierangelo Di & Gonon, François & Gorry, Philippe & Konsman, Jan Peter & Lung, Fanny & Lung, Yannick & Minard, Michel & Montalban, Matthieu & Rumeau, Nicol, 2015. "La construction des catégories diagnostiques de maladie mentale," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.
• Jitendra Kumar Chaudhary, 2015. "Harnessing stem cell potential for regenerative medicine and cell-based therapy," Journal of Studies in Dynamics and Change (JSDC), ISSN: 2348-7038, Voices of Inclusive Change and Expressions- (VOICE) Trust, Dehradun, Uttarakhand, vol. 2(1), pages 339-343, January.
• João Carlos Lopes & Ana Santos, 2015. "Vertical Specialization, Global Value Chains and the changing Geography of Trade: the Portuguese Rubber and Plastics Industry Case," Working Papers Department of Economics 2015/12, ISEG - Lisbon School of Economics and Management, Department of Economics, Universidade de Lisboa.
  • João Lopes & Ana Santos, 2015. "Vertical Specialization, Global Value Chains and the changing Geography of Trade: the Portuguese Rubber and Plastics Industry Case," Proceedings of Business and Management Conferences 3105028, International Institute of Social and Economic Sciences.
• Michael Mueller & Alexander Frenzel, 2015. "Competitive pricing within pharmaceutical classes: evidence on “follow-on” drugs in Germany 1993–2008," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(1), pages 73-82, January.
• David Granlund & Miyase Koksal-Ayhan, 2015. "Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(9), pages 969-983, December.
• Anne Boring, 2015. "The impact of patent protection on US pharmaceutical exports to developing countries," Applied Economics, Taylor & Francis Journals, vol. 47(13), pages 1314-1330, March.
• Frank R. Lichtenberg, 2015. "Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 277-299, July.
  • Frank Lichtenberg, 2015. "Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010," CESifo Working Paper Series 5166, CESifo.
• Vincent K.K. Leung & Marco Chi Keung Lau & Zhe Zhang & Flora F. Gu, 2015. "Explorative versus exploitative alliances: evidence from the glass industry in China," Journal of Chinese Economic and Business Studies, Taylor & Francis Journals, vol. 13(2), pages 127-146, May.
  • Leung, Vincent K.K. & Lau, Chi Keung Marco & Zhang, Zhe, 2013. "Explorative Versus Exploitative Alliances—Evidence From The Glass Industry In China," MPRA Paper 47065, University Library of Munich, Germany.
• Lorenzo Cassi & Anne Plunket, 2015. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Regional Studies, Taylor & Francis Journals, vol. 49(6), pages 936-954, June.
  • Cassi, Lorenzo & Plunket, Anne, 2012. "Research collaboration in co-­inventor networks: combining closure,bridging and proximities," MPRA Paper 39481, University Library of Munich, Germany.
  • Lorenzo Cassi & Anne Plunket, 2013. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00987705, HAL.
  • Lorenzo Cassi & Anne Plunket, 2013. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Post-Print hal-00987705, HAL.
• Nicolas Houy & Izabela Jelovac, 2015. "Drug Launch Timing and International Reference Pricing," Health Economics, John Wiley & Sons, Ltd., vol. 24(8), pages 978-989, August.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers halshs-00782179, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers 1301, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-00993816, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00955848, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00861222, HAL.
  • Izabela Jelovac & Nicolas Houy, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01088164, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01096276, HAL.
• Tannistra Banerjee & Stephen Martin, 2015. "Pharmaceutical Regulation and Innovative Performance: A Decision‐theoretic Model," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 36(3), pages 177-190, April.
  • Tannista Banerjee & Stephen Martin, 2013. "Pharmaceutical regulation and innovative performance: a decision-theoretic model," Auburn Economics Working Paper Series auwp2013-21, Department of Economics, Auburn University.
• Jaime de Melo, 2015. "Developing Countries in the World Economy," World Scientific Books, World Scientific Publishing Co. Pte. Ltd., number 8790, August.
  • Jaime DE MELO, 2015. "Developing Countries in the World Economy," Working Papers P128, FERDI.
  • Jaime DE MELO, 2015. "Developing Countries in the World Economy," Working Papers P128, FERDI.
• Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), 2015. "Effective Technology Transfer in Biotechnology:Best Practice Case Studies in Europe," World Scientific Books, World Scientific Publishing Co. Pte. Ltd., number p1002, August.
• Robin De Cock, 2015. "CASE STUDY 1: A Look Inside Imperial College's TTO," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 1, pages 5-18, World Scientific Publishing Co. Pte. Ltd..
• Tom Guldemont & Thomas Crispeels & Ilse Scheerlinck, 2015. "CASE STUDY 2: Technology Transfer at VIB," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 2, pages 19-32, World Scientific Publishing Co. Pte. Ltd..
• Magdalena Powierża & Piotr Potepa, 2015. "CASE STUDY 3: The Creation of a New Technology Transfer Office," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 3, pages 33-42, World Scientific Publishing Co. Pte. Ltd..
• Alexander Funkner & Nadine Schmieder-Galfe & Oliver Uecke, 2015. "CASE STUDY 4: A Model for IP Transfer and Shareholding for University Spin-Offs: The “Dresden Model”," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 4, pages 43-50, World Scientific Publishing Co. Pte. Ltd..
• Robin De Cock, 2015. "CASE STUDY 5: Environmental Success Factors of Imperial College's TTO," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 5, pages 55-69, World Scientific Publishing Co. Pte. Ltd..
• Tom Guldemont & Thomas Crispeels & Ilse Scheerlinck, 2015. "CASE STUDY 6: The Industrial Research Fund," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 6, pages 70-89, World Scientific Publishing Co. Pte. Ltd..
• Regional Development Agency Ostrava, 2015. "CASE STUDY 7: Regional Innovation Vouchers as an Effective Tool for Supporting Technology Transfer," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 7, pages 90-107, World Scientific Publishing Co. Pte. Ltd..
• Magdalena Powierża & Piotr Potepa, 2015. "CASE STUDY 8: Public Funds for Patenting, Valorization and Science–Industry Collaboration," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 8, pages 108-117, World Scientific Publishing Co. Pte. Ltd..
• Robin De Cock, 2015. "CASE STUDY 9: The Imperial Bioincubator," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 9, pages 123-135, World Scientific Publishing Co. Pte. Ltd..
• Maarika Merirand & Siim Espenberg, 2015. "CASE STUDY 10: Idea Lab — A Platform for Students to Develop New Ideas," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 10, pages 136-146, World Scientific Publishing Co. Pte. Ltd..
• Tom Guldemont & Thomas Crispeels & Ilse Scheerlinck & Marc Goldchstein, 2015. "CASE STUDY 11: Entrepreneurship and Technology Transfer Education at the Vrije Universiteit Brussel," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 11, pages 151-167, World Scientific Publishing Co. Pte. Ltd..
• Carlos Lurigados, 2015. "CASE STUDY 12: BioEmprenedorXXI: Guidance Program for Starting up and Growing Companies in the Life Sciences Arena," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 12, pages 168-181, World Scientific Publishing Co. Pte. Ltd..
• Magdalena Powierża & Piotr Potepa & Hubert Ludwiczak, 2015. "CASE STUDY 13: Education for Scientists," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 13, pages 182-192, World Scientific Publishing Co. Pte. Ltd..
• Adela Farre & Carlos Lurigados, 2015. "CASE STUDY 14: The Biocat Model: Managing the Bioregion of Catalonia," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 14, pages 197-212, World Scientific Publishing Co. Pte. Ltd..
• Tom Guldemont & Thomas Crispeels & Ilse Scheerlinck, 2015. "CASE STUDY 15: The Effects of a Cluster on a Spin-Off — The Foundation of Ablynx," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 15, pages 213-226, World Scientific Publishing Co. Pte. Ltd..
• Regional Development Agency Ostrava, 2015. "CASE STUDY 16: Brokerage Event: Matching International R&D Projects," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 16, pages 227-238, World Scientific Publishing Co. Pte. Ltd..
• Nadine Schmieder-Galfe & Alexander Funkner & Oliver Uecke, 2015. "CASE STUDY 17: The DRESDEN-concept: A Focus on Shared Services and Facilities," World Scientific Book Chapters, in: Oliver Uecke & Robin De Cock & Thomas Crispeels & Bart Clarysse (ed.), EFFECTIVE TECHNOLOGY TRANSFER IN BIOTECHNOLOGY Best Practice Case Studies in Europe, chapter 17, pages 239-249, World Scientific Publishing Co. Pte. Ltd..
• Vittorio Corbo & Jaime de Melo & James Tybout, 2015. "What Went Wrong with the Recent Reforms in the Southern Cone," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 2, pages 21-54, World Scientific Publishing Co. Pte. Ltd..
  • Corbo, Vittorio & de Melo, Jaime & Tybout, James, 1986. "What Went Wrong with the Recent Reforms in the Southern Cone," Economic Development and Cultural Change, University of Chicago Press, vol. 34(3), pages 607-640, April.
• Jaime de Melo & James Tybout, 2015. "The Effects of Financial Liberalization on Savings and Investment in Uruguay," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 3, pages 55-81, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Tybout, James, 1986. "The Effects of Financial Liberalization on Savings and Investment in Uruguay," Economic Development and Cultural Change, University of Chicago Press, vol. 34(3), pages 561-587, April.
• Shantayanan Devarajan & Jaime de Melo, 2015. "Adjustment with a Fixed Exchange Rate: Cameroon, Côte d'Ivoire, and Senegal," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 4, pages 83-123, World Scientific Publishing Co. Pte. Ltd..
  • Devarajan, Shantayanan & de Melo, Jaime, 1987. "Adjustment with a Fixed Exchange Rate: Cameroon, Cote d'Ivoire, and Senegal," The World Bank Economic Review, World Bank, vol. 1(3), pages 447-487, May.
• Riccardo Faini & Jaime De Melo & Abdelhak Senhadji & Julie Stanton, 2015. "Growth-Oriented Adjustment Programs: A Statistical Analysis," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 5, pages 125-135, World Scientific Publishing Co. Pte. Ltd..
  • Faini, Riccardo & De Melo, Jaime & Senhadji, Abdelhak & Stanton, Julie, 1991. "Growth-oriented adjustment programs: A statistical analysis," World Development, Elsevier, vol. 19(8), pages 957-967, August.
  • Faini, Riccardo & de Melo, Jaime & Senhadji-Semlali,, 1990. "Growth oriented adjustment programs : a statistical analysis," Policy Research Working Paper Series 426, The World Bank.
• Riccardo Faini & Jaime de Melo, 2015. "Adjustment, Investment and the Real Exchange Rate in Developing Countries," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 6, pages 137-165, World Scientific Publishing Co. Pte. Ltd..
  • Faini, Riccardo & de Melo, Jaime, 1990. "Adjustment, investment, and the real exchange rate in developing countries," Policy Research Working Paper Series 473, The World Bank.
• Céline Carrère & Jaime de Melo, 2015. "Fiscal Spending and Economic Growth: Some Stylized Facts," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 7, pages 167-196, World Scientific Publishing Co. Pte. Ltd..
  • Carrère, Céline & de Melo, Jaime, 2012. "Fiscal Spending and Economic Growth: Some Stylized Facts," World Development, Elsevier, vol. 40(9), pages 1750-1761.
  • Céline CARRERE & Jaime DE MELO, 2012. "Fiscal Spending and Economic Growth: Some Stylized Facts," Working Papers P35, FERDI.
  • Céline CARRERE & Jaime DE MELO, 2012. "Fiscal Spending and Economic Growth: Some Stylized Facts," Working Papers P35, FERDI.
• Jaime de Melo & Marcelo Olarreaga & Wendy Takacs, 2015. "Pricing Policy Under Double Market Power: Madagascar and the International Vanilla Market," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 8, pages 199-218, World Scientific Publishing Co. Pte. Ltd..
  • Jaime de Melo & Marcelo Olarreaga & Wendy Takacs, 2000. "Pricing Policy Under Double Market Power: Madagascar and the International Vanilla Market," Review of Development Economics, Wiley Blackwell, vol. 4(1), pages 1-20, February.
  • de Melo, Jaime & Olarreaga, Marcelo & Takacs, Wendy E, 1996. "Pricing Policy Under Double Market Power: Madagascar and the International Vanilla Market," CEPR Discussion Papers 1447, C.E.P.R. Discussion Papers.
  • Jaime MELO DE & OLARREAGA & TAKACS, 1996. "Pricing policy under Double Market Power: Madagascar and the International Vanilla Market," Working Papers 199617, CERDI.
• Jaime de MELO & Shujiro URATA, 2015. "The Influence of Increased Foreign Competition on Industrial Concentration and Profitability," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 9, pages 219-236, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Urata, Shujiro, 1986. "The influence of increased foreign competition on industrial concentration and profitability," International Journal of Industrial Organization, Elsevier, vol. 4(3), pages 287-304, September.
• James Tybout & Jaime de Melo & Vittorio Corbo, 2015. "The Effects of Trade Reforms on Scale and Technical Efficiency," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 10, pages 237-256, World Scientific Publishing Co. Pte. Ltd..
• Jaime de Melo & L Alan Winters, 2015. "Do exporters gain from VERs?," World Scientific Book Chapters, in: Non-Tariff Barriers, Regionalism and Poverty Essays in Applied International Trade Analysis, chapter 3, pages 49-67, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Winters, L. Alan, 1993. "Do exporters gain from VERs?," European Economic Review, Elsevier, vol. 37(7), pages 1331-1349, October.
  • Jaime de Melo & L. Alan Winters, 2015. "Do Exporters Gain from VERs?," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 11, pages 257-275, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Winters, L. Alan, 1990. "Do Exporters Gain From VERs?," CEPR Discussion Papers 383, C.E.P.R. Discussion Papers.
• Céline Carrère & Jaime de Melo, 2015. "Are Different Rules of Origin Equally Costly? Estimates from NAFTA," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 12, pages 277-298, World Scientific Publishing Co. Pte. Ltd..
  • Céline CARRERE & Jaime MELO DE, 2004. "Are Different Rules of Origin Equally Costly? Estimates from NAFTA," Working Papers 200412, CERDI.
  • Céline Carrere & Olivier Cadot, 2006. "Are different Rules of Origin Equally Costly? Estimates from NAFTA," Post-Print hal-00130079, HAL.
  • de Melo, Jaime & Carrère, Céline, 2004. "Are Different Rules of Origin Equally Costly? Estimates from NAFTA," CEPR Discussion Papers 4437, C.E.P.R. Discussion Papers.
• Jean-François Brun & Céline Carrère & Patrick Guillaumont & Jaime de Melo, 2015. "Has Distance Died? Evidence from a Panel Gravity Model," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 13, pages 299-320, World Scientific Publishing Co. Pte. Ltd..
  • Jean-François Brun & Céline Carrère & Patrick Guillaumont & Jaime de Melo, 2005. "Has Distance Died? Evidence from a Panel Gravity Model," The World Bank Economic Review, World Bank, vol. 19(1), pages 99-120.
  • Guillaumont, Patrick & de Melo, Jaime & Brun, Jean-François & Carrère, Céline, 2002. "Has Distance Died? Evidence from a Panel Gravity Model," CEPR Discussion Papers 3500, C.E.P.R. Discussion Papers.
  • Jean-François BRUN & Céline CARRERE & Jaime MELO DE & Patrick GUILLAUMONT, 2002. "Has Distance Died? Evidence from a Panel Gravity Model," Working Papers 200215, CERDI.
• Jaime De Melo & Arvind Panagariya & Dani Rodrik, 2015. "The New Regionalism: A Country Perspective," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 14, pages 323-357, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Panagariya, Arvind & Rodrik, Dani, 1992. "The New Regionalism: A Country Perspective," CEPR Discussion Papers 715, C.E.P.R. Discussion Papers.
  • de Melo, Jaime & Panagariya, Arvind & Rodrik, Dani, 1993. "The new regionalism : a country perspective," Policy Research Working Paper Series 1094, The World Bank.
• Olivier Cadot & Jaime de Melo & Marcelo Olarreaga, 2015. "The Protectionist Bias of Duty Drawbacks: Evidence from Mercosur," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 15, pages 359-380, World Scientific Publishing Co. Pte. Ltd..
  • Cadot, Olivier & de Melo, Jaime & Olarreaga, Marcelo, 2003. "The protectionist bias of duty drawbacks: evidence from Mercosur," Journal of International Economics, Elsevier, vol. 59(1), pages 161-182, January.
• Olivier Cadot & Jaime de Melo, 2015. "Why OECD Countries Should Reform Rules of Origin," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 16, pages 381-409, World Scientific Publishing Co. Pte. Ltd..
  • Olivier Cadot & Jaime de Melo, 2007. "Why OECD Countries Should Reform Rules of Origin," The World Bank Research Observer, World Bank, vol. 23(1), pages 77-105, October.
  • de Melo, Jaime & Cadot, Olivier, 2007. "Why OECD Countries should Reform Rules of Origin," CEPR Discussion Papers 6172, C.E.P.R. Discussion Papers.
• Jean-Marie Grether & Jaime de Melo & Tobias Müller, 2015. "The Political Economy of International Migration in a Ricardo–Viner Model," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 17, pages 411-437, World Scientific Publishing Co. Pte. Ltd..
  • Jaime MELO DE & Jean Marie GRETHER & Jean Claude MULLER, 2000. "The Political Economy of International Migration in a Ricardo-Viner Model," Working Papers 200021, CERDI.
  • de Melo, Jaime & Müller, Tobias & Grether, Jean-Marie, 2001. "The Political Economy of International Migration in a Ricardo-Viner Model," CEPR Discussion Papers 2714, C.E.P.R. Discussion Papers.
• Sanoussi Bilal & Jean-Marie Grether & Jaime de Melo, 2015. "Attitudes Towards Immigration: A Trade Theoretic Approach," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 18, pages 439-453, World Scientific Publishing Co. Pte. Ltd..
  • Sanoussi Bilal & Jean‐Marie Grether & Jaime de Melo, 2003. "Attitudes Towards Immigration: a Trade‐Theoretic Approach," Review of International Economics, Wiley Blackwell, vol. 11(2), pages 253-267, May.
• Jaime de Melo & Florence Miguet & Tobias Müller, 2015. "The Political Economy of Migration and EU Enlargement: Lessons from Switzerland," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 19, pages 455-493, World Scientific Publishing Co. Pte. Ltd..
• Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2015. "Openness, Inequality and Poverty: Endowments Matter," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 20, pages 497-532, World Scientific Publishing Co. Pte. Ltd..
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Openness, inequality and poverty: Endowments matter," The Journal of International Trade & Economic Development, Taylor & Francis Journals, vol. 17(3), pages 343-378.
  • Gourdon, Julien & Maystre, Nicolas & de Melo, Jaime, 2006. "Openness, inequality, and poverty : endowments matter," Policy Research Working Paper Series 3981, The World Bank.
  • Julien Gourdon & Jaime de Melo & Nicolas Maystre, 2008. "Openness, Inequality and Poverty: Endowment Matter?," Post-Print hal-00348921, HAL.
  • Jaime MELO DE & Julien GOURDON & Nicolas MAYSTRE, 2007. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers 200711, CERDI.
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Opennes, Inequality, and Poverty: Endowments Matter," Development Working Papers 239, Centro Studi Luca d'Agliano, University of Milano.
  • de Melo, Jaime & Gourdon, Julien & Maystre, Nicolas, 2006. "Openness, Inequality and Poverty: Endowments Matter," CEPR Discussion Papers 5738, C.E.P.R. Discussion Papers.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers halshs-00557112, HAL.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," CERDI Working papers halshs-00557112, HAL.
• Artjoms IVLEVS & Jaime DE MELO, 2015. "FDI, the Brain Drain and Trade: Channels and Evidence," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 21, pages 533-551, World Scientific Publishing Co. Pte. Ltd..
  • Artjoms Ivlevs & Jaime De Melo, 2010. "FDI, the Brain Drain and Trade: Channels and Evidence," Annals of Economics and Statistics, GENES, issue 97-98, pages 103-121.
  • Artjoms Ivlevs & Jaime de Melo, 2008. "FDI, the Brain Drain and Trade: Channels and Evidence," Discussion Papers 08/40, University of Nottingham, GEP.
  • Artjoms Ivlevs & Jaime de Melo, 2008. "FDI, the Brain Drain and Trade: Channels and Evidence," Development Working Papers 261, Centro Studi Luca d'Agliano, University of Milano.
  • de Melo, Jaime & Ivlevs, Artjoms, 2008. "FDI, the Brain Drain and Trade: Channels and Evidence," CEPR Discussion Papers 7002, C.E.P.R. Discussion Papers.
• Jean-Marie Grether & Nicole Andréa Mathys & Jaime de Melo, 2015. "Unravelling the Worldwide Pollution Haven Effect," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 23, pages 581-612, World Scientific Publishing Co. Pte. Ltd..
  • Jean-Marie Grether & Nicole Andr�a Mathys & Jaime de Melo, 2012. "Unravelling the worldwide pollution haven effect," The Journal of International Trade & Economic Development, Taylor & Francis Journals, vol. 21(1), pages 131-162, December.
  • Grether, Jean-Marie & Mathys, Nicole A. & de Melo, Jaime, 2006. "Unraveling the worldwide pollution haven effect," Policy Research Working Paper Series 4047, The World Bank.
  • Jean-Marie GRETHER & Nicole A. MATHYS & Jaime DE MELO, 2012. "Unravelling the Worldwide Pollution Haven Effect," Working Papers P40, FERDI.
  • Jean-Marie GRETHER & Nicole A. MATHYS & Jaime DE MELO, 2012. "Unravelling the Worldwide Pollution Haven Effect," Working Papers P40, FERDI.
  • Grether, Jean-Marie & Mathys, Nicole A. & de Melo, Jaime, 2011. "Unravelling the Worldwide Pollution Haven Effect," Climate Change and Sustainable Development 119097, Fondazione Eni Enrico Mattei (FEEM).
  • Jean-Marie Grether & Nicole A. Mathys & Jaime de Melo, 2006. "Unraveling the World-Wide Pollution Haven Effect," Working Papers 2006.122, Fondazione Eni Enrico Mattei.
  • Grether, Jean-Marie & Mathys, Nicole A. & de Melo, Jaime, 2006. "Unraveling the World-Wide Pollution Haven Effect," Economic Theory and Applications Working Papers 12186, Fondazione Eni Enrico Mattei (FEEM).
  • de Melo, Jaime & Grether, Jean-Marie & Mathys, Nicole Andréa, 2006. "Unravelling the World-Wide Pollution Haven Effect," CEPR Discussion Papers 5815, C.E.P.R. Discussion Papers.
  • Jean-Marie Grether & Nicole A. Mathys & Jaime de Melo, 2011. "Unravelling the Worldwide Pollution Haven Effect," Working Papers 2011.75, Fondazione Eni Enrico Mattei.
  • Jean-Marie GRETHER & Nicole A. MATHYS & Jaime DE MELO, 2006. "Unraveling the World-Wide Pollution Haven Effect," Cahiers de Recherches Economiques du Département d'économie 06.04, Université de Lausanne, Faculté des HEC, Département d’économie.
• Roblek, Vasja & Meško Maja, 2015. "Designing Mobile Application for the Over the Counter Drug Marketing," Proceedings of the ENTRENOVA - ENTerprise REsearch InNOVAtion Conference (2015), Kotor, Montengero, in: Proceedings of the ENTRENOVA - ENTerprise REsearch InNOVAtion Conference, Kotor, Montengero, 10-11 September 2015, pages 213-219, IRENET - Society for Advancing Innovation and Research in Economy, Zagreb.

2014

• Lynne G. Zucker & Michael R. Darby, 2014. "Defacto and Deeded Intellectual Property: Knowledge-Driven Co-Evolution of Firm Collaboration Boundaries and IPR Stragtegy," Annals of Economics and Statistics, GENES, issue 115-116, pages 221-251.
  • Lynne G. Zucker & Michael R. Darby, 2014. "Defacto and Deeded Intellectual Property: Knowledge-Driven Co-Evolution of Firm Collaboration Boundaries and IPR Strategy," NBER Working Papers 20249, National Bureau of Economic Research, Inc.
• Petra Moser & Alessandra Voena & Fabian Waldinger, 2014. "German Jewish ?migr?s and US Invention," American Economic Review, American Economic Association, vol. 104(10), pages 3222-3255, October.
  • Petra Moser & Alessandra Voena & Fabian Waldinger, 2014. "German-Jewish Emigres and U.S. Invention," NBER Working Papers 19962, National Bureau of Economic Research, Inc.
  • Moser, Petra & Voena, Alessandra & Waldinger, Fabian, 2014. "German Jewish émigrés and US invention," LSE Research Online Documents on Economics 68322, London School of Economics and Political Science, LSE Library.
  • Moser, Petra & Voena, Alessandra & Waldinger, Fabian, 2014. "German Jewish Emigres and US Invention," Munich Reprints in Economics 68900, University of Munich, Department of Economics.
• Keith M. Marzilli Ericson, 2014. "Consumer Inertia and Firm Pricing in the Medicare Part D Prescription Drug Insurance Exchange," American Economic Journal: Economic Policy, American Economic Association, vol. 6(1), pages 38-64, February.
  • Keith M. Marzilli Ericson, 2012. "Consumer Inertia and Firm Pricing in the Medicare Part D Prescription Drug Insurance Exchange," NBER Working Papers 18359, National Bureau of Economic Research, Inc.
• Dragutinovic, Stefan & Zubovic, Jovan & Reljic, Marija, 2014. "Pharmaceutical Sector in Serbia in the Period 1990-2013," Ekonomika, Journal for Economic Theory and Practice and Social Issues, Society of Economists Ekonomika, Nis, Serbia, vol. 60(4), December.
  • Stefan Dragutinovic, Jovan Zubovic, Marija Reljic, 2015. "Pharmaceutical Sector In Serbia In The Period 1990-2013," Ekonomika, Journal for Economic Theory and Practice and Social Issues 2014-04, „Ekonomika“ Society of Economists, Niš (Serbia).
• Carlos Gustavo Cano, 2014. "Carestía e inflación: qué esperar de la política agrícola y los gravámenes a la tierra y el carbono," Borradores de Economia 836, Banco de la Republica de Colombia.
• Marco Ceccagnoli & Matthew J. Higgins & Vincenzo Palermo, 2014. "Behind the Scenes: Sources of Complementarity in R&D," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 23(1), pages 125-148, March.
  • Marco Ceccagnoli & Matthew J. Higgins & Vincenzo Palermo, 2013. "Behind the Scenes: Sources of Complementarity in R&D," NBER Working Papers 18795, National Bureau of Economic Research, Inc.
• Jeitschko Thomas D. & Zhang Nanyun, 2014. "Adverse Effects of Patent Pooling on Product Development and Commercialization," The B.E. Journal of Theoretical Economics, De Gruyter, vol. 14(1), pages 27-57, January.
  • Thomas D. Jeitschko & Nanyun Zhang, 2012. "Adverse Effects of Patent Pooling on Product Development and Commercialization," EAG Discussions Papers 201205, Department of Justice, Antitrust Division.
  • Jeitschko, Thomas D. & Zhang, Nanyun, 2013. "Adverse effects of patent pooling on product development and commercialization," DICE Discussion Papers 92, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
• Martino Nieddu & Estelle Garnier & Christophe Bliard, 2014. "Patrimoines productifs collectifs versus exploration/exploitation. Le cas de la bioraffinerie," Revue économique, Presses de Sciences-Po, vol. 65(6), pages 957-987.
• Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016. "Patents and the Global Diffusion of New Drugs," American Economic Review, American Economic Association, vol. 106(1), pages 136-164, January.
  • Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," NBER Working Papers 20492, National Bureau of Economic Research, Inc.
  • Iain Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," CEP Discussion Papers dp1298, Centre for Economic Performance, LSE.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2016. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 65415, London School of Economics and Political Science, LSE Library.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2014. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 60450, London School of Economics and Political Science, LSE Library.
  • Schankerman, Mark & Cockburn, Iain M & Lanjouw, Jean, 2014. "Patents and the Global Diffusion of New Drugs," CEPR Discussion Papers 10149, C.E.P.R. Discussion Papers.
• Manolis Galenianos & Alessandro Gavazza, 2014. "A quantitative analysis of the retail market for illicit drugs," 2014 Meeting Papers 618, Society for Economic Dynamics.
  • Manolis Galenianos & Alessandro Gavazza, 2014. "A Quantitative Analysis of the Retail Market for Illicit Drugs," STICERD - Economics of Industry Papers 53, Suntory and Toyota International Centres for Economics and Related Disciplines, LSE.
• Tannista Banerjee & Ralph Siebert, 2013. "The Impact of R&D Cooperation on Drug Variety Offered on the Market: Evidence from the Pharmaceutical Industry," Auburn Economics Working Paper Series auwp2013-20, Department of Economics, Auburn University.
  • Tannista Banerjee & Ralph Siebert, 2014. "The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry," CESifo Working Paper Series 4567, CESifo.
• Badi Baltagi & Peter Egger & Michaela Kesina, 2015. "Sources of productivity spillovers: panel data evidence from China," Journal of Productivity Analysis, Springer, vol. 43(3), pages 389-402, June.
  • Badi H. Baltagi & Peter Egger & Michaela Kesina, 2014. "Sources of Productivity Spillovers: Panel Data Evidence from China," CESifo Working Paper Series 4812, CESifo.
• Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2016. "Firm‐Level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman‐Taylor Approach," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 31(1), pages 214-248, January.
  • Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2014. "Firm-level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," Center for Policy Research Working Papers 175, Center for Policy Research, Maxwell School, Syracuse University.
  • Badi H. Baltagi & Peter Egger & Michaela Kesina, 2014. "Firm-level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," CESifo Working Paper Series 5114, CESifo.
  • Badi H. Baltagi & Peter H. Egger, 2014. "Firm-Level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," Center for Policy Research Working Papers 173, Center for Policy Research, Maxwell School, Syracuse University.
• Julia Heller & Jan Kluge & Christian Ochsner, 2014. "Stimmt die Chemie? Die Export- und Forschungsstärke der Chemischen und Pharmazeutischen Industrie im Ost-West-Vergleich," ifo Dresden berichtet, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 21(06), pages 11-19, December.
• Evgenia Kudymowa & Klaus Wohlrabe, 2014. "Konjunkturtest im Fokus: Herstellung von Gummi- und Kunststoffwaren," ifo Schnelldienst, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 67(07), pages 23-26, April.
• Carlos Gustavo Cano, 2014. "Carestía e inflación: qué esperar de la política agrícola y los gravámenes a la tierra y el carbono," Borradores de Economia 12022, Banco de la Republica.
• Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016. "Patents and the Global Diffusion of New Drugs," American Economic Review, American Economic Association, vol. 106(1), pages 136-164, January.
  • Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," NBER Working Papers 20492, National Bureau of Economic Research, Inc.
  • Schankerman, Mark & Cockburn, Iain M & Lanjouw, Jean, 2014. "Patents and the Global Diffusion of New Drugs," CEPR Discussion Papers 10149, C.E.P.R. Discussion Papers.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2016. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 65415, London School of Economics and Political Science, LSE Library.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2014. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 60450, London School of Economics and Political Science, LSE Library.
  • Iain Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," CEP Discussion Papers dp1298, Centre for Economic Performance, LSE.
• Sylvain Béal & Marc Deschamps, 2016. "On compensation schemes for data sharing within the European REACH legislation," European Journal of Law and Economics, Springer, vol. 41(1), pages 157-181, February.
  • Sylvain Béal & Marc Deschamps, 2014. "On compensation schemes for data sharing within the european REACH legislation," Working Papers 2014-01, CRESE.
  • Sylvain Béal & Marc Deschamps, 2016. "On compensation schemes for data sharing within the European REACH legislation," Post-Print halshs-01111885, HAL.
• Sylvain Béal & Marc Deschamps & Philippe Solal, 2014. "Balanced collective contributions, the equal allocation of non-separable costs and application to data sharing games," Working Papers hal-01377926, HAL.
  • Sylvain Béal & Marc Deschamps & Philippe Solal, 2014. "Balanced collective contributions, the equal allocation of non-separable costs and application to data sharing games," Working Papers 2014-02, CRESE.
• Boschma, Ron & Heimeriks, Gaston & Balland, Pierre-Alexandre, 2014. "Scientific knowledge dynamics and relatedness in biotech cities," Research Policy, Elsevier, vol. 43(1), pages 107-114.
  • Ron Boschma & Gaston Heimeriks & Pierre-Alexandre Balland, 2013. "Scientific Knowledge Dynamics and Relatedness in Bio-Tech Cities," Papers in Evolutionary Economic Geography (PEEG) 1304, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Apr 2013.
• Nishimura, Junichi & Okada, Yosuke, 2014. "R&D portfolios and pharmaceutical licensing," Research Policy, Elsevier, vol. 43(7), pages 1250-1263.
• Pierre-Alexandre Balland & David Rigby & Ron Boschma, 2015. "The technological resilience of US cities," Cambridge Journal of Regions, Economy and Society, Cambridge Political Economy Society, vol. 8(2), pages 167-184.
  • Balland, Pierre-Alexandre & Rigby, David & Boschma, Ron, 2014. "The Technological Resilience of U.S. Cities," Papers in Innovation Studies 2014/32, Lund University, CIRCLE - Centre for Innovation Research.
  • Pierre-Alexandre Balland & David Rigby & Ron Boschma, 2014. "The Technological Resilience of U.S. Cities," Papers in Evolutionary Economic Geography (PEEG) 1419, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Oct 2014.
• Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016. "Patents and the Global Diffusion of New Drugs," American Economic Review, American Economic Association, vol. 106(1), pages 136-164, January.
  • Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," NBER Working Papers 20492, National Bureau of Economic Research, Inc.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2016. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 65415, London School of Economics and Political Science, LSE Library.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2014. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 60450, London School of Economics and Political Science, LSE Library.
  • Iain Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," CEP Discussion Papers dp1298, Centre for Economic Performance, LSE.
  • Schankerman, Mark & Cockburn, Iain M & Lanjouw, Jean, 2014. "Patents and the Global Diffusion of New Drugs," CEPR Discussion Papers 10149, C.E.P.R. Discussion Papers.
• Petra Moser & Alessandra Voena & Fabian Waldinger, 2014. "German Jewish ?migr?s and US Invention," American Economic Review, American Economic Association, vol. 104(10), pages 3222-3255, October.
  • Petra Moser & Alessandra Voena & Fabian Waldinger, 2014. "German-Jewish Emigres and U.S. Invention," NBER Working Papers 19962, National Bureau of Economic Research, Inc.
  • Moser, Petra & Voena, Alessandra & Waldinger, Fabian, 2014. "German Jewish émigrés and US invention," LSE Research Online Documents on Economics 68322, London School of Economics and Political Science, LSE Library.
  • Moser, Petra & Voena, Alessandra & Waldinger, Fabian, 2014. "German Jewish Emigres and US Invention," Munich Reprints in Economics 68900, University of Munich, Department of Economics.
• Stephen Roper & Helen Xia, 2014. "Unpacking open innovation: Absorptive capacity, exploratory and exploitative openness and the growth of entrepreneurial biopharmaceutical firms," Research Papers 0019, Enterprise Research Centre.
• William S. Comanor & Stuart O. Schweitzer, 2014. "Pharmaceutical economics," ECONOMIA E POLITICA INDUSTRIALE, FrancoAngeli Editore, vol. 2014(1), pages 55-82.
• Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers halshs-01072741, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178631, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers 1425, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178636, HAL.
  • Izabela Jelovac & Nicolas Houy, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01261578, HAL.
  • Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01138229, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178630, HAL.
  • Izabela Jelovac & Nicolas Houy, 2017. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01657274, HAL.
• Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," The Annals of Regional Science, Springer;Western Regional Science Association, vol. 53(2), pages 395-422, September.
  • Cassi, Lorenzo & Plunket, Anne, 2013. "Proximity, network formation and inventive performance: in search of the proximity paradox," MPRA Paper 47388, University Library of Munich, Germany.
  • Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00997650, HAL.
  • Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," Post-Print hal-00997650, HAL.
• Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," The Annals of Regional Science, Springer;Western Regional Science Association, vol. 53(2), pages 395-422, September.
  • Cassi, Lorenzo & Plunket, Anne, 2013. "Proximity, network formation and inventive performance: in search of the proximity paradox," MPRA Paper 47388, University Library of Munich, Germany.
  • Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," Post-Print hal-00997650, HAL.
  • Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00997650, HAL.
• Nicolas Houy & Izabela Jelovac, 2015. "Drug Launch Timing and International Reference Pricing," Health Economics, John Wiley & Sons, Ltd., vol. 24(8), pages 978-989, August.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers halshs-00782179, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-00993816, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers 1301, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00955848, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00861222, HAL.
  • Izabela Jelovac & Nicolas Houy, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01088164, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01096276, HAL.
• Garavaglia Christian & Malerba Franco & Orsenigo Luigi & Pezzoni Michele, 2014. "Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 234(2-3), pages 274-298, April.
  • Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2014. "Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data," Post-Print halshs-01074524, HAL.
• Izabela Jelovac & Nicolas Houy, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01080543, HAL.
• Sylvain Béal & Marc Deschamps, 2014. "On Compensation Schemes for Data Sharing within the European REACH Legislation," Post-Print halshs-01083135, HAL.
• Nicolas Houy & Izabela Jelovac, 2015. "Drug Launch Timing and International Reference Pricing," Health Economics, John Wiley & Sons, Ltd., vol. 24(8), pages 978-989, August.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers halshs-00782179, HAL.
  • Izabela Jelovac & Nicolas Houy, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01088164, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers 1301, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-00993816, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00955848, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00861222, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01096276, HAL.
• Nicolas Houy & Izabela Jelovac, 2015. "Drug Launch Timing and International Reference Pricing," Health Economics, John Wiley & Sons, Ltd., vol. 24(8), pages 978-989, August.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers halshs-00782179, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01096276, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers 1301, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-00993816, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00955848, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00861222, HAL.
  • Izabela Jelovac & Nicolas Houy, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01088164, HAL.
• Sylvain Béal & Marc Deschamps, 2016. "On compensation schemes for data sharing within the European REACH legislation," European Journal of Law and Economics, Springer, vol. 41(1), pages 157-181, February.
  • Sylvain Béal & Marc Deschamps, 2014. "On compensation schemes for data sharing within the european REACH legislation," Working Papers 2014-01, CRESE.
  • Sylvain Béal & Marc Deschamps, 2016. "On compensation schemes for data sharing within the European REACH legislation," Post-Print halshs-01111885, HAL.
• Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers halshs-01072741, HAL.
  • Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01138229, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178631, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178636, HAL.
  • Izabela Jelovac & Nicolas Houy, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01261578, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers 1425, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178630, HAL.
  • Izabela Jelovac & Nicolas Houy, 2017. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01657274, HAL.
• Sylvain Béal & Marc Deschamps, 2014. "On compensation schemes for data sharing within the european REACH legislation," Working Papers hal-01377925, HAL.
• Sylvain Béal & Marc Deschamps & Philippe Solal, 2014. "Balanced collective contributions, the equal allocation of non-separable costs and application to data sharing games," Working Papers 2014-02, CRESE.
  • Sylvain Béal & Marc Deschamps & Philippe Solal, 2014. "Balanced collective contributions, the equal allocation of non-separable costs and application to data sharing games," Working Papers hal-01377926, HAL.
• Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01138229, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers halshs-01072741, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178631, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Working Papers 1425, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Izabela Jelovac & Nicolas Houy, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01261578, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178636, HAL.
  • Izabela Jelovac, 2015. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01178630, HAL.
  • Izabela Jelovac & Nicolas Houy, 2017. "Drug approval decision times, international reference pricing and strategic launches of new drugs," Post-Print halshs-01657274, HAL.
• Bergman, Mats & Granlund, David & Rudholm, Niklas, 2014. "Reforming the Swedish pharmaceuticals market – consequences for costs per defined daily dose," HUI Working Papers 105, HUI Research.
• Pierre-Alexandre Balland & David Rigby & Ron Boschma, 2015. "The technological resilience of US cities," Cambridge Journal of Regions, Economy and Society, Cambridge Political Economy Society, vol. 8(2), pages 167-184.
  • Pierre-Alexandre Balland & David Rigby & Ron Boschma, 2014. "The Technological Resilience of U.S. Cities," Papers in Evolutionary Economic Geography (PEEG) 1419, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Oct 2014.
  • Balland, Pierre-Alexandre & Rigby, David & Boschma, Ron, 2014. "The Technological Resilience of U.S. Cities," Papers in Innovation Studies 2014/32, Lund University, CIRCLE - Centre for Innovation Research.
• Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune, 2015. "Price regulation and parallel imports of pharmaceuticals," Journal of Public Economics, Elsevier, vol. 129(C), pages 92-105.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2014. "Price Regulation and Parallel Imports of Pharmaceuticals," NIPE Working Papers 01/2014, NIPE - Universidade do Minho.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2015. "Price Regulation and Parallel Imports of Pharmaceuticals," CESifo Working Paper Series 5469, CESifo.
  • Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune, 2014. "Price Regulation and Parallel Imports of Pharmaceuticals," Discussion Paper Series in Economics 1/2014, Norwegian School of Economics, Department of Economics.
• Samuel Yaw Akomea & Olav Jull Sørensen & Kweku Amponsah-Efah, 2014. "Export Drivers And Barriers: Evidence From Ghanaian Pharmaceutical Manufacturing Firms," Global Journal of Business Research, The Institute for Business and Finance Research, vol. 8(2), pages 81-96.
• Garavaglia Christian & Malerba Franco & Orsenigo Luigi & Pezzoni Michele, 2014. "Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 234(2-3), pages 274-298, April.
  • Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2014. "Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data," Post-Print halshs-01074524, HAL.
• Petra Moser & Alessandra Voena & Fabian Waldinger, 2014. "German Jewish ?migr?s and US Invention," American Economic Review, American Economic Association, vol. 104(10), pages 3222-3255, October.
  • Petra Moser & Alessandra Voena & Fabian Waldinger, 2014. "German-Jewish Emigres and U.S. Invention," NBER Working Papers 19962, National Bureau of Economic Research, Inc.
  • Moser, Petra & Voena, Alessandra & Waldinger, Fabian, 2014. "German Jewish Emigres and US Invention," Munich Reprints in Economics 68900, University of Munich, Department of Economics.
  • Moser, Petra & Voena, Alessandra & Waldinger, Fabian, 2014. "German Jewish émigrés and US invention," LSE Research Online Documents on Economics 68322, London School of Economics and Political Science, LSE Library.
• Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2016. "Firm‐Level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman‐Taylor Approach," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 31(1), pages 214-248, January.
  • Badi H. Baltagi & Peter Egger & Michaela Kesina, 2014. "Firm-level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," CESifo Working Paper Series 5114, CESifo.
  • Badi H. Baltagi & Peter H. Egger, 2014. "Firm-Level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," Center for Policy Research Working Papers 173, Center for Policy Research, Maxwell School, Syracuse University.
  • Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2014. "Firm-level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," Center for Policy Research Working Papers 175, Center for Policy Research, Maxwell School, Syracuse University.
• Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2016. "Firm‐Level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman‐Taylor Approach," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 31(1), pages 214-248, January.
  • Badi H. Baltagi & Peter Egger & Michaela Kesina, 2014. "Firm-level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," CESifo Working Paper Series 5114, CESifo.
  • Badi H. Baltagi & Peter H. Egger & Michaela Kesina, 2014. "Firm-level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," Center for Policy Research Working Papers 175, Center for Policy Research, Maxwell School, Syracuse University.
  • Badi H. Baltagi & Peter H. Egger, 2014. "Firm-Level Productivity Spillovers in China's Chemical Industry: A Spatial Hausman-Taylor Approach," Center for Policy Research Working Papers 173, Center for Policy Research, Maxwell School, Syracuse University.
• Talia Bar & Dean R. Lillard, 2014. "Direct to Consumer Advertising of Pharmaceutical Drugs: Information and Persuasion," NBER Working Papers 19794, National Bureau of Economic Research, Inc.
• Eduardo Morales & Gloria Sheu & Andrés Zahler, 2014. "Gravity and Extended Gravity: Using Moment Inequalities to Estimate a Model of Export Entry," NBER Working Papers 19916, National Bureau of Economic Research, Inc.
• Rena M. Conti & Ernst R. Berndt, 2014. "Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007," NBER Working Papers 20016, National Bureau of Economic Research, Inc.
• Lynne G. Zucker & Michael R. Darby, 2014. "Defacto and Deeded Intellectual Property: Knowledge-Driven Co-Evolution of Firm Collaboration Boundaries and IPR Stragtegy," Annals of Economics and Statistics, GENES, issue 115-116, pages 221-251.
  • Lynne G. Zucker & Michael R. Darby, 2014. "Defacto and Deeded Intellectual Property: Knowledge-Driven Co-Evolution of Firm Collaboration Boundaries and IPR Strategy," NBER Working Papers 20249, National Bureau of Economic Research, Inc.
• Keith M. Drake & Martha A. Starr & Thomas McGuire, 2014. "Do "Reverse Payment" Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay?," NBER Working Papers 20292, National Bureau of Economic Research, Inc.
• Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2016. "Patents and the Global Diffusion of New Drugs," American Economic Review, American Economic Association, vol. 106(1), pages 136-164, January.
  • Schankerman, Mark & Cockburn, Iain M & Lanjouw, Jean, 2014. "Patents and the Global Diffusion of New Drugs," CEPR Discussion Papers 10149, C.E.P.R. Discussion Papers.
  • Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," NBER Working Papers 20492, National Bureau of Economic Research, Inc.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2016. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 65415, London School of Economics and Political Science, LSE Library.
  • Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark, 2014. "Patents and the global diffusion of new drugs," LSE Research Online Documents on Economics 60450, London School of Economics and Political Science, LSE Library.
  • Iain Cockburn & Jean O. Lanjouw & Mark Schankerman, 2014. "Patents and the Global Diffusion of New Drugs," CEP Discussion Papers dp1298, Centre for Economic Performance, LSE.
• Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022. "Generic competition and the incentives for early-stage pharmaceutical innovation," Research Policy, Elsevier, vol. 51(10).
  • Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
• Braginskij, O. & Tatevosjan, G. & Sedova, S., 2014. "Methodology of Investment Programs' Studying and Its Optimization in Bounded Financial Resources (the Example of Chemical Industry)," Journal of the New Economic Association, New Economic Association, vol. 23(3), pages 130-152.
• Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune, 2015. "Price regulation and parallel imports of pharmaceuticals," Journal of Public Economics, Elsevier, vol. 129(C), pages 92-105.
  • Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune, 2014. "Price Regulation and Parallel Imports of Pharmaceuticals," Discussion Paper Series in Economics 1/2014, Norwegian School of Economics, Department of Economics.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2014. "Price Regulation and Parallel Imports of Pharmaceuticals," NIPE Working Papers 01/2014, NIPE - Universidade do Minho.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2015. "Price Regulation and Parallel Imports of Pharmaceuticals," CESifo Working Paper Series 5469, CESifo.
• Frank R. Lichtenberg, 2014. "Has Medical Innovation Reduced Cancer Mortality?," CESifo Economic Studies, CESifo Group, vol. 60(1), pages 135-177.
  • Frank R. Lichtenberg, 2010. "Has medical innovation reduced cancer mortality?," NBER Working Papers 15880, National Bureau of Economic Research, Inc.
• Gaston Heimeriks & Ron Boschma, 2014. "The path- and place-dependent nature of scientific knowledge production in biotech 1986–2008," Journal of Economic Geography, Oxford University Press, vol. 14(2), pages 339-364.
  • Gaston Heimeriks & Ron Boschma, 2012. "The path- and place-dependent nature of scientific knowledge production in biotech 1986-2008," Papers in Evolutionary Economic Geography (PEEG) 1210, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Jun 2012.
• Margaritti Doina, 2014. "A New Vision Regarding the Competitive Advantages in the Romanian Pharmaceutical Market," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, vol. 0(2), pages 119-131, May.
• Mannino, Ilda & Ninka, Eniel & Turvani, Margherita, 2014. "Porto Marghera and the Industrial Ecology Challenge: Why it did not become an Eco-Industrial Park," MPRA Paper 55166, University Library of Munich, Germany.
• Kuzyaeva Anastasia & Didenko Alexander, 2014. "Productivity spillovers in the Russian Federation: the case of the chemical market," Review of Business and Economics Studies, CyberLeninka;Федеральное государственное образовательное бюджетное учреждение высшего профессионального образования «Финансовый университет при Правительстве Российской Федерации» (Финансовый университет), issue 3, pages 55-74.
  • Kuzyaeva, Anastasia & Didenko, Alexander, 2014. "Productivity Spillovers in the Russian Federation: The Case of Chemical Market," MPRA Paper 59349, University Library of Munich, Germany.
• Paolo Sylos Labini, 2014. "Montedison. Il dinosauro nel MEC," Moneta e Credito, Economia civile, vol. 67(265), pages 69-76.
• Manolis Galenianos & Alessandro Gavazza, 2014. "A Quantitative Analysis of the Retail Market for Illicit Drugs," STICERD - Economics of Industry Papers 53, Suntory and Toyota International Centres for Economics and Related Disciplines, LSE.
  • Manolis Galenianos & Alessandro Gavazza, 2014. "A quantitative analysis of the retail market for illicit drugs," 2014 Meeting Papers 618, Society for Economic Dynamics.
• Mishra SOVANJEET, 2014. "HR Issues and Challenges in Pharmaceuticals with special reference to India," REVISTA DE MANAGEMENT COMPARAT INTERNATIONAL/REVIEW OF INTERNATIONAL COMPARATIVE MANAGEMENT, Faculty of Management, Academy of Economic Studies, Bucharest, Romania, vol. 15(4), pages 423-430, October.
• Kuzyaeva Anastasia & Didenko Alexander, 2014. "Productivity spillovers in the Russian Federation: the case of the chemical market," Review of Business and Economics Studies, CyberLeninka;Федеральное государственное образовательное бюджетное учреждение высшего профессионального образования «Финансовый университет при Правительстве Российской Федерации» (Финансовый университет), issue 3, pages 55-74.
  • Kuzyaeva, Anastasia & Didenko, Alexander, 2014. "Productivity Spillovers in the Russian Federation: The Case of Chemical Market," MPRA Paper 59349, University Library of Munich, Germany.
• Mark Duggan & Craig Garthwaite & Aparajita Goyal, 2016. "The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India," American Economic Review, American Economic Association, vol. 106(1), pages 99-135, January.
  • Mark Duggan & Craig Garthwaite & Aparajita Goyal, 2014. "The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India," NBER Working Papers 20548, National Bureau of Economic Research, Inc.
  • Mark Duggan & Craig Garthwaite & Aparajita Goyal, 2014. "The Market Impacts Of Pharmaceutical Product Patents In Developing Countries: Evidence From India," Discussion Papers 14-005, Stanford Institute for Economic Policy Research.
• Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," The Annals of Regional Science, Springer;Western Regional Science Association, vol. 53(2), pages 395-422, September.
  • Cassi, Lorenzo & Plunket, Anne, 2013. "Proximity, network formation and inventive performance: in search of the proximity paradox," MPRA Paper 47388, University Library of Munich, Germany.
  • Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," Post-Print hal-00997650, HAL.
  • Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00997650, HAL.
• Javier Coronado & Sergi Jiménez-Martín & Pedro Marín, 2014. "An empirical analysis of the multimarket contact theory in pharmaceutical markets," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(6), pages 623-643, July.
• Frank R. Lichtenberg & Billie Pettersson, 2014. "The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 23(3), pages 239-273, April.
  • Frank Lichtenberg & Billie Pettersson, 2012. "The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data," CESifo Working Paper Series 3894, CESifo.
• Steven Tenn & Brett W. Wendling, 2014. "Entry Threats and Pricing in the Generic Drug Industry," The Review of Economics and Statistics, MIT Press, vol. 96(2), pages 214-228, May.
• Carlos Bianchi, 2014. "Biotechnological firms in Uruguay 2010-2012," Documentos de Trabajo (working papers) 14-24, Instituto de Economía - IECON.
• Philippe Abecassis & Nathalie Coutinet, 2014. "Les transformations du modèle de l’industrie pharmaceutique," CEPN Policy Brief, Centre d'Economie de l'Université de Paris Nord, vol. 4, pages 1-4.
• Philippe Abecassis & Nathalie Coutinet, 2014. "How the pharmaceutical business model has changed," CEPN Policy Brief, Centre d'Economie de l'Université de Paris Nord, vol. 4, pages 1-4.
• Christian Zeller & Andreas Hametner & Koen Smet & Markus Seiwald, 2014. "Internationale Expansion in der pharmazeutischen Industrie Österreichs," FIW Research Reports series V-004, FIW.
• Christian Zeller & Andreas Hametner & Koen Smet & Markus Seiwald, 2014. "Internationale Expansion in der pharmazeutischen Industrie Österreichs," FIW Research Reports series V-004, FIW.
• Kirchhoff, Jasmina, 2014. "Regionale Beschäftigungsstruktur wissensintensiver Industrien am Beispiel der Pharmabranche," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, vol. 41(3), pages 105-122.

2013

• Skipper, Niels & Vejlin, Rune, 2015. "Determinants of generic vs. brand drug choice: Evidence from population-wide Danish data," Social Science & Medicine, Elsevier, vol. 130(C), pages 204-215.
  • Niels Skipper & Rune Vejlin, 2013. "Determinants of Generic vs. Brand Drug Choice: Evidence from Population-wide Danish Data," Economics Working Papers 2013-05, Department of Economics and Business Economics, Aarhus University.
• Tannista Banerjee & Ralph Siebert, 2013. "The Impact of R&D Cooperation on Drug Variety Offered on the Market: Evidence from the Pharmaceutical Industry," Auburn Economics Working Paper Series auwp2013-20, Department of Economics, Auburn University.
  • Tannista Banerjee & Ralph Siebert, 2014. "The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry," CESifo Working Paper Series 4567, CESifo.
• Tannistra Banerjee & Stephen Martin, 2015. "Pharmaceutical Regulation and Innovative Performance: A Decision‐theoretic Model," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 36(3), pages 177-190, April.
  • Tannista Banerjee & Stephen Martin, 2013. "Pharmaceutical regulation and innovative performance: a decision-theoretic model," Auburn Economics Working Paper Series auwp2013-21, Department of Economics, Auburn University.
• David E. Fagnan & Jose Maria Fernandez & Andrew W. Lo & Roger M. Stein, 2013. "Can Financial Engineering Cure Cancer?," American Economic Review, American Economic Association, vol. 103(3), pages 406-411, May.
• Blanco Orozco, Napoleón Vicente & Zuniga Gonzalez, Carlos Alberto, 2013. "Environmental Bio Economic Impact in Nicaragua," MPRA Paper 49357, University Library of Munich, Germany, revised 12 Jun 2013.
  • Blanco Orozco, Napoleón Vicente & Zúniga-González, Carlos Alberto, 2013. "Environmental Bio Economic Impact in Nicaragua," Working Papers 153854, National Autonomous University of Nicaragua, León (Unan-León), Researching Center for Applied Economics (RCAE).
• Farasat A. S. Bokhari & Gary M. Fournier, 2013. "Entry in the ADHD drugs market: Welfare impact of generics and me-too's," Journal of Industrial Economics, Wiley Blackwell, vol. 61(2), pages 339-392, June.
  • Farasat A.S. Bokhari & Gary M. Fournier, 2009. "Entry in the ADHD drugs market: Welfare impact of generics and me-toos," Working Papers wp2009_05_01, Department of Economics, Florida State University.
• Hostenkamp, Gisela & Lichtenberg, Frank R., 2015. "The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence," Social Science & Medicine, Elsevier, vol. 130(C), pages 162-171.
  • Frank Lichtenberg & Gisela Hostenkamp, 2013. "The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence," CESifo Working Paper Series 4516, CESifo.
• José Morelos Gómez & Fabián Gazabón Arrieta & Roberto Enrique Gómez Fernández, 2013. "Análisis multivariado de la productividad y rendimientos financieros de empresas industriales en Cartagena, Colombia," Apuntes del Cenes, Universidad Pedagógica y Tecnológica de Colombia, June.
• Alireza AZIMI, 2013. "Identification of External Critical Success Factors in Microbial Biotechnology Firms," Economics and Applied Informatics, "Dunarea de Jos" University of Galati, Faculty of Economics and Business Administration, issue 1, pages 21-26.
• Finger, Stephen R. & Gamper-Rabindran, Shanti, 2013. "Mandatory disclosure of plant emissions into the environment and worker chemical exposure inside plants," Ecological Economics, Elsevier, vol. 87(C), pages 124-136.
• Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune, 2013. "Margins and market shares: Pharmacy incentives for generic substitution," European Economic Review, Elsevier, vol. 61(C), pages 116-131.
  • Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune, 2010. "Margins and Market Shares: Pharmacy Incentives for Generic Substitution," Discussion Paper Series in Economics 18/2010, Norwegian School of Economics, Department of Economics.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2012. "Margins and Market Shares: Pharmacy Incentives for Generic Substitution," CESifo Working Paper Series 4055, CESifo.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2010. "Margins and Market Shares:Pharmacy Incentives for Generic Substitution," NIPE Working Papers 20/2010, NIPE - Universidade do Minho.
• Jayawardhana, Jayani, 2013. "Direct-to-consumer advertising and consumer welfare," International Journal of Industrial Organization, Elsevier, vol. 31(2), pages 164-180.
• Hosken, Daniel & Wendling, Brett, 2013. "Informing the uninformed: How drug advertising affects check-up visits," International Journal of Industrial Organization, Elsevier, vol. 31(2), pages 181-194.
• Anderson, Simon P. & Ciliberto, Federico & Liaukonyte, Jura, 2013. "Information content of advertising: Empirical evidence from the OTC analgesic industry," International Journal of Industrial Organization, Elsevier, vol. 31(5), pages 355-367.
• Arcidiacono, Peter & Ellickson, Paul B. & Landry, Peter & Ridley, David B., 2013. "Pharmaceutical followers," International Journal of Industrial Organization, Elsevier, vol. 31(5), pages 538-553.
  • Peter Arcidiacono & Paul B. Ellickson & Peter Landry & David B. Ridley, 2013. "Pharmaceutical Followers," NBER Working Papers 19522, National Bureau of Economic Research, Inc.
• Chicu, Mark & Ziebarth, Nicolas L., 2013. "Multi-market contact and competition: evidence from the Depression-era portland cement industry," International Journal of Industrial Organization, Elsevier, vol. 31(5), pages 603-611.
• de Frutos, Maria-Angeles & Ornaghi, Carmine & Siotis, Georges, 2013. "Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?," Journal of Health Economics, Elsevier, vol. 32(1), pages 268-285.
  • Siotis, Georges & de Frutos, Maria-Angeles & Ornaghi, Carmine, 2010. "Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?," CEPR Discussion Papers 8076, C.E.P.R. Discussion Papers.
• Boschma, Ron & Heimeriks, Gaston & Balland, Pierre-Alexandre, 2014. "Scientific knowledge dynamics and relatedness in biotech cities," Research Policy, Elsevier, vol. 43(1), pages 107-114.
  • Ron Boschma & Gaston Heimeriks & Pierre-Alexandre Balland, 2013. "Scientific Knowledge Dynamics and Relatedness in Bio-Tech Cities," Papers in Evolutionary Economic Geography (PEEG) 1304, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Apr 2013.
• Ron Boschma & Pierre-Alexandre Balland & Dieter Franz Kogler, 2015. "Relatedness and technological change in cities: the rise and fall of technological knowledge in US metropolitan areas from 1981 to 2010," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 24(1), pages 223-250.
  • Ron Boschma & Pierre-Alexandre Balland & Dieter Franz Kogler, 2013. "Relatedness and Technological Change in Cities: The rise and fall of technological knowledge in U.S. metropolitan areas from 1981 to 2010," Papers in Evolutionary Economic Geography (PEEG) 1316, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Sep 2013.
• Nicolas Houy & Izabela Jelovac, 2015. "Drug Launch Timing and International Reference Pricing," Health Economics, John Wiley & Sons, Ltd., vol. 24(8), pages 978-989, August.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers halshs-00782179, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers 1301, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-00993816, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00955848, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00861222, HAL.
  • Izabela Jelovac & Nicolas Houy, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01088164, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01096276, HAL.
• Lorenzo Cassi & Anne Plunket, 2015. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Regional Studies, Taylor & Francis Journals, vol. 49(6), pages 936-954, June.
  • Cassi, Lorenzo & Plunket, Anne, 2012. "Research collaboration in co-­inventor networks: combining closure,bridging and proximities," MPRA Paper 39481, University Library of Munich, Germany.
  • Lorenzo Cassi & Anne Plunket, 2013. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00987705, HAL.
  • Lorenzo Cassi & Anne Plunket, 2013. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Post-Print hal-00987705, HAL.
• Lorenzo Cassi & Anne Plunket, 2015. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Regional Studies, Taylor & Francis Journals, vol. 49(6), pages 936-954, June.
  • Cassi, Lorenzo & Plunket, Anne, 2012. "Research collaboration in co-­inventor networks: combining closure,bridging and proximities," MPRA Paper 39481, University Library of Munich, Germany.
  • Lorenzo Cassi & Anne Plunket, 2013. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Post-Print hal-00987705, HAL.
  • Lorenzo Cassi & Anne Plunket, 2013. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00987705, HAL.
• Nicolas Houy & Izabela Jelovac, 2015. "Drug Launch Timing and International Reference Pricing," Health Economics, John Wiley & Sons, Ltd., vol. 24(8), pages 978-989, August.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers halshs-00782179, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00861222, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers 1301, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-00993816, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00955848, HAL.
  • Izabela Jelovac & Nicolas Houy, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01088164, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01096276, HAL.
• Nicolas Houy & Izabela Jelovac, 2015. "Drug Launch Timing and International Reference Pricing," Health Economics, John Wiley & Sons, Ltd., vol. 24(8), pages 978-989, August.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers halshs-00782179, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00955848, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-00993816, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers 1301, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00861222, HAL.
  • Izabela Jelovac & Nicolas Houy, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01088164, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01096276, HAL.
• Nicolas Houy & Izabela Jelovac, 2015. "Drug Launch Timing and International Reference Pricing," Health Economics, John Wiley & Sons, Ltd., vol. 24(8), pages 978-989, August.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00861222, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers halshs-00782179, HAL.
  • Izabela Jelovac & Nicolas Houy, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01088164, HAL.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-01096276, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Working Papers 1301, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Nicolas Houy & Izabela Jelovac, 2014. "Drug launch timing and international reference pricing," Post-Print halshs-00993816, HAL.
  • Nicolas Houy & Izabela Jelovac, 2013. "Drug launch timing and international reference pricing," Post-Print halshs-00955848, HAL.
• Shanti Gamper-Rabindran & Stephen Finger, 2013. "Does industry self-regulation reduce pollution? Responsible Care in the chemical industry," Journal of Regulatory Economics, Springer, vol. 43(1), pages 1-30, January.
• Stephen Finger & Shanti Gamper-Rabindran, 2013. "Testing the effects of self-regulation on industrial accidents," Journal of Regulatory Economics, Springer, vol. 43(2), pages 115-146, April.
• Cabiedes Miragaya, Laura, 2013. "Nuevas perspectivas sobre el precio de los medicamentos: El caso español/New Perspectives on Drug Pricing: The Spanish Case," Estudios de Economia Aplicada, Estudios de Economia Aplicada, vol. 31, pages 397-416, Septiembr.
• Murray L. Aitken & Ernst R. Berndt & Barry Bosworth & Iain M. Cockburn & Richard Frank & Michael Kleinrock & Bradley T. Shapiro, 2013. "The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity," NBER Chapters, in: Measuring and Modeling Health Care Costs, pages 243-271, National Bureau of Economic Research, Inc.
  • Murray L. Aitken & Ernst R. Berndt & Barry Bosworth & Iain M. Cockburn & Richard Frank & Michael Kleinrock & Bradley T. Shapiro, 2013. "The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity," NBER Working Papers 19487, National Bureau of Economic Research, Inc.
• Marco Ceccagnoli & Matthew J. Higgins & Vincenzo Palermo, 2014. "Behind the Scenes: Sources of Complementarity in R&D," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 23(1), pages 125-148, March.
  • Marco Ceccagnoli & Matthew J. Higgins & Vincenzo Palermo, 2013. "Behind the Scenes: Sources of Complementarity in R&D," NBER Working Papers 18795, National Bureau of Economic Research, Inc.
• Ernst R. Berndt & Iain M. Cockburn, 2013. "Price Indexes for Clinical Trial Research: A Feasibility Study," NBER Working Papers 18918, National Bureau of Economic Research, Inc.
• Murray L. Aitken & Ernst R. Berndt & Barry Bosworth & Iain M. Cockburn & Richard Frank & Michael Kleinrock & Bradley T. Shapiro, 2013. "The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity," NBER Chapters, in: Measuring and Modeling Health Care Costs, pages 243-271, National Bureau of Economic Research, Inc.
  • Murray L. Aitken & Ernst R. Berndt & Barry Bosworth & Iain M. Cockburn & Richard Frank & Michael Kleinrock & Bradley T. Shapiro, 2013. "The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity," NBER Working Papers 19487, National Bureau of Economic Research, Inc.
• Arcidiacono, Peter & Ellickson, Paul B. & Landry, Peter & Ridley, David B., 2013. "Pharmaceutical followers," International Journal of Industrial Organization, Elsevier, vol. 31(5), pages 538-553.
  • Peter Arcidiacono & Paul B. Ellickson & Peter Landry & David B. Ridley, 2013. "Pharmaceutical Followers," NBER Working Papers 19522, National Bureau of Economic Research, Inc.
• Nathan Rosenberg & W. Edward Steinmueller, 2013. "Engineering knowledge," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 22(5), pages 1129-1158, October.
  • Nathan Rosenberg & W. Edward Steinmuller, 2012. "Engineering Knowledge," Discussion Papers 11-022, Stanford Institute for Economic Policy Research.
• Vincent K.K. Leung & Marco Chi Keung Lau & Zhe Zhang & Flora F. Gu, 2015. "Explorative versus exploitative alliances: evidence from the glass industry in China," Journal of Chinese Economic and Business Studies, Taylor & Francis Journals, vol. 13(2), pages 127-146, May.
  • Leung, Vincent K.K. & Lau, Chi Keung Marco & Zhang, Zhe, 2013. "Explorative Versus Exploitative Alliances—Evidence From The Glass Industry In China," MPRA Paper 47065, University Library of Munich, Germany.
• Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," The Annals of Regional Science, Springer;Western Regional Science Association, vol. 53(2), pages 395-422, September.
  • Cassi, Lorenzo & Plunket, Anne, 2013. "Proximity, network formation and inventive performance: in search of the proximity paradox," MPRA Paper 47388, University Library of Munich, Germany.
  • Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," Post-Print hal-00997650, HAL.
  • Lorenzo Cassi & Anne Plunket, 2014. "Proximity, network formation and inventive performance: in search of the proximity paradox," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00997650, HAL.
• Blanco Orozco, Napoleón Vicente & Zúniga-González, Carlos Alberto, 2013. "Environmental Bio Economic Impact in Nicaragua," Working Papers 153854, National Autonomous University of Nicaragua, León (Unan-León), Researching Center for Applied Economics (RCAE).
  • Blanco Orozco, Napoleón Vicente & Zuniga Gonzalez, Carlos Alberto, 2013. "Environmental Bio Economic Impact in Nicaragua," MPRA Paper 49357, University Library of Munich, Germany, revised 12 Jun 2013.
• Botero Degiovanni, Hernan, 2013. "The Effects of Drug Enforcement on Violence in Colombia 1999-2010: A Spatial Econometric Approach," MPRA Paper 49459, University Library of Munich, Germany.
• Kulvik, Martti & Tähtinen, Marja & Ylä-Anttila, Pekka, 2013. "Business and Intellectual Capital Development in Financial Riptide - Case Studies of Finnish Biotechnology and Pharmaceutical Companies Dispersing into Global Value Chains," ETLA Reports 17, The Research Institute of the Finnish Economy.
• Clément WILS, 2013. "La chimie verte: une nouvelle industrie de substitution GREEN CHEMISTRY: A NEW INDUSTRY OF SUBSTITUTE," Working Papers 263, Laboratoire de Recherche sur l'Industrie et l'Innovation. ULCO / Research Unit on Industry and Innovation.
• Ipatova, Irina & Peresetsky, Аnatoly, 2013. "Technical efficiency of Russian plastic and rubber production firms," Applied Econometrics, Russian Presidential Academy of National Economy and Public Administration (RANEPA), vol. 32(4), pages 71-92.
• Arpita Ghose & Chandrima Chakraborti, 2013. "The Relative Role of Imports and Exports in Explaining Productivity of Indian Bio-Pharmaceutical Firms: Evidence from Non Parametric Data Envelopment Analysis," Foreign Trade Review, , vol. 48(2), pages 165-201, May.
• Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2013. "Technological Regimes and Demand Structure in the Evolution of the Pharmaceutical Industry," Economic Complexity and Evolution, in: Andreas Pyka & Esben Sloth Andersen (ed.), Long Term Economic Development, edition 127, pages 61-94, Springer.
  • Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2012. "Technological regimes and demand structure in the evolution of the pharmaceutical industry," Journal of Evolutionary Economics, Springer, vol. 22(4), pages 677-709, September.
  • Christian Garavaglia & Michele Pezzoni & Luigi Orsenigo & Franco Malerba, 2012. "Technological regimes and demand structure in the evolution of the pharmaceutical industry," Post-Print halshs-01074513, HAL.
• Frank Lichtenberg, 2013. "The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999–2007," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(1), pages 41-56, February.
• Saradindu Bhaduri & Thomas Brenner, 2013. "Examining the determinants of drug launch delay in pre-TRIPS India," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(5), pages 761-773, October.
• Roberta Piergiovanni & Enrico Santarelli, 2013. "The more you spend, the more you get? The effects of R&D and capital expenditures on the patenting activities of biotechnology firms," Scientometrics, Springer;Akadémiai Kiadó, vol. 94(2), pages 497-521, February.
  • Roberta Piergiovanni & Enrico Santarelli, 2010. "The More You Spend, the More You Get? The Effects of R&D and Capital Expenditures on the Patenting Activities of Biotechnology Firms," JRC Working Papers on Corporate R&D and Innovation 2010-06, Joint Research Centre.
• Lili Wang & Ad Notten & Alexandru Surpatean, 2013. "Interdisciplinarity of nano research fields: a keyword mining approach," Scientometrics, Springer;Akadémiai Kiadó, vol. 94(3), pages 877-892, March.
• Savita Gautam & Meghna Dasgupta, 2013. "Compulsory licensing: India’s maiden experience," ARTNeT Working Papers 137, United Nations Economic and Social Commission for Asia and the Pacific (ESCAP).
• Krogmann, Yin & Riedel, Nadine & Schwalbe, Ulrich, 2013. "Inter-firm R&D networks in pharmaceutical biotechnology: What determines firm's centrality-based partnering capability," FZID Discussion Papers 75-2013, University of Hohenheim, Center for Research on Innovation and Services (FZID).

2012

• Toshiaki Iizuka, 2012. "Physician Agency and Adoption of Generic Pharmaceuticals," American Economic Review, American Economic Association, vol. 102(6), pages 2826-2858, October.
• Craig L. Garthwaite, 2012. "The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors," American Economic Journal: Applied Economics, American Economic Association, vol. 4(3), pages 116-137, July.
• Abe Dunn, 2012. "Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-cholesterol Drugs," American Economic Journal: Applied Economics, American Economic Association, vol. 4(3), pages 167-189, July.
  • Abe Dunn, 2010. "Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-Cholesterol Drugs," BEA Working Papers 0057, Bureau of Economic Analysis.
• Ljumovic, Isidora & Cvijanovic, Janko & Lazic, Jelena, 2012. "Valuation Of Biotechnology Companies: Real Options Approach Under Uncertainty," Economics of Agriculture, Institute of Agricultural Economics, vol. 59(1), pages 1-12, April.
• Jaume Puig-Junoy & Beatriz González López-Valcárcel, "undated". "Launching Prices for New Pharmaceuticals in Heavily Regulated and Subsidized Markets," Working Papers 638, Barcelona School of Economics.
• Frank R. Lichtenberg & Billie Pettersson, 2014. "The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 23(3), pages 239-273, April.
  • Frank Lichtenberg & Billie Pettersson, 2012. "The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data," CESifo Working Paper Series 3894, CESifo.
• Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune, 2013. "Margins and market shares: Pharmacy incentives for generic substitution," European Economic Review, Elsevier, vol. 61(C), pages 116-131.
  • Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune, 2010. "Margins and Market Shares: Pharmacy Incentives for Generic Substitution," Discussion Paper Series in Economics 18/2010, Norwegian School of Economics, Department of Economics.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2012. "Margins and Market Shares: Pharmacy Incentives for Generic Substitution," CESifo Working Paper Series 4055, CESifo.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2010. "Margins and Market Shares:Pharmacy Incentives for Generic Substitution," NIPE Working Papers 20/2010, NIPE - Universidade do Minho.
• Francesca Spigarelli & Hao Way, 2012. "The rising Chinese pharmaceutical industry: local champions vs global players," Working Papers 1206, c.MET-05 - Centro Interuniversitario di Economia Applicata alle Politiche per L'industria, lo Sviluppo locale e l'Internazionalizzazione.
• Juan Gonzalo Zapata & Sergio Bernal & Jairo Castillo & Katherine Garzón, 2012. "Hacia una política integral de medicamentos biotecnológicos en Colombia," Informes de Investigación 9321, Fedesarrollo.
  • Juan Gonzalo Zapata & Sergio Bernal & Jairo Castillo & Katherine Garzón, 2012. "Hacia una política integral de medicamentos biotecnológicos en Colombia," Cuadernos de Fedesarrollo 9896, Fedesarrollo.
• Simon P. Anderson & Federico Ciliberto & Jura Liaukonyte & Régis Renault, 2016. "Push-me pull-you: comparative advertising in the OTC analgesics industry," RAND Journal of Economics, RAND Corporation, vol. 47(4), pages 1029-1056, November.
  • Anderson, Simon & Ciliberto, Federico & Liaukonyte, Jura & Renault, Regis, 2012. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," MPRA Paper 38626, University Library of Munich, Germany.
  • Anderson, Simon & Renault, Régis & Ciliberto, Federico & Liaukonyte, Jura, 2012. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," CEPR Discussion Papers 8988, C.E.P.R. Discussion Papers.
  • Simon P. Anderson & Federico Ciliberto & Jura Liaukonyte & Régis Renault, 2015. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," CESifo Working Paper Series 5418, CESifo.
• Berndt, Ernst R. & Dubois, Pierre, 2012. "Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010," IDEI Working Papers 702, Institut d'Économie Industrielle (IDEI), Toulouse.
  • Berndt, Ernst R & Dubois, Pierre, 2012. "Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010," CEPR Discussion Papers 9140, C.E.P.R. Discussion Papers.
  • Berndt, Ernst R. & Dubois, Pierre, 2012. "Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010," TSE Working Papers 12-283, Toulouse School of Economics (TSE).
• Mario Coccia, 2012. "Path-breaking innovations for lung cancer: a revolution in clinical practice," CERIS Working Paper 201201, CNR-IRCrES Research Institute on Sustainable Economic Growth - Torino (TO) ITALY - former Institute for Economic Research on Firms and Growth - Moncalieri (TO) ITALY.
• Mazumdar, Mainak & Rajeev, Meenakshi & Ray, Subhash C., 2012. "Sources of Heterogeneity in the Efficiency of Indian Pharmaceutical Firms," Indian Economic Review, Department of Economics, Delhi School of Economics, vol. 47(2), pages 191-221.
  • Subhash C Ray & Mainak Mazumdar & Meenakshi Rajeev, 2010. "Sources of Heterogeneity in the Efficiency of Indian Pharmaceutical Firms," Working Papers id:3334, eSocialSciences.
  • Mainak Mazumdar & Meenakshi Rajeev & Subhash Ray, 2011. "Sources of Heterogeneity in the Efficiency of Indian Pharmaceutical Firms," Working papers 2011-22, University of Connecticut, Department of Economics.
• Sarbapriya Ray, 2012. "Productivity Growth in Some Energy Intensive Manufacturing Industries in India: An Analytical Assessment," International Journal of Economics and Financial Issues, Econjournals, vol. 2(1), pages 54-70.
• Hellerstein, Rebecca, 2012. "What do drug monopolies cost consumers in developing countries?," Economics Letters, Elsevier, vol. 116(1), pages 108-111.
  • Rebecca Hellerstein, 2011. "What do drug monopolies cost consumers in developing countries?," Staff Reports 530, Federal Reserve Bank of New York.
• Toole, Andrew A., 2012. "The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry," Research Policy, Elsevier, vol. 41(1), pages 1-12.
• Santiago, Fernando & Alcorta, Ludovico, 2012. "Human resource management for learning through knowledge exploitation and knowledge exploration: Pharmaceuticals in Mexico," Structural Change and Economic Dynamics, Elsevier, vol. 23(4), pages 530-546.
• Céline Carrère & Jaime de Melo, 2015. "Fiscal Spending and Economic Growth: Some Stylized Facts," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 7, pages 167-196, World Scientific Publishing Co. Pte. Ltd..
  • Carrère, Céline & de Melo, Jaime, 2012. "Fiscal Spending and Economic Growth: Some Stylized Facts," World Development, Elsevier, vol. 40(9), pages 1750-1761.
  • Céline CARRERE & Jaime DE MELO, 2012. "Fiscal Spending and Economic Growth: Some Stylized Facts," Working Papers P35, FERDI.
  • Céline CARRERE & Jaime DE MELO, 2012. "Fiscal Spending and Economic Growth: Some Stylized Facts," Working Papers P35, FERDI.
• Gaston Heimeriks & Ron Boschma, 2014. "The path- and place-dependent nature of scientific knowledge production in biotech 1986–2008," Journal of Economic Geography, Oxford University Press, vol. 14(2), pages 339-364.
  • Gaston Heimeriks & Ron Boschma, 2012. "The path- and place-dependent nature of scientific knowledge production in biotech 1986-2008," Papers in Evolutionary Economic Geography (PEEG) 1210, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Jun 2012.
• Patricia M. Danzon & Andrew J. Epstein, 2012. "Effects of Regulation on Drug Launch and Pricing in Interdependent Markets," Advances in Health Economics and Health Services Research, in: The Economics of Medical Technology, pages 35-71, Emerald Group Publishing Limited.
  • Patricia M. Danzon & Andrew J. Epstein, 2008. "Effects of Regulation on Drug Launch and Pricing in Interdependent Markets," NBER Working Papers 14041, National Bureau of Economic Research, Inc.
• Frank R. Lichtenberg, 2012. "The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans: Evidence from the 2004 National Nursing Home Survey," Advances in Health Economics and Health Services Research, in: The Economics of Medical Technology, pages 73-101, Emerald Group Publishing Limited.
  • Frank R. Lichtenberg, 2012. "The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans Evidence from the 2004 National Nursing Home Survey," NBER Working Papers 17750, National Bureau of Economic Research, Inc.
• Maria Letizia Giorgetti, 2012. "Entry and submarket concentration: empirical evidence from the pharmaceutical industry," ECONOMIA E POLITICA INDUSTRIALE, FrancoAngeli Editore, vol. 2012(3), pages 5-29.
• Hokkanen, Joni & Kangasharju, Aki & Linnosmaa, Ismo & Valtonen, Hannu, 2012. "Generic substitution policy, prices and market structure: evidence from a quasi-experiment in Finland," Working Papers 35, VATT Institute for Economic Research.
• Marianna EPICOCO & Vanessa OLTRA & Maïder SAINT JEAN, 2012. "Mapping the scientific knowledge of the Green Chemistry community (In French)," Cahiers du GREThA (2007-2019) 2012-10, Groupe de Recherche en Economie Théorique et Appliquée (GREThA).
• Vanessa OLTRA & Maïder SAINT-JEAN, 2012. "Regional trajectories of innovation in Green Chemistry: Evidence from the Aquitaine region (In French)," Cahiers du GREThA (2007-2019) 2012-14, Groupe de Recherche en Economie Théorique et Appliquée (GREThA).
• Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2013. "Technological Regimes and Demand Structure in the Evolution of the Pharmaceutical Industry," Economic Complexity and Evolution, in: Andreas Pyka & Esben Sloth Andersen (ed.), Long Term Economic Development, edition 127, pages 61-94, Springer.
  • Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2012. "Technological regimes and demand structure in the evolution of the pharmaceutical industry," Journal of Evolutionary Economics, Springer, vol. 22(4), pages 677-709, September.
  • Christian Garavaglia & Michele Pezzoni & Luigi Orsenigo & Franco Malerba, 2012. "Technological regimes and demand structure in the evolution of the pharmaceutical industry," Post-Print halshs-01074513, HAL.
• Granlund, David & Yesim Köksal, Miyase, 2012. "EU Enlargement, Parallel Trade and Price Competition in Pharmaceuticals - What’s to Blame? Derogation or Perception?," HUI Working Papers 59, HUI Research.
• Granlund, David, 2012. "The effect of pharmacies’ right to negotiate discounts on the market share of parallel imported pharmaceuticals," HUI Working Papers 75, HUI Research.
• Granlund, David, 2012. "The effect of pharmacies’ right to negotiate discounts on the market share of parallel imported pharmaceuticals," Umeå Economic Studies 853, Umeå University, Department of Economics.
• Berndt, Ernst R & Dubois, Pierre, 2012. "Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010," CEPR Discussion Papers 9140, C.E.P.R. Discussion Papers.
  • Berndt, Ernst R. & Dubois, Pierre, 2012. "Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010," IDEI Working Papers 702, Institut d'Économie Industrielle (IDEI), Toulouse.
  • Berndt, Ernst R. & Dubois, Pierre, 2012. "Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010," TSE Working Papers 12-283, Toulouse School of Economics (TSE).
• Christine Sorasith & Sylvain Pichetti & Thomas Cartier & Laure Bergua & Catherine Sermet, 2012. "Déterminants de l’écart de prix entre médicaments similaires et le premier entrant d’une classe thérapeutique," Working Papers DT43, IRDES institut for research and information in health economics, revised Feb 2012.
• Luiz Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 45-60, January.
  • Luiz Flavio Andrade, 2011. "Entry time effects and follow on drug competition," Post-Print halshs-00658247, HAL.
  • Luiz Flavio Andrade, 2012. "Entry Time Effects and Follow-on Drugs Competition," Working Papers DT49, IRDES institut for research and information in health economics, revised Jun 2012.
  • Luiz Flavio Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," Post-Print halshs-01156509, HAL.
• Nicola Dimitri, 2012. "R&D for Neglected Diseases," Working Papers 2012/07, Maastricht School of Management.
• Frank R. Lichtenberg, 2012. "The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans: Evidence from the 2004 National Nursing Home Survey," Advances in Health Economics and Health Services Research, in: The Economics of Medical Technology, pages 73-101, Emerald Group Publishing Limited.
  • Frank R. Lichtenberg, 2012. "The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans Evidence from the 2004 National Nursing Home Survey," NBER Working Papers 17750, National Bureau of Economic Research, Inc.
• Bret M. Dickey & Daniel L. Rubinfeld, 2012. "Would The Per Se Illegal Treatment Of Reverse Payment Settlements Inhibit Generic Drug Investment?," Journal of Competition Law and Economics, Oxford University Press, vol. 8(3), pages 615-625.
• Mohammad Al-Tahat & Areen Al-Ali, 2012. "Energy saving opportunities in Jordanian pharmaceutical industries," Perspectives of Innovation in Economics and Business (PIEB), Prague Development Center, vol. 10(1), pages 35-50, May.
• Kamal A. M. Al-Qudah, 2012. "The Impact Of Total Quality Management On Competitive Advantage Of Pharmaceutical Manufacturing Companies In Jordan," Perspectives of Innovation in Economics and Business (PIEB), Prague Development Center, vol. 12(3), pages 59-75, November.
• Simon P. Anderson & Federico Ciliberto & Jura Liaukonyte & Régis Renault, 2016. "Push-me pull-you: comparative advertising in the OTC analgesics industry," RAND Journal of Economics, RAND Corporation, vol. 47(4), pages 1029-1056, November.
  • Anderson, Simon & Renault, Régis & Ciliberto, Federico & Liaukonyte, Jura, 2012. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," CEPR Discussion Papers 8988, C.E.P.R. Discussion Papers.
  • Simon P. Anderson & Federico Ciliberto & Jura Liaukonyte & Régis Renault, 2015. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," CESifo Working Paper Series 5418, CESifo.
  • Anderson, Simon & Ciliberto, Federico & Liaukonyte, Jura & Renault, Regis, 2012. "Push-Me Pull-You: Comparative Advertising in the OTC Analgesics Industry," MPRA Paper 38626, University Library of Munich, Germany.
• Lorenzo Cassi & Anne Plunket, 2015. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Regional Studies, Taylor & Francis Journals, vol. 49(6), pages 936-954, June.
  • Cassi, Lorenzo & Plunket, Anne, 2010. "The determinants of co-inventor tie formation: proximity and network dynamics," MPRA Paper 27303, University Library of Munich, Germany.
  • Lorenzo Cassi & Anne Plunket, 2013. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00987705, HAL.
  • Cassi, Lorenzo & Plunket, Anne, 2012. "Research collaboration in co-­inventor networks: combining closure,bridging and proximities," MPRA Paper 39481, University Library of Munich, Germany.
  • Lorenzo Cassi & Anne Plunket, 2013. "Research Collaboration in Co-inventor Networks: Combining Closure, Bridging and Proximities," Post-Print hal-00987705, HAL.
  • Lorenzo Cassi & Anne Plunket, 2010. "The determinants of co-inventor tie formation: proximity and network dynamics," Papers in Evolutionary Economic Geography (PEEG) 1015, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Nov 2010.
• Hernesniemi, Hannu & Kulvik, Martti & Ylä-Anttila, Pekka, 2012. "Competitiveness and future challenges of Pohjois-Savo - A report for The Regional Council of Pohjois-Savo (in Finnish with English abstract and summary)," Discussion Papers 1281, The Research Institute of the Finnish Economy.
• Samia GHARBI, 2012. "Le rôle de l’Etat dans la promotion du secteur pharmaceutique en Algérie: que nous enseigne l’approche par les systèmes sectoriels d’innovation THE ROLE OF THE STATE IN THE PROMOTION OF THE PHARMACEUT," Working Papers 258, Laboratoire de Recherche sur l'Industrie et l'Innovation. ULCO / Research Unit on Industry and Innovation.
• Carbonari, Lorenzo, 2012. "Quasi-fixed inputs in the Italian manufacturing: The case of the pharmaceutical industry," Applied Econometrics, Russian Presidential Academy of National Economy and Public Administration (RANEPA), vol. 25(1), pages 51-69.
• Ravi MAHALINGAM, 2012. "Dynamics of Public Policy-Making in Malaysia: The Formulation of National Biotechnology Policy," REVISTA ADMINISTRATIE SI MANAGEMENT PUBLIC, Faculty of Administration and Public Management, Academy of Economic Studies, Bucharest, Romania, vol. 2012(19), pages 53-61, December.
• Rosamaria d’Amore & Roberto Iorio & Agnieszka Stawinoga, 2011. "Who and where are the co-authors? The relationship between institutional and geographical distance in scientific publications," Working Papers 2011.4, International Network for Economic Research - INFER.
  • Rosamaria D'Amore & Roberto Iorio & Agnieszka Stawinoga, 2012. "Who and Where are the Co-Authors? The Relationship between Institutional and Geographical Distance in Scientific Publications," Working Papers 3_221, Dipartimento di Scienze Economiche e Statistiche, Università degli Studi di Salerno.
• Rosamaria D'Amore & Roberto Iorio & Sandrine Labory & Agnieszka Stawinoga, 2012. "How Do the Institutions Involved in Scientific Collaboration Deal with Different Kinds of Distance? An Analysis of the Co-Autorships of Scientific Publications," Working Papers 3_222, Dipartimento di Scienze Economiche e Statistiche, Università degli Studi di Salerno.
• Paul Joskow & Roger Noll, 2013. "Alfred E. Kahn, 1917–2010," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 42(2), pages 107-126, March.
  • Roger Noll & Paul, 2012. "Alfred E. Kahn 1917-2010," Discussion Papers 11-021, Stanford Institute for Economic Policy Research.
• Nathan Rosenberg & W. Edward Steinmueller, 2013. "Engineering knowledge," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 22(5), pages 1129-1158, October.
  • Nathan Rosenberg & W. Edward Steinmuller, 2012. "Engineering Knowledge," Discussion Papers 11-022, Stanford Institute for Economic Policy Research.
• Steven Edwards & Sarah Wordsworth & Mike Clarke, 2012. "Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(2), pages 181-192, April.
• Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2013. "Technological Regimes and Demand Structure in the Evolution of the Pharmaceutical Industry," Economic Complexity and Evolution, in: Andreas Pyka & Esben Sloth Andersen (ed.), Long Term Economic Development, edition 127, pages 61-94, Springer.
  • Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2012. "Technological regimes and demand structure in the evolution of the pharmaceutical industry," Journal of Evolutionary Economics, Springer, vol. 22(4), pages 677-709, September.
  • Christian Garavaglia & Michele Pezzoni & Luigi Orsenigo & Franco Malerba, 2012. "Technological regimes and demand structure in the evolution of the pharmaceutical industry," Post-Print halshs-01074513, HAL.
• Ramazan Uctu & Hassan Essop, 2012. "The Role of the South African Government in Developing the Biotechnology Industry – from Biotechnology Regional Innovation Centres to the Technology Innovation Agency," Working Papers 19/2012, Stellenbosch University, Department of Economics.
• Jean-Marie Grether & Nicole Andréa Mathys & Jaime de Melo, 2015. "Unravelling the Worldwide Pollution Haven Effect," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 23, pages 581-612, World Scientific Publishing Co. Pte. Ltd..
  • Jean-Marie Grether & Nicole Andr�a Mathys & Jaime de Melo, 2012. "Unravelling the worldwide pollution haven effect," The Journal of International Trade & Economic Development, Taylor & Francis Journals, vol. 21(1), pages 131-162, December.
  • Grether, Jean-Marie & Mathys, Nicole A. & de Melo, Jaime, 2006. "Unraveling the worldwide pollution haven effect," Policy Research Working Paper Series 4047, The World Bank.
  • Jean-Marie GRETHER & Nicole A. MATHYS & Jaime DE MELO, 2012. "Unravelling the Worldwide Pollution Haven Effect," Working Papers P40, FERDI.
  • Jean-Marie GRETHER & Nicole A. MATHYS & Jaime DE MELO, 2012. "Unravelling the Worldwide Pollution Haven Effect," Working Papers P40, FERDI.
  • Grether, Jean-Marie & Mathys, Nicole A. & de Melo, Jaime, 2011. "Unravelling the Worldwide Pollution Haven Effect," Climate Change and Sustainable Development 119097, Fondazione Eni Enrico Mattei (FEEM).
  • Jean-Marie Grether & Nicole A. Mathys & Jaime de Melo, 2006. "Unraveling the World-Wide Pollution Haven Effect," Working Papers 2006.122, Fondazione Eni Enrico Mattei.
  • Grether, Jean-Marie & Mathys, Nicole A. & de Melo, Jaime, 2006. "Unraveling the World-Wide Pollution Haven Effect," Economic Theory and Applications Working Papers 12186, Fondazione Eni Enrico Mattei (FEEM).
  • de Melo, Jaime & Grether, Jean-Marie & Mathys, Nicole Andréa, 2006. "Unravelling the World-Wide Pollution Haven Effect," CEPR Discussion Papers 5815, C.E.P.R. Discussion Papers.
  • Jean-Marie Grether & Nicole A. Mathys & Jaime de Melo, 2011. "Unravelling the Worldwide Pollution Haven Effect," Working Papers 2011.75, Fondazione Eni Enrico Mattei.
  • Jean-Marie GRETHER & Nicole A. MATHYS & Jaime DE MELO, 2006. "Unraveling the World-Wide Pollution Haven Effect," Cahiers de Recherches Economiques du Département d'économie 06.04, Université de Lausanne, Faculté des HEC, Département d’économie.
• Margaret K. Kyle & Anita M. McGahan, 2012. "Investments in Pharmaceuticals Before and After TRIPS," The Review of Economics and Statistics, MIT Press, vol. 94(4), pages 1157-1172, November.
  • Margaret Kyle & Anita McGahan, 2009. "Investments in Pharmaceuticals Before and After TRIPS," NBER Working Papers 15468, National Bureau of Economic Research, Inc.
  • Kyle, Margaret & McGahan, Anita M, 2011. "Investments in Pharmaceuticals Before and After TRIPS," CEPR Discussion Papers 8371, C.E.P.R. Discussion Papers.
• Berndt, Ernst R. & Dubois, Pierre, 2012. "Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010," IDEI Working Papers 702, Institut d'Économie Industrielle (IDEI), Toulouse.
  • Berndt, Ernst R. & Dubois, Pierre, 2012. "Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010," TSE Working Papers 12-283, Toulouse School of Economics (TSE).
  • Berndt, Ernst R & Dubois, Pierre, 2012. "Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010," CEPR Discussion Papers 9140, C.E.P.R. Discussion Papers.
• Jaume Puig & Beatriz González López-Valcárcel, 2012. "Launching prices for new pharmaceuticals in heavily regulated and subsidized markets," Economics Working Papers 1322, Department of Economics and Business, Universitat Pompeu Fabra.
• Kirchhoff, Jasmina, 2012. "Wissensbasis und regionale Agglomeration: Zwei Pharmacluster im Vergleich," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, vol. 39(4), pages 89-104.

2011

• Joseph E. Harrington & Andrzej Skrzypacz, 2011. "Private Monitoring and Communication in Cartels: Explaining Recent Collusive Practices," American Economic Review, American Economic Association, vol. 101(6), pages 2425-2449, October.
  • Joseph E. Harrington, Jr. & Andrzej Skrzypacz, 2009. "Private Monitoring and Communication in Cartels: Explaining Recent Collusive Practices," Economics Working Paper Archive 555, The Johns Hopkins University,Department of Economics.
• Glenn Ellison & Sara Fisher Ellison, 2011. "Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration," American Economic Journal: Microeconomics, American Economic Association, vol. 3(1), pages 1-36, February.
  • Glenn Ellison & Sara Fisher Ellison, 2007. "Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration," NBER Working Papers 13069, National Bureau of Economic Research, Inc.
• Catherine Thomas, 2011. "Too Many Products: Decentralized Decision Making in Multinational Firms," American Economic Journal: Microeconomics, American Economic Association, vol. 3(1), pages 280-306, February.
• Kensuke Kubo, 2011. "Explaining vertical integration in the generic pharmaceutical industry," Discussion Papers 11-02, Indian Statistical Institute, Delhi.
• Guanming Shi & Kyle W. Stiegert & Jean P. Chavas, 2011. "An analysis of bundle pricing in horizontal and vertical markets: The case of the U.S. cottonseed market," Agricultural Economics, International Association of Agricultural Economists, vol. 42, pages 77-88, November.
  • Shi, Guanming & Stiegert, Kyle & Chavas, Jean-Paul, 2009. "An Analysis of Bundle Pricing in Horizontal and Vertical Markets: The Case of the U.S. Cottonseed Market," Staff Paper Series 543, University of Wisconsin, Agricultural and Applied Economics.
• Berndt Ernst R. & McGuire Thomas & Newhouse Joseph P., 2011. "A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets," Forum for Health Economics & Policy, De Gruyter, vol. 14(1), pages 1-30, November.
  • Ernst R. Berndt & Thomas G. McGuire & Joseph P. Newhouse, 2011. "A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets," NBER Working Papers 16879, National Bureau of Economic Research, Inc.
• Claudia Nelcy Jiménez Hernández, 2011. "Seguimiento al desarrollo tecnológico a través de patentes el caso de la biotecnología," Documentos de Trabajo, Escuela de Economía 8843, Universidad Nacional de Colombia, FCE, CID.
• Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," Working Papers hal-03473787, HAL.
  • Kyle, Margaret & Allain, Marie-Laure, 2011. "Inefficiencies in technology transfer: theory and empirics," CEPR Discussion Papers 8206, C.E.P.R. Discussion Papers.
  • Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," SciencePo Working papers Main hal-03473787, HAL.
• Pierre Dubois & Olivier de Mouzon & Fiona Scott-Morton & Paul Seabright, 2015. "Market size and pharmaceutical innovation," RAND Journal of Economics, RAND Corporation, vol. 46(4), pages 844-871, October.
  • Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," IDEI Working Papers 670, Institut d'Économie Industrielle (IDEI), Toulouse, revised Mar 2014.
  • Seabright, Paul & Scott Morton, Fiona & Dubois, Pierre & de Mouzon, Olivier, 2011. "Market Size and Pharmaceutical Innovation," CEPR Discussion Papers 8367, C.E.P.R. Discussion Papers.
  • Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," TSE Working Papers 11-232, Toulouse School of Economics (TSE), revised Mar 2014.
• Margaret K. Kyle & Anita M. McGahan, 2012. "Investments in Pharmaceuticals Before and After TRIPS," The Review of Economics and Statistics, MIT Press, vol. 94(4), pages 1157-1172, November.
  • Margaret Kyle & Anita McGahan, 2009. "Investments in Pharmaceuticals Before and After TRIPS," NBER Working Papers 15468, National Bureau of Economic Research, Inc.
  • Kyle, Margaret & McGahan, Anita M, 2011. "Investments in Pharmaceuticals Before and After TRIPS," CEPR Discussion Papers 8371, C.E.P.R. Discussion Papers.
• Paraskevopoulou, Evita, 2011. "On the institutional innovation process : EU regulation through an evolutionary lens," DEE - Working Papers. Business Economics. WB wb111305, Universidad Carlos III de Madrid. Departamento de Economía de la Empresa.
• Scott Morton, Fiona & Kyle, Margaret, 2011. "Markets for Pharmaceutical Products11The authors thank Tom McGuire for editorial advice and improvements and participants at the Handbook conference for helpful suggestions," Handbook of Health Economics, in: Mark V. Pauly & Thomas G. Mcguire & Pedro P. Barros (ed.), Handbook of Health Economics, volume 2, chapter 0, pages 763-823, Elsevier.
• Bhattacharya, Jay & Packalen, Mikko, 2011. "Opportunities and benefits as determinants of the direction of scientific research," Journal of Health Economics, Elsevier, vol. 30(4), pages 603-615, July.
  • Mikko Packalen & Jay Bhattacharya, 2010. "Opportunities and Benefits as Determinants of the Direction of Scientific Research," Working Papers 1014, University of Waterloo, Department of Economics, revised Dec 2010.
• Brekke, Kurt R. & Holmas, Tor Helge & Straume, Odd Rune, 2011. "Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment," Journal of Public Economics, Elsevier, vol. 95(7), pages 624-638.
  • Brekke, Kurt R. & Holmas, Tor Helge & Straume, Odd Rune, 2011. "Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment," Journal of Public Economics, Elsevier, vol. 95(7-8), pages 624-638, August.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2010. "Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment," CESifo Working Paper Series 3258, CESifo.
• Brekke, Kurt R. & Holmas, Tor Helge & Straume, Odd Rune, 2011. "Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment," Journal of Public Economics, Elsevier, vol. 95(7-8), pages 624-638, August.
  • Brekke, Kurt R. & Holmas, Tor Helge & Straume, Odd Rune, 2011. "Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment," Journal of Public Economics, Elsevier, vol. 95(7), pages 624-638.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2010. "Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment," CESifo Working Paper Series 3258, CESifo.
• Kolympiris, Christos & Kalaitzandonakes, Nicholas & Miller, Douglas, 2011. "Spatial collocation and venture capital in the US biotechnology industry," Research Policy, Elsevier, vol. 40(9), pages 1188-1199.
• Anne L.J. Ter Wal, 2011. "The Dynamics of the Inventor Network in German Biotechnology: Geographical Proximity versus Triadic Closure," Papers in Evolutionary Economic Geography (PEEG) 1102, Utrecht University, Department of Human Geography and Spatial Planning, Group Economic Geography, revised Jan 2011.
• Hellerstein, Rebecca, 2012. "What do drug monopolies cost consumers in developing countries?," Economics Letters, Elsevier, vol. 116(1), pages 108-111.
  • Rebecca Hellerstein, 2011. "What do drug monopolies cost consumers in developing countries?," Staff Reports 530, Federal Reserve Bank of New York.
• Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2011. "External referencing and pharmaceutical price negotiation," Health Economics, John Wiley & Sons, Ltd., vol. 20(6), pages 737-756, June.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2008. "External referencing and pharmaceutical price negotiation," Working Papers 0815, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2011. "External referencing and pharmaceutical price negotiation," Post-Print halshs-00303682, HAL.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2010. "External referencing and pharmaceutical price negotiation," Post-Print halshs-00955856, HAL.
• Luiz Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 45-60, January.
  • Luiz Flavio Andrade, 2011. "Entry time effects and follow on drug competition," Post-Print halshs-00658247, HAL.
  • Luiz Flavio Andrade, 2012. "Entry Time Effects and Follow-on Drugs Competition," Working Papers DT49, IRDES institut for research and information in health economics, revised Jun 2012.
  • Luiz Flavio Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," Post-Print halshs-01156509, HAL.
• Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," Working Papers hal-03473787, HAL.
  • Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," SciencePo Working papers Main hal-03473787, HAL.
  • Kyle, Margaret & Allain, Marie-Laure, 2011. "Inefficiencies in technology transfer: theory and empirics," CEPR Discussion Papers 8206, C.E.P.R. Discussion Papers.
• Kyle, Margaret & Allain, Marie-Laure, 2011. "Inefficiencies in technology transfer: theory and empirics," CEPR Discussion Papers 8206, C.E.P.R. Discussion Papers.
  • Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," Working Papers hal-03473787, HAL.
  • Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," SciencePo Working papers Main hal-03473787, HAL.
• Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2015. "Openness, Inequality and Poverty: Endowments Matter," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 20, pages 497-532, World Scientific Publishing Co. Pte. Ltd..
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Openness, inequality and poverty: Endowments matter," The Journal of International Trade & Economic Development, Taylor & Francis Journals, vol. 17(3), pages 343-378.
  • de Melo, Jaime & Gourdon, Julien & Maystre, Nicolas, 2006. "Openness, Inequality and Poverty: Endowments Matter," CEPR Discussion Papers 5738, C.E.P.R. Discussion Papers.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers halshs-00557112, HAL.
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Opennes, Inequality, and Poverty: Endowments Matter," Development Working Papers 239, Centro Studi Luca d'Agliano, University of Milano.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," CERDI Working papers halshs-00557112, HAL.
  • Jaime MELO DE & Julien GOURDON & Nicolas MAYSTRE, 2007. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers 200711, CERDI.
  • Julien Gourdon & Jaime de Melo & Nicolas Maystre, 2008. "Openness, Inequality and Poverty: Endowment Matter?," Post-Print hal-00348921, HAL.
  • Gourdon, Julien & Maystre, Nicolas & de Melo, Jaime, 2006. "Openness, inequality, and poverty : endowments matter," Policy Research Working Paper Series 3981, The World Bank.
• Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," Working Papers hal-03473787, HAL.
  • Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," SciencePo Working papers hal-03473787, HAL.
  • Allain, Marie-Laure & Henry, Emeric & Kyle, Margaret K, 2011. "Inefficiencies in technology transfer: theory and empirics," CEPR Discussion Papers 8206, C.E.P.R. Discussion Papers.
  • Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," Sciences Po publications 8206, Sciences Po.
• Granlund, David & Yesim Köksal, Miyase, 2011. "Parallel Imports and Mandatory Substitution Reform: A kick or a muff for price competition in pharmaceuticals," Working Papers in Economics 496, University of Gothenburg, Department of Economics.
• Granlund, David & Yesim Köksal, Miyase, 2011. "EU Enlargement, Parallel Trade and Price Competition in Pharmaceuticals. What's blame? Derogation or perception?," Working Papers in Economics 499, University of Gothenburg, Department of Economics.
• Carlsson, Fredrik & Lampi, Elina & Li, Wanxin & Martinsson, Peter, 2011. "Subjective well-being among preadolescents - Evidence from urban China," Working Papers in Economics 500, University of Gothenburg, Department of Economics.
• Granlund, David & Köksal, Miyase Yesim, 2011. "Parallel Imports and Mandatory Substitution Reform - A Kick or A Muff for Price Competition in Pharmaceuticals?," HUI Working Papers 49, HUI Research.
• Granlund, David & Köksal , Miyase Yesim, 2011. "Parallel Imports and Mandatory Substitution Reform - A Kick or A Muff for Price Competition in Pharmaceuticals?," Umeå Economic Studies 824, Umeå University, Department of Economics.
• Granlund, David & Yesim Köksal, Miyase, 2011. "EU Enlargement, Parallel Trade and Price Competition in Pharmaceuticals - What’s to Blame? Derogation or Perception?," Umeå Economic Studies 831, Umeå University, Department of Economics.
• Pierre Dubois & Olivier de Mouzon & Fiona Scott-Morton & Paul Seabright, 2015. "Market size and pharmaceutical innovation," RAND Journal of Economics, RAND Corporation, vol. 46(4), pages 844-871, October.
  • Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," TSE Working Papers 11-232, Toulouse School of Economics (TSE), revised Mar 2014.
  • Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," IDEI Working Papers 670, Institut d'Économie Industrielle (IDEI), Toulouse, revised Mar 2014.
  • Seabright, Paul & Scott Morton, Fiona & Dubois, Pierre & de Mouzon, Olivier, 2011. "Market Size and Pharmaceutical Innovation," CEPR Discussion Papers 8367, C.E.P.R. Discussion Papers.
• Kensuke Kubo, 2011. "Explaining vertical integration in the generic pharmaceutical industry," Indian Statistical Institute, Planning Unit, New Delhi Discussion Papers 11-02, Indian Statistical Institute, New Delhi, India.
• Rosamaria d’Amore & Roberto Iorio & Agnieszka Stawinoga, 2011. "Who and where are the co-authors? The relationship between institutional and geographical distance in scientific publications," Working Papers 2011.4, International Network for Economic Research - INFER.
  • Rosamaria D'Amore & Roberto Iorio & Agnieszka Stawinoga, 2012. "Who and Where are the Co-Authors? The Relationship between Institutional and Geographical Distance in Scientific Publications," Working Papers 3_221, Dipartimento di Scienze Economiche e Statistiche, Università degli Studi di Salerno.
• Vernon Somerset (ed.), 2011. "Environmental Biosensors," Books, IntechOpen, number 1018, January-J.
• Peilei Fan, 2011. "Innovation capacity and economic development: China and India," Economic Change and Restructuring, Springer, vol. 44(1), pages 49-73, April.
• Aysegul Timur & Gabriel Picone & Jeffrey DeSimone, 2011. "Has the European union achieved a single pharmaceutical market?," International Journal of Health Economics and Management, Springer, vol. 11(4), pages 223-244, December.
  • Aysegul Timur & Gabriel Picone & Jeffrey S. DeSimone, 2010. "Has the European Union Achieved a Single Pharmaceutical Market?," NBER Working Papers 16261, National Bureau of Economic Research, Inc.
• Cédric Schneider, 2011. "The battle for patent rights in plant biotechnology: evidence from opposition fillings," The Journal of Technology Transfer, Springer, vol. 36(5), pages 565-579, October.
• Dragan Kesic, 2011. "Strategic Development Trends in the World Pharmaceutical Industry," Managing Global Transitions, University of Primorska, Faculty of Management Koper, vol. 9(3), pages 207-223.
• Roberto Iorio & Sandrine Labory & Daniele Paci, 2012. "Research Collaboration and Publication's Citation Impact: Evidence in the Italian Biotech Sector," Rivista italiana degli economisti, Società editrice il Mulino, issue 1, pages 75-100.
• Berndt Ernst R. & McGuire Thomas & Newhouse Joseph P., 2011. "A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets," Forum for Health Economics & Policy, De Gruyter, vol. 14(1), pages 1-30, November.
  • Ernst R. Berndt & Thomas G. McGuire & Joseph P. Newhouse, 2011. "A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets," NBER Working Papers 16879, National Bureau of Economic Research, Inc.
• Patricia M. Danzon & Michael F. Furukawa, 2011. "Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets," NBER Working Papers 17226, National Bureau of Economic Research, Inc.
• Nobuo Kiriyama, 2011. "Trade and Innovation: Pharmaceuticals," OECD Trade Policy Papers 113, OECD Publishing.
• Unita Lucian & Straciuc Oreste & Maghiar Teodor Traian & Uivarosan Diana, 2011. "The Production Of Medicines In Romania After 1990. What'S The Reason For Imports?," Annals of Faculty of Economics, University of Oradea, Faculty of Economics, vol. 1(2), pages 124-130, December.
• Ijaz Hussain, 2011. "Growth and Financing Behaviour of Firms of Textile Industry in Pakistan: A Panel Data Analysis," The Pakistan Development Review, Pakistan Institute of Development Economics, vol. 50(4), pages 699-714.
• Jakub Growiec & Fabio Pammolli & Massimo Riccaboni, 2020. "Innovation and Corporate Dynamics: A Theoretical Framework," Central European Journal of Economic Modelling and Econometrics, Central European Journal of Economic Modelling and Econometrics, vol. 12(1), pages 1-45, March.
  • Jakub Growiec & Fabio Pammolli & Massimo Riccaboni, 2011. "Innovation and Corporate Dynamics: A Theoretical Framework," DISA Working Papers 2011/08, Department of Computer and Management Sciences, University of Trento, Italy, revised 29 Jul 2011.
  • Massimo, Riccaboni & Jakub, Growiec & Fabio, Pammolli, 2011. "Innovation and Corporate Dynamics: A Theoretical Framework," MPRA Paper 30046, University Library of Munich, Germany.
• Morales, Eduardo & Sheu, Gloria & Zahler, Andrés, 2011. "Gravity and extended gravity: estimating a structural model of export entry," MPRA Paper 30311, University Library of Munich, Germany.
• Ohta, Hirofumi & Motohashi, Kazuyuki, 2011. "Accumulation and Circulation of the Knowledge Needed for Biotech Business Promotion by Engineers of R&D Section in an IT Enterprise: The Case of Hitachi Software Engineering Co., Ltd," MPRA Paper 50097, University Library of Munich, Germany.
• Plawgo, Bogusław & Klimczuk-Kochańska, Magdalena & Żynel-Etel, Justyna & Wyszkowski, Adam, 2011. "Startery podlaskiej gospodarki - analiza gospodarczych obszarów wzrostu i innowacji województwa podlaskiego. Sektor biotechnologii [Starters of the Podlasie Economy: Analysis of Economic Areas of G," MPRA Paper 85003, University Library of Munich, Germany.
• Saradindu Bhaduri & Thomas Brenner, 2011. "Determinants of drug launch delay in pre-TRIPS India: A survival analysis approach," Working Papers on Innovation and Space 2011-05, Philipps University Marburg, Department of Geography.
• Gagnon, Marc-André, 2011. "Marx’s social analysis of value and Big Pharma. Rethinking the social determinants of value in cognitive capitalism," European Journal of Economic and Social Systems, Lavoisier, vol. 24(1-2), pages 119-136.
• Sarbapriya, Ray & Mihir, Kumar Pal, 2011. "An Application of Economic Capacity Utilization to the Measurement of Total Factor Productivity Growth: Empirical Evidence from Indian Fertilizer Industry," Journal for Economic Forecasting, Institute for Economic Forecasting, vol. 0(1), pages 125-142, March.
• Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," Working Papers hal-03473787, HAL.
  • Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," Sciences Po publications 8206, Sciences Po.
  • Kyle, Margaret & Allain, Marie-Laure, 2011. "Inefficiencies in technology transfer: theory and empirics," CEPR Discussion Papers 8206, C.E.P.R. Discussion Papers.
  • Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2011. "Inefficiencies in technology transfer: theory and empirics," SciencePo Working papers Main hal-03473787, HAL.
• Alessandro Rosiello & Gil Avnimelech & Morris Teubal, 2011. "Towards a systemic and evolutionary framework for venture capital policy," Journal of Evolutionary Economics, Springer, vol. 21(1), pages 167-189, February.
• M. Laura Frigotto & Massimo Riccaboni, 2011. "A few special cases: scientific creativity and network dynamics in the field of rare diseases," Scientometrics, Springer;Akadémiai Kiadó, vol. 89(1), pages 397-420, October.
  • Massimo Riccaboni & Maria Laura Frigotto, 2011. "A Few Special Cases: Scientific Creativity and Network Dynamics in the Field of Rare Diseases," DISA Working Papers 2011/03, Department of Computer and Management Sciences, University of Trento, Italy, revised 24 May 2011.
• Marc-Hubert DEPRET & Abdelillah HAMDOUCH, 2011. "Multiscalar Clusters And Networks As The Foundations Of Innovation Dynamics In The Biopharmaceutical Industry," Region et Developpement, Region et Developpement, LEAD, Universite du Sud - Toulon Var, vol. 33, pages 227-268.
• M. Laura Frigotto & Massimo Riccaboni, 2011. "A few special cases: scientific creativity and network dynamics in the field of rare diseases," Scientometrics, Springer;Akadémiai Kiadó, vol. 89(1), pages 397-420, October.
  • Massimo Riccaboni & Maria Laura Frigotto, 2011. "A Few Special Cases: Scientific Creativity and Network Dynamics in the Field of Rare Diseases," DISA Working Papers 2011/03, Department of Computer and Management Sciences, University of Trento, Italy, revised 24 May 2011.
• Jakub Growiec & Fabio Pammolli & Massimo Riccaboni, 2020. "Innovation and Corporate Dynamics: A Theoretical Framework," Central European Journal of Economic Modelling and Econometrics, Central European Journal of Economic Modelling and Econometrics, vol. 12(1), pages 1-45, March.
  • Massimo, Riccaboni & Jakub, Growiec & Fabio, Pammolli, 2011. "Innovation and Corporate Dynamics: A Theoretical Framework," MPRA Paper 30046, University Library of Munich, Germany.
  • Jakub Growiec & Fabio Pammolli & Massimo Riccaboni, 2011. "Innovation and Corporate Dynamics: A Theoretical Framework," DISA Working Papers 2011/08, Department of Computer and Management Sciences, University of Trento, Italy, revised 29 Jul 2011.
• Pierre Dubois & Olivier de Mouzon & Fiona Scott-Morton & Paul Seabright, 2015. "Market size and pharmaceutical innovation," RAND Journal of Economics, RAND Corporation, vol. 46(4), pages 844-871, October.
  • Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," IDEI Working Papers 670, Institut d'Économie Industrielle (IDEI), Toulouse, revised Mar 2014.
  • Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," TSE Working Papers 11-232, Toulouse School of Economics (TSE), revised Mar 2014.
  • Seabright, Paul & Scott Morton, Fiona & Dubois, Pierre & de Mouzon, Olivier, 2011. "Market Size and Pharmaceutical Innovation," CEPR Discussion Papers 8367, C.E.P.R. Discussion Papers.
• Mazumdar, Mainak & Rajeev, Meenakshi & Ray, Subhash C., 2012. "Sources of Heterogeneity in the Efficiency of Indian Pharmaceutical Firms," Indian Economic Review, Department of Economics, Delhi School of Economics, vol. 47(2), pages 191-221.
  • Subhash C Ray & Mainak Mazumdar & Meenakshi Rajeev, 2010. "Sources of Heterogeneity in the Efficiency of Indian Pharmaceutical Firms," Working Papers id:3334, eSocialSciences.
  • Mainak Mazumdar & Meenakshi Rajeev & Subhash Ray, 2011. "Sources of Heterogeneity in the Efficiency of Indian Pharmaceutical Firms," Working papers 2011-22, University of Connecticut, Department of Economics.
• Wang, Lili & Notten, Ad, 2011. "Mapping the interdisciplinary nature and co-evolutionary patterns in five nano-industrial sectors," MERIT Working Papers 2011-029, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Daems, Rutger & Maes, Edith & Ramani, Shyama V., 2011. "Global Framework for Differential Pricing of Pharmaceuticals," MERIT Working Papers 2011-054, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2011. "External referencing and pharmaceutical price negotiation," Health Economics, John Wiley & Sons, Ltd., vol. 20(6), pages 737-756, June.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2008. "External referencing and pharmaceutical price negotiation," Working Papers 0815, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2011. "External referencing and pharmaceutical price negotiation," Post-Print halshs-00303682, HAL.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2010. "External referencing and pharmaceutical price negotiation," Post-Print halshs-00955856, HAL.
• Ivan Moreno-Torres, 2011. "What if there was a stronger pharmaceutical price competition in Spain? When regulation has a similar effect to collusion," Working Papers XREAP2011-02, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.
• Ivan Moreno-Torres, 2011. "Generic drugs in Spain: price competition vs. moral hazard," Working Papers XREAP2011-04, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.
• Krogmann, Yin & Schwalbe, Ulrich, 2011. "Inter-firm R&D networks in the global pharmaceutical biotechnology industry during 1985 - 1998: A conceptual and empirical analysis," FZID Discussion Papers 38-2011, University of Hohenheim, Center for Research on Innovation and Services (FZID).
• Toole, Andrew A., 2011. "The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry," ZEW Discussion Papers 11-063, ZEW - Leibniz Centre for European Economic Research.

2010

• Artjoms IVLEVS & Jaime DE MELO, 2015. "FDI, the Brain Drain and Trade: Channels and Evidence," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 21, pages 533-551, World Scientific Publishing Co. Pte. Ltd..
  • Artjoms Ivlevs & Jaime De Melo, 2010. "FDI, the Brain Drain and Trade: Channels and Evidence," Annals of Economics and Statistics, GENES, issue 97-98, pages 103-121.
  • de Melo, Jaime & Ivlevs, Artjoms, 2008. "FDI, the Brain Drain and Trade: Channels and Evidence," CEPR Discussion Papers 7002, C.E.P.R. Discussion Papers.
  • Artjoms Ivlevs & Jaime de Melo, 2008. "FDI, the Brain Drain and Trade: Channels and Evidence," Development Working Papers 261, Centro Studi Luca d'Agliano, University of Milano.
  • Artjoms Ivlevs & Jaime de Melo, 2008. "FDI, the Brain Drain and Trade: Channels and Evidence," Discussion Papers 08/40, University of Nottingham, GEP.
• Josh Lerner & Ulrike Malmendier, 2010. "Contractibility and the Design of Research Agreements," American Economic Review, American Economic Association, vol. 100(1), pages 214-246, March.
  • Josh Lerner & Ulrike Malmendier, 2005. "Contractibility and the Design of Research Agreements," NBER Working Papers 11292, National Bureau of Economic Research, Inc.
  • Lerner, Josh & Malmendier, Ulrike, 2008. "Contractibility and the Design of Research Agreements," Department of Economics, Working Paper Series qt2gg4h8z0, Department of Economics, Institute for Business and Economic Research, UC Berkeley.
• Angus Deaton, 2010. "Price Indexes, Inequality, and the Measurement of World Poverty," American Economic Review, American Economic Association, vol. 100(1), pages 5-34, March.
  • Angus Deaton, 2010. "Price indexes, inequality, and the measurement of world poverty," Working Papers 1207, Princeton University, Woodrow Wilson School of Public and International Affairs, Research Program in Development Studies..
• Mark Duggan & Fiona Scott Morton, 2010. "The Effect of Medicare Part D on Pharmaceutical Prices and Utilization," American Economic Review, American Economic Association, vol. 100(1), pages 590-607, March.
  • Mark Duggan & Fiona Scott Morton, 2008. "The Effect of Medicare Part D on Pharmaceutical Prices and Utilization," NBER Working Papers 13917, National Bureau of Economic Research, Inc.
• Hal R. Varian, 2010. "Computer Mediated Transactions," American Economic Review, American Economic Association, vol. 100(2), pages 1-10, May.
• Joachim Henkel & Stephen M. Maurer, 2010. "Network Effects in Biology R&D," American Economic Review, American Economic Association, vol. 100(2), pages 159-164, May.
• Seema Jayachandran & Adriana Lleras-Muney & Kimberly V. Smith, 2010. "Modern Medicine and the Twentieth Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs," American Economic Journal: Applied Economics, American Economic Association, vol. 2(2), pages 118-146, April.
• Guy David & Sara Markowitz & Seth Richards-Shubik, 2010. "The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation," American Economic Journal: Economic Policy, American Economic Association, vol. 2(4), pages 1-25, November.
  • Guy David & Sara Markowitz & Seth Richards, 2009. "The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation," NBER Working Papers 14634, National Bureau of Economic Research, Inc.
• Xu, Zheng & Hennessy, David A. & Moschini, GianCarlo, 2010. "Have Biotech Seeds Increased Maize Yields?," 2010 Annual Meeting, July 25-27, 2010, Denver, Colorado 61303, Agricultural and Applied Economics Association.
• Shi, Guanming & Chavas, Jean-Paul, 2009. "On Pricing and Vertical Organization of Differentiated Products," Staff Paper Series 535, University of Wisconsin, Agricultural and Applied Economics.
  • Shi, Guanming & Chavas, Jean-Paul, 2010. "Pricing and Vertical Organization of Differentiated Products," Staff Papers 92228, University of Wisconsin-Madison, Department of Agricultural and Applied Economics.
• Vlatka Bilas & Vedran Baci, 2010. "The Influence Of The Acquisition Experience On The Successfulness Of International Mergers And Acquisitions In Pharmaceutical Industry 2003-2009," Economic Thought and Practice, Department of Economics and Business, University of Dubrovnik, vol. 19(2), pages 187-209, december.
• Frank Lichtenberg, 2010. "The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France," CESifo Working Paper Series 3095, CESifo.
• Marilena Locatelli & Steinar Strøm, 2015. "Longitudinal Analysis of Generic Substitution," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 43(3), pages 363-374, September.
  • Dalen Dag Morten & Strom Steinar & Locatelli Marilena, 2010. "Longitudinal analysis of generic substitution," Department of Economics and Statistics Cognetti de Martiis. Working Papers 201013, University of Turin.
  • Dag Morten Dalen & Marilena Locatelli & Steinar Strøm, 2010. "Longitudinal Analysis of Generic Substitution," CESifo Working Paper Series 3176, CESifo.
• Brekke, Kurt R. & Holmas, Tor Helge & Straume, Odd Rune, 2011. "Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment," Journal of Public Economics, Elsevier, vol. 95(7-8), pages 624-638, August.
  • Brekke, Kurt R. & Holmas, Tor Helge & Straume, Odd Rune, 2011. "Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment," Journal of Public Economics, Elsevier, vol. 95(7), pages 624-638.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2010. "Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment," CESifo Working Paper Series 3258, CESifo.
• Mathias Kifmann & Sven Neelsen, 2010. "Germany's Struggle with Prices for Patent-protected Drugs," ifo DICE Report, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 8(03), pages 43-52, October.
• Mathias Kifmann & Sven Neelsen, 2010. "Germany's Struggle with Prices for Patent-protected Drugs," ifo DICE Report, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 8(3), pages 43-52, October.
• de Frutos, Maria-Angeles & Ornaghi, Carmine & Siotis, Georges, 2013. "Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?," Journal of Health Economics, Elsevier, vol. 32(1), pages 268-285.
  • Siotis, Georges & de Frutos, Maria-Angeles & Ornaghi, Carmine, 2010. "Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?," CEPR Discussion Papers 8076, C.E.P.R. Discussion Papers.
• Christian Garavaglia & Franco Malerba & Luigi Orsenigo & Michele Pezzoni, 2010. "A History-Friendly Model of the Evolution of the Pharmaceutical Industry: Technological Regimes and Demand Structure," KITeS Working Papers 036, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, revised Nov 2010.
• Anne Boring, 2010. "Political contributions to influence consumers: the example of the u.s. drug reimportation debate," Working Papers DT/2010/03, DIAL (Développement, Institutions et Mondialisation).
• Ernst R. Berndt & Joseph P. Newhouse, 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," NBER Working Papers 16297, National Bureau of Economic Research, Inc.
  • Berndt, Ernst R. & Newhouse, Joseph P., 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," Working Paper Series rwp10-039, Harvard University, John F. Kennedy School of Government.
  • Newhouse, Joseph Paul & Berndt, Ernst R., 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," Scholarly Articles 4450127, Harvard Kennedy School of Government.
• Ching, Andrew T., 2010. "Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration," International Journal of Industrial Organization, Elsevier, vol. 28(6), pages 619-638, November.
  • Ching, Andrew, 2008. "Consumer Learning and Heterogeneity: Dynamics of Demand for Prescription Drugs after Patent Expiration," MPRA Paper 7265, University Library of Munich, Germany.
• Capelle-Blancard, Gunther & Laguna, Marie-Aude, 2010. "How does the stock market respond to chemical disasters?," Journal of Environmental Economics and Management, Elsevier, vol. 59(2), pages 192-205, March.
  • Marie-Aude Laguna & Gunther Capelle-Blancard, 2010. "How Does the Stock Market Respond to Chemical Disasters?," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-00637961, HAL.
  • Marie-Aude Laguna & Gunther Capelle-Blancard, 2010. "How Does the Stock Market Respond to Chemical Disasters?," Post-Print halshs-00637961, HAL.
• Daniel B. Klein & Jason Briggeman, 2010. "305 Economists Called to Answer Questionnaire on the Pre-Market Approval of Drugs and Devices," Econ Journal Watch, Econ Journal Watch, vol. 7(1), pages 99-106, January.
• Frank R. Lichtenberg, 2010. "The effect of drug vintage on survival: Micro evidence from Puerto Rico's Medicaid program," Advances in Health Economics and Health Services Research, in: Pharmaceutical Markets and Insurance Worldwide, pages 273-292, Emerald Group Publishing Limited.
  • Frank R. Lichtenberg, 2004. "The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program," NBER Working Papers 10884, National Bureau of Economic Research, Inc.
• Mazumdar, Mainak & Rajeev, Meenakshi & Ray, Subhash C., 2012. "Sources of Heterogeneity in the Efficiency of Indian Pharmaceutical Firms," Indian Economic Review, Department of Economics, Delhi School of Economics, vol. 47(2), pages 191-221.
  • Subhash C Ray & Mainak Mazumdar & Meenakshi Rajeev, 2010. "Sources of Heterogeneity in the Efficiency of Indian Pharmaceutical Firms," Working Papers id:3334, eSocialSciences.
  • Mainak Mazumdar & Meenakshi Rajeev & Subhash Ray, 2011. "Sources of Heterogeneity in the Efficiency of Indian Pharmaceutical Firms," Working papers 2011-22, University of Connecticut, Department of Economics.
• Capelle-Blancard, Gunther & Laguna, Marie-Aude, 2010. "How does the stock market respond to chemical disasters?," Journal of Environmental Economics and Management, Elsevier, vol. 59(2), pages 192-205, March.
  • Marie-Aude Laguna & Gunther Capelle-Blancard, 2010. "How Does the Stock Market Respond to Chemical Disasters?," Post-Print halshs-00637961, HAL.
  • Marie-Aude Laguna & Gunther Capelle-Blancard, 2010. "How Does the Stock Market Respond to Chemical Disasters?," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-00637961, HAL.
• Capelle-Blancard, Gunther & Laguna, Marie-Aude, 2010. "How does the stock market respond to chemical disasters?," Journal of Environmental Economics and Management, Elsevier, vol. 59(2), pages 192-205, March.
  • Marie-Aude Laguna & Gunther Capelle-Blancard, 2010. "How Does the Stock Market Respond to Chemical Disasters?," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-00637961, HAL.
  • Marie-Aude Laguna & Gunther Capelle-Blancard, 2010. "How Does the Stock Market Respond to Chemical Disasters?," Post-Print halshs-00637961, HAL.
• Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2011. "External referencing and pharmaceutical price negotiation," Health Economics, John Wiley & Sons, Ltd., vol. 20(6), pages 737-756, June.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2008. "External referencing and pharmaceutical price negotiation," Working Papers 0815, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2010. "External referencing and pharmaceutical price negotiation," Post-Print halshs-00955856, HAL.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2011. "External referencing and pharmaceutical price negotiation," Post-Print halshs-00303682, HAL.
• Schneider, Cédric, 2010. "The Battle for Patent Rights in Plant Biotechnology: Evidence from Opposition," Working Papers 06-2010, Copenhagen Business School, Department of Economics.
• Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune, 2013. "Margins and market shares: Pharmacy incentives for generic substitution," European Economic Review, Elsevier, vol. 61(C), pages 116-131.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2010. "Margins and Market Shares:Pharmacy Incentives for Generic Substitution," NIPE Working Papers 20/2010, NIPE - Universidade do Minho.
  • Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune, 2010. "Margins and Market Shares: Pharmacy Incentives for Generic Substitution," Discussion Paper Series in Economics 18/2010, Norwegian School of Economics, Department of Economics.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2012. "Margins and Market Shares: Pharmacy Incentives for Generic Substitution," CESifo Working Paper Series 4055, CESifo.
• Ernst R. Berndt & Joseph P. Newhouse, 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," NBER Working Papers 16297, National Bureau of Economic Research, Inc.
  • Newhouse, Joseph Paul & Berndt, Ernst R., 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," Scholarly Articles 4450127, Harvard Kennedy School of Government.
  • Berndt, Ernst R. & Newhouse, Joseph P., 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," Working Paper Series rwp10-039, Harvard University, John F. Kennedy School of Government.
• Junichi Nishimura & Yosuke Okada, 2010. "R&D Portfolios and Pharmaceutical Licensing," Global COE Hi-Stat Discussion Paper Series gd10-155, Institute of Economic Research, Hitotsubashi University.
• Andrew T. Ching, 2010. "A Dynamic Oligopoly Structural Model For The Prescription Drug Market After Patent Expiration," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 51(4), pages 1175-1207, November.
  • Andrew Ching, 2004. "A Dynamic Oligopoly Structural Model for the Prescription Drug Market After Patent Expiration," Econometric Society 2004 Far Eastern Meetings 735, Econometric Society.
• Victor Platon & Simona Frone & Andreea Constantinescu & Sorina Jurist, 2010. "Current Perspectives and Challenges of Biofuel Production and Consumption," Romanian Journal of Economics, Institute of National Economy, vol. 31(2(40)), pages 107-128, December.
• Roberta Piergiovanni & Enrico Santarelli, 2013. "The more you spend, the more you get? The effects of R&D and capital expenditures on the patenting activities of biotechnology firms," Scientometrics, Springer;Akadémiai Kiadó, vol. 94(2), pages 497-521, February.
  • Roberta Piergiovanni & Enrico Santarelli, 2010. "The More You Spend, the More You Get? The Effects of R&D and Capital Expenditures on the Patenting Activities of Biotechnology Firms," JRC Working Papers on Corporate R&D and Innovation 2010-06, Joint Research Centre.
• Kubo, Kensuke, 2010. "Inferring the Effects of Vertical Integration from Entry Games : An Analysis of the Generic Pharmaceutical Industry," IDE Discussion Papers 221, Institute of Developing Economies, Japan External Trade Organization(JETRO).
• Giulio Bottazzi & Tatiana Plotnikova, 2010. "Productivity and Heterogeneous Knowledge: Exploring the Relationship in a Sample of Drug Developers," Jena Economics Research Papers 2010-044, Friedrich-Schiller-University Jena.
• Tatiana Plotnikova, 2010. "Success in Pharmaceutical Research: The Changing Role of Scale and Scope Economies, Spillovers and Competition," Jena Economics Research Papers 2010-045, Friedrich-Schiller-University Jena.
• Michel Trommetter, 2010. "Flexibility in the implementation of intellectual property rights in agricultural biotechnology," European Journal of Law and Economics, Springer, vol. 30(3), pages 223-245, December.
  • Trommetter, M., 2007. "Flexibility in the implementation of intellectual property rights in agricultural biotechnology," Working Papers 200708, Grenoble Applied Economics Laboratory (GAEL).
• Jorgen Lauridsen & Mariluz Sánchez & Mickael Bech, 2010. "Public pharmaceutical expenditure: identification of spatial effects," Journal of Geographical Systems, Springer, vol. 12(2), pages 175-188, June.
• Marc Fischer & Peter Leeflang & Peter Verhoef, 2010. "Drivers of peak sales for pharmaceutical brands," Quantitative Marketing and Economics (QME), Springer, vol. 8(4), pages 429-460, December.
• Oleg Badunenko, 2010. "Downsizing in the German chemical manufacturing industry during the 1990s. Why is small beautiful?," Small Business Economics, Springer, vol. 34(4), pages 413-431, May.
• Kiki Verico & Williater Leonardo Batubara, 2010. "Sub-Regional Economic Cooperation In Southeast Asia : ITRO’s Effect to Rubber’s FDI Inflows & Indonesia’s Rubber Economic Multipliers," Economics and Finance in Indonesia, Faculty of Economics and Business, University of Indonesia, vol. 58, pages 173-195, August.
• Frank R. Lichtenberg, 2014. "Has Medical Innovation Reduced Cancer Mortality?," CESifo Economic Studies, CESifo Group, vol. 60(1), pages 135-177.
  • Frank R. Lichtenberg, 2010. "Has medical innovation reduced cancer mortality?," NBER Working Papers 15880, National Bureau of Economic Research, Inc.
• Mark Trusheim & Murray L. Aitken & Ernst R. Berndt, 2010. "Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?," NBER Working Papers 16014, National Bureau of Economic Research, Inc.
• Newhouse, Joseph Paul & Berndt, Ernst R., 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," Scholarly Articles 4450127, Harvard Kennedy School of Government.
  • Ernst R. Berndt & Joseph P. Newhouse, 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," NBER Working Papers 16297, National Bureau of Economic Research, Inc.
  • Berndt, Ernst R. & Newhouse, Joseph P., 2010. "Pricing and Reimbursement in U.S. Pharmaceutical Markets," Working Paper Series rwp10-039, Harvard University, John F. Kennedy School of Government.
• Ernst R. Berndt & Murray L. Aitken, 2010. "Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation," NBER Working Papers 16431, National Bureau of Economic Research, Inc.
• Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune, 2013. "Margins and market shares: Pharmacy incentives for generic substitution," European Economic Review, Elsevier, vol. 61(C), pages 116-131.
  • Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune, 2010. "Margins and Market Shares: Pharmacy Incentives for Generic Substitution," Discussion Paper Series in Economics 18/2010, Norwegian School of Economics, Department of Economics.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2010. "Margins and Market Shares:Pharmacy Incentives for Generic Substitution," NIPE Working Papers 20/2010, NIPE - Universidade do Minho.
  • Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2012. "Margins and Market Shares: Pharmacy Incentives for Generic Substitution," CESifo Working Paper Series 4055, CESifo.
• Nobuo Kiriyama, 2010. "Trade and Innovation: Report on the Chemicals Sector," OECD Trade Policy Papers 103, OECD Publishing.
• Guanming Shi & Jean-paul Chavas & Kyle Stiegert, 2010. "An Analysis of the Pricing of Traits in the U.S. Corn Seed Market," American Journal of Agricultural Economics, Agricultural and Applied Economics Association, vol. 92(5), pages 1324-1338.
  • Shi, Guanming & Chavas, Jean-Paul & Steigert, Kyle, 2009. "An Analysis of the Pricing of Traits in the U.S. Corn Seed Market," Staff Paper Series 544, University of Wisconsin, Agricultural and Applied Economics.
  • Shi, Guanming & Chavas, Jean-Paul & Stiegert, Kyle W., 2009. "An Analysis of the Pricing of Traits in the U.S. Corn Seed Market," Staff Papers 92249, University of Wisconsin-Madison, Department of Agricultural and Applied Economics.
• Guido Buenstorf & Steven Klepper, 2010. "Submarket dynamics and innovation: the case of the US tire industry," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 19(5), pages 1563-1587, October.
  • Guido Buenstorf & Steven Klepper, 2009. "Submarket Dynamics and Innovation: The Case of the U.S. Tire Industry," Papers on Economics and Evolution 2009-15, Philipps University Marburg, Department of Geography.
• Kiro Mojsov, 2010. "The Effects Of Inorganic Salts On Biosynthesis Of Pectinolytic Enzymes By Aspergillus Niger," Perspectives of Innovation in Economics and Business (PIEB), Prague Development Center, vol. 4(1), pages 109-112, February.
• Oleg Glovatsky & Rustam Ergashev & Bakhtier Uralov & Holmatzhan Isakov, 2010. "Reliability Assessment And Measures For Resource-Saving In Water Lifting Engine Systems In Uzbekistan," Perspectives of Innovation in Economics and Business (PIEB), Prague Development Center, vol. 0(1), pages 118-120.
• Kiro Mojsov, 2010. "Application Of Solid-State Fermentation For Cellulase Enzyme Production Using Trichoderma Viride," Perspectives of Innovation in Economics and Business (PIEB), Prague Development Center, vol. 5(2), pages 108-110, June.
• Anderson, Simon & Ciliberto, Federico & Liaukonyte, Jura, 2010. "Getting into Your Head(Ache): The Information Content of Advertising in the Over-the-Counter Analgesics Industry," MPRA Paper 24916, University Library of Munich, Germany.
• Havas, Attila, 2010. "Diversity in firms’ innovation strategies and activities: Main findings of interviews and implications in the context of the Hungarian national," MPRA Paper 55852, University Library of Munich, Germany.
• Rousselière, Damien & Rousselière, Samira, 2010. "On the impact of trust on consumer willingness to purchase GM food:Evidence from a European survey," Review of Agricultural and Environmental Studies - Revue d'Etudes en Agriculture et Environnement (RAEStud), Institut National de la Recherche Agronomique (INRA), vol. 91(1).
  • Damien Rousselière & Samira Rousselière, 2010. "On the impact of trust on consumer willingness to purchase GM food:Evidence from a European survey," Review of Agricultural and Environmental Studies - Revue d'Etudes en Agriculture et Environnement, INRA Department of Economics, vol. 91(1), pages 5-26.
  • Rousselière, D. & Rousselière, S., 2009. "On the impact of trust on consumer willingness to purchase GM food : evidence from a European survey," Working Papers 200901, Grenoble Applied Economics Laboratory (GAEL).
• Yun , Mikyung, 2010. "The Structure of Trade in Genetic Resources: Implications for the International ABS Regime Negotiation," East Asian Economic Review, Korea Institute for International Economic Policy, vol. 14(1), pages 175-194, June.
• Khairiah Salwa MOKHTAR & Ravi MAHALINGAM, 2010. "The current biotechnology outlook in Malaysia," Economia. Seria Management, Faculty of Management, Academy of Economic Studies, Bucharest, Romania, vol. 13(1), pages 11-26, June.
• Virgil ENE-VOICULESCU & Carmen ENE-VOICULESCU, 2010. "The Study Of Biochemical Parameters For Naval Academy Team In The Naval Pentathlon," Proceedings of the 5th International Conference on Knowledge Management: Projects, Systems and Technologies,Bucharest, November 12-13 2010 49, Faculty of Economic Cybernetics, Statistics and Informatics, Academy of Economic Studies and National Defence University "Carol I", Department for Management of the Defence Resources and Education.
• Sanda VISAN, 2010. "Risk and Risk Management in Chemical Industry," REVISTA DE MANAGEMENT COMPARAT INTERNATIONAL/REVIEW OF INTERNATIONAL COMPARATIVE MANAGEMENT, Faculty of Management, Academy of Economic Studies, Bucharest, Romania, vol. 11(3), pages 526-533, July.
• Jorgen Lauridsen & Mickael Bech & Fernando López & Mariluz Sánchez, 2010. "A spatiotemporal analysis of public pharmaceutical expenditure," The Annals of Regional Science, Springer;Western Regional Science Association, vol. 44(2), pages 299-314, April.
• Yogesh Punekar & Neil Hawkins, 2010. "Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(1), pages 67-76, February.
• Pinelopi Koujianou Goldberg, 2010. "Alfred Marshall Lecture Intellectual Property Rights Protection in Developing Countries: The Case of Pharmaceuticals," Journal of the European Economic Association, MIT Press, vol. 8(2-3), pages 326-353, 04-05.
• Philipp Ackermann, 2010. "External Price Benchmarking vs. Price Negotiation for Pharmaceuticals," Diskussionsschriften dp1004, Universitaet Bern, Departement Volkswirtschaft.
• Franco Mariuzzo & Xiaoheng Zhang, 2010. "Size Metrics and Dynamics of Firms Expansion in the European Pharmaceutical Industry," Working Papers 201037, Geary Institute, University College Dublin.
• Liam Delaney & Colm Harmon & Cathy Remond, 2010. "Decomposing Gender Differences in College Student Earnings Expectations," Working Papers 201038, Geary Institute, University College Dublin.
• Carly Cheevers & Orla Doyle & Kelly McNamara, 2010. "Child Externalising and Internalising Behaviour in the First Year of School: The Role of Parenting in a Low SES Population," Working Papers 201039, Geary Institute, University College Dublin.
• Santiago-Rodriguez, Fernando & Dutrenit, Gabriela, 2010. "Determinants of PRO-industry interactions in pharmaceutical R&D: the case of Mexico," MERIT Working Papers 2010-053, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Marilena Locatelli & Steinar Strøm, 2015. "Longitudinal Analysis of Generic Substitution," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 43(3), pages 363-374, September.
  • Dag Morten Dalen & Marilena Locatelli & Steinar Strøm, 2010. "Longitudinal Analysis of Generic Substitution," CESifo Working Paper Series 3176, CESifo.
  • Dalen Dag Morten & Strom Steinar & Locatelli Marilena, 2010. "Longitudinal analysis of generic substitution," Department of Economics and Statistics Cognetti de Martiis. Working Papers 201013, University of Turin.
• Bhattacharya, Jay & Packalen, Mikko, 2011. "Opportunities and benefits as determinants of the direction of scientific research," Journal of Health Economics, Elsevier, vol. 30(4), pages 603-615, July.
  • Mikko Packalen & Jay Bhattacharya, 2010. "Opportunities and Benefits as Determinants of the Direction of Scientific Research," Working Papers 1014, University of Waterloo, Department of Economics, revised Dec 2010.
• Kaier, Klaus, 2010. "The impact of pricing and patent expiration on the demand for pharmaceuticals: An examination of the use of broad-spectrum antimicrobials," FZG Discussion Papers 48, University of Freiburg, Research Center for Generational Contracts (FZG).

2009

• Shi, Guanming & Chavas, Jean-Paul, 2009. "On Pricing and Vertical Organization of Differentiated Products: The Case of Soybean Seed Industry," 2009 Annual Meeting, July 26-28, 2009, Milwaukee, Wisconsin 49186, Agricultural and Applied Economics Association.
• Shi, Guanming & Stiegert, Kyle W. & Chavas, Jean-Paul, 2009. "An Analysis of Pricing in the U.S. Cotton Seed Market," 2009 Annual Meeting, July 26-28, 2009, Milwaukee, Wisconsin 51617, Agricultural and Applied Economics Association.
• Shi, Guanming & Stiegert, Kyle & Chavas, Jean-Paul, 2009. "An Analysis of Bundle Pricing in Horizontal and Vertical Markets: The Case of the U.S. Cottonseed Market," Staff Paper Series 543, University of Wisconsin, Agricultural and Applied Economics.
  • Shi, Guanming & Stiegert, Kyle W. & Chavas, Jean-Paul, 2009. "An Analysis of Bundle Pricing in Horizontal and Vertical Markets: The Case of the U.S. Cottonseed Market," Staff Papers 92248, University of Wisconsin-Madison, Department of Agricultural and Applied Economics.
• Guanming Shi & Jean-paul Chavas & Kyle Stiegert, 2010. "An Analysis of the Pricing of Traits in the U.S. Corn Seed Market," American Journal of Agricultural Economics, Agricultural and Applied Economics Association, vol. 92(5), pages 1324-1338.
  • Shi, Guanming & Chavas, Jean-Paul & Steigert, Kyle, 2009. "An Analysis of the Pricing of Traits in the U.S. Corn Seed Market," Staff Paper Series 544, University of Wisconsin, Agricultural and Applied Economics.
  • Shi, Guanming & Chavas, Jean-Paul & Stiegert, Kyle W., 2009. "An Analysis of the Pricing of Traits in the U.S. Corn Seed Market," Staff Papers 92249, University of Wisconsin-Madison, Department of Agricultural and Applied Economics.
• Summer La Croix & Ming Liu, 2009. "The Effect of GDP Growth on Pharmaceutical Patent Protection, 1945-2005," Brussels Economic Review, ULB -- Universite Libre de Bruxelles, vol. 52(3/4), pages 355-375.
• Abdelilah Hamdouch & Feng He, 2009. "R&D offshoring and clustering dynamics in pharmaceuticals and biotechnology: key features and insights from the Chinese case," Journal of Innovation Economics, De Boeck Université, vol. 0(2), pages 95-117.
• Carlos Gustavo Cano, 2009. "La `dominancia´ alimentaria de la política monetaria, biotecnología y política de tierras," Borradores de Economia 5727, Banco de la Republica.
• Misas A., Martha & López-Enciso, Enrique Antonio & Parra Álvarez, Juan Carlos, 2011. "La formación de precios en las empresas colombianas : evidencia a partir de una encuesta directa," Chapters, in: López Enciso, Enrique & Ramírez Giraldo, María Teresa (ed.), Formación de precios y salarios en Colombia T.1, volume 1, chapter 9, pages 297-375, Banco de la Republica de Colombia.
  • Martha Misas A. & Enrique López E. & Juan Carlos Parra A., 2009. "La formación de precios en las empresas colombianas: evidencia a partir de una encuesta directa," Borradores de Economia 569, Banco de la Republica de Colombia.
  • Martha Misas Arango & Enrique López Enciso & Juan Carlos Parra, 2009. "La formación de precios en las empresas colombianas: evidencia a partir de una encuesta directa," Borradores de Economia 5735, Banco de la Republica.
• José Luis Ramos R. & Rubén Darío Rangel R., 2009. "Ventajas competitivas basadas en la gestión del conocimiento: El caso de tres sectores industriales del departamento del Atlántico," Revista de Economía del Caribe 7115, Universidad del Norte.
• Ayadi, Inès, 2009. "Impact de la réforme de l’assurance maladie en Tunisie sur l’offre et la demande des médicaments," Economics Thesis from University Paris Dauphine, Paris Dauphine University, number 123456789/7671 edited by Joël, Marie-Eve & Boujelbene, Younès.
• Oleg Badunenko, 2009. "Small is beautiful: deutsche Chemieunternehmen schrumpfen sich produktiv," DIW Wochenbericht, DIW Berlin, German Institute for Economic Research, vol. 76(32), pages 542-545.
• Shi, Guanming & Chavas, Jean-Paul, 2009. "On Pricing and Vertical Organization of Differentiated Products," Staff Paper Series 535, University of Wisconsin, Agricultural and Applied Economics.
  • Shi, Guanming & Chavas, Jean-Paul, 2010. "Pricing and Vertical Organization of Differentiated Products," Staff Papers 92228, University of Wisconsin-Madison, Department of Agricultural and Applied Economics.
• Guanming Shi & Kyle W. Stiegert & Jean P. Chavas, 2011. "An analysis of bundle pricing in horizontal and vertical markets: The case of the U.S. cottonseed market," Agricultural Economics, International Association of Agricultural Economists, vol. 42, pages 77-88, November.
  • Shi, Guanming & Stiegert, Kyle W. & Chavas, Jean-Paul, 2009. "An Analysis of Bundle Pricing in Horizontal and Vertical Markets: The Case of the U.S. Cottonseed Market," Staff Papers 92248, University of Wisconsin-Madison, Department of Agricultural and Applied Economics.
  • Shi, Guanming & Stiegert, Kyle & Chavas, Jean-Paul, 2009. "An Analysis of Bundle Pricing in Horizontal and Vertical Markets: The Case of the U.S. Cottonseed Market," Staff Paper Series 543, University of Wisconsin, Agricultural and Applied Economics.
• Guanming Shi & Jean-paul Chavas & Kyle Stiegert, 2010. "An Analysis of the Pricing of Traits in the U.S. Corn Seed Market," American Journal of Agricultural Economics, Agricultural and Applied Economics Association, vol. 92(5), pages 1324-1338.
  • Shi, Guanming & Chavas, Jean-Paul & Stiegert, Kyle W., 2009. "An Analysis of the Pricing of Traits in the U.S. Corn Seed Market," Staff Papers 92249, University of Wisconsin-Madison, Department of Agricultural and Applied Economics.
  • Shi, Guanming & Chavas, Jean-Paul & Steigert, Kyle, 2009. "An Analysis of the Pricing of Traits in the U.S. Corn Seed Market," Staff Paper Series 544, University of Wisconsin, Agricultural and Applied Economics.
• Brekke, Kurt R. & Grasdal, Astrid L. & Holms, Tor Helge, 2009. "Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?," European Economic Review, Elsevier, vol. 53(2), pages 170-185, February.
  • Brekke, Kurt R. & Grasdal, Astrid L. & Holmås, Tor Helge, 2006. "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?," Working Papers in Economics 14/06, University of Bergen, Department of Economics.
  • Kurt R. Brekke & Astrid L. Grasdal & Tor Helge Holmås, 2007. "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?," CESifo Working Paper Series 2059, CESifo.
• Sergey Filippov & Kálmán Kalotay, 2009. "New Europe’s Promise for Life Sciences," Chapters, in: Wilfred Dolfsma & Geert Duysters & Ionara Costa (ed.), Multinationals and Emerging Economies, chapter 3, Edward Elgar Publishing.
  • Filippov, Sergey & Kalotay, Kalman, 2008. "New Europe's Promise for Life Sciences," MERIT Working Papers 2008-026, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Costa-Font, Joan & Kanavos, Panos, 2009. "¿A quién beneficia el comercio paralelo de medicamentos en la Unión Europea?," El Trimestre Económico, Fondo de Cultura Económica, vol. 0(302), pages 331-347, abril-jun.
• Ines Ayadi & Houssem Eddine Chebbi & Younes Boujelbene, 2009. "Investigating Generic and Brand Name Pharmaceutical’s Market Shares and Prices in Tunisia," Working Papers 497, Economic Research Forum, revised Jul 2009.
• Guido Buenstorf & Steven Klepper, 2010. "Submarket dynamics and innovation: the case of the US tire industry," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 19(5), pages 1563-1587, October.
  • Guido Buenstorf & Steven Klepper, 2009. "Submarket Dynamics and Innovation: The Case of the U.S. Tire Industry," Papers on Economics and Evolution 2009-15, Philipps University Marburg, Department of Geography.
• Abdulkadir Civan, 2009. "An Alternative Patent Mechanism for Pharmaceutical Drugs for Tropical Diseases," European Journal of Economic and Political Studies, Fatih University, vol. 2(1), pages 21-38.
• Farasat A. S. Bokhari & Gary M. Fournier, 2013. "Entry in the ADHD drugs market: Welfare impact of generics and me-too's," Journal of Industrial Economics, Wiley Blackwell, vol. 61(2), pages 339-392, June.
  • Farasat A.S. Bokhari & Gary M. Fournier, 2009. "Entry in the ADHD drugs market: Welfare impact of generics and me-toos," Working Papers wp2009_05_01, Department of Economics, Florida State University.
• Matthieu MONTALBAN (, 2009. "How financialisation shapes productive models in pharmaceutical industry: the domination and contradictions of the blockbuster conception of control (In French)," Cahiers du GREThA (2007-2019) 2009-01, Groupe de Recherche en Economie Théorique et Appliquée (GREThA).
  • Matthieu MONTALBAN (GREThA-GRES), 2009. "How financialisation shapes productive models in pharmaceutical industry: the domination and contradictions of the blockbuster conception of control (In French)," Cahiers du GRES (2002-2009) 2009-01, Groupement de Recherches Economiques et Sociales.
• Matthieu MONTALBAN (GREThA-GRES), 2009. "How financialisation shapes productive models in pharmaceutical industry: the domination and contradictions of the blockbuster conception of control (In French)," Cahiers du GRES (2002-2009) 2009-01, Groupement de Recherches Economiques et Sociales.
  • Matthieu MONTALBAN (, 2009. "How financialisation shapes productive models in pharmaceutical industry: the domination and contradictions of the blockbuster conception of control (In French)," Cahiers du GREThA (2007-2019) 2009-01, Groupe de Recherche en Economie Théorique et Appliquée (GREThA).
• Claude DUPUY & Matthieu MONTALBAN & Sylvain MOURA, 2009. "Finance and Industrial Dynamics (In French)," Cahiers du GREThA (2007-2019) 2009-24, Groupe de Recherche en Economie Théorique et Appliquée (GREThA).
• Granlund, David, 2009. "Price and welfare effects of a pharmaceutical substitution reform," HUI Working Papers 21, HUI Research.
• Granlund, David & Rudholm, Niklas, 2009. "Does Increased Price Competition Affect Entry of New Pharmaceutical Products?," HUI Working Papers 26, HUI Research.
• Granlund, David, 2009. "Price and welfare effects of a pharmaceutical substitution reform," Umeå Economic Studies 777, Umeå University, Department of Economics.
• Aragón, Edgar & Fouquet, Anne & Campos, Marcia, 2009. "The Emergence of Successful Export Activities in Mexico: Three Case Studies," IDB Publications (Working Papers) 3711, Inter-American Development Bank.
• Casacuberta, Carlos & Domingo, Rosario & Pittaluga, Lucía & Pastori, Héctor, 2009. "The Emergence of Successful Export Activities in Uruguay: Four Case Studies," IDB Publications (Working Papers) 3714, Inter-American Development Bank.
• Claudio Bravo-Ortega & Manuel Agosin Trumper, 2007. "The Emergence Of New Successful Export Activities In Latin America: The Case Of Chile," Working Papers wp236, University of Chile, Department of Economics.
  • Agosin, Manuel R. & Bravo Ortega, Claudio, 2009. "The Emergence of New Successful Export Activities in Latin America: The Case of Chile," IDB Publications (Working Papers) 3716, Inter-American Development Bank.
  • Manuel Agosin & Claudio Bravo-Ortega, 2009. "The Emergence of New Successful Export Activities in Latin America: The Case of Chile," Research Department Publications 3265, Inter-American Development Bank, Research Department.
• Claudio Bravo-Ortega & Manuel Agosin Trumper, 2007. "The Emergence Of New Successful Export Activities In Latin America: The Case Of Chile," Working Papers wp236, University of Chile, Department of Economics.
  • Manuel R. Agosin & Claudio Bravo Ortega, 2009. "The Emergence of New Successful Export Activities in Latin America: The Case of Chile," IDB Publications (Working Papers) 44838, Inter-American Development Bank.
  • Manuel Agosin & Claudio Bravo-Ortega, 2009. "The Emergence of New Successful Export Activities in Latin America: The Case of Chile," Research Department Publications 3265, Inter-American Development Bank, Research Department.
• Michele Snoeck & Lucia Pittaluga & Hector Pastori & Rosario Domingo & Carlos Casacuberta, 2009. "The Emergence of Successful Export Activities in Uruguay: Four Case Studies," Research Department Publications 3267, Inter-American Development Bank, Research Department.
  • Carlos Casacuberta & Rosario Domingo & Lucía Pittaluga & Héctor Pastori, 2009. "The Emergence of Successful Export Activities in Uruguay: Four Case Studies," IDB Publications (Working Papers) 44858, Inter-American Development Bank.
• Edgar Aragón & Anne Fouquet & Marcia Campos, 2009. "The Emergence of Successful Export Activities in Mexico: Three Case Studies," IDB Publications (Working Papers) 44898, Inter-American Development Bank.
• Edgar Aragon & Anne Fouquet & Marcia Campos, 2009. "The Emergence of Successful Export Activities in Mexico: Three Case Studies," Research Department Publications 3264, Inter-American Development Bank, Research Department.
• Claudio Bravo-Ortega & Manuel Agosin Trumper, 2007. "The Emergence Of New Successful Export Activities In Latin America: The Case Of Chile," Working Papers wp236, University of Chile, Department of Economics.
  • Manuel Agosin & Claudio Bravo-Ortega, 2009. "The Emergence of New Successful Export Activities in Latin America: The Case of Chile," Research Department Publications 3265, Inter-American Development Bank, Research Department.
  • Agosin, Manuel R. & Bravo Ortega, Claudio, 2009. "The Emergence of New Successful Export Activities in Latin America: The Case of Chile," IDB Publications (Working Papers) 3716, Inter-American Development Bank.
• Manuel Agosin & Claudio Bravo-Ortega, 2009. "Surgimiento de nuevas actividades de exportación en América Latina: el caso de Chile," Research Department Publications 3266, Inter-American Development Bank, Research Department.
• Michele Snoeck & Lucia Pittaluga & Hector Pastori & Rosario Domingo & Carlos Casacuberta, 2009. "The Emergence of Successful Export Activities in Uruguay: Four Case Studies," Research Department Publications 3267, Inter-American Development Bank, Research Department.
• Michele Snoeck & Lucia Pittaluga & Hector Pastori & Rosario Domingo & Carlos Casacuberta, 2009. "Surgimiento de actividades de exportación exitosas en Uruguay: cuatro casos específicos," Research Department Publications 3268, Inter-American Development Bank, Research Department.
• Edgar Aragon & Anne Fouquet & Marcia Campos, 2009. "Surgimiento de actividades de exportación exitosas en México: tres casos específicos," Research Department Publications 3269, Inter-American Development Bank, Research Department.
• Matthew Adler & Claire Brunel & Gary Clyde Hufbauer & Jeffrey J. Schott, 2009. "What’s on the Table? The Doha Round as of August 2009," Working Paper Series WP09-6, Peterson Institute for International Economics.
• Andrew A. Toole & Dirk Czarnitzki, 2009. "Exploring the Relationship Between Scientist Human Capital and Firm Performance: The Case of Biomedical Academic Entrepreneurs in the SBIR Program," Management Science, INFORMS, vol. 55(1), pages 101-114, January.
  • Czarnitzki, Dirk & Toole, Andrew A., 2007. "Exploring the relationship between scientist human capital and firm performance: The case of biomedical academic entrepreneurs in the SBIR program," ZEW Discussion Papers 07-011, ZEW - Leibniz Centre for European Economic Research.
• Nathalie Grandfils & Catherine Sermet, 2009. "Evolution 1998-2002 of the antidepressant consumption in France, Germany and the United Kingdom," Working Papers DT21, IRDES institut for research and information in health economics, revised Feb 2009.
• Joseph E. Harrington & Andrzej Skrzypacz, 2011. "Private Monitoring and Communication in Cartels: Explaining Recent Collusive Practices," American Economic Review, American Economic Association, vol. 101(6), pages 2425-2449, October.
  • Joseph E. Harrington, Jr. & Andrzej Skrzypacz, 2009. "Private Monitoring and Communication in Cartels: Explaining Recent Collusive Practices," Economics Working Paper Archive 555, The Johns Hopkins University,Department of Economics.
• Uwe Cantner & Tatiana Plotnikova, 2009. "Technological Diversity and Future Product Diversity in the Drug Industry," Jena Economics Research Papers 2009-031, Friedrich-Schiller-University Jena.
• Tatiana Plotnikova, 2009. "Technology, Competition and the Time of Entry: Diversification Patterns in the Development of New Drugs," Jena Economics Research Papers 2009-078, Friedrich-Schiller-University Jena.
• Iván Moreno-Torres & Jaume Puig-Junoy & Joan-Ramon Borrell, 2009. "Generic Entry into the Regulated Spanish Pharmaceutical Market," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 34(4), pages 373-388, June.
• Todd Watkins & Lolita Paff, 2009. "Absorptive capacity and R&D tax policy: Are in-house and external contract R&D substitutes or complements?," Small Business Economics, Springer, vol. 33(2), pages 207-227, August.
  • Todd A. Watkins & Lolita Paff, 2007. "Absorptive Capacity and R&D Tax Policy: Are In-house and External Contract R&D Substitutes or Complements?," Working Papers 116, National University of Ireland Galway, Department of Economics, revised 2007.
• Margaret K. Kyle & Anita M. McGahan, 2012. "Investments in Pharmaceuticals Before and After TRIPS," The Review of Economics and Statistics, MIT Press, vol. 94(4), pages 1157-1172, November.
  • Margaret Kyle & Anita McGahan, 2009. "Investments in Pharmaceuticals Before and After TRIPS," NBER Working Papers 15468, National Bureau of Economic Research, Inc.
  • Kyle, Margaret & McGahan, Anita M, 2011. "Investments in Pharmaceuticals Before and After TRIPS," CEPR Discussion Papers 8371, C.E.P.R. Discussion Papers.
• Suma Athreye & Dinar Kale & Shyama V. Ramani, 2009. "Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 18(4), pages 729-759, August.
  • Athreye, Suma & Kale, Dinar & Ramani, Shyama V., 2008. "Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector," MERIT Working Papers 2008-041, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Maud Roucan-Kane & Allan Gray, 2009. "The U.S. Seed Industustustry: An Exploration of Statistics Highlighting the Economic Cctivity of the U.S. Row Crop Seed Industry," Working Papers 09-08, Purdue University, College of Agriculture, Department of Agricultural Economics.
• Beatrix Lanyi, 2009. "Innovation Co-Operation Modes In Hungarian Chemical Industry," Perspectives of Innovation in Economics and Business (PIEB), Prague Development Center, vol. 3(3), pages 11-14.
• Quaye, Wilhemina & Yawson, Ivy & Yawson, Robert M. & Williams, Irene E., 2009. "Acceptance of biotechnology and social-cultural implications in Ghana," MPRA Paper 33237, University Library of Munich, Germany.
• James Bessen & Michael J. Meurer, 2009. "Of Patents and Property," Working Papers 0901, Research on Innovation.
• Lorenzo Carbonari, 2009. "How variable is labor input in the Italian manufacturing: the case of the pharmaceutical industry," CEIS Research Paper 140, Tor Vergata University, CEIS, revised 30 Jun 2009.
• Marc Reimann & Philippe Schiltknecht, 2009. "The role of risk preferences and flexibility for risk management: lessons from a custom manufacturing environment," Review of Managerial Science, Springer, vol. 3(2), pages 117-140, July.
• Hans-Martin Zademach & Manuel Rimkus, 2009. "Herausforderung Wissenstransfer in Clustern - Neues Wissen vom Biotechnologiestandort Martinsried," Schmalenbach Journal of Business Research, Springer, vol. 61(4), pages 416-438, June.
• Enrico Sorisio, 2009. "Patenting activity in biotechnology and pharmaceuticals: a comparative analysis of the Nordic Countries," Working Papers on Innovation Studies 20090722, Centre for Technology, Innovation and Culture, University of Oslo.
• Mariana Saidón, 2009. "Biofuels: Players and discussions in Latin America," Economía, Instituto de Investigaciones Económicas y Sociales (IIES). Facultad de Ciencias Económicas y Sociales. Universidad de Los Andes. Mérida, Venezuela, vol. 34(27), pages 171-198, January-j.

2008

• Beata Javorcik & Wolfgang Keller & James Tybout, 2008. "Openness and Industrial Response in a Wal‐Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers," The World Economy, Wiley Blackwell, vol. 31(12), pages 1558-1580, December.
  • Beata Smarzynska Javorcik & Wolfgang Keller & James R. Tybout, 2006. "Openness and Industrial Responses in a Wal-Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers," NBER Working Papers 12457, National Bureau of Economic Research, Inc.
  • Javorcik, Beata & Keller, Wolfgang & Tybout, James, 2006. "Openness and industrial response in a Wal-Mart world : a case study of Mexican soaps, detergents, and surfactant producers," Policy Research Working Paper Series 3999, The World Bank.
  • Tybout, James & Keller, Wolfgang & Javorcik, Beata, 2006. "Openness and Industrial Response in a Wal-Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers," CEPR Discussion Papers 5823, C.E.P.R. Discussion Papers.
• Sandy Campart & Étienne Pfister, 2008. "Course technologique et valeur boursière. Une étude d'événements basée sur l'industrie pharmaceutique," Revue économique, Presses de Sciences-Po, vol. 59(2), pages 307-329.
• Josh Lerner & Ulrike Malmendier, 2010. "Contractibility and the Design of Research Agreements," American Economic Review, American Economic Association, vol. 100(1), pages 214-246, March.
  • Josh Lerner & Ulrike Malmendier, 2005. "Contractibility and the Design of Research Agreements," NBER Working Papers 11292, National Bureau of Economic Research, Inc.
  • Lerner, Josh & Malmendier, Ulrike, 2008. "Contractibility and the Design of Research Agreements," Department of Economics, Working Paper Series qt2gg4h8z0, Department of Economics, Institute for Business and Economic Research, UC Berkeley.
• Brekke, Kurt R. & Kuhn, Michael, 2006. "Direct to consumer advertising in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 25(1), pages 102-130, January.
  • Kurt R Brekke & Michael Kuhn, "undated". "Direct-to-Consumer Advertising in Pharmaceutical Markets," Discussion Papers 03/11, Department of Economics, University of York.
  • Kurt R. Brekke & Michael Kuhn, 2005. "Direct to Consumer Advertising in Pharmaceutical Markets," CESifo Working Paper Series 1493, CESifo.
  • Brekke, Kurt R. & Kuhn, Michael, 2003. "Direct-to-Consumer Advertising in Pharmaceutical Markets," Working Papers in Economics 05/03, University of Bergen, Department of Economics.
• Zouikri, Messaoud, 2008. "Stratégies de R et D et innovation dans l’industrie pharmaceutique en France : une étude économétrique sur données individuelles," Economics Thesis from University Paris Dauphine, Paris Dauphine University, number 123456789/4544 edited by Torre, André.
• Jayan Jose Thomas, 2008. "Innovation In India And China: Challenges And Prospects In Pharmaceuticals And Biotechnology," Working Papers 2008-035, Madras School of Economics,Chennai,India.
  • Jayan Jose Thomas, 2008. "Innovation in India and China : Challenges and Prospects in Pharmaceuticals and Biotechnology," Development Economics Working Papers 22518, East Asian Bureau of Economic Research.
• Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2008. "Allocative efficiency measurement revisited--Do we really need input prices?," Economic Modelling, Elsevier, vol. 25(5), pages 1093-1109, September.
  • Oleg Badunenko & Michael Fritsch & Andreas Stephan, 2006. "Allocative Efficiency Measurement Revisited: Do We Really Need Input Prices?," Discussion Papers of DIW Berlin 591, DIW Berlin, German Institute for Economic Research.
  • Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2006. "Allocative efficiency measurement revisited: Do we really need input prices?," Working Paper Series 2006,7, European University Viadrina Frankfurt (Oder), The Postgraduate Research Programme Capital Markets and Finance in the Enlarged Europe.
  • Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2006. "Allocative efficiency measurement revisited: do we really need input prices?," Freiberg Working Papers 2006/04, TU Bergakademie Freiberg, Faculty of Economics and Business Administration.
• Garci­a-Alonso, Mari­a D.C. & Garci­a-Mariñoso, Begoña, 2008. "The strategic interaction between firms and formulary committees: Effects on the prices of new drugs," Journal of Health Economics, Elsevier, vol. 27(2), pages 377-404, March.
• Javier Coronado & Sergi Jiménez-Martín & Pedro L Marín, 2007. "Multimarket Contact in Pharmaceutical Markets," Working Papers 303, Barcelona School of Economics.
  • Javier Coronado & Sergi Jiménez Martín & Pedro L. Marín, 2008. "Multimarket Contact in Pharmaceutical Markets," Working Papers 2008-20, FEDEA.
  • Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín, 2007. "Multimarket Contact in Pharmaceutical Markets," UFAE and IAE Working Papers 698.07, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC), revised 18 Jul 2007.
  • Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín, 2007. "Multimarket contact in pharmaceutical markets," Economics Working Papers 1033, Department of Economics and Business, Universitat Pompeu Fabra, revised Jul 2007.
• Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2011. "External referencing and pharmaceutical price negotiation," Health Economics, John Wiley & Sons, Ltd., vol. 20(6), pages 737-756, June.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2008. "External referencing and pharmaceutical price negotiation," Working Papers 0815, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2011. "External referencing and pharmaceutical price negotiation," Post-Print halshs-00303682, HAL.
  • Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2010. "External referencing and pharmaceutical price negotiation," Post-Print halshs-00955856, HAL.
• Trommetter, M., 2008. "Intellectual property rights in agricultural and agro-food biotechnologies to 2030 (© OECD International Futures Programme)," Working Papers 200805, Grenoble Applied Economics Laboratory (GAEL).
• Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," PSE-Ecole d'économie de Paris (Postprint) hal-00387535, HAL.
  • Bruno AMABLE (Université Paris I and CEPREMAP) & Yannick LUNG (GREThA-GRES), 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusions," Cahiers du GRES (2002-2009) 2008-20, Groupement de Recherches Economiques et Sociales.
  • Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00387535, HAL.
  • Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," Post-Print hal-00387535, HAL.
• Bruno AMABLE & Yannick LUNG, 2008. "The European Socio-Economic Models of a Knowledge-based society. \r\nMain findings and conclusion \r\n," Cahiers du GREThA (2007-2019) 2008-26, Groupe de Recherche en Economie Théorique et Appliquée (GREThA).
• Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," PSE-Ecole d'économie de Paris (Postprint) hal-00387535, HAL.
  • Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00387535, HAL.
  • Bruno AMABLE (Université Paris I and CEPREMAP) & Yannick LUNG (GREThA-GRES), 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusions," Cahiers du GRES (2002-2009) 2008-20, Groupement de Recherches Economiques et Sociales.
  • Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," Post-Print hal-00387535, HAL.
• Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff, 2005. "Strategic Reasons for Patenting: Between Exclusion and Coordination Rationales," Rivista di Politica Economica, SIPI Spa, vol. 95(5), pages 19-46, September.
  • Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff, 2006. "Strategic Reasons for Patenting : Between Exclusion and Coordination Rationales," Post-Print hal-00279139, HAL.
  • Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff, 2008. "Strategic Reasons for Patenting : Between Exclusion and Coordination Rationales," Post-Print hal-00279475, HAL.
• Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2015. "Openness, Inequality and Poverty: Endowments Matter," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 20, pages 497-532, World Scientific Publishing Co. Pte. Ltd..
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Openness, inequality and poverty: Endowments matter," The Journal of International Trade & Economic Development, Taylor & Francis Journals, vol. 17(3), pages 343-378.
  • Gourdon, Julien & Maystre, Nicolas & de Melo, Jaime, 2006. "Openness, inequality, and poverty : endowments matter," Policy Research Working Paper Series 3981, The World Bank.
  • Julien Gourdon & Jaime de Melo & Nicolas Maystre, 2008. "Openness, Inequality and Poverty: Endowment Matter?," Post-Print hal-00348921, HAL.
  • Jaime MELO DE & Julien GOURDON & Nicolas MAYSTRE, 2007. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers 200711, CERDI.
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Opennes, Inequality, and Poverty: Endowments Matter," Development Working Papers 239, Centro Studi Luca d'Agliano, University of Milano.
  • de Melo, Jaime & Gourdon, Julien & Maystre, Nicolas, 2006. "Openness, Inequality and Poverty: Endowments Matter," CEPR Discussion Papers 5738, C.E.P.R. Discussion Papers.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers halshs-00557112, HAL.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," CERDI Working papers halshs-00557112, HAL.
• Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," PSE-Ecole d'économie de Paris (Postprint) hal-00387535, HAL.
  • Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," Post-Print hal-00387535, HAL.
  • Bruno AMABLE (Université Paris I and CEPREMAP) & Yannick LUNG (GREThA-GRES), 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusions," Cahiers du GRES (2002-2009) 2008-20, Groupement de Recherches Economiques et Sociales.
  • Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00387535, HAL.
• Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," Post-Print hal-00387535, HAL.
  • Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," PSE-Ecole d'économie de Paris (Postprint) hal-00387535, HAL.
  • Bruno AMABLE (Université Paris I and CEPREMAP) & Yannick LUNG (GREThA-GRES), 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusions," Cahiers du GRES (2002-2009) 2008-20, Groupement de Recherches Economiques et Sociales.
  • Yannick Lung & Bruno Amable, 2008. "The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusion," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00387535, HAL.
• Andersson, Martin & Johansson, Börje & Karlsson, Charlie & Lööf, Hans, 2008. "Multinationals in the Knowledge Economy - a case study of AstraZeneca in Sweden," Working Paper Series in Economics and Institutions of Innovation 154, Royal Institute of Technology, CESIS - Centre of Excellence for Science and Innovation Studies.
• Furu, Kari & Dalen, Dag Morten & Locatelli, Marilena & Strøm, Steinar, 2008. "Generic Substitution," Memorandum 11/2008, Oslo University, Department of Economics.
• Alexander Cuntz, 2008. "Genetic Codes of Mergers, Post Merger Technology Evolution and Why Mergers Fail," SFB 649 Discussion Papers SFB649DP2008-029, Sonderforschungsbereich 649, Humboldt University, Berlin, Germany.
• M.S. Harilal, 2008. "Home to Market: Response,Resurgence and Transformation of Ayurveda from 1830's to 1920," Centre for Development Studies, Trivendrum Working Papers 408, Centre for Development Studies, Trivendrum, India.
• Nathalie Grandfils, 2008. "Drug price setting and regulation in France," Working Papers DT16, IRDES institut for research and information in health economics, revised Sep 2008.
• Meng-Shiunn Lee, 2008. "Critical Success Factors for Intra-Disciplinary Transformation of the Agricultural Biotechnology Industry in Taiwan based on the Value Chain Concept," Journal of Economics and Management, College of Business, Feng Chia University, Taiwan, vol. 4(1), pages 65-88, January.
• Jan Larsson & Kjetil Telle, 2008. "Consequences of the IPPC’s BAT Requirements for Emissions and Abatement Costs: A DEA Analysis on Norwegian Data," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 41(4), pages 563-578, December.
• Muhammad Rafiq & Asif Iqbal & Muhammad Atiq, 2008. "The Determinants of Capital Structure of the Chemical Industry in Pakistan," Lahore Journal of Economics, Department of Economics, The Lahore School of Economics, vol. 13(1), pages 139-158, Jan-Jun.
• Jayan Jose Thomas, 2008. "Innovation in India and China : Challenges and Prospects in Pharmaceuticals and Biotechnology," Development Economics Working Papers 22518, East Asian Bureau of Economic Research.
  • Jayan Jose Thomas, 2008. "Innovation In India And China: Challenges And Prospects In Pharmaceuticals And Biotechnology," Working Papers 2008-035, Madras School of Economics,Chennai,India.
• Patricia M. Danzon & Andrew J. Epstein, 2012. "Effects of Regulation on Drug Launch and Pricing in Interdependent Markets," Advances in Health Economics and Health Services Research, in: The Economics of Medical Technology, pages 35-71, Emerald Group Publishing Limited.
  • Patricia M. Danzon & Andrew J. Epstein, 2008. "Effects of Regulation on Drug Launch and Pricing in Interdependent Markets," NBER Working Papers 14041, National Bureau of Economic Research, Inc.
• Vincenzo Atella & Jay Bhattacharya & Lorenzo Carbonari, 2008. "Pharmaceutical industry, drug quality and regulation. Evidence from US and Italy," CEIS Research Paper 138, Tor Vergata University, CEIS, revised 16 Dec 2008.
  • Vincenzo Atella & Jay Bhattacharya & Lorenzo Carbonari, 2008. "Pharmaceutical Industry, Drug Quality and Regulation: Evidence from US and Italy," NBER Working Papers 14567, National Bureau of Economic Research, Inc.
• Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2008. "Regulation, generic competition and pharmaceutical prices: Theory and evidence from a natural experiment," NIPE Working Papers 01/2008, NIPE - Universidade do Minho.
• Pradhan, Jaya Prakash, 2008. "Overcoming Innovation Limits through Outward FDI: The Overseas Acquisition Strategy of Indian Pharmaceutical Firms," MPRA Paper 12362, University Library of Munich, Germany.
• Gay, Brigitte, 2008. "Firm dynamic governance of global innovation by means of flexible networks of connections," MPRA Paper 12525, University Library of Munich, Germany.
• Yawson, Robert M. & Yawson, Ivy, 2008. "Policy options of agricultural biotechnology R&D in Sub-Saharan Africa: key issues and aspects," MPRA Paper 34880, University Library of Munich, Germany.
• Ching, Andrew T., 2010. "Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration," International Journal of Industrial Organization, Elsevier, vol. 28(6), pages 619-638, November.
  • Ching, Andrew, 2008. "Consumer Learning and Heterogeneity: Dynamics of Demand for Prescription Drugs after Patent Expiration," MPRA Paper 7265, University Library of Munich, Germany.
• Heiner Minssen & Susanne Schmidt, 2008. "Selbstselektion statt Personalauswahl? Auslandsentsendungen in der deutschen chemischen Industrie," Zeitschrift fuer Personalforschung. German Journal of Research in Human Resource Management, Rainer Hampp Verlag, vol. 22(3), pages 228-248.
• Éric Vernier & Hubert Delval, 2008. "La lutte anti-blanchiment dans le secteur de l’assurance (the fight against money laundering in the insurance sector)," Working Papers 188, Laboratoire de Recherche sur l'Industrie et l'Innovation. ULCO / Research Unit on Industry and Innovation.
• Blandine Laperche, 2008. "Stratégies d’innovation des firmes des sciences de la vie et appropriation des ressources végétales : processus et enjeux Innovations strategies of firms in life science and appropriation of vegetal r," Working Papers 189, Laboratoire de Recherche sur l'Industrie et l'Innovation. ULCO / Research Unit on Industry and Innovation.
• Nejla Yacoub, 2008. "The Tunisian Pharmaceutical Sector in Transformation: Inventory of Fixtures and Innovation Prospects," Working Papers 190, Laboratoire de Recherche sur l'Industrie et l'Innovation. ULCO / Research Unit on Industry and Innovation.
• Lauridsen, Jorgen & Bech, Mickael & Lopez, Fernando & Mate Sanchez, Mariluz, 2008. "Geographic and Temporal Heterogeneity in Public Prescription Pharmaceutical Expenditures in Spain," The Review of Regional Studies, Southern Regional Science Association, vol. 38(1), pages 89-103.
• Ville Aalto-Setälä, 2008. "The impact of generic substitution on price competition in Finland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 9(2), pages 185-191, May.
• Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2015. "Openness, Inequality and Poverty: Endowments Matter," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 20, pages 497-532, World Scientific Publishing Co. Pte. Ltd..
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Openness, inequality and poverty: Endowments matter," The Journal of International Trade & Economic Development, Taylor & Francis Journals, vol. 17(3), pages 343-378.
  • Gourdon, Julien & Maystre, Nicolas & de Melo, Jaime, 2006. "Openness, inequality, and poverty : endowments matter," Policy Research Working Paper Series 3981, The World Bank.
  • Julien Gourdon & Jaime de Melo & Nicolas Maystre, 2008. "Openness, Inequality and Poverty: Endowment Matter?," Post-Print hal-00348921, HAL.
  • Jaime MELO DE & Julien GOURDON & Nicolas MAYSTRE, 2007. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers 200711, CERDI.
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Opennes, Inequality, and Poverty: Endowments Matter," Development Working Papers 239, Centro Studi Luca d'Agliano, University of Milano.
  • de Melo, Jaime & Gourdon, Julien & Maystre, Nicolas, 2006. "Openness, Inequality and Poverty: Endowments Matter," CEPR Discussion Papers 5738, C.E.P.R. Discussion Papers.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers halshs-00557112, HAL.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," CERDI Working papers halshs-00557112, HAL.
• Sandra Phlippen & An Vermeersch, 2008. "Pharmaceutical Research Strategies," Tinbergen Institute Discussion Papers 08-022/3, Tinbergen Institute, revised 08 May 2008.
• Riemer P. Faber & Maarten C.W. Janssen, 2008. "On the Effects of Suggested Prices in Gasoline Markets," Tinbergen Institute Discussion Papers 08-116/1, Tinbergen Institute.
• Marianela Luzardo Briceño, 2008. "A hybrid methodology for the Cox proportional hazard model," Economía, Instituto de Investigaciones Económicas y Sociales (IIES). Facultad de Ciencias Económicas y Sociales. Universidad de Los Andes. Mérida, Venezuela, vol. 33(26), pages 179-188, july-dece.
• Santiago-Rodriguez, Fernando, 2008. "Facing the Trial of Internationalizing Clinical Trials to Developing Countries: Some Evidence from Mexico," MERIT Working Papers 2008-023, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Sergey Filippov & Kálmán Kalotay, 2009. "New Europe’s Promise for Life Sciences," Chapters, in: Wilfred Dolfsma & Geert Duysters & Ionara Costa (ed.), Multinationals and Emerging Economies, chapter 3, Edward Elgar Publishing.
  • Filippov, Sergey & Kalotay, Kalman, 2008. "New Europe's Promise for Life Sciences," MERIT Working Papers 2008-026, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Suma Athreye & Dinar Kale & Shyama V. Ramani, 2009. "Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 18(4), pages 729-759, August.
  • Athreye, Suma & Kale, Dinar & Ramani, Shyama V., 2008. "Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector," MERIT Working Papers 2008-041, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Athreye, Suma & Godley, Andrew, 2008. "Internationalising to create Firm Specific Advantages: Leapfrogging strategies of U.S. Pharmaceutical firms in the 1930s and 1940s & Indian Pharmaceutical firms in the 1990s and 2000s," MERIT Working Papers 2008-051, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Paul S Teng, 2008. "Bioscience Entrepreneurship in Asia:Creating Value with Biology," World Scientific Books, World Scientific Publishing Co. Pte. Ltd., number 6234, August.
• Paul S. Teng, 2008. "Exploiting Developments in Science for New Bioscience Enterprises," World Scientific Book Chapters, in: Bioscience Entrepreneurship In Asia Creating Value with Biology, chapter 1, pages 1-36, World Scientific Publishing Co. Pte. Ltd..
• Paul S. Teng, 2008. "Hybrid Plant and Seed Varieties," World Scientific Book Chapters, in: Bioscience Entrepreneurship In Asia Creating Value with Biology, chapter 2, pages 37-59, World Scientific Publishing Co. Pte. Ltd..
• Paul S. Teng, 2008. "Tissue Culture as a Bioscience Enterprise," World Scientific Book Chapters, in: Bioscience Entrepreneurship In Asia Creating Value with Biology, chapter 3, pages 61-102, World Scientific Publishing Co. Pte. Ltd..
• Paul S. Teng, 2008. "Biofermentation, Biofertilizers and Biopesticides," World Scientific Book Chapters, in: Bioscience Entrepreneurship In Asia Creating Value with Biology, chapter 4, pages 103-143, World Scientific Publishing Co. Pte. Ltd..
• Paul S. Teng, 2008. "Mushroom Culture as a Bioscience Enterprise," World Scientific Book Chapters, in: Bioscience Entrepreneurship In Asia Creating Value with Biology, chapter 5, pages 145-171, World Scientific Publishing Co. Pte. Ltd..
• Paul S. Teng, 2008. "Biofuels," World Scientific Book Chapters, in: Bioscience Entrepreneurship In Asia Creating Value with Biology, chapter 6, pages 173-199, World Scientific Publishing Co. Pte. Ltd..
• Paul S. Teng, 2008. "Bioremediation," World Scientific Book Chapters, in: Bioscience Entrepreneurship In Asia Creating Value with Biology, chapter 7, pages 201-223, World Scientific Publishing Co. Pte. Ltd..
• Paul S. Teng, 2008. "Biodetection — Diagnosing Plant Diseases and Detecting Genetically Modified Food," World Scientific Book Chapters, in: Bioscience Entrepreneurship In Asia Creating Value with Biology, chapter 8, pages 225-263, World Scientific Publishing Co. Pte. Ltd..
• Paul S. Teng, 2008. "Biotechnology Crops (Genetically Modified Plants)," World Scientific Book Chapters, in: Bioscience Entrepreneurship In Asia Creating Value with Biology, chapter 9, pages 265-301, World Scientific Publishing Co. Pte. Ltd..
• Paul S. Teng, 2008. "Growing the Opportunities for Bioscience Entrepreneurship in Asia," World Scientific Book Chapters, in: Bioscience Entrepreneurship In Asia Creating Value with Biology, chapter 10, pages 303-329, World Scientific Publishing Co. Pte. Ltd..
• Cuntz, Alexander, 2008. "Genetic codes of mergers, post merger technology evolution and why mergers fail," SFB 649 Discussion Papers 2008-029, Humboldt University Berlin, Collaborative Research Center 649: Economic Risk.

2007

• Kolympiris, Christos & Klein, Peter G. & Kalaitzandonakes, Nicholas G., 2007. "The Entrepreneur's Choice of Location: Evidence from the Life Sciences," 2007 Annual Meeting, July 29-August 1, 2007, Portland, Oregon 9761, American Agricultural Economics Association (New Name 2008: Agricultural and Applied Economics Association).
• Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The determinants of pricing in pharmaceuticals: Are U.S. prices really higher than those of Canada?," Economics Working Papers 1032, Department of Economics and Business, Universitat Pompeu Fabra.
  • Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The Determinants of Pricing in Pharmaceuticals: Are U.S. Prices Really Higher than Those of Canada?," UFAE and IAE Working Papers 697.07, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC).
  • Jiménez-Martín, Sergi & Cabrales, Antonio, 2007. "The determinants of pricing in pharmaceuticals : are U.S. prices really higher than those of Canada?," UC3M Working papers. Economics we074021, Universidad Carlos III de Madrid. Departamento de Economía.
  • Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The Determinants of Pricing in Pharmaceuticals: Are U.S. prices really higher than those of Canada?," Working Papers 304, Barcelona School of Economics.
• Javier Coronado & Sergi Jiménez-Martín & Pedro L Marín, 2007. "Multimarket Contact in Pharmaceutical Markets," Working Papers 303, Barcelona School of Economics.
  • Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín, 2007. "Multimarket Contact in Pharmaceutical Markets," UFAE and IAE Working Papers 698.07, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC), revised 18 Jul 2007.
  • Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín, 2007. "Multimarket contact in pharmaceutical markets," Economics Working Papers 1033, Department of Economics and Business, Universitat Pompeu Fabra, revised Jul 2007.
  • Javier Coronado & Sergi Jiménez Martín & Pedro L. Marín, 2008. "Multimarket Contact in Pharmaceutical Markets," Working Papers 2008-20, FEDEA.
• Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín, 2007. "Multimarket contact in pharmaceutical markets," Economics Working Papers 1033, Department of Economics and Business, Universitat Pompeu Fabra, revised Jul 2007.
  • Javier Coronado & Sergi Jiménez-Martín & Pedro L Marín, 2007. "Multimarket Contact in Pharmaceutical Markets," Working Papers 303, Barcelona School of Economics.
  • Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín, 2007. "Multimarket Contact in Pharmaceutical Markets," UFAE and IAE Working Papers 698.07, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC), revised 18 Jul 2007.
  • Javier Coronado & Sergi Jiménez Martín & Pedro L. Marín, 2008. "Multimarket Contact in Pharmaceutical Markets," Working Papers 2008-20, FEDEA.
• Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The determinants of pricing in pharmaceuticals: Are U.S. prices really higher than those of Canada?," Economics Working Papers 1032, Department of Economics and Business, Universitat Pompeu Fabra.
  • Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The Determinants of Pricing in Pharmaceuticals: Are U.S. prices really higher than those of Canada?," Working Papers 304, Barcelona School of Economics.
  • Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The Determinants of Pricing in Pharmaceuticals: Are U.S. Prices Really Higher than Those of Canada?," UFAE and IAE Working Papers 697.07, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC).
  • Jiménez-Martín, Sergi & Cabrales, Antonio, 2007. "The determinants of pricing in pharmaceuticals : are U.S. prices really higher than those of Canada?," UC3M Working papers. Economics we074021, Universidad Carlos III de Madrid. Departamento de Economía.
• Banri ITO & Tatsufumi YAMAGATA, 2007. "Who Develops Innovations In Medicine For The Poor? Trends In Patent Applications Related To Medicines For Hiv/Aids, Tuberculosis, Malaria, And Neglected Diseases," The Developing Economies, Institute of Developing Economies, vol. 45(2), pages 141-171, June.
  • Ito, Banri & Yamagata, Tatsufumi, 2005. "Who Develops Innovations in Medicine for the Poor? Trends in Patent Applications Related to Medicines for HIV/AIDS, Tuberculosis, Malaria and Neglected Diseases," IDE Discussion Papers 24, Institute of Developing Economies, Japan External Trade Organization(JETRO).
• Pedro L. Marín & Georges Siotis, 2007. "Innovation And Market Structure: An Empirical Evaluation Of The ‘Bounds Approach’ In The Chemical Industry," Journal of Industrial Economics, Wiley Blackwell, vol. 55(1), pages 93-111, March.
  • Siotis, Georges & Marín Uribe, Pedro Luis, 2002. "Innovation and Market Structure: An Empirical Evaluation of the 'Bounds Approach' in the Chemical Industry," CEPR Discussion Papers 3162, C.E.P.R. Discussion Papers.
• Gautier Duflos & Étienne Pfister, 2007. "Les déterminants des fusions-acquisitions. Le cas de l'industrie pharmaceutique," Revue économique, Presses de Sciences-Po, vol. 58(3), pages 577-586.
• Antoine Bureth & Moritz Müller & Julien Pénin & Sandrine Wolf, 2007. "Brevet, innovation modulaire et collaboration. Le cas des vaccins géniques," Revue d'économie industrielle, De Boeck Université, vol. 0(4), pages 8-8.
  • Antoine Bureth & Moritz Mueller & Julien Pénin & Sandrine Wolff, 2007. "Brevet, innovation modulaire et collaboration : Le cas des vaccins géniques," Working Papers of BETA 2007-22, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg.
• Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2015. "Openness, Inequality and Poverty: Endowments Matter," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 20, pages 497-532, World Scientific Publishing Co. Pte. Ltd..
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Openness, inequality and poverty: Endowments matter," The Journal of International Trade & Economic Development, Taylor & Francis Journals, vol. 17(3), pages 343-378.
  • Gourdon, Julien & Maystre, Nicolas & de Melo, Jaime, 2006. "Openness, inequality, and poverty : endowments matter," Policy Research Working Paper Series 3981, The World Bank.
  • Julien Gourdon & Jaime de Melo & Nicolas Maystre, 2008. "Openness, Inequality and Poverty: Endowment Matter?," Post-Print hal-00348921, HAL.
  • Jaime MELO DE & Julien GOURDON & Nicolas MAYSTRE, 2007. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers 200711, CERDI.
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Opennes, Inequality, and Poverty: Endowments Matter," Development Working Papers 239, Centro Studi Luca d'Agliano, University of Milano.
  • de Melo, Jaime & Gourdon, Julien & Maystre, Nicolas, 2006. "Openness, Inequality and Poverty: Endowments Matter," CEPR Discussion Papers 5738, C.E.P.R. Discussion Papers.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers halshs-00557112, HAL.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," CERDI Working papers halshs-00557112, HAL.
• Brekke, Kurt R. & Grasdal, Astrid L. & Holms, Tor Helge, 2009. "Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?," European Economic Review, Elsevier, vol. 53(2), pages 170-185, February.
  • Brekke, Kurt R. & Grasdal, Astrid L. & Holmås, Tor Helge, 2006. "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?," Working Papers in Economics 14/06, University of Bergen, Department of Economics.
  • Kurt R. Brekke & Astrid L. Grasdal & Tor Helge Holmås, 2007. "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?," CESifo Working Paper Series 2059, CESifo.
• Michael Reinhard & Hans Schedl & Achim Buchwald & Ralph Henger, 2007. "Positionierung der deutschen Industrie im globalen Konsolidierungsprozess : im Auftrag des Bundesministeriums für Wirtschaft und Technologie," ifo Forschungsberichte, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, number 36, September.
• Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The determinants of pricing in pharmaceuticals: Are U.S. prices really higher than those of Canada?," Economics Working Papers 1032, Department of Economics and Business, Universitat Pompeu Fabra.
  • Jiménez-Martín, Sergi & Cabrales, Antonio, 2007. "The determinants of pricing in pharmaceuticals : are U.S. prices really higher than those of Canada?," UC3M Working papers. Economics we074021, Universidad Carlos III de Madrid. Departamento de Economía.
  • Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The Determinants of Pricing in Pharmaceuticals: Are U.S. Prices Really Higher than Those of Canada?," UFAE and IAE Working Papers 697.07, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC).
  • Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The Determinants of Pricing in Pharmaceuticals: Are U.S. prices really higher than those of Canada?," Working Papers 304, Barcelona School of Economics.
• García-Alonso, M. D. C. & Garcia-Marinoso, B., 2007. "The strategic interaction between firms and formulary committees: effects on the prices of new drugs," Working Papers 07/16, Department of Economics, City University London.
• Oleg Badunenko, 2007. "Downsizing in German Chemical Manufacturing Industry during the 1990s: Why Small Is Beautiful?," Discussion Papers of DIW Berlin 722, DIW Berlin, German Institute for Economic Research.
• Sachin Chaturvedi, 2007. "Indian Innovation Systems and Emergence of Biopharmaceutical Sector : Issues and Prospects," Development Economics Working Papers 22090, East Asian Bureau of Economic Research.
• Balaguer, Jacint & Orts, Vicente & Uriel, Ezequiel, 2007. "Testing price-fixing agreements in a multimarket context: The European case of vitamin C," International Review of Law and Economics, Elsevier, vol. 27(2), pages 245-257.
• Brekke, Kurt R. & Konigbauer, Ingrid & Straume, Odd Rune, 2007. "Reference pricing of pharmaceuticals," Journal of Health Economics, Elsevier, vol. 26(3), pages 613-642, May.
  • Brekke, Kurt R & Königbauer, Ingrid & Straume, Odd Rune, 2005. "Reference Pricing of Pharmaceuticals," Working Papers in Economics 19/05, University of Bergen, Department of Economics.
  • Kurt R. Brekke & Ingrid Königbauer & Odd Rune Straume, 2006. "Reference Pricing of Pharmaceuticals," CESifo Working Paper Series 1825, CESifo.
• Steven Klepper, 2007. "The Evolution of Geographic Structure in New Industries," Chapters, in: Koen Frenken (ed.), Applied Evolutionary Economics and Economic Geography, chapter 4, Edward Elgar Publishing.
  • Steven Klepper, 2006. "The Evolution of Geographic Structure in New Industries," Revue de l'OFCE, Presses de Sciences-Po, vol. 97(5), pages 135-158.
• Bergmann, Manfred & Schmitz, Andreas & Hayden, Mark & Kosonen, Katri, 2007. "Imposing a unilateral carbon constraint on European energy-intensive industries and its impact on their international competitiveness - data & analysis," MPRA Paper 9563, University Library of Munich, Germany.
  • Manfred Bergmann & Andreas Schmitz & Mark Hayden & Katri Kosonen, 2007. "Imposing a unilateral carbon constraint on European energy-intensive industries and its impact on their international competitiveness - data & analysis," European Economy - Economic Papers 2008 - 2015 298, Directorate General Economic and Financial Affairs (DG ECFIN), European Commission.
• Michel Trommetter, 2010. "Flexibility in the implementation of intellectual property rights in agricultural biotechnology," European Journal of Law and Economics, Springer, vol. 30(3), pages 223-245, December.
  • Trommetter, M., 2007. "Flexibility in the implementation of intellectual property rights in agricultural biotechnology," Working Papers 200708, Grenoble Applied Economics Laboratory (GAEL).
• Vanessa Oltra & Maïder Saint Jean, 2007. "Incrementalism of environmental innovations versus paradigmatic change: a comparative study of the automotive and chemical industries," Post-Print hal-00155039, HAL.
  • Vanessa OLTRA (GREThA-GRES) & Maïder SAINT JEAN (GREThA-GRES), 2007. "Incrementalism of environmental innovations versus paradigmatic change: A comparative study of the automotive and chemical industries," Cahiers du GRES (2002-2009) 2007-19, Groupement de Recherches Economiques et Sociales.
  • Vanessa OLTRA & Maïder SAINT JEAN, 2007. "Incrementalism of environmental innovations versus paradigmatic change: A comparative study of the automotive and chemical industries," Cahiers du GREThA (2007-2019) 2007-14, Groupe de Recherche en Economie Théorique et Appliquée (GREThA).
• Vanessa Oltra & Maïder Saint Jean, 2007. "Incrementalism of environmental innovations versus paradigmatic change: a comparative study of the automotive and chemical industries," Post-Print hal-00155039, HAL.
  • Vanessa OLTRA & Maïder SAINT JEAN, 2007. "Incrementalism of environmental innovations versus paradigmatic change: A comparative study of the automotive and chemical industries," Cahiers du GREThA (2007-2019) 2007-14, Groupe de Recherche en Economie Théorique et Appliquée (GREThA).
  • Vanessa OLTRA (GREThA-GRES) & Maïder SAINT JEAN (GREThA-GRES), 2007. "Incrementalism of environmental innovations versus paradigmatic change: A comparative study of the automotive and chemical industries," Cahiers du GRES (2002-2009) 2007-19, Groupement de Recherches Economiques et Sociales.
• Vanessa OLTRA (GREThA-GRES) & Maïder SAINT JEAN (GREThA-GRES), 2007. "Incrementalism of environmental innovations versus paradigmatic change: A comparative study of the automotive and chemical industries," Cahiers du GRES (2002-2009) 2007-19, Groupement de Recherches Economiques et Sociales.
  • Vanessa Oltra & Maïder Saint Jean, 2007. "Incrementalism of environmental innovations versus paradigmatic change: a comparative study of the automotive and chemical industries," Post-Print hal-00155039, HAL.
  • Vanessa OLTRA & Maïder SAINT JEAN, 2007. "Incrementalism of environmental innovations versus paradigmatic change: A comparative study of the automotive and chemical industries," Cahiers du GREThA (2007-2019) 2007-14, Groupe de Recherche en Economie Théorique et Appliquée (GREThA).
• Granlund, David & Rudholm, Niklas, 2007. "Consumer Information and Pharmaceutical Prices: Theory and Evidence," HUI Working Papers 8, HUI Research.
• Granlund, David & Rudholm, Niklas, 2007. "Consumer Information and Pharmaceutical Prices: Theory and Evidence," Umeå Economic Studies 709, Umeå University, Department of Economics.
• Granlund, David, 2007. "Economic Policy in Health Care: Sickness Absence and Pharmaceutical Cost," Umeå Economic Studies 710, Umeå University, Department of Economics.
• Enrico Santarelli & Francesca Lotti, 2007. "The Relationship among innovative Output, Productivity, and Profitability. A test comparing USPTO and EPO data," Jena Economics Research Papers 2007-020, Friedrich-Schiller-University Jena.
• Finn Valentin & Rasmus Jensen, 2007. "Effects on academia-industry collaboration of extending university property rights," The Journal of Technology Transfer, Springer, vol. 32(3), pages 251-276, June.
• Paul Grootendorst, 2007. "Effects of 'Authorized-Generics' on Canadian Drug Prices," Social and Economic Dimensions of an Aging Population Research Papers 201, McMaster University.
• Glenn Ellison & Sara Fisher Ellison, 2011. "Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration," American Economic Journal: Microeconomics, American Economic Association, vol. 3(1), pages 1-36, February.
  • Glenn Ellison & Sara Fisher Ellison, 2007. "Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration," NBER Working Papers 13069, National Bureau of Economic Research, Inc.
• Joseph H. Golec & John A. Vernon, 2007. "Financial Risk in the Biotechnology Industry," NBER Working Papers 13604, National Bureau of Economic Research, Inc.
• Olivier Cadot & Jaime de Melo, 2015. "Why OECD Countries Should Reform Rules of Origin," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 16, pages 381-409, World Scientific Publishing Co. Pte. Ltd..
  • Olivier Cadot & Jaime de Melo, 2007. "Why OECD Countries Should Reform Rules of Origin," The World Bank Research Observer, World Bank, vol. 23(1), pages 77-105, October.
  • de Melo, Jaime & Cadot, Olivier, 2007. "Why OECD Countries should Reform Rules of Origin," CEPR Discussion Papers 6172, C.E.P.R. Discussion Papers.
• Kitsak, Maksim & Havlin, Shlomo & Paul, Gerald & Riccaboni, Massimo & Pammolli, Fabio & Stanley, H. Eugene, 2007. "Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks," MPRA Paper 15907, University Library of Munich, Germany.
• Manfred Bergmann & Andreas Schmitz & Mark Hayden & Katri Kosonen, 2007. "Imposing a unilateral carbon constraint on European energy-intensive industries and its impact on their international competitiveness - data & analysis," European Economy - Economic Papers 2008 - 2015 298, Directorate General Economic and Financial Affairs (DG ECFIN), European Commission.
  • Bergmann, Manfred & Schmitz, Andreas & Hayden, Mark & Kosonen, Katri, 2007. "Imposing a unilateral carbon constraint on European energy-intensive industries and its impact on their international competitiveness - data & analysis," MPRA Paper 9563, University Library of Munich, Germany.
• Hermans, Raine & Kulvik, Martti, 2007. "Simulaatio lääkekehitysalan kannattavuudesta ja riskeistä," Discussion Papers 1075, The Research Institute of the Finnish Economy.
• Brusoni, Stefano, 2007. "Managing the Uneven Evolution of Know-How. Engineering Design as "Social technology"," European Journal of Economic and Social Systems, Lavoisier, vol. 20(2), pages 147-162.
• Bureth, Antoine & Pénin, Julien, 2007. "Modular Innovations and Distributed Processes. The Case of Genetically Engineered Vaccines," European Journal of Economic and Social Systems, Lavoisier, vol. 20(2), pages 251-273.
• Sonja Kind & Dodo zu Knyphausen-Aufseß, 2007. "What is "Business Development"? - The Case of Biotechnology," Schmalenbach Business Review (sbr), LMU Munich School of Management, vol. 59(2), pages 176-199, April.
• Marina Geenhuizen, 2007. "Modelling dynamics of knowledge networks and local connectedness: a case study of urban high-tech companies in The Netherlands," The Annals of Regional Science, Springer;Western Regional Science Association, vol. 41(4), pages 813-833, December.
• Sergey V. Buldyrev & Jakub Growiec & Fabio Pammolli & Massimo Riccaboni & H. Eugene Stanley, 2007. "The Growth of Business Firms: Facts and Theory," Journal of the European Economic Association, MIT Press, vol. 5(2-3), pages 574-584, 04-05.
• Claudio Bravo-Ortega & Manuel Agosin Trumper, 2007. "The Emergence Of New Successful Export Activities In Latin America: The Case Of Chile," Working Papers wp236, University of Chile, Department of Economics.
  • Manuel Agosin & Claudio Bravo-Ortega, 2009. "The Emergence of New Successful Export Activities in Latin America: The Case of Chile," Research Department Publications 3265, Inter-American Development Bank, Research Department.
  • Agosin, Manuel R. & Bravo Ortega, Claudio, 2009. "The Emergence of New Successful Export Activities in Latin America: The Case of Chile," IDB Publications (Working Papers) 3716, Inter-American Development Bank.
• Michele Snoeck & Carlos Casacuberta & Rosario Domingo & Héctor Pastori & Lucía Pittaluga, 2007. "The Emergence of new Successful Export Activities in Uruguay," Documentos de Trabajo (working papers) 0908, Department of Economics - dECON.
• Antoine Bureth & Moritz Müller & Julien Pénin & Sandrine Wolf, 2007. "Brevet, innovation modulaire et collaboration. Le cas des vaccins géniques," Revue d'économie industrielle, De Boeck Université, vol. 0(4), pages 8-8.
  • Antoine Bureth & Moritz Mueller & Julien Pénin & Sandrine Wolff, 2007. "Brevet, innovation modulaire et collaboration : Le cas des vaccins géniques," Working Papers of BETA 2007-22, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg.
• Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué, 2007. "Generic entry into a regulated pharmaceutical market," Working Papers, Research Center on Health and Economics 1014, Department of Economics and Business, Universitat Pompeu Fabra.
  • Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué, 2007. "Generic entry into a regulated pharmaceutical market," Economics Working Papers 1014, Department of Economics and Business, Universitat Pompeu Fabra.
• Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The Determinants of Pricing in Pharmaceuticals: Are U.S. prices really higher than those of Canada?," Working Papers 304, Barcelona School of Economics.
  • Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The determinants of pricing in pharmaceuticals: Are U.S. prices really higher than those of Canada?," Economics Working Papers 1032, Department of Economics and Business, Universitat Pompeu Fabra.
  • Antonio Cabrales & Sergi Jiménez-Martín, 2007. "The Determinants of Pricing in Pharmaceuticals: Are U.S. Prices Really Higher than Those of Canada?," UFAE and IAE Working Papers 697.07, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC).
  • Jiménez-Martín, Sergi & Cabrales, Antonio, 2007. "The determinants of pricing in pharmaceuticals : are U.S. prices really higher than those of Canada?," UC3M Working papers. Economics we074021, Universidad Carlos III de Madrid. Departamento de Economía.
• Javier Coronado & Sergi Jiménez-Martín & Pedro L Marín, 2007. "Multimarket Contact in Pharmaceutical Markets," Working Papers 303, Barcelona School of Economics.
  • Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín, 2007. "Multimarket contact in pharmaceutical markets," Economics Working Papers 1033, Department of Economics and Business, Universitat Pompeu Fabra, revised Jul 2007.
  • Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín, 2007. "Multimarket Contact in Pharmaceutical Markets," UFAE and IAE Working Papers 698.07, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC), revised 18 Jul 2007.
  • Javier Coronado & Sergi Jiménez Martín & Pedro L. Marín, 2008. "Multimarket Contact in Pharmaceutical Markets," Working Papers 2008-20, FEDEA.
• Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué, 2007. "Generic entry into a regulated pharmaceutical market," Economics Working Papers 1014, Department of Economics and Business, Universitat Pompeu Fabra.
  • Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué, 2007. "Generic entry into a regulated pharmaceutical market," Working Papers, Research Center on Health and Economics 1014, Department of Economics and Business, Universitat Pompeu Fabra.
• Edward Christie & Gabor Hunya & Waltraut Urban, 2007. "Restructuring of Energy-intensive Industrial Branches in Romania and Proposals for Industrial Policy Measures," wiiw Research Reports 339, The Vienna Institute for International Economic Studies, wiiw.
• David Reiffen & Michael R. Ward, 2007. "'Branded Generics' as a strategy to limit cannibalization of pharmaceutical markets," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 251-265.
  • Michael R. Ward & David Reiffen, 2005. "“Branded Generics” As A Strategy To Limit Cannibalization Of Pharmaceutical Markets," Working Papers 0502, University of Texas at Arlington, Department of Economics.
• Frank R. Lichtenberg & Suchin Virabhak, 2007. "Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as 'Equipment for Your Health'," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 371-392.
  • Frank R. Lichtenberg & Suchin Virabhak, 2002. "Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health"," NBER Working Papers 9351, National Bureau of Economic Research, Inc.
• Frank R. Lichtenberg, 2007. "Benefits and costs of newer drugs: an update," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 485-490.
  • Frank Lichtenberg, 2002. "Benefits and Costs of Newer Drugs: An Update," NBER Working Papers 8996, National Bureau of Economic Research, Inc.
• Andrew A. Toole & Dirk Czarnitzki, 2009. "Exploring the Relationship Between Scientist Human Capital and Firm Performance: The Case of Biomedical Academic Entrepreneurs in the SBIR Program," Management Science, INFORMS, vol. 55(1), pages 101-114, January.
  • Czarnitzki, Dirk & Toole, Andrew A., 2007. "Exploring the relationship between scientist human capital and firm performance: The case of biomedical academic entrepreneurs in the SBIR program," ZEW Discussion Papers 07-011, ZEW - Leibniz Centre for European Economic Research.

2006

• Finn Valentin & Henrich Dahlgren & Rasmus Lund Jensen, 2006. "Research Strategies in Science-based Start-ups - Effects on performance in Danish and Swedish biotechnology," DRUID Working Papers 06-11, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
• Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn, 2006. "Did Medicare Induce Pharmaceutical Innovation?," American Economic Review, American Economic Association, vol. 96(2), pages 103-107, May.
  • Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn, 2006. "Did Medicare Induce Pharmaceutical Innovation?," NBER Working Papers 11949, National Bureau of Economic Research, Inc.
  • Acemoglu, Daron & Finkelstein, Amy & Cutler, David & Linn, Joshua, 2006. "Did Medicare Induce Pharmaceutical Innovation?," Scholarly Articles 2664267, Harvard University Department of Economics.
• Buldyrev, Sergey V. & Pammolli, Fabio & Riccaboni, Massimo & Yamasaki, Kazuko & Fu, Dongfeng & Matia, Kaushik & Stanley, H. Eugene, 2006. "A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment," MPRA Paper 15980, University Library of Munich, Germany.
  • S. V. Buldyrev & F. Pammolli & M. Riccaboni & K. Yamasaki & D. Fu & K. Matia & H. E. Stanley, 2006. "A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment," Papers physics/0609020, arXiv.org.
• Aoki, Reiko & Kubo, Kensuke & Yamane, Hiroko, 2006. "Indian Patent Policy and Publich Health : implications from the Japanese Experience," IDE Discussion Papers 57, Institute of Developing Economies, Japan External Trade Organization(JETRO).
  • Aoki, Reiko & Kubo, Kensuke & Yamane, Hiroko, 2006. "Indian Patent Policy and Public Health:Implications from the Japanese Experience," Working Papers 199, Department of Economics, The University of Auckland.
• Steven Klepper, 2007. "The Evolution of Geographic Structure in New Industries," Chapters, in: Koen Frenken (ed.), Applied Evolutionary Economics and Economic Geography, chapter 4, Edward Elgar Publishing.
  • Steven Klepper, 2006. "The Evolution of Geographic Structure in New Industries," Revue de l'OFCE, Presses de Sciences-Po, vol. 97(5), pages 135-158.
• Thomas Grebel & Jackie Krafft & Pier-Paolo Saviotti, 2006. "On the Life Cycle of Knowledge Intensive Sectors," Revue de l'OFCE, Presses de Sciences-Po, vol. 97(5), pages 63-85.
• Franco Malerba & Luigi Orsenigo & Sandrine Selosse, 2006. "Biotechnologies et industrie pharmaceutique. Un modèle évolutionnaire conforme à l'histoire," Revue de l'OFCE, Presses de Sciences-Po, vol. 96(1), pages 157-209.
• Lionel Nesta & Pier-Paolo Saviotti, 2006. "Intégration technologique et valeur boursière des firmes de biotechnologies," Revue de l'OFCE, Presses de Sciences-Po, vol. 96(1), pages 211-233.
• Paul Belleflamme & Tanguy van Ypersele, 2006. "Comment favoriser l'innovation dans le secteur pharmaceutique : brevets et/ou récompenses ?," Reflets et perspectives de la vie économique, De Boeck Université, vol. 0(4), pages 23-35.
  • BELLEFLAMME, Paul & van YPERSELE, Tanguy, 2006. "Comment favoriser l’innovation dans le secteur pharmaceutique: brevets et/ou récompenses ?," LIDAM Reprints CORE 1920, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
• Michel Trommetter, 2006. "La propriété intellectuelle dans les biotechnologies agricoles : quels enjeux pour quelles perspectives ?," Reflets et perspectives de la vie économique, De Boeck Université, vol. 0(4), pages 37-48.
  • Michel Trommetter, 2006. "La proprieté intellectuelle dans les biotechnologies agricoles : Quels enjeux pour quelles perspectives ?," Working Papers hal-00243036, HAL.
• Brekke, Kurt R. & Konigbauer, Ingrid & Straume, Odd Rune, 2007. "Reference pricing of pharmaceuticals," Journal of Health Economics, Elsevier, vol. 26(3), pages 613-642, May.
  • Brekke, Kurt R & Königbauer, Ingrid & Straume, Odd Rune, 2005. "Reference Pricing of Pharmaceuticals," Working Papers in Economics 19/05, University of Bergen, Department of Economics.
  • Kurt R. Brekke & Ingrid Königbauer & Odd Rune Straume, 2006. "Reference Pricing of Pharmaceuticals," CESifo Working Paper Series 1825, CESifo.
• Emilio J. Archila & Gabriel Carrasquilla & Marcela Meléndez & Juan Pablo Uribe, 2006. "Estudio sobre la propiedad intelectual en el sector farmacéutico colombiano," Cuadernos de Fedesarrollo 12708, Fedesarrollo.
  • Emilio Archila & Gabriel Carrasquilla & Marcela Meléndez & Juan Pablo Uribe, 2006. "Estudio sobre la propiedad intelectual en el sector farmacéutico colombiano," Informes de Investigación 2622, Fedesarrollo.
• Emilio Archila & Gabriel Carrasquilla & Marcela Meléndez & Juan Pablo Uribe, 2006. "Estudio sobre la propiedad intelectual en el sector farmacéutico colombiano," Informes de Investigación 2622, Fedesarrollo.
  • Emilio J. Archila & Gabriel Carrasquilla & Marcela Meléndez & Juan Pablo Uribe, 2006. "Estudio sobre la propiedad intelectual en el sector farmacéutico colombiano," Cuadernos de Fedesarrollo 12708, Fedesarrollo.
• Genesove, David, 2006. "The Dye Famine and its Aftermath: Knowledge Diffusion and Entry," CEPR Discussion Papers 5890, C.E.P.R. Discussion Papers.
• Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2008. "Allocative efficiency measurement revisited--Do we really need input prices?," Economic Modelling, Elsevier, vol. 25(5), pages 1093-1109, September.
  • Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2006. "Allocative efficiency measurement revisited: do we really need input prices?," Freiberg Working Papers 2006/04, TU Bergakademie Freiberg, Faculty of Economics and Business Administration.
  • Oleg Badunenko & Michael Fritsch & Andreas Stephan, 2006. "Allocative Efficiency Measurement Revisited: Do We Really Need Input Prices?," Discussion Papers of DIW Berlin 591, DIW Berlin, German Institute for Economic Research.
  • Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2006. "Allocative efficiency measurement revisited: Do we really need input prices?," Working Paper Series 2006,7, European University Viadrina Frankfurt (Oder), The Postgraduate Research Programme Capital Markets and Finance in the Enlarged Europe.
• Annika Bergman, 2006. "FDI and Spillover Effects in the Indian Pharmaceutical Industry," Finance Working Papers 22084, East Asian Bureau of Economic Research.
• Brekke, Kurt R. & Kuhn, Michael, 2006. "Direct to consumer advertising in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 25(1), pages 102-130, January.
  • Kurt R Brekke & Michael Kuhn, "undated". "Direct-to-Consumer Advertising in Pharmaceutical Markets," Discussion Papers 03/11, Department of Economics, University of York.
  • Kurt R. Brekke & Michael Kuhn, 2005. "Direct to Consumer Advertising in Pharmaceutical Markets," CESifo Working Paper Series 1493, CESifo.
  • Brekke, Kurt R. & Kuhn, Michael, 2003. "Direct-to-Consumer Advertising in Pharmaceutical Markets," Working Papers in Economics 05/03, University of Bergen, Department of Economics.
• Céline Carrère & Jaime de Melo, 2015. "Are Different Rules of Origin Equally Costly? Estimates from NAFTA," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 12, pages 277-298, World Scientific Publishing Co. Pte. Ltd..
  • Céline CARRERE & Jaime MELO DE, 2004. "Are Different Rules of Origin Equally Costly? Estimates from NAFTA," Working Papers 200412, CERDI.
  • Céline Carrere & Olivier Cadot, 2006. "Are different Rules of Origin Equally Costly? Estimates from NAFTA," Post-Print hal-00130079, HAL.
  • de Melo, Jaime & Carrère, Céline, 2004. "Are Different Rules of Origin Equally Costly? Estimates from NAFTA," CEPR Discussion Papers 4437, C.E.P.R. Discussion Papers.
• Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff, 2005. "Strategic Reasons for Patenting: Between Exclusion and Coordination Rationales," Rivista di Politica Economica, SIPI Spa, vol. 95(5), pages 19-46, September.
  • Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff, 2006. "Strategic Reasons for Patenting : Between Exclusion and Coordination Rationales," Post-Print hal-00279139, HAL.
  • Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff, 2008. "Strategic Reasons for Patenting : Between Exclusion and Coordination Rationales," Post-Print hal-00279475, HAL.
• Marc-Hubert Depret & Abdelillah Hamdouch, 2004. "La gouvernance des jeunes entreprises innovantes:un éclairage analytique à partir du cas des sociétés de biotechnologies," Revue Finance Contrôle Stratégie, revues.org, vol. 7(2), pages 67-94, June.
  • Marc-Hubert Depret & Abdellilah Hamdouch, 2004. "La gouvernance des jeunes entreprises innovantes : un éclairage analytique à partir du cas des sociétés de biotechnologies," Post-Print halshs-00006702, HAL.
  • Marc-Hubert Depret & Abdelillah Hamdouch, 2006. "La gouvernance des jeunes entreprises innovantes : Un éclairage analytique a partir du cas des sociétés de biotechnologies," Post-Print hal-00279284, HAL.
• Michel Trommetter, 2006. "La propriété intellectuelle dans les biotechnologies agricoles : quels enjeux pour quelles perspectives ?," Reflets et perspectives de la vie économique, De Boeck Université, vol. 0(4), pages 37-48.
  • Michel Trommetter, 2006. "La proprieté intellectuelle dans les biotechnologies agricoles : Quels enjeux pour quelles perspectives ?," Working Papers hal-00243036, HAL.
• Brekke, Kurt R. & Grasdal, Astrid L. & Holms, Tor Helge, 2009. "Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?," European Economic Review, Elsevier, vol. 53(2), pages 170-185, February.
  • Brekke, Kurt R. & Grasdal, Astrid L. & Holmås, Tor Helge, 2006. "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?," Working Papers in Economics 14/06, University of Bergen, Department of Economics.
  • Kurt R. Brekke & Astrid L. Grasdal & Tor Helge Holmås, 2007. "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?," CESifo Working Paper Series 2059, CESifo.
• Eliasson, Gunnar & Eliasson, Åsa, 2006. "The Pharmacia Story of Entrepreneurship and as a Creative Technical University - An Experiment in Innovation, Organizational Break Up and Industrial Renaissance," Ratio Working Papers 97, The Ratio Institute.
• Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn, 2006. "Did Medicare Induce Pharmaceutical Innovation?," American Economic Review, American Economic Association, vol. 96(2), pages 103-107, May.
  • Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn, 2006. "Did Medicare Induce Pharmaceutical Innovation?," NBER Working Papers 11949, National Bureau of Economic Research, Inc.
  • Acemoglu, Daron & Finkelstein, Amy & Cutler, David & Linn, Joshua, 2006. "Did Medicare Induce Pharmaceutical Innovation?," Scholarly Articles 2664267, Harvard University Department of Economics.
• Aoki, Reiko & Kubo, Kensuke & Yamane, Hiroko, 2006. "Indian Patent Policy and Public Health:Implications from the Japanese Experience," Working Papers 199, Department of Economics, The University of Auckland.
  • Aoki, Reiko & Kubo, Kensuke & Yamane, Hiroko, 2006. "Indian Patent Policy and Publich Health : implications from the Japanese Experience," IDE Discussion Papers 57, Institute of Developing Economies, Japan External Trade Organization(JETRO).
• Jörg Mahlich & Thomas Roediger-Schluga, 2006. "The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 28(2), pages 145-164, March.
  • Mahlich, Jörg C. & Roediger-Schluga, Thomas, 2006. "The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan," MERIT Working Papers 2006-015, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Simeon Schudy, 2006. "Jüngere Entwicklungen auf dem Risikokapitalmarkt für Biotechnologie in Deutschland," Kiel Working Papers 1270, Kiel Institute for the World Economy.
• Helga De Doncker, 2006. "R&D in the Belgian Pharmaceutical Sector," Working Paper Document 106, National Bank of Belgium.
• Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn, 2006. "Did Medicare Induce Pharmaceutical Innovation?," American Economic Review, American Economic Association, vol. 96(2), pages 103-107, May.
  • Acemoglu, Daron & Finkelstein, Amy & Cutler, David & Linn, Joshua, 2006. "Did Medicare Induce Pharmaceutical Innovation?," Scholarly Articles 2664267, Harvard University Department of Economics.
  • Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn, 2006. "Did Medicare Induce Pharmaceutical Innovation?," NBER Working Papers 11949, National Bureau of Economic Research, Inc.
• Beata Javorcik & Wolfgang Keller & James Tybout, 2008. "Openness and Industrial Response in a Wal‐Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers," The World Economy, Wiley Blackwell, vol. 31(12), pages 1558-1580, December.
  • Tybout, James & Keller, Wolfgang & Javorcik, Beata, 2006. "Openness and Industrial Response in a Wal-Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers," CEPR Discussion Papers 5823, C.E.P.R. Discussion Papers.
  • Beata Smarzynska Javorcik & Wolfgang Keller & James R. Tybout, 2006. "Openness and Industrial Responses in a Wal-Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers," NBER Working Papers 12457, National Bureau of Economic Research, Inc.
  • Javorcik, Beata & Keller, Wolfgang & Tybout, James, 2006. "Openness and industrial response in a Wal-Mart world : a case study of Mexican soaps, detergents, and surfactant producers," Policy Research Working Paper Series 3999, The World Bank.
• Jeffrey Furman & Margaret K. Kyle & Alain Cockburn & Rebecca M. Henderson, 2005. "Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research," Annals of Economics and Statistics, GENES, issue 79-80, pages 165-188.
  • Jeffrey L. Furman & Margaret K. Kyle & Iain M. Cockburn & Rebecca Henderson, 2006. "Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research," NBER Working Papers 12509, National Bureau of Economic Research, Inc.
• Jaya Prakash Pradhan & Abhinav Alakshendra, "undated". "Overseas Acquisition Versus Greenfield Foreign Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises?," Working Papers 0607, Institute for Studies in Industrial Development (ISID).
  • Pradhan, Jaya Prakash & Alakshendra, Abhinav, 2006. "Overseas Acquisition versus Greenfield Foreign Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises?," MPRA Paper 12339, University Library of Munich, Germany.
• Jaya Prakash Pradhan, "undated". "Global competitiveness of Indian Pharmaceutical Industry: Trends and Strategies," Working Papers 0605, Institute for Studies in Industrial Development (ISID).
  • Pradhan, Jaya Prakash, 2006. "Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies," MPRA Paper 12340, University Library of Munich, Germany.
• S. V. Buldyrev & F. Pammolli & M. Riccaboni & K. Yamasaki & D. Fu & K. Matia & H. E. Stanley, 2006. "A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment," Papers physics/0609020, arXiv.org.
  • Buldyrev, Sergey V. & Pammolli, Fabio & Riccaboni, Massimo & Yamasaki, Kazuko & Fu, Dongfeng & Matia, Kaushik & Stanley, H. Eugene, 2006. "A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment," MPRA Paper 15980, University Library of Munich, Germany.
• Fabio Pammolli & Dongfeng Fu & S. V. Buldyrev & Massimo Riccaboni & Kaushik Matia & Kazuko Yamasaki & H. E. Stanley, 2006. "A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence," Papers physics/0609011, arXiv.org.
  • Pammolli, Fabio & Fu, Dongfeng & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene, 2006. "A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence," MPRA Paper 15983, University Library of Munich, Germany.
• Havas, Attila, 2006. "Private Sector R&D in the New Member States: Hungary," MPRA Paper 55786, University Library of Munich, Germany.
• Hernesniemi, Hannu & Kulvik, Martti, 2006. "Helsingin seudun klusterit sekä erikoistuminen bioteknologiaan ja logistiikkaan," Discussion Papers 1013, The Research Institute of the Finnish Economy.
• Maunula, Mari, 2006. "The Perceived Value-added of Venture Capital Investors. Evidence from Finnish Biotechnology Industry," Discussion Papers 1030, The Research Institute of the Finnish Economy.
• Terttu Luukkonen, & Mari Maunula,, 2006. "Coaching Small Biotech Companies into Success: The Value-adding Function of VC," Discussion Papers 1032, The Research Institute of the Finnish Economy.
• Kulvik, Martti & Linnosmaa, Ismo & Hermans, Raine, 2006. "Adaption of New Technologies and Costs of Health Care," Discussion Papers 1037, The Research Institute of the Finnish Economy.
• Luukkonen, Terttu & Maunula, Mari, 2006. "Riskirahoituksen merkitys biotekniikka-alalla: Pääomasijoittajien vertailu yritysten näkökulmasta," Discussion Papers 1057, The Research Institute of the Finnish Economy.
• Isamel Rafols & Martin Meyer, 2006. "Knowledge-sourcing strategies for cross-disciplinarity in bionanotechnology," SPRU Working Paper Series 152, SPRU - Science Policy Research Unit, University of Sussex Business School.
• Gehl Sampath, Padmashree, 2006. "Breaking the Fence: Patent Rights and Biomedical Innovation in 'Technology Followers'," MERIT Working Papers 2006-008, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Jörg Mahlich & Thomas Roediger-Schluga, 2006. "The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 28(2), pages 145-164, March.
  • Mahlich, Jörg C. & Roediger-Schluga, Thomas, 2006. "The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan," MERIT Working Papers 2006-015, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Gehl Sampath, Padmashree, 2006. "India's product patent protection regime: Less or more of "pills for the poor"?," MERIT Working Papers 2006-019, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Oyelaran-Oyeyinka, Banji & Gehl Sampath, Padmashree, 2006. "Rough Road to Market: Institutional Barriers to Innovations in Africa," MERIT Working Papers 2006-026, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Gehl Sampath, Padmashree, 2006. "Indian Pharma Within Global Reach?," MERIT Working Papers 2006-031, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
• Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2015. "Openness, Inequality and Poverty: Endowments Matter," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 20, pages 497-532, World Scientific Publishing Co. Pte. Ltd..
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Openness, inequality and poverty: Endowments matter," The Journal of International Trade & Economic Development, Taylor & Francis Journals, vol. 17(3), pages 343-378.
  • de Melo, Jaime & Gourdon, Julien & Maystre, Nicolas, 2006. "Openness, Inequality and Poverty: Endowments Matter," CEPR Discussion Papers 5738, C.E.P.R. Discussion Papers.
  • Julien Gourdon & Nicolas Maystre & Jaime de Melo, 2008. "Opennes, Inequality, and Poverty: Endowments Matter," Development Working Papers 239, Centro Studi Luca d'Agliano, University of Milano.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," CERDI Working papers halshs-00557112, HAL.
  • Jaime MELO DE & Julien GOURDON & Nicolas MAYSTRE, 2007. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers 200711, CERDI.
  • Julien Gourdon & Jaime de Melo & Nicolas Maystre, 2008. "Openness, Inequality and Poverty: Endowment Matter?," Post-Print hal-00348921, HAL.
  • Gourdon, Julien & Maystre, Nicolas & de Melo, Jaime, 2006. "Openness, inequality, and poverty : endowments matter," Policy Research Working Paper Series 3981, The World Bank.
  • Julien Gourdon & Nicolas Maystre & Jaime Melo De, 2011. "Openness, Inequality, and Poverty: Endowments Matter," Working Papers halshs-00557112, HAL.
• Beata Javorcik & Wolfgang Keller & James Tybout, 2008. "Openness and Industrial Response in a Wal‐Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers," The World Economy, Wiley Blackwell, vol. 31(12), pages 1558-1580, December.
  • Beata Smarzynska Javorcik & Wolfgang Keller & James R. Tybout, 2006. "Openness and Industrial Responses in a Wal-Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers," NBER Working Papers 12457, National Bureau of Economic Research, Inc.
  • Javorcik, Beata & Keller, Wolfgang & Tybout, James, 2006. "Openness and industrial response in a Wal-Mart world : a case study of Mexican soaps, detergents, and surfactant producers," Policy Research Working Paper Series 3999, The World Bank.
  • Tybout, James & Keller, Wolfgang & Javorcik, Beata, 2006. "Openness and Industrial Response in a Wal-Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers," CEPR Discussion Papers 5823, C.E.P.R. Discussion Papers.
• Jean-Marie Grether & Nicole Andréa Mathys & Jaime de Melo, 2015. "Unravelling the Worldwide Pollution Haven Effect," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 23, pages 581-612, World Scientific Publishing Co. Pte. Ltd..
  • Jean-Marie Grether & Nicole Andr�a Mathys & Jaime de Melo, 2012. "Unravelling the worldwide pollution haven effect," The Journal of International Trade & Economic Development, Taylor & Francis Journals, vol. 21(1), pages 131-162, December.
  • Grether, Jean-Marie & Mathys, Nicole A. & de Melo, Jaime, 2006. "Unraveling the World-Wide Pollution Haven Effect," Economic Theory and Applications Working Papers 12186, Fondazione Eni Enrico Mattei (FEEM).
  • Grether, Jean-Marie & Mathys, Nicole A. & de Melo, Jaime, 2011. "Unravelling the Worldwide Pollution Haven Effect," Climate Change and Sustainable Development 119097, Fondazione Eni Enrico Mattei (FEEM).
  • Grether, Jean-Marie & Mathys, Nicole A. & de Melo, Jaime, 2006. "Unraveling the worldwide pollution haven effect," Policy Research Working Paper Series 4047, The World Bank.
  • Jean-Marie Grether & Nicole A. Mathys & Jaime de Melo, 2006. "Unraveling the World-Wide Pollution Haven Effect," Working Papers 2006.122, Fondazione Eni Enrico Mattei.
  • de Melo, Jaime & Grether, Jean-Marie & Mathys, Nicole Andréa, 2006. "Unravelling the World-Wide Pollution Haven Effect," CEPR Discussion Papers 5815, C.E.P.R. Discussion Papers.
  • Jean-Marie Grether & Nicole A. Mathys & Jaime de Melo, 2011. "Unravelling the Worldwide Pollution Haven Effect," Working Papers 2011.75, Fondazione Eni Enrico Mattei.
  • Jean-Marie GRETHER & Nicole A. MATHYS & Jaime DE MELO, 2012. "Unravelling the Worldwide Pollution Haven Effect," Working Papers P40, FERDI.
  • Jean-Marie GRETHER & Nicole A. MATHYS & Jaime DE MELO, 2012. "Unravelling the Worldwide Pollution Haven Effect," Working Papers P40, FERDI.
  • Jean-Marie GRETHER & Nicole A. MATHYS & Jaime DE MELO, 2006. "Unraveling the World-Wide Pollution Haven Effect," Cahiers de Recherches Economiques du Département d'économie 06.04, Université de Lausanne, Faculté des HEC, Département d’économie.
• Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2008. "Allocative efficiency measurement revisited--Do we really need input prices?," Economic Modelling, Elsevier, vol. 25(5), pages 1093-1109, September.
  • Oleg Badunenko & Michael Fritsch & Andreas Stephan, 2006. "Allocative Efficiency Measurement Revisited: Do We Really Need Input Prices?," Discussion Papers of DIW Berlin 591, DIW Berlin, German Institute for Economic Research.
  • Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2006. "Allocative efficiency measurement revisited: Do we really need input prices?," Working Paper Series 2006,7, European University Viadrina Frankfurt (Oder), The Postgraduate Research Programme Capital Markets and Finance in the Enlarged Europe.
  • Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2006. "Allocative efficiency measurement revisited: do we really need input prices?," Freiberg Working Papers 2006/04, TU Bergakademie Freiberg, Faculty of Economics and Business Administration.
• Neunteufel, Herbert & Rössel, Gottfried & Sassenberg, Uwe & Laske, Michael & Kipura, Janine & Brüning, Andreas, 2006. "Überwindung betriebswirtschaftlicher Defizite im Innoregio-Netzwerk Kunststoffzentrum Westmecklenburg," Wismar Discussion Papers 18/2006, Hochschule Wismar, Wismar Business School.
• Schudy, Simeon, 2006. "Jüngere Entwicklungen auf dem Risikokapitalmarkt für Biotechnologie in Deutschland," Kiel Working Papers 1270, Kiel Institute for the World Economy (IfW Kiel).
• Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2008. "Allocative efficiency measurement revisited--Do we really need input prices?," Economic Modelling, Elsevier, vol. 25(5), pages 1093-1109, September.
  • Oleg Badunenko & Michael Fritsch & Andreas Stephan, 2006. "Allocative Efficiency Measurement Revisited: Do We Really Need Input Prices?," Discussion Papers of DIW Berlin 591, DIW Berlin, German Institute for Economic Research.
  • Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2006. "Allocative efficiency measurement revisited: do we really need input prices?," Freiberg Working Papers 2006/04, TU Bergakademie Freiberg, Faculty of Economics and Business Administration.
  • Badunenko, Oleg & Fritsch, Michael & Stephan, Andreas, 2006. "Allocative efficiency measurement revisited: Do we really need input prices?," Working Paper Series 2006,7, European University Viadrina Frankfurt (Oder), The Postgraduate Research Programme Capital Markets and Finance in the Enlarged Europe.

2005

• Jeffrey Furman & Margaret K. Kyle & Alain Cockburn & Rebecca M. Henderson, 2005. "Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research," Annals of Economics and Statistics, GENES, issue 79-80, pages 165-188.
  • Jeffrey L. Furman & Margaret K. Kyle & Iain M. Cockburn & Rebecca Henderson, 2006. "Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research," NBER Working Papers 12509, National Bureau of Economic Research, Inc.
• James, Harvey S., Jr., 2005. "Trust in Scientists and Food Manufacturers, with Implications for the Public Support of Biotechnology," Working Papers 92649, University of Missouri Columbia, Department of Agricultural Economics.
• Fu, Dongfeng & Pammolli, Fabio & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene, 2005. "The Growth of Business Firms: Theoretical Framework and Empirical Evidence," MPRA Paper 15905, University Library of Munich, Germany.
  • Dongfeng Fu & Fabio Pammolli & S. V. Buldyrev & Massimo Riccaboni & Kaushik Matia & Kazuko Yamasaki & H. E. Stanley, 2005. "The Growth of Business Firms: Theoretical Framework and Empirical Evidence," Papers physics/0512005, arXiv.org.
• Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck, 2005. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Chapters, in: Frontiers in Health Policy Research, Volume 8, National Bureau of Economic Research, Inc.
  • Berndt Ernst R. & Gottschalk Adrian H. B. & Philipson Tomas & Strobeck Matthew W., 2005. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," Forum for Health Economics & Policy, De Gruyter, vol. 8(1), pages 1-25, January.
  • Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck, 2004. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Working Papers 10822, National Bureau of Economic Research, Inc.
• Ma. Teresa Dueñas-Caparas, 2005. "State of Competition in the Wholesale and Retail Sector," Development Economics Working Papers 22630, East Asian Bureau of Economic Research.
• Sachin Chaturvedi & Lian Chawii, 2005. "Biosafety Protocol, International Trade and Agricultural Biotechnology : Policy Inferences for India," Trade Working Papers 22086, East Asian Bureau of Economic Research.
• Wuyts, Stefan & Colombo, Massimo G. & Dutta, Shantanu & Nooteboom, Bart, 2005. "Empirical tests of optimal cognitive distance," Journal of Economic Behavior & Organization, Elsevier, vol. 58(2), pages 277-302, October.
  • Wuyts, S.H.K. & Colombo, M.G. & Dutta, S. & Nooteboom, B., 2004. "Empirical Tests Of Optimal Cognitive Distance," ERIM Report Series Research in Management ERS-2004-007-ORG, Erasmus Research Institute of Management (ERIM), ERIM is the joint research institute of the Rotterdam School of Management, Erasmus University and the Erasmus School of Economics (ESE) at Erasmus University Rotterdam.
  • Wuyts, S.H.K. & Colombo, M. & Dutta, S. & Nooteboom, B., 2005. "Empirical Tests of Optimal Cognitive Distance," Other publications TiSEM bb2687cd-5724-4e0c-a58c-a, Tilburg University, School of Economics and Management.
  • Wuyts, S.H.K. & Colombo, M. & Dutta, S. & Nooteboom, B., 2005. "Empirical Tests of Optimal Cognitive Distance," Discussion Paper 2005-45, Tilburg University, Center for Economic Research.
• Lionel Nesta, 2005. "Knowledge and Productivity in the World's Largest Manufacturing Corporations Level:Panel Data analysis on Compustat and Patent data," Documents de Travail de l'OFCE 2005-17, Observatoire Francais des Conjonctures Economiques (OFCE).
• Avenel, E. & Corolleur, F. & Gauthier, C. & Rieu, C., 2005. "Start-ups, firm growth and the consolidation of the French biotech industry," Working Papers 200503, Grenoble Applied Economics Laboratory (GAEL).
• Izabela Jelovac & Catalina Bordoy, 2005. "Pricing and Welfare Implications of Parallel Imports in the Pharmaceutical Industry," International Journal of Health Economics and Management, Springer, vol. 5(1), pages 5-21, January.
  • Izabela Jelovac & Catalina Bordoy, 2005. "Pricing and Welfare Implications of Parallel Imports in the Pharmaceutical Industry," Post-Print hal-03881154, HAL.
• Nicolas Berland & Marie-Claire Loison, 2005. "" RESPONSIBLE CARE " ET MANAGEMENT DURABLE : COMPORTEMENT VOLONTAIRE OU RÉACTION ADAPTATIVE ? Généalogie et pratiques dans l'industrie chimique," Post-Print halshs-00581125, HAL.
• Brekke, Kurt R. & Konigbauer, Ingrid & Straume, Odd Rune, 2007. "Reference pricing of pharmaceuticals," Journal of Health Economics, Elsevier, vol. 26(3), pages 613-642, May.
  • Brekke, Kurt R & Königbauer, Ingrid & Straume, Odd Rune, 2005. "Reference Pricing of Pharmaceuticals," Working Papers in Economics 19/05, University of Bergen, Department of Economics.
  • Kurt R. Brekke & Ingrid Königbauer & Odd Rune Straume, 2006. "Reference Pricing of Pharmaceuticals," CESifo Working Paper Series 1825, CESifo.
• Jacint Balaguer & Ezequiel Uriel Jiménez & Vicente Orts, 2005. "Testing Collusive Prices In A Multimarket Context: The European Case Of Vitamin C," Working Papers. Serie EC 2005-06, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie).
• Banri ITO & Tatsufumi YAMAGATA, 2007. "Who Develops Innovations In Medicine For The Poor? Trends In Patent Applications Related To Medicines For Hiv/Aids, Tuberculosis, Malaria, And Neglected Diseases," The Developing Economies, Institute of Developing Economies, vol. 45(2), pages 141-171, June.
  • Ito, Banri & Yamagata, Tatsufumi, 2005. "Who Develops Innovations in Medicine for the Poor? Trends in Patent Applications Related to Medicines for HIV/AIDS, Tuberculosis, Malaria and Neglected Diseases," IDE Discussion Papers 24, Institute of Developing Economies, Japan External Trade Organization(JETRO).
• Ken Tabata & Testuya Shinkai & Satoru Tanaka & Makoto Okamura, 2005. "Parallel Imports, Drag Price Control and Pharmaceutical Innovation," Discussion Paper Series 26, School of Economics, Kwansei Gakuin University, revised Aug 2005.
• David M. Cutler & Alan M. Garber, 2005. "Frontiers in Health Policy Research, Volume 8," NBER Books, National Bureau of Economic Research, Inc, number cutl05-1.
• Berndt Ernst R. & Gottschalk Adrian H. B. & Philipson Tomas & Strobeck Matthew W., 2005. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," Forum for Health Economics & Policy, De Gruyter, vol. 8(1), pages 1-25, January.
  • Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck, 2005. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Chapters, in: Frontiers in Health Policy Research, Volume 8, National Bureau of Economic Research, Inc.
  • Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck, 2004. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Working Papers 10822, National Bureau of Economic Research, Inc.
• Lynne G. Zucker & Michael R. Darby, 2005. "Socio-economic Impact of Nanoscale Science: Initial Results and NanoBank," NBER Working Papers 11181, National Bureau of Economic Research, Inc.
• Joseph Golec & Shantaram Hegde & John A. Vernon, 2005. "Pharmaceutical Stock Price Reactions to Price Constraint Threats and Firm-Level R&D Spending," NBER Working Papers 11229, National Bureau of Economic Research, Inc.
• Alka Chadha, 2005. "Product cycles, innovation and exports: A study of Indian pharmaceuticals," Departmental Working Papers wp0511, National University of Singapore, Department of Economics.
• Alka Chadha, 2005. "Trips and Patenting Activity: Evidence from the Indian Pharmaceutical Industry," Departmental Working Papers wp0512, National University of Singapore, Department of Economics.
• Jean-François Brun & Céline Carrère & Patrick Guillaumont & Jaime de Melo, 2015. "Has Distance Died? Evidence from a Panel Gravity Model," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 13, pages 299-320, World Scientific Publishing Co. Pte. Ltd..
  • Jean-François Brun & Céline Carrère & Patrick Guillaumont & Jaime de Melo, 2005. "Has Distance Died? Evidence from a Panel Gravity Model," The World Bank Economic Review, World Bank, vol. 19(1), pages 99-120.
  • Guillaumont, Patrick & de Melo, Jaime & Brun, Jean-François & Carrère, Céline, 2002. "Has Distance Died? Evidence from a Panel Gravity Model," CEPR Discussion Papers 3500, C.E.P.R. Discussion Papers.
  • Jean-François BRUN & Céline CARRERE & Jaime MELO DE & Patrick GUILLAUMONT, 2002. "Has Distance Died? Evidence from a Panel Gravity Model," Working Papers 200215, CERDI.
• Dongfeng Fu & Fabio Pammolli & S. V. Buldyrev & Massimo Riccaboni & Kaushik Matia & Kazuko Yamasaki & H. E. Stanley, 2005. "The Growth of Business Firms: Theoretical Framework and Empirical Evidence," Papers physics/0512005, arXiv.org.
  • Fu, Dongfeng & Pammolli, Fabio & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene, 2005. "The Growth of Business Firms: Theoretical Framework and Empirical Evidence," MPRA Paper 15905, University Library of Munich, Germany.
• Sharma , Shalendra D., 2005. "Agricultural Development for Inclusive Growth: A Strategy for Achieving the Millennium Development Goals," East Asian Economic Review, Korea Institute for International Economic Policy, vol. 9(1), pages 59-84, June.
• Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff, 2005. "Strategic Reasons for Patenting: Between Exclusion and Coordination Rationales," Rivista di Politica Economica, SIPI Spa, vol. 95(5), pages 19-46, September.
  • Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff, 2006. "Strategic Reasons for Patenting : Between Exclusion and Coordination Rationales," Post-Print hal-00279139, HAL.
  • Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff, 2008. "Strategic Reasons for Patenting : Between Exclusion and Coordination Rationales," Post-Print hal-00279475, HAL.
• Jan Larsson & Kjetil Telle, 2005. "Consequences of the IPPC-directive's BAT requirements for abatement costs and emissions," Discussion Papers 411, Statistics Norway, Research Department.
• Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2005. "The knowledge bases of the world's largest pharmaceutical groups: what do patent citations to non-patent literature reveal?," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 14(5), pages 395-415.
  • Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2003. "The Knowledge Bases of the World's Largest Pharmaceuticals Groups: what do Patent Citations to Non-Patent Literature Reveal?," SPRU Working Paper Series 90, SPRU - Science Policy Research Unit, University of Sussex Business School.
• Philip Cooke & Nick Clifton, 2005. "Visionary, precautionary and constrained 'varieties of devolution' in the economic governance of the devolved UK territories," Regional Studies, Taylor & Francis Journals, vol. 39(4), pages 437-451.
• Gilsing, V. & Nooteboom, B., 2004. "Density and strength of ties in innovation networks: an analysis of multimedia and biotechnology," Working Papers 04.16, Eindhoven Center for Innovation Studies.
  • Gilsing, V.A. & Nooteboom, B., 2005. "Density and Strength of Ties in Innovation Networks : An Analysis of Multi-Media and Biotechnology," Discussion Paper 2005-41, Tilburg University, Center for Economic Research.
  • Gilsing, V.A. & Nooteboom, B., 2005. "Density and Strength of Ties in Innovation Networks : An Analysis of Multi-Media and Biotechnology," Other publications TiSEM 778502fd-6813-4ba2-b746-f, Tilburg University, School of Economics and Management.
• Wuyts, Stefan & Colombo, Massimo G. & Dutta, Shantanu & Nooteboom, Bart, 2005. "Empirical tests of optimal cognitive distance," Journal of Economic Behavior & Organization, Elsevier, vol. 58(2), pages 277-302, October.
  • Wuyts, S.H.K. & Colombo, M.G. & Dutta, S. & Nooteboom, B., 2004. "Empirical Tests Of Optimal Cognitive Distance," ERIM Report Series Research in Management ERS-2004-007-ORG, Erasmus Research Institute of Management (ERIM), ERIM is the joint research institute of the Rotterdam School of Management, Erasmus University and the Erasmus School of Economics (ESE) at Erasmus University Rotterdam.
  • Wuyts, S.H.K. & Colombo, M. & Dutta, S. & Nooteboom, B., 2005. "Empirical Tests of Optimal Cognitive Distance," Discussion Paper 2005-45, Tilburg University, Center for Economic Research.
  • Wuyts, S.H.K. & Colombo, M. & Dutta, S. & Nooteboom, B., 2005. "Empirical Tests of Optimal Cognitive Distance," Other publications TiSEM bb2687cd-5724-4e0c-a58c-a, Tilburg University, School of Economics and Management.
• Gilsing, V. & Nooteboom, B., 2004. "Density and strength of ties in innovation networks: an analysis of multimedia and biotechnology," Working Papers 04.16, Eindhoven Center for Innovation Studies.
  • Gilsing, V.A. & Nooteboom, B., 2005. "Density and Strength of Ties in Innovation Networks : An Analysis of Multi-Media and Biotechnology," Other publications TiSEM 778502fd-6813-4ba2-b746-f, Tilburg University, School of Economics and Management.
  • Gilsing, V.A. & Nooteboom, B., 2005. "Density and Strength of Ties in Innovation Networks : An Analysis of Multi-Media and Biotechnology," Discussion Paper 2005-41, Tilburg University, Center for Economic Research.
• David Reiffen & Michael R. Ward, 2005. "Generic Drug Industry Dynamics," The Review of Economics and Statistics, MIT Press, vol. 87(1), pages 37-49, February.
• Tınis Mets, 2005. "Innovation Paths of Estonian Biotechnology," Working Papers 131, Tallinn School of Economics and Business Administration, Tallinn University of Technology.
• David Reiffen & Michael R. Ward, 2007. "'Branded Generics' as a strategy to limit cannibalization of pharmaceutical markets," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 251-265.
  • Michael R. Ward & David Reiffen, 2005. "“Branded Generics” As A Strategy To Limit Cannibalization Of Pharmaceutical Markets," Working Papers 0502, University of Texas at Arlington, Department of Economics.
• Daniel Rais & Jonathan Goldman, 2005. "Phases of Imitation and Innovation in a North-South Endogenous Growth Model," Working Papers template, University of Texas at Arlington, Department of Economics.
• Xia Wang, 2005. "Technological Characteristics and R&D Alliance Form: Evidence from the U.S. Biotechnology Industry," Working papers 2005-35, University of Connecticut, Department of Economics.
• Marcello Basili & Roberto Renò & Carlo Zappia, 2005. "Production of a New Drug: A Sequential Investment ProcessUnder Uncertainty," Department of Economics University of Siena 453, Department of Economics, University of Siena.
• Castellini, Alessandra & Canavari, Maurizio & Pirazzoli, Carlo, 2002. "Functional Foods In The European Union: An Overview Of The Sector'S Main Issues," Working Papers 14456, University of Minnesota, Center for International Food and Agricultural Policy.
  • Alessandra CASTELLINI & Maurizio Canavari & Carlo Pirazzoli, 2005. "Functional Foods In The European Union: An Overview Of The Sector'S Main Issues," Others 0505004, University Library of Munich, Germany.
• Fier, Andreas & Heneric, Oliver, 2005. "Public R&D Policy: The Right Turns of the Wrong Screw? The Case of the German Biotechnology Industry," ZEW Discussion Papers 05-60, ZEW - Leibniz Centre for European Economic Research.
• Toole, Andrew A., 2005. "Does Public Scientific Research Complement Industry R&D Investment? The Case of NIH Supported Basic and Clinical Research and Pharmaceutical Industry R&D," ZEW Discussion Papers 05-75, ZEW - Leibniz Centre for European Economic Research.

2004

• Joan Ramon Borrell Arque, 2004. "Las patentes aceleran o retrasan la comercializacion de nuevos medicamentos en los paises en desarrollo?," Working Papers in Economics 122, Universitat de Barcelona. Espai de Recerca en Economia.
• Sophie-Hélène Bataïni, 2004. "L'interaction des dynamiques individuelles et collectives dans le processus de développement territorial," Revue d'économie régionale et urbaine, Armand Colin, vol. 0(5), pages 713-735.
• Céline Carrère & Jaime de Melo, 2015. "Are Different Rules of Origin Equally Costly? Estimates from NAFTA," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 12, pages 277-298, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Carrère, Céline, 2004. "Are Different Rules of Origin Equally Costly? Estimates from NAFTA," CEPR Discussion Papers 4437, C.E.P.R. Discussion Papers.
  • Céline CARRERE & Jaime MELO DE, 2004. "Are Different Rules of Origin Equally Costly? Estimates from NAFTA," Working Papers 200412, CERDI.
  • Céline Carrere & Olivier Cadot, 2006. "Are different Rules of Origin Equally Costly? Estimates from NAFTA," Post-Print hal-00130079, HAL.
• Frank Lichtenberg, 2000. "The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey," CESifo Working Paper Series 404, CESifo.
  • Frank R. Lichtenberg, 2001. "The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey," NBER Working Papers 8147, National Bureau of Economic Research, Inc.
• Marc-Hubert Depret & Abdelillah Hamdouch, 2004. "La gouvernance des jeunes entreprises innovantes:un éclairage analytique à partir du cas des sociétés de biotechnologies," Revue Finance Contrôle Stratégie, revues.org, vol. 7(2), pages 67-94, June.
  • Marc-Hubert Depret & Abdellilah Hamdouch, 2004. "La gouvernance des jeunes entreprises innovantes : un éclairage analytique à partir du cas des sociétés de biotechnologies," Post-Print halshs-00006702, HAL.
  • Marc-Hubert Depret & Abdelillah Hamdouch, 2006. "La gouvernance des jeunes entreprises innovantes : Un éclairage analytique a partir du cas des sociétés de biotechnologies," Post-Print hal-00279284, HAL.
• Tomofumi & Anegawa, 2004. "Price Regulation and Competition in Japanese Pharmaceutical Market," Econometric Society 2004 Far Eastern Meetings 481, Econometric Society.
• Andrew T. Ching, 2010. "A Dynamic Oligopoly Structural Model For The Prescription Drug Market After Patent Expiration," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 51(4), pages 1175-1207, November.
  • Andrew Ching, 2004. "A Dynamic Oligopoly Structural Model for the Prescription Drug Market After Patent Expiration," Econometric Society 2004 Far Eastern Meetings 735, Econometric Society.
• Gilsing, V. & Nooteboom, B., 2004. "Density and strength of ties in innovation networks: an analysis of multimedia and biotechnology," Working Papers 04.16, Eindhoven Center for Innovation Studies.
  • Gilsing, V.A. & Nooteboom, B., 2005. "Density and Strength of Ties in Innovation Networks : An Analysis of Multi-Media and Biotechnology," Other publications TiSEM 778502fd-6813-4ba2-b746-f, Tilburg University, School of Economics and Management.
  • Gilsing, V.A. & Nooteboom, B., 2005. "Density and Strength of Ties in Innovation Networks : An Analysis of Multi-Media and Biotechnology," Discussion Paper 2005-41, Tilburg University, Center for Economic Research.
• G. Buenstorf & S. Klepper, 2004. "The Origin and Location of Entrants in the Evolution of the U.S. Tire Industry," Papers on Economics and Evolution 2004-07, Philipps University Marburg, Department of Geography.
• Marc-Hubert Depret & Abdelillah Hamdouch, 2004. "La gouvernance des jeunes entreprises innovantes:un éclairage analytique à partir du cas des sociétés de biotechnologies," Revue Finance Contrôle Stratégie, revues.org, vol. 7(2), pages 67-94, June.
  • Marc-Hubert Depret & Abdellilah Hamdouch, 2004. "La gouvernance des jeunes entreprises innovantes : un éclairage analytique à partir du cas des sociétés de biotechnologies," Post-Print halshs-00006702, HAL.
  • Marc-Hubert Depret & Abdelillah Hamdouch, 2006. "La gouvernance des jeunes entreprises innovantes : Un éclairage analytique a partir du cas des sociétés de biotechnologies," Post-Print hal-00279284, HAL.
• Razzolini, Tiziano, 2004. "The Norwegian market for pharmaceuticals and the non-mandatory substitution reform of 2001: the case of enalapril," Memorandum 12/2004, Oslo University, Department of Economics.
• Eliasson, Gunnar & Eliasson, Åsa, 2004. "Competence in Health Care - An Industrial Systems Analysis Using Competence Bloc Theory to Compare European and US Health Care," Ratio Working Papers 46, The Ratio Institute.
• Reisinger, Markus, 2004. "Vertical Product Differentiation, Market Entry, and Welfare," Discussion Papers in Economics 479, University of Munich, Department of Economics.
• Berndt Ernst R. & Gottschalk Adrian H. B. & Philipson Tomas & Strobeck Matthew W., 2005. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," Forum for Health Economics & Policy, De Gruyter, vol. 8(1), pages 1-25, January.
  • Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck, 2005. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Chapters, in: Frontiers in Health Policy Research, Volume 8, National Bureau of Economic Research, Inc.
  • Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck, 2004. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Working Papers 10822, National Bureau of Economic Research, Inc.
• Frank R. Lichtenberg, 2010. "The effect of drug vintage on survival: Micro evidence from Puerto Rico's Medicaid program," Advances in Health Economics and Health Services Research, in: Pharmaceutical Markets and Insurance Worldwide, pages 273-292, Emerald Group Publishing Limited.
  • Frank R. Lichtenberg, 2004. "The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program," NBER Working Papers 10884, National Bureau of Economic Research, Inc.
• Steven N. Wiggins & Robert Maness, 2004. "Price Competition in Pharmaceuticals: The Case of Anti-infectives," Economic Inquiry, Western Economic Association International, vol. 42(2), pages 247-263, April.
• Yamasaki, Kazuko & Matia, Kaushik & Buldyrev, Sergey V. & Fu, Dongfeng & Pammolli, Fabio & Riccaboni, Massimo & Stanley, H. Eugene, 2004. "Preferential attachment and growth dynamics in complex systems," MPRA Paper 15908, University Library of Munich, Germany, revised 06 Feb 2006.
• Magazzini, Laura & Pammolli, Fabio & Riccaboni, Massimo, 2004. "Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure," MPRA Paper 15968, University Library of Munich, Germany.
• Pammolli, Fabio & Riccaboni, Massimo, 2004. "Market Structure and Drug Innovation," MPRA Paper 16212, University Library of Munich, Germany.
• Pradhan, Jaya Prakash, 2004. "FDI spillovers and local productivity growth: evidence from Indian pharmaceutical industry," MPRA Paper 17080, University Library of Munich, Germany.
• Tyabji, Nasir, 2004. "Gaining Technical Know-How in an Unequal World: Penicillin Manufacture in Nehru's India," MPRA Paper 84236, University Library of Munich, Germany.
• Christine de Mazières & Valérie Paris, 2004. "La régulation de l’industrie pharmaceutique," Revue d'Économie Financière, Programme National Persée, vol. 76(3), pages 241-265.
• Pablo D'Este Cukierman, 2004. "Persistent Knowledge Specialisation and Intra-Industry Heterogeneity: an Analysis of the Spanish Pharmaceutical Industry," SPRU Working Paper Series 110, SPRU - Science Policy Research Unit, University of Sussex Business School.
• Drusilla K. Brown & George Norman, 2004. "Optimal Intellectual Property Rights Protection and Humanitarian Assistance during and International Health Emergency," Discussion Papers Series, Department of Economics, Tufts University 0416, Department of Economics, Tufts University.
• María Inés Terra & Gustavo Bittencourt & Rosario Domingo & Carmen Estrades & Gabriel Katz & Alvaro Ons & Héctor Pastori, 2004. "Estudios de competitividad sectoriales. Industria manufacturera," Documentos de Trabajo (working papers) 2305, Department of Economics - dECON.
• Joan Costa & Jaume Puig, 2004. "Regulatory ambivalence and the limitations of pharmaceutical policy in Spain," Working Papers, Research Center on Health and Economics 762, Department of Economics and Business, Universitat Pompeu Fabra.
  • Joan Costa & Jaume Puig, 2004. "Regulatory ambivalence and the limitations of pharmaceutical policy in Spain," Economics Working Papers 762, Department of Economics and Business, Universitat Pompeu Fabra.
• Joan Costa & Jaume Puig, 2004. "Regulatory ambivalence and the limitations of pharmaceutical policy in Spain," Economics Working Papers 762, Department of Economics and Business, Universitat Pompeu Fabra.
  • Joan Costa & Jaume Puig, 2004. "Regulatory ambivalence and the limitations of pharmaceutical policy in Spain," Working Papers, Research Center on Health and Economics 762, Department of Economics and Business, Universitat Pompeu Fabra.
• Dan Marsh, 2004. "Biotechnology in New Zealand," Working Papers in Economics 04/01, University of Waikato.

2003

• Lori D. Snyder & Nolan H. Miller & Robert N. Stavins, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," American Economic Review, American Economic Association, vol. 93(2), pages 431-435, May.
  • Snyder, Lori & Miller, Nolan & Stavins, Robert, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Paper Series rwp03-014, Harvard University, John F. Kennedy School of Government.
  • Snyder, Lori D. & Miller, Nolan & Stavins, Robert N., 2003. "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," Discussion Papers 10554, Resources for the Future.
  • Stavins, Robert & Snyder, Lori & Miller, Nolan, 2003. "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," RFF Working Paper Series dp-03-25, Resources for the Future.
  • Lori Snyder & Nolan Miller & Robert Stavins, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Papers 2003.48, Fondazione Eni Enrico Mattei.
• Lori D. Snyder & Nolan H. Miller & Robert N. Stavins, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," American Economic Review, American Economic Association, vol. 93(2), pages 431-435, May.
  • Snyder, Lori & Miller, Nolan & Stavins, Robert, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Paper Series rwp03-014, Harvard University, John F. Kennedy School of Government.
  • Snyder, Lori D. & Miller, Nolan & Stavins, Robert N., 2003. "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," Discussion Papers 10554, Resources for the Future.
  • Stavins, Robert & Snyder, Lori & Miller, Nolan, 2003. "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," RFF Working Paper Series dp-03-25, Resources for the Future.
  • Lori Snyder & Nolan Miller & Robert Stavins, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Papers 2003.48, Fondazione Eni Enrico Mattei.
• Antonio Cabrales, 2003. "Pharmaceutical generics, vertical product differentiation and public policy," Economics Working Papers 662, Department of Economics and Business, Universitat Pompeu Fabra.
  • Antonio Cabrales, 2003. "Pharmaceutical Generics, Vertical Product Differentiation, and Public Policy," Working Papers 54, Barcelona School of Economics.
  • Antonio Cabrales, 2003. "Pharmaceutical generics, vertical product differentiation and public policy," Working Papers, Research Center on Health and Economics 662, Department of Economics and Business, Universitat Pompeu Fabra.
• Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay, 2003. "Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs," Journal of Industrial Economics, Wiley Blackwell, vol. 51(2), pages 243-270, June.
  • Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay, 2000. "Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs," NBER Working Papers 7772, National Bureau of Economic Research, Inc.
• Sanoussi Bilal & Jean-Marie Grether & Jaime de Melo, 2015. "Attitudes Towards Immigration: A Trade Theoretic Approach," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 18, pages 439-453, World Scientific Publishing Co. Pte. Ltd..
  • Sanoussi Bilal & Jean‐Marie Grether & Jaime de Melo, 2003. "Attitudes Towards Immigration: a Trade‐Theoretic Approach," Review of International Economics, Wiley Blackwell, vol. 11(2), pages 253-267, May.
• Christel Lane & Jocelyn Probert, 2003. "Globalisation and Its Impact on Competitiveness: the Case of the British and German Pharmaceutical Industry," Working Papers wp262, Centre for Business Research, University of Cambridge.
• Thomas Röhm, 2003. "Die Bedeutung von Patentschutz für den Technologietransfer in Entwicklungsländer : Erfahrungen der chemischen Industrie in Südkorea, Malaysia und Chile im Vergleich," ifo Beiträge zur Wirtschaftsforschung, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, number 12.
• Andrea Gebauer & Chang Woon Nam & Rüdiger Parsche & Doina Radulescu & Bettina Reichl, 2002. "Possibilities and Risks of the Introduction of Cross-border Input VAT Deduction System in the EU," ifo Forschungsberichte, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, number 12, September.
• Lanjouw, J.O., 1997. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Papers 775, Yale - Economic Growth Center.
  • Jean O Lanjouw, 2003. "The Introduction of Pharmaceutical Product Patents in India: Heartless Exploitation of the Poor and Suffering?," Levine's Working Paper Archive 618897000000000598, David K. Levine.
  • Lanjouw, Jean O., 1997. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Center Discussion Papers 28385, Yale University, Economic Growth Center.
  • Jean O. Lanjouw, 1998. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," NBER Working Papers 6366, National Bureau of Economic Research, Inc.
• Lori D. Snyder & Nolan H. Miller & Robert N. Stavins, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," American Economic Review, American Economic Association, vol. 93(2), pages 431-435, May.
  • Lori Snyder & Nolan Miller & Robert Stavins, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Papers 2003.48, Fondazione Eni Enrico Mattei.
  • Snyder, Lori & Miller, Nolan & Stavins, Robert, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Paper Series rwp03-014, Harvard University, John F. Kennedy School of Government.
  • Snyder, Lori D. & Miller, Nolan & Stavins, Robert N., 2003. "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," Discussion Papers 10554, Resources for the Future.
  • Stavins, Robert & Snyder, Lori & Miller, Nolan, 2003. "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," RFF Working Paper Series dp-03-25, Resources for the Future.
• Olivier Cadot & Jaime de Melo & Marcelo Olarreaga, 2015. "The Protectionist Bias of Duty Drawbacks: Evidence from Mercosur," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 15, pages 359-380, World Scientific Publishing Co. Pte. Ltd..
  • Cadot, Olivier & de Melo, Jaime & Olarreaga, Marcelo, 2003. "The protectionist bias of duty drawbacks: evidence from Mercosur," Journal of International Economics, Elsevier, vol. 59(1), pages 161-182, January.
• De Fabritiis, G. & Pammolli, F. & Riccaboni, M., 2003. "On size and growth of business firms," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 324(1), pages 38-44.
  • De Fabritiis, Gianni & Riccaboni, Massimo & Pammolli, Fabio, 2003. "On Size and Growth of Business Firms," MPRA Paper 15866, University Library of Munich, Germany.
• Lori D. Snyder & Nolan H. Miller & Robert N. Stavins, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," American Economic Review, American Economic Association, vol. 93(2), pages 431-435, May.
  • Snyder, Lori & Miller, Nolan & Stavins, Robert, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Paper Series rwp03-014, Harvard University, John F. Kennedy School of Government.
  • Lori Snyder & Nolan Miller & Robert Stavins, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Papers 2003.48, Fondazione Eni Enrico Mattei.
  • Snyder, Lori D. & Miller, Nolan & Stavins, Robert N., 2003. "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," Discussion Papers 10554, Resources for the Future.
  • Stavins, Robert & Snyder, Lori & Miller, Nolan, 2003. "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," RFF Working Paper Series dp-03-25, Resources for the Future.
• Brekke, Kurt R. & Kuhn, Michael, 2006. "Direct to consumer advertising in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 25(1), pages 102-130, January.
  • Kurt R Brekke & Michael Kuhn, "undated". "Direct-to-Consumer Advertising in Pharmaceutical Markets," Discussion Papers 03/11, Department of Economics, University of York.
  • Kurt R. Brekke & Michael Kuhn, 2005. "Direct to Consumer Advertising in Pharmaceutical Markets," CESifo Working Paper Series 1493, CESifo.
  • Brekke, Kurt R. & Kuhn, Michael, 2003. "Direct-to-Consumer Advertising in Pharmaceutical Markets," Working Papers in Economics 05/03, University of Bergen, Department of Economics.
• Fridh, Ann-Charlotte, 2003. "Titanium Implants – A Comparison of a Swedish and an Ohio Firm," Ratio Working Papers 21, The Ratio Institute.
• Hellström, Jörgen & Rudholm, Niklas, 2003. "Uncertainty in the Generic Versus Brand Name Prescription Decision," Umeå Economic Studies 602, Umeå University, Department of Economics.
• Jorge Mestre, 2003. "Reference prices: The Spanish way," Investigaciones Economicas, Fundación SEPI, vol. 27(1), pages 125-149, January.
• Michael Dickson & Stephane Jacobzone, 2003. "Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke: A Study of 12 OECD Countries," OECD Health Working Papers 1, OECD Publishing.
• Professor Tony VanDuzer, 2003. "TRIPS and the Pharmaceutical Industry in Bangladesh: Towards a National Strategy," CPD Working Paper 24, Centre for Policy Dialogue (CPD).
• De Fabritiis, G. & Pammolli, F. & Riccaboni, M., 2003. "On size and growth of business firms," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 324(1), pages 38-44.
  • De Fabritiis, Gianni & Riccaboni, Massimo & Pammolli, Fabio, 2003. "On Size and Growth of Business Firms," MPRA Paper 15866, University Library of Munich, Germany.
• Pradhan, Jaya Prakash, 2003. "Liberalization, Firm Size and R&D performance: A Firm Level Study of Indian Pharmaceutical Industry," MPRA Paper 17079, University Library of Munich, Germany.
• Allen, Thomas & Gabe, Todd, 2003. "The economic impact of Biotechnology in New England," MPRA Paper 65984, University Library of Munich, Germany.
• Lori D. Snyder & Nolan H. Miller & Robert N. Stavins, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," American Economic Review, American Economic Association, vol. 93(2), pages 431-435, May.
  • Lori Snyder & Nolan Miller & Robert Stavins, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Papers 2003.48, Fondazione Eni Enrico Mattei.
  • Stavins, Robert & Snyder, Lori & Miller, Nolan, 2003. "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," RFF Working Paper Series dp-03-25, Resources for the Future.
  • Snyder, Lori D. & Miller, Nolan & Stavins, Robert N., 2003. "The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing," Discussion Papers 10554, Resources for the Future.
  • Snyder, Lori & Miller, Nolan & Stavins, Robert, 2003. "The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing," Working Paper Series rwp03-014, Harvard University, John F. Kennedy School of Government.
• Paola Criscuolo, 2003. "Reverse Technology Transfer: A Patent Citation Analysis of the European Chemical and Pharmaceutical Sectors," SPRU Working Paper Series 107, SPRU - Science Policy Research Unit, University of Sussex Business School.
• Lionel Nesta & Pier-Paolo Saviotti, 2003. "Intangible Assests and Market Value: Evidence from Biotechnology Firms," SPRU Working Paper Series 87, SPRU - Science Policy Research Unit, University of Sussex Business School.
• Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2005. "The knowledge bases of the world's largest pharmaceutical groups: what do patent citations to non-patent literature reveal?," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 14(5), pages 395-415.
  • Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2003. "The Knowledge Bases of the World's Largest Pharmaceuticals Groups: what do Patent Citations to Non-Patent Literature Reveal?," SPRU Working Paper Series 90, SPRU - Science Policy Research Unit, University of Sussex Business School.
• Andreas Pyka & Paul Windrum, 2003. "The self-organisation of strategic alliances," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 12(3), pages 245-268.
  • Andreas Pyka & Paul Windrum, 2001. "The Self-Organisation of Strategic Alliances," Discussion Paper Series 209, Universitaet Augsburg, Institute for Economics.
• Drusilla K. Brown & George Norman, 2003. "Optimal Intellectual Property Rights Exhaustion and Humanitarian Assistance during a National Health Emergency," Discussion Papers Series, Department of Economics, Tufts University 0314, Department of Economics, Tufts University.
• Margaret Levenstein & Valerie Suslow & Lynda Oswald, 2003. "International Price-Fixing Cartels and Developing Countries: A Discussion of Effects and Policy Remedies," NBER Working Papers 9511, National Bureau of Economic Research, Inc.
  • Lynda Oswald & Valerie Suslow & Margaret Levenstein & Manuel Pastor, 2003. "International Price-Fixing Cartels and Developing Countries: A Discussion of Effects and Policy Remedies," Working Papers wp53, Political Economy Research Institute, University of Massachusetts at Amherst.
  • Margaret Levenstein & Valerie Suslow & Lynda Oswald, 2003. "International Price-Fixing Cartels and Developing Countries: A Discussion of Effects and Policy Remedies," William Davidson Institute Working Papers Series 538, William Davidson Institute at the University of Michigan.
• Antonio Cabrales, 2003. "Pharmaceutical generics, vertical product differentiation and public policy," Working Papers, Research Center on Health and Economics 662, Department of Economics and Business, Universitat Pompeu Fabra.
  • Antonio Cabrales, 2003. "Pharmaceutical generics, vertical product differentiation and public policy," Economics Working Papers 662, Department of Economics and Business, Universitat Pompeu Fabra.
  • Antonio Cabrales, 2003. "Pharmaceutical Generics, Vertical Product Differentiation, and Public Policy," Working Papers 54, Barcelona School of Economics.
• Antonio Cabrales, 2003. "Pharmaceutical generics, vertical product differentiation and public policy," Economics Working Papers 662, Department of Economics and Business, Universitat Pompeu Fabra.
  • Antonio Cabrales, 2003. "Pharmaceutical generics, vertical product differentiation and public policy," Working Papers, Research Center on Health and Economics 662, Department of Economics and Business, Universitat Pompeu Fabra.
  • Antonio Cabrales, 2003. "Pharmaceutical Generics, Vertical Product Differentiation, and Public Policy," Working Papers 54, Barcelona School of Economics.
• Lynda Oswald & Valerie Suslow & Margaret Levenstein & Manuel Pastor, 2003. "International Price-Fixing Cartels and Developing Countries: A Discussion of Effects and Policy Remedies," Working Papers wp53, Political Economy Research Institute, University of Massachusetts at Amherst.
  • Margaret Levenstein & Valerie Suslow & Lynda Oswald, 2003. "International Price-Fixing Cartels and Developing Countries: A Discussion of Effects and Policy Remedies," William Davidson Institute Working Papers Series 538, William Davidson Institute at the University of Michigan.
  • Margaret Levenstein & Valerie Suslow & Lynda Oswald, 2003. "International Price-Fixing Cartels and Developing Countries: A Discussion of Effects and Policy Remedies," NBER Working Papers 9511, National Bureau of Economic Research, Inc.
• Uwe Dulleck & Neil Foster-McGregor & Doris Hanzl-Weiss & Zdenek Lukas & Josef Pöschl & Robert Stehrer & Julia Wörz, 2003. "wiiw Structural Report 2003 on Central and Eastern Europe, Volume 3," wiiw Structural Report 3, The Vienna Institute for International Economic Studies, wiiw.
• Neunteufel, Herbert & Rössel, Gottfried & Sassenberg, Uwe, 2003. "Das Marketingniveau in der Kunststoffbranche Westmecklenburgs," Wismar Discussion Papers 06/2003, Hochschule Wismar, Wismar Business School.

2002

• Castellini, Alessandra & Canavari, Maurizio & Pirazzoli, Carlo, 2002. "Functional Foods In The European Union: An Overview Of The Sector'S Main Issues," Working Papers 14456, University of Minnesota, Center for International Food and Agricultural Policy.
  • Alessandra CASTELLINI & Maurizio Canavari & Carlo Pirazzoli, 2005. "Functional Foods In The European Union: An Overview Of The Sector'S Main Issues," Others 0505004, University Library of Munich, Germany.
• Jean-François Brun & Céline Carrère & Patrick Guillaumont & Jaime de Melo, 2015. "Has Distance Died? Evidence from a Panel Gravity Model," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 13, pages 299-320, World Scientific Publishing Co. Pte. Ltd..
  • Jean-François Brun & Céline Carrère & Patrick Guillaumont & Jaime de Melo, 2005. "Has Distance Died? Evidence from a Panel Gravity Model," The World Bank Economic Review, World Bank, vol. 19(1), pages 99-120.
  • Guillaumont, Patrick & de Melo, Jaime & Brun, Jean-François & Carrère, Céline, 2002. "Has Distance Died? Evidence from a Panel Gravity Model," CEPR Discussion Papers 3500, C.E.P.R. Discussion Papers.
  • Jean-François BRUN & Céline CARRERE & Jaime MELO DE & Patrick GUILLAUMONT, 2002. "Has Distance Died? Evidence from a Panel Gravity Model," Working Papers 200215, CERDI.
• Joan-Ramon Borrell & Jayashree Watal, 2002. "Impact of Patents on Access to HIV/AIDS Drugs in Developing Countries," CID Working Papers 92, Center for International Development at Harvard University.
• Javier Guerrero Barón, 2002. "Mercados de violencia" y guerra civil en América Latina en los 90*"," Apuntes del Cenes, Universidad Pedagógica y Tecnológica de Colombia, June.
• Pedro L. Marín & Georges Siotis, 2007. "Innovation And Market Structure: An Empirical Evaluation Of The ‘Bounds Approach’ In The Chemical Industry," Journal of Industrial Economics, Wiley Blackwell, vol. 55(1), pages 93-111, March.
  • Siotis, Georges & Marín Uribe, Pedro Luis, 2002. "Innovation and Market Structure: An Empirical Evaluation of the 'Bounds Approach' in the Chemical Industry," CEPR Discussion Papers 3162, C.E.P.R. Discussion Papers.
• Riccaboni, Massimo & Pammolli, Fabio, 2002. "On firm growth in networks," Research Policy, Elsevier, vol. 31(8-9), pages 1405-1416, December.
  • Riccaboni, Massimo & Pammolli, Fabio, 2001. "On Firm Growth in Networks," MPRA Paper 15964, University Library of Munich, Germany, revised 12 Nov 2001.
• Mª Carmen Fernández Díez, 2002. "Los derechos sobre las patentes biotecnológicas y su repercusión económica en la Unión Europea," EKONOMIAZ. Revista vasca de Economía, Gobierno Vasco / Eusko Jaurlaritza / Basque Government, vol. 51(03), pages 140-153.
• Silveira, José Maria F. J. da, 2002. "Biotecnologia: corporações, financiamento da inovação e novas formas organizacionais," Revista Economia e Sociedade, Instituto de Economia, Universidade Estadual de Campinas (UNICAMP), vol. 18, pages 1-36, January.
• Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2002. "A Comparison of U.S. and European University-Industry Relations in the Life Sciences," Management Science, INFORMS, vol. 48(1), pages 24-43, January.
  • Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2001. "A Comparison of U.S. And European University-Industry Relations in the Life Sciences," LEM Papers Series 2001/03, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  • Owen-Smith, Jason & Riccaboni, Massimo & Pammolli, Fabio & Powell, Walter W., 2002. "A Comparison of U.S. and European University-Industry Relations in the Life Sciences," MPRA Paper 15963, University Library of Munich, Germany.
• Erik Biørn & Kjersti-Gro Lindquist & Terje Skjerpen, 2002. "Heterogeneity in Returns to Scale: A Random Coefficient Analysis with Unbalanced Panel Data," Journal of Productivity Analysis, Springer, vol. 18(1), pages 39-57, July.
  • Erik Biørn & Kjersti-Gro Lindquist & Terje Skjerpen, 2000. "Heterogeneity in Returns to Scale: A Random Coefficient Analysis with Unbalanced Panel Data," Discussion Papers 292, Statistics Norway, Research Department.
• Frank R. Lichtenberg, 2007. "Benefits and costs of newer drugs: an update," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 485-490.
  • Frank Lichtenberg, 2002. "Benefits and Costs of Newer Drugs: An Update," NBER Working Papers 8996, National Bureau of Economic Research, Inc.
• Frank R. Lichtenberg & Suchin Virabhak, 2007. "Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as 'Equipment for Your Health'," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 371-392.
  • Frank R. Lichtenberg & Suchin Virabhak, 2002. "Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health"," NBER Working Papers 9351, National Bureau of Economic Research, Inc.
• Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2002. "A Comparison of U.S. and European University-Industry Relations in the Life Sciences," Management Science, INFORMS, vol. 48(1), pages 24-43, January.
  • Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2001. "A Comparison of U.S. And European University-Industry Relations in the Life Sciences," LEM Papers Series 2001/03, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  • Owen-Smith, Jason & Riccaboni, Massimo & Pammolli, Fabio & Powell, Walter W., 2002. "A Comparison of U.S. and European University-Industry Relations in the Life Sciences," MPRA Paper 15963, University Library of Munich, Germany.
• Bernard Gilroy & Tobias Volpert, 2002. "Economic insights and deficits in European biotechnology patent policy," Intereconomics: Review of European Economic Policy, Springer;ZBW - Leibniz Information Centre for Economics;Centre for European Policy Studies (CEPS), vol. 37(3), pages 150-155, May.
  • Gilroy, Bernard Michael & Volpert, Tobias, 2002. "Economic Insights and Deficits in European Biotechnology Patent Policy," MPRA Paper 22619, University Library of Munich, Germany.
  • Gilroy, Bernard Michael & Vollpert, Tobias, 2002. "Economic Insights and Deficits in European Biotechnology Patent Policy," MPRA Paper 17979, University Library of Munich, Germany.
• Bernard Gilroy & Tobias Volpert, 2002. "Economic insights and deficits in European biotechnology patent policy," Intereconomics: Review of European Economic Policy, Springer;ZBW - Leibniz Information Centre for Economics;Centre for European Policy Studies (CEPS), vol. 37(3), pages 150-155, May.
  • Gilroy, Bernard Michael & Vollpert, Tobias, 2002. "Economic Insights and Deficits in European Biotechnology Patent Policy," MPRA Paper 17979, University Library of Munich, Germany.
  • Gilroy, Bernard Michael & Volpert, Tobias, 2002. "Economic Insights and Deficits in European Biotechnology Patent Policy," MPRA Paper 22619, University Library of Munich, Germany.
• Bernard Gilroy & Tobias Volpert, 2002. "Economic insights and deficits in European biotechnology patent policy," Intereconomics: Review of European Economic Policy, Springer;ZBW - Leibniz Information Centre for Economics;Centre for European Policy Studies (CEPS), vol. 37(3), pages 150-155, May.
  • Gilroy, Bernard Michael & Vollpert, Tobias, 2002. "Economic Insights and Deficits in European Biotechnology Patent Policy," MPRA Paper 17979, University Library of Munich, Germany.
  • Gilroy, Bernard Michael & Volpert, Tobias, 2002. "Economic Insights and Deficits in European Biotechnology Patent Policy," MPRA Paper 22619, University Library of Munich, Germany.
• Dan Marsh, 2002. "Does New Zealand have an Innovation System for Biotechnology?," Working Papers in Economics 02/03, University of Waikato.
• Zwick, Thomas & Wolf, Elke & Beblo, Miriam, 2002. "Erfolgsabhängige Vergütung: Ein sicherer Weg zur Steigerung der Leistung von Top-Managern?," ZEW Discussion Papers 02-72, ZEW - Leibniz Centre for European Economic Research.

2001

• Andreas Pyka & Paolo Saviotti, 2001. "Innovation Networks in the Biotechnology-Based Sectors," Discussion Paper Series 205, Universitaet Augsburg, Institute for Economics.
  • Andreas Pyka & Paolo Saviotti, 2002. "Innovation Networks in the Biotechnology-Based Sectors," Discussion Paper Series 220, Universitaet Augsburg, Institute for Economics.
• Andreas Pyka & Paul Windrum, 2003. "The self-organisation of strategic alliances," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 12(3), pages 245-268.
  • Andreas Pyka & Paul Windrum, 2001. "The Self-Organisation of Strategic Alliances," Discussion Paper Series 209, Universitaet Augsburg, Institute for Economics.
• Arora, Ashish & Fosfuri, Andrea & Gambardella, Alfonso, 2001. "Specialized technology suppliers, international spillovers and investment: evidence from the chemical industry," Journal of Development Economics, Elsevier, vol. 65(1), pages 31-54, June.
• Evans, R.G. & Morgan, S.G. & Barer, M.L., 2001. "Buying Science, Selling Drugs," Centre for Health Services and Policy Research 2001:4r, University of British Columbia - Centre for Health Services and Policy Research..
• Ostry, A., 2001. "The World Trade Organization and Publicly Funded Healthcare in Canada," Centre for Health Services and Policy Research 2001:9r, University of British Columbia - Centre for Health Services and Policy Research..
• Rey, P., 2001. "Research Incentives in Competing Markets: A Model of the Development of New Vaccines," Papers 0102, Centro de Estudios Monetarios Y Financieros-.
• Campart, S. & Pfister, E., 2001. "Innovation et marche financiers: l'impact des avancees therapeutiques sur les rentabilites boursieres des firmes," Papiers d'Economie Mathématique et Applications 2001.28, Université Panthéon-Sorbonne (Paris 1).
• Marie-Claude BÉLIS-BERGOUIGNAN (IFREDE-E3i) & Vincent FRIGANT (IFREDE-E3i) & Damien TALBOT (LEREPS), 2001. "Global/local articulation in industrial models for phamaceuticals, automobile and aeronautics (In French)," Working Papers 2001-6, Equipe Industries Innovation Institutions, Université Bordeaux IV, France.
• Nicola Lacetera, 2001. "Corporate Governance and the Governance of Innovation: The Case of Pharmaceutical Industry," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), vol. 5(1), pages 29-59, March.
• Frank Lichtenberg, 2000. "The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey," CESifo Working Paper Series 404, CESifo.
  • Frank R. Lichtenberg, 2001. "The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey," NBER Working Papers 8147, National Bureau of Economic Research, Inc.
• Alan T. Sorensen, 2001. "An Empirical Model of Heterogeneous Consumer Search for Retail Prescription Drugs," NBER Working Papers 8548, National Bureau of Economic Research, Inc.
• Riccaboni, Massimo & Pammolli, Fabio, 2002. "On firm growth in networks," Research Policy, Elsevier, vol. 31(8-9), pages 1405-1416, December.
  • Riccaboni, Massimo & Pammolli, Fabio, 2001. "On Firm Growth in Networks," MPRA Paper 15964, University Library of Munich, Germany, revised 12 Nov 2001.
• Schweickert, Rainer, 2001. "Restricciones Macroeconómicas al Desarrollo Económico y la Reducción de la Pobreza: El Caso de Bolivia," Documentos de trabajo 8/2001, Instituto de Investigaciones Socio-Económicas (IISEC), Universidad Católica Boliviana.
• Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2002. "A Comparison of U.S. and European University-Industry Relations in the Life Sciences," Management Science, INFORMS, vol. 48(1), pages 24-43, January.
  • Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2001. "A Comparison of U.S. And European University-Industry Relations in the Life Sciences," LEM Papers Series 2001/03, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  • Owen-Smith, Jason & Riccaboni, Massimo & Pammolli, Fabio & Powell, Walter W., 2002. "A Comparison of U.S. and European University-Industry Relations in the Life Sciences," MPRA Paper 15963, University Library of Munich, Germany.
• Dan Marsh, 2001. "Modern Biotechnology in New Zealand: Further Analysis of Data from the Biotechnology Survey 1998/99," Working Papers in Economics 01/03, University of Waikato.
• Leon Taylor, 2001. "Do court-ordered breakups spur innovation?," Law and Economics 0105001, University Library of Munich, Germany.

2000

• Jaime de Melo & Marcelo Olarreaga & Wendy Takacs, 2015. "Pricing Policy Under Double Market Power: Madagascar and the International Vanilla Market," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 8, pages 199-218, World Scientific Publishing Co. Pte. Ltd..
  • Jaime de Melo & Marcelo Olarreaga & Wendy Takacs, 2000. "Pricing Policy Under Double Market Power: Madagascar and the International Vanilla Market," Review of Development Economics, Wiley Blackwell, vol. 4(1), pages 1-20, February.
  • de Melo, Jaime & Olarreaga, Marcelo & Takacs, Wendy E, 1996. "Pricing Policy Under Double Market Power: Madagascar and the International Vanilla Market," CEPR Discussion Papers 1447, C.E.P.R. Discussion Papers.
  • Jaime MELO DE & OLARREAGA & TAKACS, 1996. "Pricing policy under Double Market Power: Madagascar and the International Vanilla Market," Working Papers 199617, CERDI.
• Jean-Marie Grether & Jaime de Melo & Tobias Müller, 2015. "The Political Economy of International Migration in a Ricardo–Viner Model," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 17, pages 411-437, World Scientific Publishing Co. Pte. Ltd..
  • Jaime MELO DE & Jean Marie GRETHER & Jean Claude MULLER, 2000. "The Political Economy of International Migration in a Ricardo-Viner Model," Working Papers 200021, CERDI.
  • de Melo, Jaime & Müller, Tobias & Grether, Jean-Marie, 2001. "The Political Economy of International Migration in a Ricardo-Viner Model," CEPR Discussion Papers 2714, C.E.P.R. Discussion Papers.
• Nicola Lacetera, 2000. "Corporate Governance and the Governance of Innovation: the Case of Pharmaceutical Industry," KITeS Working Papers 122, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, revised Dec 2000.
• Franco Malerba & Luigi Orsenigo, 2000. "Towards a History Friendly Model of Innovation, Market Structure and Regulation in the Dynamics of the Pharmaceutical Industry: the Age of Random Screening," KITeS Working Papers 124, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, revised Jan 2001.
• Abdelillah Hamdouch & Marc-Hubert Depret, 2000. "Coalitions industrielles, réseaux de firmes et dynamiques de concurrence-coopération dans les secteurs en cours de globalisation : le cas de l'industrie pharmaceutique," Cahiers de la Maison des Sciences Economiques r00024, Université Panthéon-Sorbonne (Paris 1).
  • Hamdouch, A. & Depret, M.-H., 2000. "Coalitions industrielles, reseaux de firmes et dynamiques de concurrence-cooperation dans les secteurs en cours de globalisation : le cas de l'industrie pharmaceutique," Papiers d'Economie Mathématique et Applications 2000.24, Université Panthéon-Sorbonne (Paris 1).
• Perrochon, D. & Lebert, D., 2000. "L'utilisation des notions de confiance et de proximite dans l'etude des processus de R&D pharmaceutiques," Papiers d'Economie Mathématique et Applications 2000.56, Université Panthéon-Sorbonne (Paris 1).
• Fairise, X. & Feve, P., 2000. "Heternenous Labor Demand and Aggregate Job Flows. Specification, Estimation and Testing with French Data," Papiers d'Economie Mathématique et Applications 2000.59, Université Panthéon-Sorbonne (Paris 1).
• Jochen Streb, 1999. "How to Win Schumpeterian Competition: Technological Transfers in the German Plastics Industry from the 1930s to the 1970s," Working Papers 811, Economic Growth Center, Yale University.
  • Streb, J., 2000. "How to win Schumpeterian Competition. Technological Transfers in the German Plastics Industry from the 1930s to the 1970s," Papers 811, Yale - Economic Growth Center.
• Rudholm, Niklas, 2000. "Entry and the Number of firms in the Swedish Pharmaceuticals Market," Umeå Economic Studies 541, Umeå University, Department of Economics.
• Hamdouch, A. & Depret, M.-H., 2000. "Coalitions industrielles, reseaux de firmes et dynamiques de concurrence-cooperation dans les secteurs en cours de globalisation : le cas de l'industrie pharmaceutique," Papiers d'Economie Mathématique et Applications 2000.24, Université Panthéon-Sorbonne (Paris 1).
  • Abdelillah Hamdouch & Marc-Hubert Depret, 2000. "Coalitions industrielles, réseaux de firmes et dynamiques de concurrence-coopération dans les secteurs en cours de globalisation : le cas de l'industrie pharmaceutique," Cahiers de la Maison des Sciences Economiques r00024, Université Panthéon-Sorbonne (Paris 1).
• Dominique Perrochon & Didier Lebert, 2000. "L'utilisation des notions de confiance et de proximité dans l'étude des processus de R&D pharmaceutiques," Cahiers de la Maison des Sciences Economiques r00056, Université Panthéon-Sorbonne (Paris 1).
• Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay, 2003. "Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs," Journal of Industrial Economics, Wiley Blackwell, vol. 51(2), pages 243-270, June.
  • Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay, 2000. "Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs," NBER Working Papers 7772, National Bureau of Economic Research, Inc.
• Gambardella, Alfonso & Orsenigo, Luigi & Pammolli, Fabio, 2000. "Global Competitiveness in Pharmaceuticals: A European Perspective," MPRA Paper 15965, University Library of Munich, Germany.
• Arora, Ashish & Gambardella, Alfonso & Pammolli, Fabio & Riccaboni, Massimo, 2000. "The Nature and the Extent of the Market for Technology in Biopharmaceuticals," MPRA Paper 15977, University Library of Munich, Germany.
• Henry Grabowski & John Vernon, 2000. "The determinants of pharmaceutical research and development expenditures," Journal of Evolutionary Economics, Springer, vol. 10(1), pages 201-215.
• Erik Biørn & Kjersti-Gro Lindquist & Terje Skjerpen, 2002. "Heterogeneity in Returns to Scale: A Random Coefficient Analysis with Unbalanced Panel Data," Journal of Productivity Analysis, Springer, vol. 18(1), pages 39-57, July.
  • Erik Biørn & Kjersti-Gro Lindquist & Terje Skjerpen, 2000. "Heterogeneity in Returns to Scale: A Random Coefficient Analysis with Unbalanced Panel Data," Discussion Papers 292, Statistics Norway, Research Department.
• Dan Marsh, 2000. "Fostering Innovation in a Small Open Economy: The Case of the New Zealand Biotechnology Sector," Working Papers in Economics 00/01, University of Waikato.

1999

• Luis Alberto Zuleta Jaramillo & Mónica Lylián Parra Torrado, 1999. "Incidencia del régimen de patentes de la industria farmacéutica sobre la economía colombiana," Informes de Investigación 2831, Fedesarrollo.
• Jochen Streb, 1999. "How to Win Schumpeterian Competition: Technological Transfers in the German Plastics Industry from the 1930s to the 1970s," Working Papers 811, Economic Growth Center, Yale University.
  • Streb, J., 2000. "How to win Schumpeterian Competition. Technological Transfers in the German Plastics Industry from the 1930s to the 1970s," Papers 811, Yale - Economic Growth Center.
• Berndt, Ernst R. & Pindyck, Robert S. & Azoulay, Pierre, 1970-, 1998. "Network effects and diffusion in pharmaceutical markets : antiulcer drugs," Working papers WP 4059-98., Massachusetts Institute of Technology (MIT), Sloan School of Management.
  • Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay, 1999. "Network Effects and Diffusion in Pharmaceutical Markets: Antiulcer Drugs," NBER Working Papers 7024, National Bureau of Economic Research, Inc.
• Michael M. Hopkins, 1999. "An Examination of Technology Strategies for the Integration of Bioinformatics in Pharmaceutical R&D Processes," SPRU Working Paper Series 32, SPRU - Science Policy Research Unit, University of Sussex Business School.

1998

• Aronsson, Thomas & Bergman, Mats A. & Rudholm, Niklas, 1998. "The Impact of Generic Competition on Brand Name Market Shares: Evidence from Micro Data," SSE/EFI Working Paper Series in Economics and Finance 274, Stockholm School of Economics.
• Aronsson, Thomas & Bergman, Mats & Rudholm, Niklas, 1998. "The Impact of Generic Competition on Brand Name Market Shares - Evidence from Micro Data," Umeå Economic Studies 462, Umeå University, Department of Economics.
• Berndt, Ernst R. & Pindyck, Robert S. & Azoulay, Pierre, 1970-, 1998. "Network effects and diffusion in pharmaceutical markets : antiulcer drugs," Working papers WP 4059-98., Massachusetts Institute of Technology (MIT), Sloan School of Management.
  • Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay, 1999. "Network Effects and Diffusion in Pharmaceutical Markets: Antiulcer Drugs," NBER Working Papers 7024, National Bureau of Economic Research, Inc.
• Lanjouw, J.O., 1997. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Papers 775, Yale - Economic Growth Center.
  • Jean O. Lanjouw, 1998. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," NBER Working Papers 6366, National Bureau of Economic Research, Inc.
  • Lanjouw, Jean O., 1997. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Center Discussion Papers 28385, Yale University, Economic Growth Center.
  • Jean O Lanjouw, 2003. "The Introduction of Pharmaceutical Product Patents in India: Heartless Exploitation of the Poor and Suffering?," Levine's Working Paper Archive 618897000000000598, David K. Levine.
• Havas, Attila, 1998. "International Co-operative Agreements in Hungary in the mid-1990s: Evolution, organisational forms and industry characteristics," MPRA Paper 68375, University Library of Munich, Germany.
• Maureen McKelvey, 1998. "Evolutionary innovations: learning, entrepreneurship and the dynamics of the firm," Journal of Evolutionary Economics, Springer, vol. 8(2), pages 157-175.
• Erik Biørn & Kjersti-Gro Lindquist, 1998. "Random Coefficients and Unbalanced Panels: An Application on Data from Norwegian Chemical Plants," Discussion Papers 235, Statistics Norway, Research Department.
• John Cantwell & Pllar Barrera, 1998. "The Localisation Of Corporate Technological Trajectories In The Interwar Cartels: Cooperative Learning Versus An Exchange Of Knowledge," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 6(2-3), pages 257-290.
• Matthew Shum, 1998. "Characterizing Informational Barriers To Entry In The Anti-Ulcer Drug Market," Working Papers mshum-98-03, University of Toronto, Department of Economics.
• Rika Onishi Mortimer, 1998. "Demand for Prescription Drugs: The Effects of Managed Care Pharmacy Benefits," HEW 9802002, University Library of Munich, Germany.

1997

• Lanjouw, J.O., 1997. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Papers 775, Yale - Economic Growth Center.
  • Lanjouw, Jean O., 1997. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Center Discussion Papers 28385, Yale University, Economic Growth Center.
  • Jean O. Lanjouw, 1998. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," NBER Working Papers 6366, National Bureau of Economic Research, Inc.
  • Jean O Lanjouw, 2003. "The Introduction of Pharmaceutical Product Patents in India: Heartless Exploitation of the Poor and Suffering?," Levine's Working Paper Archive 618897000000000598, David K. Levine.
• Jonathan Haskel & Pasquale Scaramozzino, 1997. "Do Other Firms Matter in Oligopolies?," Journal of Industrial Economics, Wiley Blackwell, vol. 45(1), pages 27-45, March.
  • J.E. Haskel & P. Scaramozzino, 1994. "Do Other Firms Matter in Oligopolies?," Working Papers 328, Queen Mary University of London, School of Economics and Finance.
  • Haskel, Jonathan & Scaramozzino, Pasquale, 1995. "Do Other Firms Matter in Oligopolies?," CEPR Discussion Papers 1194, C.E.P.R. Discussion Papers.
• Froissart, S., 1997. "Malaisie: Secteur de l'equipement medical de haute technologie," Papers g97-01, Ecole des Hautes Etudes Commerciales de Montreal-.
• Froissart, S., 1997. "Thailande: Secteur de l'equipement medical," Papers g97-02, Ecole des Hautes Etudes Commerciales de Montreal-.
• Froissart, S., 1997. "Belgique: Secteur de l'equipement medical haute technologie," Papers g97-03, Ecole des Hautes Etudes Commerciales de Montreal-.
• Froissart, S., 1997. "Chili:Secteur de l'equipement medical," Papers g97-04, Ecole des Hautes Etudes Commerciales de Montreal-.
• Theriault, V., 1997. "Israel: Secteur de l'equipement medical," Papers g97-20, Ecole des Hautes Etudes Commerciales de Montreal-.
• Randle, K., 1997. "Merger, Retionalisation and the "High Commitment" Organisation," Papers 1997:3, University of Hertfordshire - Business Schoool.
• Mattiuzzo, N. & Le Goff, J., 1997. "Les prestataires logistiques et la distribution pharmaceutique. Les barrieres a l'entree: vitres blindees ou glaces sans tain," Papers 97-08, Institut de Recherche en Gestion. Universite de Paris XII-.
• Lambert, J. & Srivastava, J. & Vietmeyer, N., 1997. "Medicinal Plants, Rescuing Global Heritage," Papers 355, World Bank - Technical Papers.
• Felker, G. & Chaudhuri, S. & Gyorgy, K. & Goldman, M., 1997. "The Pharmaceutical Industry in India and Hungary. Policies, Institutions, and Technological Development," Papers 392, World Bank - Technical Papers.
• Lanjouw, Jean O., 1997. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Center Discussion Papers 28385, Yale University, Economic Growth Center.
  • Lanjouw, J.O., 1997. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Papers 775, Yale - Economic Growth Center.
  • Jean O. Lanjouw, 1998. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," NBER Working Papers 6366, National Bureau of Economic Research, Inc.
  • Jean O Lanjouw, 2003. "The Introduction of Pharmaceutical Product Patents in India: Heartless Exploitation of the Poor and Suffering?," Levine's Working Paper Archive 618897000000000598, David K. Levine.
• Tapon, F. & Thong, M., 1997. "Outsourcing of Research by Pharmaceutical and Biotechnology Firms," Working Papers 1997-2, University of Guelph, Department of Economics and Finance.
• Bartsch, Elga, 1997. "Economic consequences of the German environmental liability act: Capital market response for the chemical industry," Kiel Working Papers 822, Kiel Institute for the World Economy.
• Steven White & Xielin Liu, 1997. "Alternative Transition Trajectories for Complementary Asset Markets in China's Pharmaceutical Industry," Discussion Paper Series 83, Research Institute for Economics & Business Administration, Kobe University.
• Steven White, 1997. "Organizational Dynamics and Strcuture in the Chinese Pharmaceutical Industry: A Technological System Perspective," Discussion Paper Series 85, Research Institute for Economics & Business Administration, Kobe University.
• Steven White & Hideki Yoshihara & Xielin Liu, 1997. "Foreign Direct Investment, Technological Capabilities and Performance in the Chinese Pharmaceutical Industry," Discussion Paper Series 86, Research Institute for Economics & Business Administration, Kobe University.
• Fiona Scott Morton, 1997. "The Objectives of the FDA's Office of Generic Drugs," NBER Working Papers 6143, National Bureau of Economic Research, Inc.
• Fiona M. Scott Morton, 1997. "Entry Decisions in the Generic Pharmaceutical Industry," NBER Working Papers 6190, National Bureau of Economic Research, Inc.
• Sara Ellison Fisher & Iain Cockburn & Zvi Griliches & Jerry Hausman, 1997. "Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins," RAND Journal of Economics, The RAND Corporation, vol. 28(3), pages 426-446, Autumn.
  • Ellison, S & Cockburn, I & Griliches, A & Hausman, J, 1996. "Characteristics of Demand for Pharmaceutical Products : an Examination of four Cephalosporins," Working papers 96-24, Massachusetts Institute of Technology (MIT), Department of Economics.
• H. E. Frech, 1997. "Introduction," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 4(3), pages 237-238.
• F. M. Scherer, 1997. "How US Antitrust Can Go Astray: The Brand Name Prescription Drug Litigation," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 4(3), pages 239-256.
• Roy Weinstein & John Culbertson, 1997. "How US Antitrust Can Be On Target: The Brand-Name Prescription Drug Litigation," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 4(3), pages 257-264.
• Peter Zweifel, 1997. "Comment on: F.M. Scherer, "How US Antitrust Can Go Astray: The Brand Name Prescription Drug Litigation"," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 4(3), pages 277-278.
• W. Duncan Reekie, 1997. "Cartels, Spontaneous Price Discrimination and International Pharmacy Retailing," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 4(3), pages 279-285.
• Kenneth Elzinga & David Mills, 1997. "The Distribution and Pricing of Prescription Drugs," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 4(3), pages 287-300.
• Patricia Danzon, 1997. "Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 4(3), pages 301-322.
• Elli Malki, 1997. "Intellectual property and the valuation of biotechnology," Finance 9709002, University Library of Munich, Germany.
• Elli Malki, 1997. "The economic sense of royalty rates," Finance 9709003, University Library of Munich, Germany.
• Elli Malki, 1997. "Royalty rates, sub licensing considerations and joint ventures," Finance 9709004, University Library of Munich, Germany.
• Fiona M. Scott Morton, 1997. "The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules," Yale School of Management Working Papers ysm58, Yale School of Management.
• Bartsch, Elga, 1997. "Economic consequences of the German environmental liability act: Capital market response for the chemical industry," Kiel Working Papers 822, Kiel Institute for the World Economy (IfW Kiel).

1996

• Jaime de Melo & Marcelo Olarreaga & Wendy Takacs, 2015. "Pricing Policy Under Double Market Power: Madagascar and the International Vanilla Market," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 8, pages 199-218, World Scientific Publishing Co. Pte. Ltd..
  • Jaime de Melo & Marcelo Olarreaga & Wendy Takacs, 2000. "Pricing Policy Under Double Market Power: Madagascar and the International Vanilla Market," Review of Development Economics, Wiley Blackwell, vol. 4(1), pages 1-20, February.
  • de Melo, Jaime & Olarreaga, Marcelo & Takacs, Wendy E, 1996. "Pricing Policy Under Double Market Power: Madagascar and the International Vanilla Market," CEPR Discussion Papers 1447, C.E.P.R. Discussion Papers.
  • Jaime MELO DE & OLARREAGA & TAKACS, 1996. "Pricing policy under Double Market Power: Madagascar and the International Vanilla Market," Working Papers 199617, CERDI.
• Randle, K., 1996. "Rewarding Failure: Performance Related Pay in a Pharmaceutical research and Development Company," Papers 1996:1, University of Hertfordshire - Business Schoool.
• Sara Ellison Fisher & Iain Cockburn & Zvi Griliches & Jerry Hausman, 1997. "Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins," RAND Journal of Economics, The RAND Corporation, vol. 28(3), pages 426-446, Autumn.
  • Ellison, S & Cockburn, I & Griliches, A & Hausman, J, 1996. "Characteristics of Demand for Pharmaceutical Products : an Examination of four Cephalosporins," Working papers 96-24, Massachusetts Institute of Technology (MIT), Department of Economics.
• Ernst R. Berndt & Linda T. Bui & David H. Lucking-Reiley & Glen L. Urban, 1996. "The Roles of Marketing, Product Quality, and Price Competition in the Growth and Composition of the U.S. Antiulcer Drug Industry," NBER Chapters, in: The Economics of New Goods, pages 277-328, National Bureau of Economic Research, Inc.
  • Ernst R. Berndt & Linda Bui & David Reiley & Glen Urban, 1994. "The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry," NBER Working Papers 4904, National Bureau of Economic Research, Inc.
• Rohini Acharya & Thomas Ziesemer, 1996. "A Closed Economy Model of Horizontal and Vertical Product Differentiation: The Case of Innovation in Biotechnology," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 4(3), pages 245-264.

1995

• Lancia, G., 1995. "Genotyping by Combinatorial Optimization Techniques," GSIA Working Papers 1995-30, Carnegie Mellon University, Tepper School of Business.
• Jonathan Haskel & Pasquale Scaramozzino, 1997. "Do Other Firms Matter in Oligopolies?," Journal of Industrial Economics, Wiley Blackwell, vol. 45(1), pages 27-45, March.
  • J.E. Haskel & P. Scaramozzino, 1994. "Do Other Firms Matter in Oligopolies?," Working Papers 328, Queen Mary University of London, School of Economics and Finance.
  • Haskel, Jonathan & Scaramozzino, Pasquale, 1995. "Do Other Firms Matter in Oligopolies?," CEPR Discussion Papers 1194, C.E.P.R. Discussion Papers.
• Joseph Dimasi & Henry Grabowski & John Vernon, 1995. "R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 2(2), pages 201-219.
  • Joseph A. Dimasi & Grabowski, Henry G. & Vernon, John, 1995. "R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry," Working Papers 95-16, Duke University, Department of Economics.
• Paulo Guilherme Correa, 1995. "Regional integration, triangular trade and policy recommendations: the case of the Brazilian fine chemical industry," Brazilian Journal of Political Economy, Center of Political Economy, vol. 15(4), pages 517-535.
• Shigetomi, Shinichi, 1995. "The transmission of information in the transacting of primary products: the case of quality improvement in Thailand's natural rubber production," The Developing Economies, Institute of Developing Economies, Japan External Trade Organization(JETRO), vol. 33(2), pages 203-221, June.
• Joseph Dimasi & Henry Grabowski & John Vernon, 1995. "R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 2(2), pages 201-219.
  • Joseph A. Dimasi & Grabowski, Henry G. & Vernon, John, 1995. "R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry," Working Papers 95-16, Duke University, Department of Economics.

1994

• Griliches, Zvi & Cockburn, Iain, 1994. "Generics and New Goods in Pharmaceutical Price Indexes," American Economic Review, American Economic Association, vol. 84(5), pages 1213-1232, December.
  • Griliches, Z. & Cockborn, I., 1993. "Generics and New Goods in Pharmaceutical Price Indexes," Harvard Institute of Economic Research Working Papers 1664, Harvard - Institute of Economic Research.
  • Zvi Griliches & Iain Cockburn, 1993. "Generics and New Goods in Pharmaceutical Price Indexes," NBER Working Papers 4272, National Bureau of Economic Research, Inc.
• Ernst R. Berndt & Linda T. Bui & David H. Lucking-Reiley & Glen L. Urban, 1996. "The Roles of Marketing, Product Quality, and Price Competition in the Growth and Composition of the U.S. Antiulcer Drug Industry," NBER Chapters, in: The Economics of New Goods, pages 277-328, National Bureau of Economic Research, Inc.
  • Ernst R. Berndt & Linda Bui & David Reiley & Glen Urban, 1994. "The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry," NBER Working Papers 4904, National Bureau of Economic Research, Inc.
• Jonathan Haskel & Pasquale Scaramozzino, 1997. "Do Other Firms Matter in Oligopolies?," Journal of Industrial Economics, Wiley Blackwell, vol. 45(1), pages 27-45, March.
  • J.E. Haskel & P. Scaramozzino, 1994. "Do Other Firms Matter in Oligopolies?," Working Papers 328, Queen Mary University of London, School of Economics and Finance.
  • Haskel, Jonathan & Scaramozzino, Pasquale, 1995. "Do Other Firms Matter in Oligopolies?," CEPR Discussion Papers 1194, C.E.P.R. Discussion Papers.
• Gavin C Reid, 1994. "Fast Growing Small Entrepreneurial Firms and their Venture Capital Backers: an Applied Principal-Agent Analysis," CRIEFF Discussion Papers 9421, Centre for Research into Industry, Enterprise, Finance and the Firm.

1993

• F. M. Scherer, 1993. "Pricing, Profits, and Technological Progress in the Pharmaceutical Industry," Journal of Economic Perspectives, American Economic Association, vol. 7(3), pages 97-115, Summer.
• Jaime de Melo & L Alan Winters, 2015. "Do exporters gain from VERs?," World Scientific Book Chapters, in: Non-Tariff Barriers, Regionalism and Poverty Essays in Applied International Trade Analysis, chapter 3, pages 49-67, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Winters, L. Alan, 1993. "Do exporters gain from VERs?," European Economic Review, Elsevier, vol. 37(7), pages 1331-1349, October.
  • Jaime de Melo & L. Alan Winters, 2015. "Do Exporters Gain from VERs?," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 11, pages 257-275, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Winters, L. Alan, 1990. "Do Exporters Gain From VERs?," CEPR Discussion Papers 383, C.E.P.R. Discussion Papers.
• Griliches, Zvi & Cockburn, Iain, 1994. "Generics and New Goods in Pharmaceutical Price Indexes," American Economic Review, American Economic Association, vol. 84(5), pages 1213-1232, December.
  • Zvi Griliches & Iain Cockburn, 1993. "Generics and New Goods in Pharmaceutical Price Indexes," NBER Working Papers 4272, National Bureau of Economic Research, Inc.
  • Griliches, Z. & Cockborn, I., 1993. "Generics and New Goods in Pharmaceutical Price Indexes," Harvard Institute of Economic Research Working Papers 1664, Harvard - Institute of Economic Research.
• Jaime de Melo & L. Alan Winters, 2015. "Do Exporters Gain from VERs?," World Scientific Book Chapters,in: Developing Countries in the World Economy, chapter 11, pages 257-275 World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Winters, L. Alan, 1993. "Do exporters gain from VERs?," European Economic Review, Elsevier, vol. 37(7), pages 1331-1349, October.
  • de Melo, Jaime & Winters, L. Alan, 1990. "Do Exporters Gain From VERs?," CEPR Discussion Papers 383, C.E.P.R. Discussion Papers.
  • Melo, J. de & Winters, L.A., 1993. "Do Exporters Gain from VERs?," Research Papers by the Institute of Economics and Econometrics, Geneva School of Economics and Management, University of Geneva 93.18, Institut d'Economie et Econométrie, Université de Genève.
• Griliches, Zvi & Cockburn, Iain, 1994. "Generics and New Goods in Pharmaceutical Price Indexes," American Economic Review, American Economic Association, vol. 84(5), pages 1213-1232, December.
  • Griliches, Z. & Cockborn, I., 1993. "Generics and New Goods in Pharmaceutical Price Indexes," Harvard Institute of Economic Research Working Papers 1664, Harvard - Institute of Economic Research.
  • Zvi Griliches & Iain Cockburn, 1993. "Generics and New Goods in Pharmaceutical Price Indexes," NBER Working Papers 4272, National Bureau of Economic Research, Inc.
• Rebecca Henderson & Iain Cockburn, 1993. "Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry," NBER Working Papers 4466, National Bureau of Economic Research, Inc.
• Jaime De Melo & Arvind Panagariya & Dani Rodrik, 2015. "The New Regionalism: A Country Perspective," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 14, pages 323-357, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Panagariya, Arvind & Rodrik, Dani, 1992. "The New Regionalism: A Country Perspective," CEPR Discussion Papers 715, C.E.P.R. Discussion Papers.
  • de Melo, Jaime & Panagariya, Arvind & Rodrik, Dani, 1993. "The new regionalism : a country perspective," Policy Research Working Paper Series 1094, The World Bank.

1991

• Riccardo Faini & Jaime De Melo & Abdelhak Senhadji & Julie Stanton, 2015. "Growth-Oriented Adjustment Programs: A Statistical Analysis," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 5, pages 125-135, World Scientific Publishing Co. Pte. Ltd..
  • Faini, Riccardo & De Melo, Jaime & Senhadji, Abdelhak & Stanton, Julie, 1991. "Growth-oriented adjustment programs: A statistical analysis," World Development, Elsevier, vol. 19(8), pages 957-967, August.
  • Faini, Riccardo & de Melo, Jaime & Senhadji-Semlali,, 1990. "Growth oriented adjustment programs : a statistical analysis," Policy Research Working Paper Series 426, The World Bank.

1990

• Jaime de Melo & L Alan Winters, 2015. "Do exporters gain from VERs?," World Scientific Book Chapters, in: Non-Tariff Barriers, Regionalism and Poverty Essays in Applied International Trade Analysis, chapter 3, pages 49-67, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Winters, L. Alan, 1993. "Do exporters gain from VERs?," European Economic Review, Elsevier, vol. 37(7), pages 1331-1349, October.
  • Jaime de Melo & L. Alan Winters, 2015. "Do Exporters Gain from VERs?," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 11, pages 257-275, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Winters, L. Alan, 1990. "Do Exporters Gain From VERs?," CEPR Discussion Papers 383, C.E.P.R. Discussion Papers.
• Juan Blas Domínguez, 1990. "Aplicaciones de la biotecnología en la industria agroalimentaria," EKONOMIAZ. Revista vasca de Economía, Gobierno Vasco / Eusko Jaurlaritza / Basque Government, vol. 16(01), pages 156-171.
• Riccardo Faini & Jaime De Melo & Abdelhak Senhadji & Julie Stanton, 2015. "Growth-Oriented Adjustment Programs: A Statistical Analysis," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 5, pages 125-135, World Scientific Publishing Co. Pte. Ltd..
  • Faini, Riccardo & De Melo, Jaime & Senhadji, Abdelhak & Stanton, Julie, 1991. "Growth-oriented adjustment programs: A statistical analysis," World Development, Elsevier, vol. 19(8), pages 957-967, August.
  • Faini, Riccardo & de Melo, Jaime & Senhadji-Semlali,, 1990. "Growth oriented adjustment programs : a statistical analysis," Policy Research Working Paper Series 426, The World Bank.
• Riccardo Faini & Jaime de Melo, 2015. "Adjustment, Investment and the Real Exchange Rate in Developing Countries," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 6, pages 137-165, World Scientific Publishing Co. Pte. Ltd..
  • Faini, Riccardo & de Melo, Jaime, 1990. "Adjustment, investment, and the real exchange rate in developing countries," Policy Research Working Paper Series 473, The World Bank.

1987

• Shantayanan Devarajan & Jaime de Melo, 2015. "Adjustment with a Fixed Exchange Rate: Cameroon, Côte d'Ivoire, and Senegal," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 4, pages 83-123, World Scientific Publishing Co. Pte. Ltd..
  • Devarajan, Shantayanan & de Melo, Jaime, 1987. "Adjustment with a Fixed Exchange Rate: Cameroon, Cote d'Ivoire, and Senegal," The World Bank Economic Review, World Bank, vol. 1(3), pages 447-487, May.

1986

• Jaime de MELO & Shujiro URATA, 2015. "The Influence of Increased Foreign Competition on Industrial Concentration and Profitability," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 9, pages 219-236, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Urata, Shujiro, 1986. "The influence of increased foreign competition on industrial concentration and profitability," International Journal of Industrial Organization, Elsevier, vol. 4(3), pages 287-304, September.
• Jaime de Melo & James Tybout, 2015. "The Effects of Financial Liberalization on Savings and Investment in Uruguay," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 3, pages 55-81, World Scientific Publishing Co. Pte. Ltd..
  • de Melo, Jaime & Tybout, James, 1986. "The Effects of Financial Liberalization on Savings and Investment in Uruguay," Economic Development and Cultural Change, University of Chicago Press, vol. 34(3), pages 561-587, April.
• Vittorio Corbo & Jaime de Melo & James Tybout, 2015. "What Went Wrong with the Recent Reforms in the Southern Cone," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 2, pages 21-54, World Scientific Publishing Co. Pte. Ltd..
  • Corbo, Vittorio & de Melo, Jaime & Tybout, James, 1986. "What Went Wrong with the Recent Reforms in the Southern Cone," Economic Development and Cultural Change, University of Chicago Press, vol. 34(3), pages 607-640, April.

1970

• Doris Hanzl-Weiss, 1970. "Development and Prospects of the Chemicals, Chemical Products and Man-made Fibres Sector in the Central and Eastern European Countries," wiiw Industry Study 2001_3, The Vienna Institute for International Economic Studies, wiiw.

0

• Pammolli, Fabio & Fu, Dongfeng & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene, 2006. "A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence," MPRA Paper 15983, University Library of Munich, Germany.
  • Fabio Pammolli & Dongfeng Fu & S. V. Buldyrev & Massimo Riccaboni & Kaushik Matia & Kazuko Yamasaki & H. E. Stanley, 2006. "A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence," Papers physics/0609011, arXiv.org.
• Carlos Gustavo Cano, 2009. "La ‘dominancia’ alimentaria de la política monetaria, biotecnología y política de tierras," Borradores de Economia 568, Banco de la Republica de Colombia.
• Misas A., Martha & López-Enciso, Enrique Antonio & Parra Álvarez, Juan Carlos, 2011. "La formación de precios en las empresas colombianas : evidencia a partir de una encuesta directa," Chapters, in: López Enciso, Enrique & Ramírez Giraldo, María Teresa (ed.), Formación de precios y salarios en Colombia T.1, volume 1, chapter 9, pages 297-375, Banco de la Republica de Colombia.
  • Martha Misas Arango & Enrique López Enciso & Juan Carlos Parra, 2009. "La formación de precios en las empresas colombianas: evidencia a partir de una encuesta directa," Borradores de Economia 5735, Banco de la Republica.
  • Martha Misas A. & Enrique López E. & Juan Carlos Parra A., 2009. "La formación de precios en las empresas colombianas: evidencia a partir de una encuesta directa," Borradores de Economia 569, Banco de la Republica de Colombia.
• Paul Belleflamme & Tanguy van Ypersele, 2006. "Comment favoriser l'innovation dans le secteur pharmaceutique : brevets et/ou récompenses ?," Reflets et perspectives de la vie économique, De Boeck Université, vol. 0(4), pages 23-35.
  • BELLEFLAMME, Paul & van YPERSELE, Tanguy, 2006. "Comment favoriser l’innovation dans le secteur pharmaceutique: brevets et/ou récompenses ?," LIDAM Reprints CORE 1920, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
• Artjoms IVLEVS & Jaime DE MELO, 2015. "FDI, the Brain Drain and Trade: Channels and Evidence," World Scientific Book Chapters, in: Developing Countries in the World Economy, chapter 21, pages 533-551, World Scientific Publishing Co. Pte. Ltd..
  • Artjoms Ivlevs & Jaime De Melo, 2010. "FDI, the Brain Drain and Trade: Channels and Evidence," Annals of Economics and Statistics, GENES, issue 97-98, pages 103-121.
  • de Melo, Jaime & Ivlevs, Artjoms, 2008. "FDI, the Brain Drain and Trade: Channels and Evidence," CEPR Discussion Papers 7002, C.E.P.R. Discussion Papers.
  • Artjoms Ivlevs & Jaime de Melo, 2008. "FDI, the Brain Drain and Trade: Channels and Evidence," Discussion Papers 08/40, University of Nottingham, GEP.
  • Artjoms Ivlevs & Jaime de Melo, 2008. "FDI, the Brain Drain and Trade: Channels and Evidence," Development Working Papers 261, Centro Studi Luca d'Agliano, University of Milano.
• Jaya Prakash Pradhan, "undated". "Global competitiveness of Indian Pharmaceutical Industry: Trends and Strategies," Working Papers 0605, Institute for Studies in Industrial Development (ISID).
  • Pradhan, Jaya Prakash, 2006. "Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies," MPRA Paper 12340, University Library of Munich, Germany.
• Jaya Prakash Pradhan & Abhinav Alakshendra, "undated". "Overseas Acquisition Versus Greenfield Foreign Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises?," Working Papers 0607, Institute for Studies in Industrial Development (ISID).
  • Pradhan, Jaya Prakash & Alakshendra, Abhinav, 2006. "Overseas Acquisition versus Greenfield Foreign Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises?," MPRA Paper 12339, University Library of Munich, Germany.
• Brekke, Kurt R. & Kuhn, Michael, 2006. "Direct to consumer advertising in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 25(1), pages 102-130, January.
  • Kurt R Brekke & Michael Kuhn, "undated". "Direct-to-Consumer Advertising in Pharmaceutical Markets," Discussion Papers 03/11, Department of Economics, University of York.
  • Brekke, Kurt R. & Kuhn, Michael, 2003. "Direct-to-Consumer Advertising in Pharmaceutical Markets," Working Papers in Economics 05/03, University of Bergen, Department of Economics.
  • Kurt R. Brekke & Michael Kuhn, 2005. "Direct to Consumer Advertising in Pharmaceutical Markets," CESifo Working Paper Series 1493, CESifo.

• Kyle Margaret, 2011. "Strategic Responses to Parallel Trade," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 11(2), pages 1-34, January.
  • Margaret K. Kyle, 2007. "Strategic Responses to Parallel Trade," NBER Working Papers 12968, National Bureau of Economic Research, Inc.
• Linnosmaa Ismo Erkki, 2008. "Advertising, Free-Riding, and Price Differences in the Market for Prescription Drugs," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 8(2), pages 1-37, July.
• Simona Carmen Litescu & Sandra A.V. Eremia & Mirela Diaconu & Andreia Tache & Gabriel-Lucian Radu, 2011. "Biosensors Applications on Assessment of Reactive Oxygen Species and Antioxidants," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Ahmed Arafat & Muhammad A Daous, 2011. "Silicon and Silicon-Related Surfaces for Biosensor Applications," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Man Singh, 2011. "New Materials for Biosensor Construction," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Gab-Joo Chee, 2011. "Biosensor for the Determination of Biochemical Oxygen Demand in Rivers," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Katrine Kiilerich-Hansen & Claus R. Poulsen & Johannes Dapra & Nikolaj O. Christiansen & Noemi Rozlosnik, 2011. "Polymer Based Biosensors for Pathogen Diagnostics," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Liliana Serna & Jeyson Perenguez-Verdugo, 2011. "Biosensors Applications in Agri-food Industry," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Seyda Korkut Ozoner & Elif Erhan & Faruk Yilmaz, 2011. "Enzyme based phenol biosensors," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Monika Hoskovcova & Zbynek Kobliha, 2011. "Modified Cholinesterase Technology in the Construction of Biosensors for Organophosphorus Nerve Agents and Pesticides Detection," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Mitsuhiro Shimojo & Kei Amada & Hidekazu Koya & mitsuyasu kawakami, 2011. "Flow Injection Biosensor System for 2,4-Dichlorophenoxyacetate Based on a Microbial Reactor and Tyrosinase-modified Electrode," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Angela Winstead & Richard Williams, 2011. "Application of Microwave Assisted Organic Synthesis to the Development of Near-IR Cyanine Dye Probes," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Robert Valentin Sandulescu & Cecilia Cristea & Veronica Harceaga & Ede Bodoki, 2011. "Electrochemical sensors and biosensors for the pharmaceutical and environmental analysis," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Daniel Shelton & Shuhong Li & Peixuan Zhu & Daniel Adams & Platte Amstutz & Lynda Kiefer & Cha-Mei Tang, 2011. "Ultra-sensitive fluorescence detection using integrated waveguide technology," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Jadwiga Soloducho & Joanna Cabaj, 2011. "Hybrid Film Biosensor for Phenolic Compounds Detection," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Florence Lagarde & Nicole jaffrezic-Renault, 2011. "New Trends in Biosensors for Water Monitoring," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Andrea Medeiros Salgado & Livia Maria da Costa Silva & Ariana Farias Melo, 2011. "Biosensor for Environmental Applications," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.
• Maria DeRosa, 2011. "Advances in Aptamer-Based Biosensors for Food Safety," Chapters, in: Vernon Somerset (ed.), Environmental Biosensors, IntechOpen.